data_2k1a_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2k1a _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 967' ' ' TRP . . . . . 0.427 ' O ' ' CG2' ' A' ' 971' ' ' VAL . 98.4 m95 . . . . . 0 N--CA 1.448 -0.547 0 N-CA-C 110.658 -0.127 . . . . 0.72999999999999998 110.658 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 64.4 m95 -65.33 -32.73 74.53 Favored 'General case' 0 CA--C 1.518 -0.272 0 C-N-CA 120.277 -0.569 . . . . 1.1299999999999999 110.144 178.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 95.5 t -67.79 -47.24 80.39 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.391 0 N-CA-C 108.248 -1.019 . . . . 1.28 108.248 178.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 2.0 tp -61.84 -42.35 98.93 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 114.088 -1.415 . . . . 2.4500000000000002 107.414 178.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 971' ' ' VAL . . . . . 0.427 ' CG2' ' O ' ' A' ' 967' ' ' TRP . 99.4 t -62.03 -46.06 97.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.872 0.368 . . . . 1.28 110.299 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -59.15 -42.32 97.07 Favored Glycine 0 C--N 1.338 0.644 0 N-CA-C 111.736 -0.546 . . . . 0.16 111.736 -179.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 63.6 t -67.31 -48.48 77.84 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.512 0 CA-C-N 114.94 -0.63 . . . . 1.53 109.48 -178.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 89.5 mt -61.99 -42.0 98.66 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 115.37 -0.832 . . . . 1.8200000000000001 109.15 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -67.88 -47.5 60.19 Favored Glycine 0 C--N 1.335 0.478 0 N-CA-C 110.342 -1.103 . . . . 0.16 110.342 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -60.59 -37.98 94.26 Favored Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 108.805 -1.718 . . . . 0.17000000000000001 108.805 178.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 46.0 tp -66.11 -44.4 84.39 Favored 'General case' 0 C--O 1.225 -0.197 0 N-CA-C 109.364 -0.606 . . . . 2.23 109.364 178.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 1.1 mt -61.52 -46.27 90.66 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.689 -0.486 . . . . 2.4300000000000002 109.689 178.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 57.2 mt -61.67 -43.62 98.51 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.186 -0.606 . . . . 1.5700000000000001 109.884 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 980' ' ' LEU . . . . . 0.459 ' O ' ' CG2' ' A' ' 984' ' ' VAL . 22.7 mt -63.69 -41.45 98.13 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 119.981 -0.688 . . . . 1.8899999999999999 109.971 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 7.2 m -63.15 -47.4 82.85 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.254 -0.885 . . . . 1.0700000000000001 110.928 -179.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 93.6 mt -64.38 -44.54 97.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.655 0.264 . . . . 1.3700000000000001 110.598 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 13.1 mt -63.31 -36.81 84.91 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.978 -0.749 . . . . 2.3199999999999998 108.978 179.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 984' ' ' VAL . . . . . 0.459 ' CG2' ' O ' ' A' ' 980' ' ' LEU . 23.0 t -69.14 -50.37 53.61 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 CA-C-N 115.321 -0.854 . . . . 1.1000000000000001 110.92 -178.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 94.9 mt -65.45 -40.22 92.98 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.39 -0.823 . . . . 1.1499999999999999 109.329 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 986' ' ' ALA . . . . . . . . . . . . . . . -64.54 -45.4 87.31 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 121.509 0.671 . . . . 1.03 110.273 -179.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 987' ' ' MET . . . . . 0.45 ' O ' ' N ' ' A' ' 992' ' ' PHE . 25.6 mtp -63.25 -28.63 70.16 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 122.174 0.988 . . . . 1.21 109.582 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 988' ' ' TRP . . . . . . . . . . . . . 7.8 t90 -77.64 -35.41 52.57 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.016 -1.447 . . . . 2.9100000000000001 108.014 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.5 -41.08 76.55 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.514 0.673 . . . . 1.3400000000000001 109.874 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 990' ' ' VAL . . . . . . . . . . . . . 2.4 m -79.42 -8.91 11.91 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 CA-C-N 115.124 -0.944 . . . . 1.04 109.72 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 991' ' ' GLY . . . . . . . . . . . . . . . 85.87 3.66 85.47 Favored Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 114.772 -1.104 . . . . 0.17000000000000001 112.19 179.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 992' ' ' PHE . . . . . 0.45 ' N ' ' O ' ' A' ' 987' ' ' MET . 0.3 OUTLIER -55.07 -37.92 67.38 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 120.133 1.966 . . . . 0.51000000000000001 113.762 -176.232 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 993' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 . . . . . 0 N--CA 1.479 0.987 0 CA-C-O 124.684 2.183 . . . . 2.3900000000000001 109.293 178.177 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 967' ' ' TRP . . . . . . . . . . . . . 98.7 m95 . . . . . 0 N--CA 1.463 0.213 0 N-CA-C 112.03 0.381 . . . . 1.0 112.03 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 31.3 m95 -69.3 -35.54 76.09 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 110.279 -0.267 . . . . 1.0 110.279 179.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 67.5 t -66.31 -45.01 90.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 109.097 -0.705 . . . . 1.0 109.097 178.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 92.4 mt -63.79 -41.81 97.85 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.997 -1.002 . . . . 1.0 109.961 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 971' ' ' VAL . . . . . . . . . . . . . 76.0 t -62.71 -45.27 99.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.965 0.412 . . . . 1.0 110.855 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.14 -41.78 98.27 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.665 -0.574 . . . . 1.0 111.665 -179.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 72.2 t -65.57 -46.78 88.63 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.541 0 CA-C-O 120.998 0.428 . . . . 1.0 110.574 -179.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 88.9 mt -62.24 -41.18 98.2 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.921 -0.77 . . . . 1.0 108.921 179.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -65.92 -46.18 83.41 Favored Glycine 0 C--N 1.329 0.163 0 N-CA-C 110.284 -1.126 . . . . 1.0 110.284 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -61.25 -37.93 94.82 Favored Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 109.141 -1.584 . . . . 1.0 109.141 179.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 55.4 tp -65.49 -42.53 92.07 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.196 -0.668 . . . . 1.0 109.196 178.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 42.9 tp -63.66 -45.47 90.0 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.304 -0.558 . . . . 1.0 110.694 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 90.9 mt -61.89 -42.8 99.5 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.017 -0.673 . . . . 1.0 109.908 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 980' ' ' LEU . . . . . . . . . . . . . 84.6 mt -63.99 -41.41 97.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.988 0.423 . . . . 1.0 110.437 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 7.7 m -62.65 -46.41 88.34 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.738 -0.664 . . . . 1.0 110.29 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 94.5 mt -63.65 -43.75 98.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 C-N-CA 120.781 -0.368 . . . . 1.0 110.838 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 33.0 mt -64.72 -41.04 96.26 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.867 -0.333 . . . . 1.0 111.236 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 984' ' ' VAL . . . . . . . . . . . . . 88.3 t -67.83 -49.07 72.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.25 0.548 . . . . 1.0 110.033 -179.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 81.6 mt -63.22 -43.32 98.45 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.433 -0.803 . . . . 1.0 109.698 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 986' ' ' ALA . . . . . . . . . . . . . . . -61.72 -43.48 98.78 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 108.918 -0.771 . . . . 1.0 108.918 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 27.3 mtp -62.29 -30.79 71.38 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 114.804 -1.089 . . . . 1.0 109.648 179.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 988' ' ' TRP . . . . . . . . . . . . . 1.8 t90 -75.3 -37.79 60.65 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.035 -1.438 . . . . 1.0 108.271 179.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.22 -39.11 78.76 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.766 0.793 . . . . 1.0 110.048 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 990' ' ' VAL . . . . . . . . . . . . . 1.4 m -83.39 -8.78 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-N 115.052 -0.976 . . . . 1.0 110.756 -178.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 991' ' ' GLY . . . . . 0.563 ' C ' ' H ' ' A' ' 993' ' ' PHE . . . 83.53 2.55 90.05 Favored Glycine 0 C--N 1.337 0.591 0 CA-C-O 119.222 -0.766 . . . . 1.0 112.594 178.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -52.64 -1.64 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 119.644 1.722 . . . . 1.0 112.386 -177.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 993' ' ' PHE . . . . . 0.563 ' H ' ' C ' ' A' ' 991' ' ' GLY . 12.2 m-85 . . . . . 0 C--N 1.332 -0.186 0 C-N-CA 120.426 -0.51 . . . . 1.0 110.975 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 967' ' ' TRP . . . . . . . . . . . . . 91.5 m95 . . . . . 0 CA--C 1.522 -0.126 0 CA-C-O 120.859 0.361 . . . . 1.0 110.704 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 87.0 m95 -68.37 -37.03 80.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.74 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 96.2 t -66.78 -42.78 89.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 109.046 -0.724 . . . . 1.0 109.046 178.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 87.4 mt -62.9 -41.77 99.56 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.209 -0.905 . . . . 1.0 109.796 178.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 971' ' ' VAL . . . . . . . . . . . . . 76.2 t -62.5 -45.57 98.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.819 0.342 . . . . 1.0 110.829 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -61.24 -40.96 99.31 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 111.837 -0.505 . . . . 1.0 111.837 -179.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 62.6 t -65.87 -46.22 89.18 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.376 0 CA-C-N 115.092 -0.554 . . . . 1.0 110.037 -179.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 86.7 mt -63.26 -41.4 99.03 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 121.327 0.584 . . . . 1.0 109.432 178.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -66.44 -46.8 74.79 Favored Glycine 0 C--N 1.332 0.341 0 N-CA-C 110.489 -1.044 . . . . 1.0 110.489 -179.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -60.18 -36.74 91.5 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 108.886 -1.686 . . . . 1.0 108.886 178.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 50.5 tp -66.41 -43.4 85.84 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.263 -0.575 . . . . 1.0 109.912 178.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 53.0 mt -61.94 -44.13 97.41 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 119.739 -0.784 . . . . 1.0 109.726 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 84.5 mt -62.5 -43.41 98.89 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 119.744 -0.782 . . . . 1.0 110.297 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 980' ' ' LEU . . . . . . . . . . . . . 66.6 mt -64.56 -42.19 95.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.075 0.464 . . . . 1.0 110.606 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 5.9 m -64.18 -47.1 81.12 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.558 -0.747 . . . . 1.0 110.109 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 94.3 mt -64.07 -44.49 97.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 120.74 -0.384 . . . . 1.0 111.433 -179.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 6.4 mp -64.55 -40.27 95.27 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.638 -0.425 . . . . 1.0 111.087 179.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 984' ' ' VAL . . . . . . . . . . . . . 54.1 t -68.5 -48.98 69.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.21 0.529 . . . . 1.0 109.843 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 85.3 mt -63.33 -43.27 98.24 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.574 -0.739 . . . . 1.0 109.451 178.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 986' ' ' ALA . . . . . . . . . . . . . . . -62.08 -42.7 99.48 Favored 'General case' 0 CA--C 1.511 -0.544 0 N-CA-C 108.997 -0.742 . . . . 1.0 108.997 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 30.9 mtp -62.1 -31.69 72.17 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 114.729 -1.123 . . . . 1.0 109.238 178.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 988' ' ' TRP . . . . . . . . . . . . . 1.8 t90 -73.23 -38.57 66.0 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 113.884 -1.507 . . . . 1.0 108.166 179.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.26 -39.6 78.34 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.434 -0.803 . . . . 1.0 110.39 -179.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 990' ' ' VAL . . . . . . . . . . . . . 1.4 m -83.58 -8.66 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 CA-C-N 115.003 -0.998 . . . . 1.0 110.204 -178.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 991' ' ' GLY . . . . . 0.543 ' C ' ' H ' ' A' ' 993' ' ' PHE . . . 81.43 5.07 90.25 Favored Glycine 0 C--N 1.339 0.713 0 CA-C-O 119.199 -0.779 . . . . 1.0 112.508 179.148 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -52.5 -1.24 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 119.74 1.77 . . . . 1.0 112.932 -177.031 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 993' ' ' PHE . . . . . 0.543 ' H ' ' C ' ' A' ' 991' ' ' GLY . 16.1 m-85 . . . . . 0 N--CA 1.465 0.315 0 C-N-CA 120.646 -0.422 . . . . 1.0 111.18 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 967' ' ' TRP . . . . . . . . . . . . . 98.9 m95 . . . . . 0 CA--C 1.514 -0.41 0 CA-C-O 120.572 0.225 . . . . 1.0 111.447 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 90.9 m95 -70.53 -36.42 73.71 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.474 -0.33 . . . . 1.0 110.367 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 95.2 t -66.81 -45.12 88.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 N-CA-C 108.389 -0.967 . . . . 1.0 108.389 178.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 58.9 tp -63.2 -42.51 99.32 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 114.564 -1.198 . . . . 1.0 109.199 178.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 971' ' ' VAL . . . . . . . . . . . . . 79.3 t -62.29 -45.08 99.6 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.087 0 N-CA-C 109.727 -0.472 . . . . 1.0 109.727 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.23 -43.25 98.66 Favored Glycine 0 CA--C 1.526 0.736 0 CA-C-N 116.151 -0.477 . . . . 1.0 112.127 -179.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 58.2 t -65.24 -46.72 89.9 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.416 0 CA-C-N 115.169 -0.515 . . . . 1.0 110.066 -179.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 88.8 mt -62.11 -41.98 98.76 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 109.038 -0.727 . . . . 1.0 109.038 178.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -65.98 -47.4 74.45 Favored Glycine 0 C--O 1.225 -0.418 0 N-CA-C 110.248 -1.141 . . . . 1.0 110.248 -179.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -59.13 -37.46 91.73 Favored Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 109.144 -1.582 . . . . 1.0 109.144 178.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 35.7 mt -65.49 -42.97 91.56 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 119.982 -0.687 . . . . 1.0 110.257 178.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 35.7 mt -61.98 -44.05 97.55 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.021 -0.671 . . . . 1.0 110.304 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 10.7 mp -63.82 -43.57 95.82 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 119.555 -0.858 . . . . 1.0 111.501 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 980' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -63.66 -39.58 94.68 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.731 -0.388 . . . . 1.0 110.966 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 6.7 m -64.64 -47.74 77.38 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.137 -0.483 . . . . 1.0 110.853 -179.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 92.9 mt -63.27 -44.48 99.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.385 -0.371 . . . . 1.0 111.265 -178.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -64.83 -40.83 95.82 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.333 -0.394 . . . . 1.0 111.564 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 984' ' ' VAL . . . . . . . . . . . . . 41.2 t -67.48 -48.48 77.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.425 0.631 . . . . 1.0 110.277 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 85.9 mt -64.45 -42.78 95.78 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.136 -0.938 . . . . 1.0 109.894 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 986' ' ' ALA . . . . . . . . . . . . . . . -62.92 -45.74 91.06 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.351 0.596 . . . . 1.0 109.825 -179.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 26.8 mtp -62.0 -32.56 73.05 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.966 -1.016 . . . . 1.0 109.522 179.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 988' ' ' TRP . . . . . 0.471 ' O ' ' CD1' ' A' ' 988' ' ' TRP . 11.4 t90 -74.47 -37.52 63.19 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.315 -1.311 . . . . 1.0 108.838 178.433 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.98 -40.58 78.72 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.797 0.808 . . . . 1.0 110.071 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 990' ' ' VAL . . . . . . . . . . . . . 1.4 m -81.43 -8.08 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-N 114.639 -1.164 . . . . 1.0 110.1 -179.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 991' ' ' GLY . . . . . 0.568 ' C ' ' H ' ' A' ' 993' ' ' PHE . . . 83.28 2.83 90.33 Favored Glycine 0 C--N 1.338 0.654 0 CA-C-O 119.116 -0.825 . . . . 1.0 112.479 178.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -52.98 -1.95 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 119.722 1.761 . . . . 1.0 112.132 -177.306 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 993' ' ' PHE . . . . . 0.568 ' H ' ' C ' ' A' ' 991' ' ' GLY . 11.0 m-85 . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 116.398 -0.364 . . . . 1.0 110.961 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 967' ' ' TRP . . . . . . . . . . . . . 97.6 m95 . . . . . 0 N--CA 1.455 -0.195 0 CA-C-O 120.857 0.36 . . . . 1.0 110.716 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -69.05 -35.49 76.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.166 -0.47 . . . . 1.0 109.98 178.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 77.6 t -67.33 -44.6 87.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.539 0.685 . . . . 1.0 109.284 178.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 57.3 tp -63.61 -43.16 97.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.702 -1.135 . . . . 1.0 109.468 179.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 971' ' ' VAL . . . . . . . . . . . . . 46.7 t -62.08 -45.01 99.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.998 0.428 . . . . 1.0 110.469 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.08 -39.42 95.74 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 111.348 -0.701 . . . . 1.0 111.348 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 74.5 t -66.61 -47.51 83.14 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.29 0 CA-C-N 114.999 -0.6 . . . . 1.0 110.585 -179.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 92.9 mt -62.91 -41.69 99.54 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.191 -0.67 . . . . 1.0 109.191 179.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -66.28 -46.71 76.88 Favored Glycine 0 C--N 1.329 0.175 0 N-CA-C 110.74 -0.944 . . . . 1.0 110.74 -179.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -60.29 -37.03 92.41 Favored Glycine 0 N--CA 1.448 -0.505 0 N-CA-C 109.181 -1.568 . . . . 1.0 109.181 179.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 38.2 mt -65.97 -42.54 89.74 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.119 -0.632 . . . . 1.0 110.158 179.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 76.7 mt -62.38 -44.46 96.41 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.149 -0.62 . . . . 1.0 110.496 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 96.7 mt -63.1 -43.61 98.0 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.248 -0.581 . . . . 1.0 110.676 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 980' ' ' LEU . . . . . . . . . . . . . 81.3 mt -64.35 -40.38 95.75 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.079 0.466 . . . . 1.0 110.417 -179.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 7.1 m -63.54 -45.79 88.94 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.525 -0.761 . . . . 1.0 109.748 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 89.7 mt -63.57 -44.18 98.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.318 -0.401 . . . . 1.0 111.366 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 85.1 mt -64.48 -42.63 95.77 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 121.125 -0.23 . . . . 1.0 111.347 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 984' ' ' VAL . . . . . . . . . . . . . 47.3 t -67.9 -47.96 77.12 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.374 0 CA-C-O 121.223 0.535 . . . . 1.0 109.968 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 89.3 mt -63.49 -42.75 98.53 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.458 -0.792 . . . . 1.0 109.348 179.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 986' ' ' ALA . . . . . . . . . . . . . . . -63.18 -45.64 90.84 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 121.513 0.673 . . . . 1.0 109.621 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 32.6 mtp -62.34 -33.44 74.71 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.614 -1.175 . . . . 1.0 109.188 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 988' ' ' TRP . . . . . 0.489 ' O ' ' CD1' ' A' ' 988' ' ' TRP . 12.9 t90 -73.2 -35.2 66.32 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.473 -1.239 . . . . 1.0 108.379 178.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.04 -40.14 75.32 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.589 -0.732 . . . . 1.0 109.795 -179.412 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 990' ' ' VAL . . . . . . . . . . . . . 1.2 m -81.91 -7.12 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 CA-C-N 114.989 -1.005 . . . . 1.0 110.063 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 991' ' ' GLY . . . . . 0.538 ' C ' ' H ' ' A' ' 993' ' ' PHE . . . 82.15 3.77 90.45 Favored Glycine 0 C--N 1.34 0.784 0 CA-C-O 119.011 -0.883 . . . . 1.0 112.666 178.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -54.13 -0.93 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 119.607 1.704 . . . . 1.0 112.839 -177.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 993' ' ' PHE . . . . . 0.538 ' H ' ' C ' ' A' ' 991' ' ' GLY . 13.1 m-85 . . . . . 0 N--CA 1.465 0.28 0 CA-C-O 121.051 0.453 . . . . 1.0 110.135 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 967' ' ' TRP . . . . . . . . . . . . . 99.5 m95 . . . . . 0 N--CA 1.457 -0.101 0 CA-C-O 120.867 0.365 . . . . 1.0 110.98 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 94.0 m95 -69.56 -34.47 74.23 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.361 -0.382 . . . . 1.0 110.247 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 73.9 t -65.83 -43.22 93.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 C-N-CA 119.889 -0.724 . . . . 1.0 109.175 177.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 93.2 mt -62.74 -42.35 99.63 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.145 -0.934 . . . . 1.0 109.923 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 971' ' ' VAL . . . . . . . . . . . . . 47.5 t -61.87 -46.23 96.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.864 0.364 . . . . 1.0 110.175 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -59.79 -43.55 97.81 Favored Glycine 0 CA--C 1.521 0.418 0 CA-C-N 116.095 -0.502 . . . . 1.0 112.016 -179.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 71.6 t -65.17 -46.45 90.94 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.555 0 CA-C-O 120.996 0.426 . . . . 1.0 110.703 -178.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 91.5 mt -63.12 -40.38 97.43 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 109.17 -0.678 . . . . 1.0 109.17 179.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -67.76 -45.35 76.01 Favored Glycine 0 CA--C 1.518 0.236 0 N-CA-C 110.415 -1.074 . . . . 1.0 110.415 -179.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -61.24 -37.54 94.17 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 109.622 -1.391 . . . . 1.0 109.622 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 57.9 tp -67.52 -41.68 84.01 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 119.698 -0.801 . . . . 1.0 109.874 179.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 65.9 mt -62.04 -43.77 98.13 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 119.86 -0.736 . . . . 1.0 110.298 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 82.3 mt -62.59 -44.03 97.32 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.323 -0.551 . . . . 1.0 110.825 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 980' ' ' LEU . . . . . . . . . . . . . 88.6 mt -63.96 -40.26 96.0 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.067 0.461 . . . . 1.0 110.168 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 6.8 m -64.09 -46.65 83.31 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.612 -0.722 . . . . 1.0 110.293 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 93.9 mt -64.07 -44.57 97.73 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 C-N-CA 120.827 -0.349 . . . . 1.0 111.118 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 59.7 tp -63.96 -40.88 97.43 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.624 -0.43 . . . . 1.0 110.21 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 984' ' ' VAL . . . . . . . . . . . . . 77.8 t -65.7 -47.69 85.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.311 0.577 . . . . 1.0 110.252 -179.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 64.7 mt -63.71 -41.38 98.11 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.37 -0.832 . . . . 1.0 109.533 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 986' ' ' ALA . . . . . . . . . . . . . . . -62.96 -47.13 84.5 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.107 0.48 . . . . 1.0 110.511 -179.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 13.3 mtm -64.09 -32.35 73.87 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 122.112 0.958 . . . . 1.0 109.622 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 988' ' ' TRP . . . . . 0.483 ' O ' ' CD1' ' A' ' 988' ' ' TRP . 9.4 t90 -69.27 -36.46 77.11 Favored 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 107.499 -1.297 . . . . 1.0 107.499 178.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.81 -39.56 76.47 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.117 -0.947 . . . . 1.0 110.321 -179.366 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 990' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -84.88 -9.89 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 CA-C-N 115.198 -0.91 . . . . 1.0 110.651 -178.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 991' ' ' GLY . . . . . 0.5 ' C ' ' H ' ' A' ' 993' ' ' PHE . . . 82.47 6.53 88.55 Favored Glycine 0 C--N 1.336 0.56 0 CA-C-O 118.744 -1.031 . . . . 1.0 112.876 179.171 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -57.45 0.26 0.05 Allowed 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 120.056 1.928 . . . . 1.0 112.997 -177.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 993' ' ' PHE . . . . . 0.5 ' H ' ' C ' ' A' ' 991' ' ' GLY . 10.3 m-85 . . . . . 0 C--N 1.326 -0.445 0 CA-C-O 121.379 0.609 . . . . 1.0 109.688 179.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 967' ' ' TRP . . . . . . . . . . . . . 81.7 m95 . . . . . 0 N--CA 1.454 -0.241 0 CA-C-O 120.763 0.316 . . . . 1.0 110.621 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 95.3 m95 -68.73 -36.72 78.77 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.3 178.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 56.1 t -66.02 -43.88 92.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.149 -0.685 . . . . 1.0 109.149 178.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 62.9 tp -62.72 -41.94 99.41 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.179 -0.919 . . . . 1.0 109.484 179.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 971' ' ' VAL . . . . . . . . . . . . . 41.6 t -63.47 -45.79 96.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.165 -0.47 . . . . 1.0 111.321 -179.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -62.51 -44.17 97.96 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-N 116.253 -0.43 . . . . 1.0 113.532 -178.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 35.0 m -68.29 -42.96 84.8 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 CA-C-O 120.787 0.327 . . . . 1.0 110.861 -178.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 97.9 mt -63.09 -40.17 96.86 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.444 -0.947 . . . . 1.0 108.444 178.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -66.13 -46.75 78.05 Favored Glycine 0 C--N 1.33 0.222 0 N-CA-C 110.447 -1.061 . . . . 1.0 110.447 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -59.33 -36.16 87.83 Favored Glycine 0 N--CA 1.448 -0.514 0 N-CA-C 108.804 -1.718 . . . . 1.0 108.804 178.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 58.9 tp -65.54 -43.64 89.32 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.17 -0.612 . . . . 1.0 109.719 178.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 45.7 tp -61.84 -45.45 93.77 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.653 -0.419 . . . . 1.0 110.436 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 10.8 mp -63.18 -43.16 99.0 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 119.935 -0.706 . . . . 1.0 110.719 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 980' ' ' LEU . . . . . . . . . . . . . 80.7 mt -63.94 -40.85 97.4 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 121.186 0.517 . . . . 1.0 110.149 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 8.2 m -62.75 -46.79 86.42 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.37 -0.832 . . . . 1.0 110.015 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 88.9 mt -63.84 -43.83 97.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 C-N-CA 120.633 -0.427 . . . . 1.0 111.203 -179.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 91.1 mt -65.2 -41.07 94.88 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.519 -0.309 . . . . 1.0 111.03 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 984' ' ' VAL . . . . . . . . . . . . . 72.0 t -70.02 -50.16 50.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.064 0.459 . . . . 1.0 110.449 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 89.8 mt -63.79 -42.92 97.63 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.783 -0.644 . . . . 1.0 109.622 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 986' ' ' ALA . . . . . . . . . . . . . . . -62.53 -43.28 99.2 Favored 'General case' 0 CA--C 1.511 -0.531 0 N-CA-C 108.926 -0.768 . . . . 1.0 108.926 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 31.5 mtp -61.95 -30.53 70.97 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 122.512 1.148 . . . . 1.0 109.073 178.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 988' ' ' TRP . . . . . . . . . . . . . 1.6 t90 -74.02 -36.98 64.48 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 113.64 -1.618 . . . . 1.0 107.874 179.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.71 -39.05 73.64 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.595 0.712 . . . . 1.0 110.248 -179.359 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 990' ' ' VAL . . . . . . . . . . . . . 1.1 m -81.76 -7.28 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-N 114.967 -1.015 . . . . 1.0 110.09 -179.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 991' ' ' GLY . . . . . 0.54 ' C ' ' H ' ' A' ' 993' ' ' PHE . . . 81.85 3.73 90.51 Favored Glycine 0 C--N 1.34 0.79 0 CA-C-O 119.136 -0.813 . . . . 1.0 112.414 178.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -52.63 -1.56 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 119.45 1.625 . . . . 1.0 112.932 -177.016 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 993' ' ' PHE . . . . . 0.54 ' H ' ' C ' ' A' ' 991' ' ' GLY . 15.4 m-85 . . . . . 0 C--N 1.327 -0.389 0 CA-C-O 121.287 0.565 . . . . 1.0 110.433 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 967' ' ' TRP . . . . . . . . . . . . . 98.7 m95 . . . . . 0 CA--C 1.52 -0.174 0 CA-C-O 120.677 0.275 . . . . 1.0 110.877 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -69.25 -34.88 75.47 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 110.029 -0.36 . . . . 1.0 110.029 179.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 75.3 t -68.52 -47.02 79.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.203 0.525 . . . . 1.0 110.489 178.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 8.8 mp -64.01 -41.68 97.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.509 -0.768 . . . . 1.0 110.18 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 971' ' ' VAL . . . . . . . . . . . . . 59.1 t -62.3 -44.53 99.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.879 0.371 . . . . 1.0 110.541 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -61.43 -40.49 98.74 Favored Glycine 0 CA--C 1.529 0.915 0 CA-C-N 116.064 -0.516 . . . . 1.0 112.006 -179.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 75.9 t -67.0 -45.26 87.46 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.519 0 CA-C-N 115.445 -0.378 . . . . 1.0 110.735 -178.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 9.2 mp -62.5 -40.23 96.06 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.597 -0.89 . . . . 1.0 108.597 178.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -65.07 -45.8 90.78 Favored Glycine 0 N--CA 1.46 0.247 0 N-CA-C 110.29 -1.124 . . . . 1.0 110.29 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -59.69 -36.73 90.74 Favored Glycine 0 N--CA 1.444 -0.767 0 N-CA-C 108.771 -1.731 . . . . 1.0 108.771 178.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 55.7 tp -66.86 -44.11 81.83 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.187 -0.605 . . . . 1.0 110.514 179.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 83.2 mt -62.54 -44.94 95.09 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.091 -0.643 . . . . 1.0 110.757 -179.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 10.2 mp -63.51 -44.11 95.22 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 119.675 -0.81 . . . . 1.0 111.924 -179.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 980' ' ' LEU . . . . . . . . . . . . . 7.1 mp -63.83 -37.65 88.15 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.156 -0.618 . . . . 1.0 110.79 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 5.4 m -65.5 -46.61 79.04 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.521 -179.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 80.1 mt -63.11 -43.41 98.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 120.495 -0.482 . . . . 1.0 110.732 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 57.1 mt -63.66 -41.78 98.17 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 121.153 -0.219 . . . . 1.0 110.722 179.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 984' ' ' VAL . . . . . . . . . . . . . 56.6 t -68.38 -47.99 75.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 120.928 0.394 . . . . 1.0 110.052 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 84.3 mt -62.63 -42.41 99.58 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.937 -0.574 . . . . 1.0 109.524 179.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 986' ' ' ALA . . . . . . . . . . . . . . . -63.26 -44.32 95.48 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 121.696 0.76 . . . . 1.0 108.981 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 30.7 mtp -62.11 -32.44 73.01 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 114.566 -1.197 . . . . 1.0 109.159 178.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 988' ' ' TRP . . . . . . . . . . . . . 2.0 t90 -72.32 -38.25 68.73 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.292 -1.322 . . . . 1.0 108.104 178.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.58 -39.62 84.85 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.335 -0.848 . . . . 1.0 110.306 -179.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 990' ' ' VAL . . . . . . . . . . . . . 1.2 m -83.88 -8.94 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-N 115.286 -0.87 . . . . 1.0 110.956 -178.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 991' ' ' GLY . . . . . 0.584 ' C ' ' H ' ' A' ' 993' ' ' PHE . . . 82.58 4.24 90.19 Favored Glycine 0 C--N 1.338 0.671 0 CA-C-O 119.245 -0.753 . . . . 1.0 112.703 178.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -53.02 -2.91 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 119.259 1.529 . . . . 1.0 111.867 -177.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 993' ' ' PHE . . . . . 0.584 ' H ' ' C ' ' A' ' 991' ' ' GLY . 11.7 m-85 . . . . . 0 C--N 1.329 -0.292 0 CA-C-O 121.037 0.446 . . . . 1.0 109.916 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 967' ' ' TRP . . . . . . . . . . . . . 98.3 m95 . . . . . 0 N--CA 1.463 0.181 0 CA-C-O 120.637 0.256 . . . . 1.0 111.498 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -70.24 -36.84 74.78 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.605 -0.27 . . . . 1.0 110.475 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 73.8 t -66.66 -44.35 89.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 108.937 -0.764 . . . . 1.0 108.937 178.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 60.9 tp -62.96 -43.2 99.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.817 -1.083 . . . . 1.0 109.499 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 971' ' ' VAL . . . . . . . . . . . . . 56.2 t -61.93 -46.19 97.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.391 -0.368 . . . . 1.0 111.102 -179.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.15 -40.6 97.43 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 111.612 -0.595 . . . . 1.0 111.612 -179.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 64.8 t -66.8 -48.37 80.05 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.483 0 CA-C-O 121.028 0.442 . . . . 1.0 111.068 -178.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -62.74 -41.2 99.08 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 109.297 -0.631 . . . . 1.0 109.297 179.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -65.16 -43.52 95.37 Favored Glycine 0 C--O 1.229 -0.172 0 N-CA-C 109.456 -1.457 . . . . 1.0 109.456 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -62.01 -37.24 94.09 Favored Glycine 0 CA--C 1.521 0.462 0 N-CA-C 109.759 -1.336 . . . . 1.0 109.759 179.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 60.7 tp -67.81 -44.53 77.06 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 109.856 -0.424 . . . . 1.0 109.856 179.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -62.16 -43.81 98.0 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.329 -0.548 . . . . 1.0 110.28 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 86.3 mt -62.88 -43.67 98.18 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.07 -0.652 . . . . 1.0 110.62 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 980' ' ' LEU . . . . . . . . . . . . . 64.4 mt -63.99 -40.62 96.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.123 0.487 . . . . 1.0 110.269 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 7.5 m -63.4 -45.78 89.46 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.439 -0.801 . . . . 1.0 109.725 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 85.6 mt -63.97 -44.71 97.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.266 -0.425 . . . . 1.0 111.118 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 56.9 tp -64.89 -43.55 92.54 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.171 -0.468 . . . . 1.0 111.397 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 984' ' ' VAL . . . . . . . . . . . . . 51.9 t -66.71 -47.97 81.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.438 0.637 . . . . 1.0 110.134 -179.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 81.6 mt -63.22 -42.9 99.32 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.07 -0.968 . . . . 1.0 109.605 178.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 986' ' ' ALA . . . . . . . . . . . . . . . -61.98 -44.92 95.74 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-O 121.348 0.594 . . . . 1.0 109.487 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 19.6 mtp -62.17 -30.29 70.96 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 122.349 1.071 . . . . 1.0 109.563 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 988' ' ' TRP . . . . . . . . . . . . . 1.7 t90 -74.75 -38.09 62.33 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.018 -1.446 . . . . 1.0 108.396 178.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.88 -39.94 79.53 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.467 -0.788 . . . . 1.0 109.741 -179.068 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 990' ' ' VAL . . . . . . . . . . . . . 1.4 m -82.14 -7.9 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 CA-C-N 114.829 -1.078 . . . . 1.0 110.408 -179.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 991' ' ' GLY . . . . . 0.574 ' C ' ' H ' ' A' ' 993' ' ' PHE . . . 82.4 3.41 90.55 Favored Glycine 0 C--N 1.336 0.567 0 CA-C-O 119.366 -0.685 . . . . 1.0 112.385 178.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -52.67 -1.37 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 119.624 1.712 . . . . 1.0 112.418 -177.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 993' ' ' PHE . . . . . 0.574 ' H ' ' C ' ' A' ' 991' ' ' GLY . 14.0 m-85 . . . . . 0 C--O 1.233 0.207 0 C-N-CA 120.713 -0.395 . . . . 1.0 111.497 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 967' ' ' TRP . . . . . . . . . . . . . 97.7 m95 . . . . . 0 N--CA 1.454 -0.236 0 CA-C-O 120.614 0.245 . . . . 1.0 111.101 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 23.9 m95 -69.3 -34.66 75.03 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.569 -0.287 . . . . 1.0 110.557 178.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 93.8 t -66.97 -44.61 88.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 108.715 -0.846 . . . . 1.0 108.715 178.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 80.1 mt -63.16 -41.43 99.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.728 -1.124 . . . . 1.0 109.39 178.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 971' ' ' VAL . . . . . . . . . . . . . 66.8 t -61.88 -45.0 99.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 CA-C-O 120.989 0.423 . . . . 1.0 109.978 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -59.83 -41.05 97.49 Favored Glycine 0 CA--C 1.523 0.594 0 N-CA-C 111.301 -0.72 . . . . 1.0 111.301 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 54.1 t -65.63 -45.16 93.0 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.374 0 CA-C-N 115.333 -0.434 . . . . 1.0 109.882 -179.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 86.9 mt -62.25 -42.18 99.1 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.197 -0.668 . . . . 1.0 109.197 178.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -65.96 -45.74 85.95 Favored Glycine 0 N--CA 1.459 0.175 0 N-CA-C 110.26 -1.136 . . . . 1.0 110.26 -179.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -60.92 -37.98 94.66 Favored Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 109.142 -1.583 . . . . 1.0 109.142 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 56.2 tp -65.82 -44.46 85.55 Favored 'General case' 0 C--O 1.226 -0.172 0 N-CA-C 109.736 -0.468 . . . . 1.0 109.736 178.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 50.6 tp -62.42 -46.04 90.38 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.375 -0.53 . . . . 1.0 110.642 -179.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 87.8 mt -62.58 -44.5 96.15 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.281 -0.567 . . . . 1.0 110.952 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 980' ' ' LEU . . . . . . . . . . . . . 80.7 mt -63.58 -40.92 98.19 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.852 -0.425 . . . . 1.0 109.852 -179.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 6.8 m -63.96 -46.84 82.9 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.718 -0.674 . . . . 1.0 110.64 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 93.4 mt -63.59 -44.41 98.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 120.807 -0.357 . . . . 1.0 111.562 -178.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 93.9 mt -64.76 -40.18 94.86 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.727 -0.389 . . . . 1.0 110.976 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 984' ' ' VAL . . . . . . . . . . . . . 38.9 t -69.02 -48.05 72.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.257 0.551 . . . . 1.0 111.014 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 86.5 mt -62.96 -42.63 99.88 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.037 -0.727 . . . . 1.0 109.037 178.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 986' ' ' ALA . . . . . . . . . . . . . . . -63.52 -44.6 93.78 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.265 0.555 . . . . 1.0 110.11 -179.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 21.5 mtp -63.52 -31.12 72.19 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 122.527 1.156 . . . . 1.0 110.153 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 988' ' ' TRP . . . . . 0.439 ' O ' ' CD1' ' A' ' 988' ' ' TRP . 14.0 t90 -75.89 -35.03 59.98 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.163 -1.38 . . . . 1.0 108.313 179.128 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.5 -38.36 74.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.468 0.651 . . . . 1.0 109.807 -179.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 990' ' ' VAL . . . . . . . . . . . . . 1.6 m -78.96 0.2 3.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.19 -0.913 . . . . 1.0 109.394 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 991' ' ' GLY . . . . . . . . . . . . . . . 79.69 1.13 86.44 Favored Glycine 0 CA--C 1.506 -0.502 0 CA-C-O 119.478 -0.623 . . . . 1.0 112.252 177.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -48.38 -41.45 28.89 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-N 118.88 1.34 . . . . 1.0 111.256 -176.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 993' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 . . . . . 0 N--CA 1.463 0.198 0 CA-C-O 121.819 0.819 . . . . 1.0 111.009 179.937 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 967' ' ' TRP . . . . . . . . . . . . . 98.2 m95 . . . . . 0 C--O 1.229 0.023 0 CA-C-O 120.603 0.24 . . . . 1.0 111.181 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 99.7 m95 -70.29 -35.58 73.81 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.571 -0.286 . . . . 1.0 110.334 179.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 86.2 t -67.31 -45.63 85.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 N-CA-C 109.107 -0.701 . . . . 1.0 109.107 178.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 10.0 mp -63.29 -43.01 99.1 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.656 -0.702 . . . . 1.0 109.866 178.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 971' ' ' VAL . . . . . . . . . . . . . 77.8 t -62.37 -45.06 99.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.378 -0.374 . . . . 1.0 110.922 -179.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.45 -41.48 98.62 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 112.074 -0.41 . . . . 1.0 112.074 -179.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 84.5 t -66.61 -45.97 87.22 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.306 0 CA-C-N 115.195 -0.503 . . . . 1.0 110.392 -178.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 90.7 mt -62.41 -41.38 98.63 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 109.042 -0.725 . . . . 1.0 109.042 178.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -65.77 -46.0 85.54 Favored Glycine 0 C--N 1.331 0.299 0 N-CA-C 110.26 -1.136 . . . . 1.0 110.26 -179.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -60.77 -37.48 93.68 Favored Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 109.195 -1.562 . . . . 1.0 109.195 179.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 56.0 tp -66.97 -43.28 83.44 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.49 -0.484 . . . . 1.0 109.936 178.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 39.9 mt -61.94 -44.94 95.73 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.359 -0.382 . . . . 1.0 110.223 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 94.8 mt -62.86 -42.96 99.95 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 119.669 -0.812 . . . . 1.0 110.315 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 980' ' ' LEU . . . . . . . . . . . . . 81.1 mt -64.17 -41.57 97.08 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.964 0.411 . . . . 1.0 111.093 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 7.5 m -62.81 -47.63 82.61 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.693 -0.685 . . . . 1.0 110.188 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 84.7 mt -63.61 -44.28 98.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 116.111 -0.495 . . . . 1.0 111.117 -179.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 15.1 tp -64.19 -43.14 95.99 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.498 -0.319 . . . . 1.0 110.955 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 984' ' ' VAL . . . . . . . . . . . . . 54.1 t -68.57 -48.7 70.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.171 0.51 . . . . 1.0 110.974 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 83.5 mt -62.15 -42.61 99.43 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.805 -0.813 . . . . 1.0 108.805 179.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 986' ' ' ALA . . . . . . . . . . . . . . . -61.69 -44.01 97.76 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 109.062 -0.718 . . . . 1.0 109.062 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 27.4 mtp -61.59 -30.87 70.95 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.761 -1.108 . . . . 1.0 108.964 178.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 988' ' ' TRP . . . . . . . . . . . . . 1.7 t90 -73.46 -38.64 65.4 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 113.928 -1.487 . . . . 1.0 108.455 179.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.2 -37.79 78.29 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.594 -0.73 . . . . 1.0 110.378 -179.204 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 990' ' ' VAL . . . . . . . . . . . . . 1.3 m -85.16 -7.56 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 CA-C-N 115.116 -0.947 . . . . 1.0 110.668 -178.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 991' ' ' GLY . . . . . 0.532 ' C ' ' H ' ' A' ' 993' ' ' PHE . . . 80.02 6.51 89.11 Favored Glycine 0 C--N 1.339 0.719 0 CA-C-O 119.264 -0.742 . . . . 1.0 112.192 179.307 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -53.0 -1.58 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 119.32 1.56 . . . . 1.0 112.736 -176.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 993' ' ' PHE . . . . . 0.532 ' H ' ' C ' ' A' ' 991' ' ' GLY . 17.1 m-85 . . . . . 0 N--CA 1.465 0.298 0 CA-C-O 121.401 0.62 . . . . 1.0 110.704 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 967' ' ' TRP . . . . . . . . . . . . . 89.7 m95 . . . . . 0 N--CA 1.463 0.195 0 CA-C-O 120.589 0.233 . . . . 1.0 111.559 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 88.8 m95 -71.04 -35.18 71.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.724 -0.216 . . . . 1.0 110.837 179.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 76.0 t -67.14 -44.88 87.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 108.808 -0.812 . . . . 1.0 108.808 178.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 59.4 tp -64.07 -43.02 96.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.039 -0.982 . . . . 1.0 110.199 179.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 971' ' ' VAL . . . . . . . . . . . . . 51.0 t -62.99 -45.14 99.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.959 0.409 . . . . 1.0 111.294 -179.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.29 -41.03 98.2 Favored Glycine 0 CA--C 1.528 0.882 0 CA-C-N 116.025 -0.534 . . . . 1.0 111.853 -179.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 74.8 t -66.95 -47.5 82.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.115 0.483 . . . . 1.0 111.092 -178.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -62.87 -40.88 98.85 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.88 -0.6 . . . . 1.0 109.499 178.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -65.97 -45.27 88.86 Favored Glycine 0 CA--C 1.513 -0.051 0 N-CA-C 109.869 -1.292 . . . . 1.0 109.869 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -61.26 -37.39 93.94 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 109.233 -1.547 . . . . 1.0 109.233 178.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 53.5 tp -64.87 -42.48 94.8 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 109.433 -0.581 . . . . 1.0 109.433 178.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 60.3 tp -62.28 -44.82 95.64 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.894 -0.409 . . . . 1.0 109.894 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 92.3 mt -62.59 -45.09 94.51 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.462 -0.495 . . . . 1.0 111.355 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 980' ' ' LEU . . . . . . . . . . . . . 9.2 mp -63.05 -39.28 94.28 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.322 -0.551 . . . . 1.0 110.217 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 7.8 m -62.5 -47.3 84.58 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.839 -0.619 . . . . 1.0 110.846 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 96.4 mt -64.21 -44.6 97.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.39 -0.368 . . . . 1.0 111.863 -178.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 7.5 mp -65.08 -40.09 94.13 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 120.663 -0.415 . . . . 1.0 110.943 179.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 984' ' ' VAL . . . . . . . . . . . . . 55.7 t -68.47 -48.85 70.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.288 -0.414 . . . . 1.0 110.367 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 86.3 mt -64.4 -41.77 96.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.959 -0.564 . . . . 1.0 109.53 178.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 986' ' ' ALA . . . . . . . . . . . . . . . -62.96 -43.87 97.6 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-O 121.689 0.757 . . . . 1.0 109.032 -179.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 32.7 mtp -62.57 -31.13 71.89 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 114.415 -1.266 . . . . 1.0 109.174 178.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 988' ' ' TRP . . . . . . . . . . . . . 1.6 t90 -74.22 -37.82 63.73 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 113.957 -1.474 . . . . 1.0 108.037 179.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.24 -39.43 78.49 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.944 0.878 . . . . 1.0 110.303 -179.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 990' ' ' VAL . . . . . . . . . . . . . 1.4 m -82.57 -7.94 11.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 114.92 -1.036 . . . . 1.0 110.57 -178.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 991' ' ' GLY . . . . . 0.59 ' C ' ' H ' ' A' ' 993' ' ' PHE . . . 82.68 2.94 90.69 Favored Glycine 0 C--N 1.339 0.698 0 CA-C-O 119.145 -0.808 . . . . 1.0 112.439 178.758 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -52.63 -1.37 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 119.723 1.762 . . . . 1.0 112.112 -177.505 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 993' ' ' PHE . . . . . 0.59 ' H ' ' C ' ' A' ' 991' ' ' GLY . 10.4 m-85 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.567 -0.288 . . . . 1.0 111.44 -179.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 967' ' ' TRP . . . . . . . . . . . . . 88.5 m95 . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.484 0.183 . . . . 1.0 111.358 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 96.1 m95 -68.43 -34.91 76.83 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 110.117 -0.327 . . . . 1.0 110.117 179.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 57.1 t -67.14 -43.96 88.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 CA-C-O 121.649 0.737 . . . . 1.0 109.06 178.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 98.2 mt -63.34 -42.55 98.94 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 114.749 -1.114 . . . . 1.0 109.675 179.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 971' ' ' VAL . . . . . . . . . . . . . 71.0 t -62.27 -45.31 99.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.064 0.459 . . . . 1.0 110.507 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.49 -41.34 98.63 Favored Glycine 0 C--N 1.332 0.306 0 N-CA-C 111.271 -0.732 . . . . 1.0 111.271 -179.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 84.4 t -65.57 -47.56 85.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 114.971 -0.615 . . . . 1.0 110.678 -179.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 78.3 mt -61.36 -40.43 94.27 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.697 -0.853 . . . . 1.0 108.697 178.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -64.54 -46.04 91.35 Favored Glycine 0 N--CA 1.461 0.305 0 N-CA-C 110.843 -0.903 . . . . 1.0 110.843 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -60.86 -36.93 92.86 Favored Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 109.474 -1.45 . . . . 1.0 109.474 179.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 82.2 mt -67.3 -43.21 82.29 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 120.4 -0.52 . . . . 1.0 110.619 179.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 55.7 tp -61.94 -44.89 95.82 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.673 -0.411 . . . . 1.0 110.178 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 97.2 mt -63.77 -42.92 97.7 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 120.187 -0.605 . . . . 1.0 110.91 -179.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 980' ' ' LEU . . . . . . . . . . . . . 76.2 mt -64.03 -39.52 94.27 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.918 0.39 . . . . 1.0 110.362 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 7.1 m -64.12 -46.67 83.16 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.877 -0.601 . . . . 1.0 109.764 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 90.9 mt -62.65 -44.46 99.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.052 -0.522 . . . . 1.0 111.145 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 97.6 mt -64.72 -40.69 95.77 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.728 -0.389 . . . . 1.0 111.143 179.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 984' ' ' VAL . . . . . . . . . . . . . 46.7 t -67.99 -48.09 76.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.04 0.448 . . . . 1.0 110.323 179.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 85.2 mt -64.17 -43.83 93.91 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.733 -0.667 . . . . 1.0 109.564 179.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 986' ' ' ALA . . . . . . . . . . . . . . . -62.09 -44.94 95.57 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-O 121.361 0.601 . . . . 1.0 109.397 -179.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 30.9 mtp -61.99 -34.19 75.72 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 114.885 -1.052 . . . . 1.0 109.537 179.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 988' ' ' TRP . . . . . 0.463 ' O ' ' CD1' ' A' ' 988' ' ' TRP . 13.0 t90 -73.25 -36.02 66.32 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 114.137 -1.392 . . . . 1.0 108.527 179.33 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.22 -41.38 77.13 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 115.402 -0.817 . . . . 1.0 109.912 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 990' ' ' VAL . . . . . . . . . . . . . 1.2 m -82.42 -8.7 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 CA-C-N 114.811 -1.086 . . . . 1.0 110.062 -179.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 991' ' ' GLY . . . . . 0.553 ' C ' ' H ' ' A' ' 993' ' ' PHE . . . 82.2 5.14 89.9 Favored Glycine 0 C--N 1.342 0.91 0 CA-C-O 119.15 -0.805 . . . . 1.0 112.692 179.022 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -51.93 -2.17 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 119.543 1.672 . . . . 1.0 112.851 -177.384 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 993' ' ' PHE . . . . . 0.553 ' H ' ' C ' ' A' ' 991' ' ' GLY . 13.6 m-85 . . . . . 0 C--N 1.327 -0.385 0 C-N-CA 120.992 -0.283 . . . . 1.0 110.399 179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 967' ' ' TRP . . . . . . . . . . . . . 97.1 m95 . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.821 0.343 . . . . 1.0 111.304 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 93.1 m95 -69.1 -35.69 76.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.462 . . . . 1.0 110.38 179.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 71.4 t -65.3 -43.87 94.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 108.396 -0.964 . . . . 1.0 108.396 177.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 89.9 mt -62.33 -42.86 99.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 114.513 -1.221 . . . . 1.0 109.688 179.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 971' ' ' VAL . . . . . . . . . . . . . 49.9 t -60.99 -44.87 99.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.865 0.364 . . . . 1.0 110.128 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.88 -39.01 96.3 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 111.538 -0.625 . . . . 1.0 111.538 -179.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 56.8 t -66.67 -47.47 83.09 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.382 0 CA-C-N 114.92 -0.64 . . . . 1.0 110.439 -179.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 7.9 mp -62.95 -41.1 99.4 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.663 -0.866 . . . . 1.0 108.663 179.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -66.08 -45.58 86.27 Favored Glycine 0 CA--C 1.518 0.258 0 N-CA-C 110.308 -1.117 . . . . 1.0 110.308 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -60.19 -38.72 94.91 Favored Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 108.903 -1.679 . . . . 1.0 108.903 178.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 52.7 tp -66.66 -44.32 82.16 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.313 -0.555 . . . . 1.0 110.26 179.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 59.1 tp -62.29 -45.86 91.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.619 -0.264 . . . . 1.0 110.364 -179.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 93.5 mt -63.26 -43.53 97.73 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 119.976 -0.69 . . . . 1.0 110.765 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 980' ' ' LEU . . . . . . . . . . . . . 8.5 mp -63.99 -39.06 93.26 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.74 -0.384 . . . . 1.0 110.708 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 6.9 m -64.35 -45.98 85.45 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.963 -0.562 . . . . 1.0 110.188 -179.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 97.5 mt -63.45 -44.01 98.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 C-N-CA 120.938 -0.305 . . . . 1.0 111.539 -179.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 91.0 mt -65.07 -41.08 95.42 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 120.954 -0.298 . . . . 1.0 110.788 179.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 984' ' ' VAL . . . . . . . . . . . . . 54.4 t -66.39 -47.78 82.94 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.426 0 CA-C-O 121.472 0.653 . . . . 1.0 109.538 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 87.1 mt -63.4 -43.71 96.77 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.058 -0.974 . . . . 1.0 109.739 178.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 986' ' ' ALA . . . . . . . . . . . . . . . -61.49 -45.12 95.57 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-O 121.595 0.712 . . . . 1.0 109.406 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 29.5 mtp -61.62 -30.19 70.53 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.651 -1.158 . . . . 1.0 108.778 179.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 988' ' ' TRP . . . . . . . . . . . . . 1.7 t90 -74.29 -38.85 63.26 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 113.912 -1.495 . . . . 1.0 108.424 179.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.22 -38.55 82.02 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.357 -0.838 . . . . 1.0 110.223 -179.05 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 990' ' ' VAL . . . . . . . . . . . . . 1.4 m -84.55 -7.96 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 115.075 -0.966 . . . . 1.0 110.747 -178.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 991' ' ' GLY . . . . . 0.544 ' C ' ' H ' ' A' ' 993' ' ' PHE . . . 81.27 5.33 90.12 Favored Glycine 0 C--N 1.338 0.655 0 CA-C-O 119.17 -0.794 . . . . 1.0 112.453 179.056 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -53.4 -1.81 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 119.34 1.57 . . . . 1.0 112.532 -177.323 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 993' ' ' PHE . . . . . 0.544 ' H ' ' C ' ' A' ' 991' ' ' GLY . 10.2 m-85 . . . . . 0 C--N 1.326 -0.421 0 CA-C-O 121.584 0.707 . . . . 1.0 110.501 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 967' ' ' TRP . . . . . . . . . . . . . 94.2 m95 . . . . . 0 N--CA 1.453 -0.289 0 CA-C-O 120.564 0.221 . . . . 1.0 110.821 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 83.9 m95 -72.06 -36.27 69.54 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.695 -0.229 . . . . 1.0 111.113 179.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 62.1 t -67.03 -44.82 88.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 108.691 -0.855 . . . . 1.0 108.691 178.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 56.4 tp -63.3 -44.22 95.64 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.738 -1.119 . . . . 1.0 110.204 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 971' ' ' VAL . . . . . . . . . . . . . 54.4 t -61.85 -45.44 98.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 120.625 -0.43 . . . . 1.0 111.367 -178.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.23 -36.93 92.1 Favored Glycine 0 CA--C 1.529 0.959 0 CA-C-O 121.659 0.588 . . . . 1.0 111.679 -179.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 53.5 t -68.28 -49.08 70.05 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.492 0 CA-C-N 114.87 -0.665 . . . . 1.0 109.948 -179.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 69.4 mt -62.21 -42.23 99.1 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 115.493 -0.776 . . . . 1.0 109.008 179.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -65.96 -45.55 87.08 Favored Glycine 0 N--CA 1.46 0.259 0 N-CA-C 110.061 -1.216 . . . . 1.0 110.061 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -59.62 -38.7 94.11 Favored Glycine 0 C--O 1.226 -0.366 0 N-CA-C 108.642 -1.783 . . . . 1.0 108.642 178.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 49.1 tp -65.55 -42.93 91.33 Favored 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 120.717 -0.393 . . . . 1.0 110.188 179.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 76.3 mt -64.52 -44.32 91.24 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.457 -0.497 . . . . 1.0 111.054 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 80.6 mt -63.29 -44.28 95.49 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.325 -0.55 . . . . 1.0 110.732 -179.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 980' ' ' LEU . . . . . . . . . . . . . 83.8 mt -63.51 -39.47 94.52 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.08 0.467 . . . . 1.0 110.115 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 7.3 m -64.59 -46.2 83.7 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.474 -0.785 . . . . 1.0 110.225 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 3.2 mm -64.09 -43.62 97.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.296 -0.411 . . . . 1.0 111.854 -178.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 98.2 mt -66.71 -40.72 88.55 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.093 -0.503 . . . . 1.0 111.377 -179.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 984' ' ' VAL . . . . . . . . . . . . . 65.8 t -68.61 -46.65 79.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.438 0.637 . . . . 1.0 109.492 179.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 80.9 mt -63.08 -43.44 98.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.261 -0.881 . . . . 1.0 109.039 178.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 986' ' ' ALA . . . . . . . . . . . . . . . -62.01 -43.84 97.98 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.141 -0.688 . . . . 1.0 109.141 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 29.5 mtp -64.07 -32.58 74.19 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 114.955 -1.021 . . . . 1.0 110.367 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 988' ' ' TRP . . . . . 0.477 ' O ' ' CD1' ' A' ' 988' ' ' TRP . 12.7 t90 -73.48 -34.08 65.16 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.171 -1.377 . . . . 1.0 107.75 178.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.37 -39.37 71.27 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 114.866 -1.061 . . . . 1.0 110.478 -179.558 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 990' ' ' VAL . . . . . . . . . . . . . 1.4 m -85.26 -7.6 10.96 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 CA-C-N 115.128 -0.942 . . . . 1.0 110.339 -178.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 991' ' ' GLY . . . . . 0.529 ' C ' ' H ' ' A' ' 993' ' ' PHE . . . 81.54 5.09 90.19 Favored Glycine 0 C--N 1.331 0.304 0 CA-C-O 118.813 -0.993 . . . . 1.0 112.76 179.35 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -52.79 -1.87 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 120.07 1.935 . . . . 1.0 112.729 -178.036 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 993' ' ' PHE . . . . . 0.529 ' H ' ' C ' ' A' ' 991' ' ' GLY . 17.5 m-85 . . . . . 0 C--O 1.236 0.383 0 CA-C-O 121.03 0.443 . . . . 1.0 110.37 179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 967' ' ' TRP . . . . . . . . . . . . . 89.7 m95 . . . . . 0 C--O 1.226 -0.172 0 N-CA-C 113.293 0.849 . . . . 1.0 113.293 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 39.3 m95 -71.57 -39.61 70.49 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 112.957 0.725 . . . . 1.0 112.957 -178.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 17.3 m -66.86 -41.3 87.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 119.536 -0.866 . . . . 1.0 109.23 179.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 61.9 tp -64.35 -42.78 96.04 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.246 -0.888 . . . . 1.0 109.973 179.052 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 971' ' ' VAL . . . . . . . . . . . . . 70.2 t -62.79 -44.83 99.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 120.523 -0.471 . . . . 1.0 110.668 -179.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -59.34 -41.65 97.02 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.555 -0.618 . . . . 1.0 111.555 -179.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 77.0 t -64.63 -46.9 91.05 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.593 0 CA-C-O 121.038 0.447 . . . . 1.0 110.623 -179.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 98.7 mt -61.99 -40.67 96.44 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 108.595 -0.891 . . . . 1.0 108.595 179.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -67.13 -48.21 60.65 Favored Glycine 0 C--N 1.334 0.419 0 CA-C-N 115.1 -0.955 . . . . 1.0 110.943 -179.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -60.12 -36.41 90.47 Favored Glycine 0 N--CA 1.449 -0.446 0 N-CA-C 108.915 -1.674 . . . . 1.0 108.915 179.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 54.1 tp -66.97 -43.22 83.63 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.179 -0.608 . . . . 1.0 109.993 179.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 4.3 tt -61.64 -45.24 94.88 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.348 -0.541 . . . . 1.0 110.33 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 96.1 mt -62.17 -45.16 94.65 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.487 -0.485 . . . . 1.0 111.315 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 980' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -64.13 -39.97 95.16 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.083 0.468 . . . . 1.0 111.163 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 6.9 m -64.11 -46.71 83.01 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.487 -0.778 . . . . 1.0 110.121 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 4.0 mm -63.68 -43.82 98.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.499 -0.319 . . . . 1.0 111.477 -179.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 83.7 mt -63.67 -41.58 98.17 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.381 -0.372 . . . . 1.0 110.366 179.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 984' ' ' VAL . . . . . . . . . . . . . 40.0 t -66.7 -47.1 84.11 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.332 0 CA-C-O 121.345 0.593 . . . . 1.0 110.356 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 82.2 mt -64.43 -43.04 95.6 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.292 -0.867 . . . . 1.0 109.919 179.134 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 986' ' ' ALA . . . . . . . . . . . . . . . -63.85 -46.05 86.76 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 121.371 0.605 . . . . 1.0 109.726 -179.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 30.2 mtp -61.8 -33.75 74.68 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.817 -1.083 . . . . 1.0 109.286 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 988' ' ' TRP . . . . . 0.505 ' O ' ' CD1' ' A' ' 988' ' ' TRP . 12.8 t90 -72.1 -37.27 69.57 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.338 -1.301 . . . . 1.0 108.57 178.186 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.91 -40.3 79.19 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 121.717 0.77 . . . . 1.0 110.204 -179.501 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 990' ' ' VAL . . . . . . . . . . . . . 1.2 m -82.63 -6.63 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 CA-C-N 114.707 -1.133 . . . . 1.0 109.989 -178.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 991' ' ' GLY . . . . . 0.568 ' C ' ' H ' ' A' ' 993' ' ' PHE . . . 83.58 2.6 89.99 Favored Glycine 0 C--N 1.337 0.586 0 CA-C-O 119.296 -0.724 . . . . 1.0 112.317 178.693 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -52.16 -2.5 0.02 OUTLIER 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 119.418 1.609 . . . . 1.0 112.145 -177.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 993' ' ' PHE . . . . . 0.568 ' H ' ' C ' ' A' ' 991' ' ' GLY . 11.6 m-85 . . . . . 0 C--N 1.332 -0.191 0 CA-C-O 121.077 0.465 . . . . 1.0 110.101 179.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 967' ' ' TRP . . . . . . . . . . . . . 96.9 m95 . . . . . 0 N--CA 1.456 -0.147 0 CA-C-O 120.573 0.225 . . . . 1.0 111.578 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 24.7 m95 -70.33 -34.66 72.95 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.577 -0.283 . . . . 1.0 110.479 179.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 74.1 t -67.38 -43.93 87.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 108.99 -0.744 . . . . 1.0 108.99 178.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 51.6 tp -63.91 -41.33 97.71 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.232 -0.894 . . . . 1.0 109.104 179.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 971' ' ' VAL . . . . . . . . . . . . . 53.2 t -62.29 -45.33 99.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 C-N-CA 120.895 -0.322 . . . . 1.0 111.372 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.63 -41.31 98.83 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 112.161 -0.376 . . . . 1.0 112.161 -178.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 72.8 t -67.22 -47.23 82.15 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.517 0 CA-C-O 120.94 0.4 . . . . 1.0 110.668 -178.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 6.9 mp -63.44 -41.04 98.66 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.974 -0.557 . . . . 1.0 109.522 179.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -66.08 -44.95 90.29 Favored Glycine 0 C--N 1.334 0.433 0 N-CA-C 110.348 -1.101 . . . . 1.0 110.348 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -61.32 -36.11 91.98 Favored Glycine 0 N--CA 1.448 -0.527 0 N-CA-C 109.061 -1.615 . . . . 1.0 109.061 179.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 54.2 tp -67.37 -43.72 80.74 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.443 -0.503 . . . . 1.0 110.075 178.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 50.9 tp -62.43 -44.82 95.51 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.289 -0.564 . . . . 1.0 109.998 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 87.5 mt -61.94 -42.93 99.67 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 119.783 -0.767 . . . . 1.0 110.118 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 980' ' ' LEU . . . . . . . . . . . . . 33.2 mt -63.42 -40.41 97.1 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.058 0.456 . . . . 1.0 110.334 -179.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 6.9 m -64.16 -46.27 84.79 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.409 -0.814 . . . . 1.0 110.17 -179.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 90.8 mt -64.29 -44.27 97.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.332 -0.394 . . . . 1.0 111.236 -179.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 983' ' ' LEU . . . . . 0.487 ' CD1' ' SD ' ' A' ' 987' ' ' MET . 39.1 tp -65.67 -42.74 90.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.544 -0.298 . . . . 1.0 111.454 -179.773 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 984' ' ' VAL . . . . . . . . . . . . . 53.1 t -66.81 -47.64 82.19 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.402 0 CA-C-O 121.411 0.624 . . . . 1.0 110.341 -179.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 84.0 mt -63.58 -41.59 98.36 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.134 -0.939 . . . . 1.0 109.132 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 986' ' ' ALA . . . . . . . . . . . . . . . -62.65 -47.77 82.23 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.275 0.559 . . . . 1.0 110.38 -179.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 987' ' ' MET . . . . . 0.487 ' SD ' ' CD1' ' A' ' 983' ' ' LEU . 16.2 mtp -62.81 -30.26 71.35 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 122.632 1.206 . . . . 1.0 110.313 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 988' ' ' TRP . . . . . 0.467 ' O ' ' CD1' ' A' ' 988' ' ' TRP . 12.1 t90 -75.64 -35.34 60.48 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 113.976 -1.465 . . . . 1.0 107.926 178.523 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.25 -39.57 74.94 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-O 121.516 0.674 . . . . 1.0 109.902 -179.447 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 990' ' ' VAL . . . . . . . . . . . . . 1.4 m -78.28 -3.45 5.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 114.946 -1.025 . . . . 1.0 109.221 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 991' ' ' GLY . . . . . . . . . . . . . . . 82.83 1.44 90.59 Favored Glycine 0 C--N 1.333 0.414 0 CA-C-O 119.404 -0.664 . . . . 1.0 112.397 177.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -47.22 -41.92 19.26 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-N 119.046 1.423 . . . . 1.0 110.926 -176.712 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 993' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 . . . . . 0 N--CA 1.466 0.344 0 CA-C-O 121.861 0.838 . . . . 1.0 111.1 179.479 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 967' ' ' TRP . . . . . . . . . . . . . 98.8 m95 . . . . . 0 N--CA 1.455 -0.195 0 CA-C-O 120.688 0.28 . . . . 1.0 110.313 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 87.4 m95 -68.58 -36.6 78.94 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.462 -0.335 . . . . 1.0 111.4 179.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 72.6 t -66.3 -44.56 91.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.307 0.575 . . . . 1.0 109.551 178.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 90.4 mt -62.82 -42.19 99.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.04 -0.982 . . . . 1.0 109.597 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 971' ' ' VAL . . . . . . . . . . . . . 54.1 t -61.6 -45.33 98.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.51 -0.314 . . . . 1.0 111.14 -179.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.78 -41.67 99.19 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 121.377 -0.44 . . . . 1.0 112.331 -178.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 57.2 t -65.82 -47.45 85.63 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.534 0 CA-C-O 121.145 0.497 . . . . 1.0 110.605 -178.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 86.9 mt -62.59 -41.58 99.04 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.556 -0.747 . . . . 1.0 109.365 179.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -66.02 -46.25 82.28 Favored Glycine 0 N--CA 1.452 -0.243 0 N-CA-C 110.421 -1.072 . . . . 1.0 110.421 -179.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -61.0 -37.33 93.69 Favored Glycine 0 N--CA 1.451 -0.339 0 N-CA-C 109.244 -1.542 . . . . 1.0 109.244 179.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 30.1 mt -64.34 -42.4 96.29 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.437 -0.505 . . . . 1.0 109.753 178.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -62.98 -43.78 97.86 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 119.628 -0.829 . . . . 1.0 110.144 179.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 98.4 mt -61.72 -43.66 98.43 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.17 -0.612 . . . . 1.0 109.906 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 980' ' ' LEU . . . . . . . . . . . . . 31.1 mt -62.82 -41.93 99.51 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.56 -0.456 . . . . 1.0 109.891 179.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 7.3 m -62.69 -47.32 84.13 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.646 -0.707 . . . . 1.0 111.183 -179.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 92.7 mt -64.26 -43.94 97.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 C-N-CA 120.775 -0.37 . . . . 1.0 111.152 -179.389 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 983' ' ' LEU . . . . . 0.403 ' O ' ' SD ' ' A' ' 987' ' ' MET . 83.0 mt -65.04 -41.76 94.92 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.329 -0.396 . . . . 1.0 111.307 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 984' ' ' VAL . . . . . . . . . . . . . 42.2 t -69.15 -49.86 58.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.208 0.528 . . . . 1.0 110.793 -179.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 90.7 mt -63.37 -42.53 98.87 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.47 -0.786 . . . . 1.0 109.44 179.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 986' ' ' ALA . . . . . . . . . . . . . . . -61.87 -43.97 97.77 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 109.18 -0.674 . . . . 1.0 109.18 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 987' ' ' MET . . . . . 0.403 ' SD ' ' O ' ' A' ' 983' ' ' LEU . 21.9 mtp -62.14 -30.29 70.94 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 114.653 -1.158 . . . . 1.0 109.387 179.028 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 988' ' ' TRP . . . . . . . . . . . . . 1.8 t90 -74.87 -36.12 62.31 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 113.797 -1.547 . . . . 1.0 108.28 178.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.44 -38.92 71.29 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.599 0.714 . . . . 1.0 110.0 -179.374 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 990' ' ' VAL . . . . . . . . . . . . . 1.3 m -80.41 -5.33 8.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 114.957 -1.02 . . . . 1.0 109.873 -179.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 991' ' ' GLY . . . . . 0.578 ' C ' ' H ' ' A' ' 993' ' ' PHE . . . 85.05 0.38 88.93 Favored Glycine 0 C--N 1.338 0.686 0 CA-C-O 119.466 -0.63 . . . . 1.0 112.546 177.576 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -51.92 -2.98 0.02 OUTLIER 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 118.901 1.35 . . . . 1.0 112.386 -177.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 993' ' ' PHE . . . . . 0.578 ' H ' ' C ' ' A' ' 991' ' ' GLY . 32.8 m-85 . . . . . 0 N--CA 1.463 0.202 0 CA-C-O 122.511 1.148 . . . . 1.0 110.543 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 967' ' ' TRP . . . . . . . . . . . . . 99.4 m95 . . . . . 0 N--CA 1.46 0.056 0 CA-C-O 120.556 0.217 . . . . 1.0 110.569 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 90.9 m95 -70.01 -34.3 73.12 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.614 -0.434 . . . . 1.0 110.426 179.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 53.9 t -66.94 -45.59 86.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.694 -0.484 . . . . 1.0 109.694 178.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 80.7 mt -63.72 -40.83 97.73 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.285 -0.871 . . . . 1.0 109.908 179.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 971' ' ' VAL . . . . . . . . . . . . . 45.2 t -64.77 -45.18 95.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 C-N-CA 120.694 -0.403 . . . . 1.0 111.309 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -63.05 -43.76 98.32 Favored Glycine 0 CA--C 1.529 0.932 0 CA-C-N 116.365 -0.38 . . . . 1.0 113.49 -177.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 31.6 m -67.48 -43.12 87.61 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.403 0 CA-C-O 120.897 0.38 . . . . 1.0 110.352 -178.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 93.3 mt -63.39 -41.24 98.76 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.962 -0.755 . . . . 1.0 108.962 178.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -66.21 -46.16 81.49 Favored Glycine 0 C--N 1.329 0.151 0 N-CA-C 110.338 -1.105 . . . . 1.0 110.338 -179.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -59.2 -38.51 93.29 Favored Glycine 0 N--CA 1.446 -0.64 0 N-CA-C 108.647 -1.781 . . . . 1.0 108.647 178.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 38.3 mt -63.87 -42.17 97.58 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.135 -0.626 . . . . 1.0 109.518 178.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 55.6 tp -62.44 -46.22 89.53 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.713 -0.395 . . . . 1.0 110.408 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 9.5 mp -62.29 -42.49 99.39 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 119.724 -0.79 . . . . 1.0 110.148 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 980' ' ' LEU . . . . . . . . . . . . . 86.7 mt -63.04 -40.25 97.17 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.486 -0.486 . . . . 1.0 110.11 179.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 7.1 m -63.86 -46.72 83.73 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.667 -0.697 . . . . 1.0 110.808 -179.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 97.6 mt -63.56 -44.52 98.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.396 -0.365 . . . . 1.0 110.815 -179.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -65.73 -40.18 91.89 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.168 -0.469 . . . . 1.0 111.309 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 984' ' ' VAL . . . . . . . . . . . . . 45.6 t -67.24 -48.66 77.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.301 0.572 . . . . 1.0 110.337 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 88.2 mt -63.67 -42.29 98.07 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.224 -0.898 . . . . 1.0 109.407 178.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 986' ' ' ALA . . . . . . . . . . . . . . . -63.01 -46.93 85.33 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-O 121.384 0.611 . . . . 1.0 110.487 -179.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 19.2 mtp -63.18 -32.23 73.57 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 122.601 1.191 . . . . 1.0 109.607 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 988' ' ' TRP . . . . . . . . . . . . . 14.2 t90 -72.99 -36.96 67.16 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 114.202 -1.363 . . . . 1.0 107.554 178.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 989' ' ' LYS . . . . . 0.543 ' O ' ' NZ ' ' A' ' 989' ' ' LYS . 0.1 OUTLIER -66.7 -41.18 88.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.224 -0.898 . . . . 1.0 109.816 -179.875 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 990' ' ' VAL . . . . . . . . . . . . . 1.3 m -79.15 -3.03 5.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.112 -0.949 . . . . 1.0 109.518 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 991' ' ' GLY . . . . . . . . . . . . . . . 82.97 1.21 90.64 Favored Glycine 0 C--N 1.338 0.668 0 CA-C-O 119.28 -0.733 . . . . 1.0 112.565 177.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -45.87 -42.81 12.99 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 118.953 1.377 . . . . 1.0 111.332 -177.157 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 993' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 . . . . . 0 N--CA 1.468 0.467 0 CA-C-O 121.684 0.754 . . . . 1.0 111.454 179.836 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 967' ' ' TRP . . . . . . . . . . . . . 98.4 m95 . . . . . 0 N--CA 1.46 0.075 0 CA-C-O 120.608 0.242 . . . . 1.0 110.677 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 24.6 m95 -70.16 -35.25 73.88 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.636 -0.256 . . . . 1.0 110.422 179.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 91.2 t -67.03 -45.93 85.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.682 0.753 . . . . 1.0 109.201 178.015 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 57.1 tp -63.0 -42.74 99.93 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.75 -1.114 . . . . 1.0 109.207 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 971' ' ' VAL . . . . . . . . . . . . . 55.6 t -62.4 -45.4 98.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.952 0.406 . . . . 1.0 110.756 -179.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.35 -42.06 98.7 Favored Glycine 0 CA--C 1.524 0.603 0 CA-C-N 115.928 -0.578 . . . . 1.0 111.891 -179.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 63.6 t -66.1 -44.78 91.71 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.458 0 CA-C-O 120.909 0.385 . . . . 1.0 110.662 -178.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 80.9 mt -61.94 -40.49 95.71 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.402 -0.962 . . . . 1.0 108.402 178.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -66.63 -43.82 91.17 Favored Glycine 0 N--CA 1.46 0.261 0 N-CA-C 110.22 -1.152 . . . . 1.0 110.22 -179.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -61.29 -37.09 93.45 Favored Glycine 0 N--CA 1.447 -0.624 0 N-CA-C 109.297 -1.521 . . . . 1.0 109.297 179.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 76.2 mt -67.38 -42.53 83.21 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 119.815 -0.754 . . . . 1.0 110.207 178.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 70.8 mt -62.04 -44.75 96.03 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.26 -0.576 . . . . 1.0 110.507 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 90.3 mt -63.5 -44.59 93.89 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 119.815 -0.754 . . . . 1.0 110.855 -179.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 980' ' ' LEU . . . . . . . . . . . . . 6.2 mp -64.1 -40.76 96.9 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.232 -0.587 . . . . 1.0 110.606 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 7.4 m -62.35 -47.8 82.6 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.883 -0.599 . . . . 1.0 110.352 -179.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 96.6 mt -64.56 -44.85 96.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 C-N-CA 120.403 -0.519 . . . . 1.0 111.563 -178.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 7.1 mp -64.74 -41.93 95.57 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 111.801 0.297 . . . . 1.0 111.801 -179.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 984' ' ' VAL . . . . . . . . . . . . . 51.1 t -65.64 -48.68 81.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-O 121.313 0.578 . . . . 1.0 110.383 -179.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 82.5 mt -62.28 -41.9 98.88 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.967 -1.015 . . . . 1.0 109.478 178.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 986' ' ' ALA . . . . . . . . . . . . . . . -61.58 -46.34 90.28 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.314 0.578 . . . . 1.0 110.106 -179.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 22.7 mtp -63.33 -29.77 71.02 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 122.679 1.228 . . . . 1.0 110.043 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 988' ' ' TRP . . . . . . . . . . . . . 1.6 t90 -76.31 -34.87 59.05 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 113.57 -1.65 . . . . 1.0 107.549 179.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.22 -38.67 68.92 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.113 -0.949 . . . . 1.0 110.14 -179.43 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 990' ' ' VAL . . . . . . . . . . . . . 1.5 m -79.37 -0.69 3.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.118 -0.946 . . . . 1.0 109.129 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 991' ' ' GLY . . . . . . . . . . . . . . . 80.8 1.0 89.18 Favored Glycine 0 C--N 1.337 0.585 0 CA-C-O 119.137 -0.813 . . . . 1.0 112.783 177.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -47.04 -40.88 15.71 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 119.263 1.531 . . . . 1.0 111.53 -177.075 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 993' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 . . . . . 0 N--CA 1.465 0.296 0 CA-C-O 121.981 0.896 . . . . 1.0 111.673 -179.308 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 967' ' ' TRP . . . . . . . . . . . . . 98.0 m95 . . . . . 0 N--CA 1.455 -0.193 0 N-CA-C 112.407 0.521 . . . . 1.0 112.407 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 38.9 m95 -69.67 -33.89 73.2 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.903 -0.406 . . . . 1.0 109.903 179.501 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 90.7 t -68.34 -46.04 81.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 C-N-CA 119.925 -0.71 . . . . 1.0 110.032 178.092 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 61.5 tp -66.15 -46.35 77.77 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 115.372 -0.831 . . . . 1.0 112.389 -179.165 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 971' ' ' VAL . . . . . . . . . . . . . 26.9 m -63.69 -41.56 93.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 119.732 -0.787 . . . . 1.0 110.614 -177.974 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.51 -40.45 97.77 Favored Glycine 0 CA--C 1.525 0.657 0 CA-C-N 115.569 -0.741 . . . . 1.0 111.541 -179.459 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 92.2 t -66.09 -47.08 86.11 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.34 0 CA-C-O 121.007 0.432 . . . . 1.0 110.364 -179.048 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 92.9 mt -62.27 -40.38 96.03 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 108.655 -0.869 . . . . 1.0 108.655 179.312 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -65.36 -45.19 91.66 Favored Glycine 0 CA--C 1.516 0.146 0 N-CA-C 109.866 -1.294 . . . . 1.0 109.866 -179.84 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -61.03 -38.05 94.89 Favored Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 109.417 -1.473 . . . . 1.0 109.417 178.864 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.24 -43.97 85.04 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 120.24 -0.584 . . . . 1.0 109.556 179.51 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 39.1 mt -61.56 -44.77 96.42 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.352 -0.539 . . . . 1.0 110.208 -179.724 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 97.1 mt -62.63 -43.47 98.73 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.419 -0.512 . . . . 1.0 110.368 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 980' ' ' LEU . . . . . . . . . . . . . 56.0 mt -63.48 -39.88 95.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.111 0.482 . . . . 1.0 109.847 -179.86 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 5.6 m -64.26 -47.1 80.89 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.592 -0.731 . . . . 1.0 110.248 -179.633 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 97.4 mt -64.23 -45.25 96.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.473 -0.331 . . . . 1.0 111.66 -178.608 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -64.89 -40.75 95.6 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.869 -0.332 . . . . 1.0 110.775 179.575 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 984' ' ' VAL . . . . . . . . . . . . . 55.5 t -67.2 -48.08 79.57 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.402 0 CA-C-O 121.441 0.638 . . . . 1.0 110.024 179.904 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 84.4 mt -63.55 -42.29 98.38 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.172 -0.922 . . . . 1.0 109.584 179.175 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 986' ' ' ALA . . . . . . . . . . . . . . . -62.99 -42.49 99.86 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-O 121.66 0.743 . . . . 1.0 109.34 -179.716 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 28.9 mtp -63.87 -30.06 71.19 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 114.643 -1.162 . . . . 1.0 109.426 179.677 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 988' ' ' TRP . . . . . . . . . . . . . 1.7 t90 -76.11 -35.86 59.13 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.073 -1.421 . . . . 1.0 108.042 178.734 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.02 -38.98 76.05 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.494 0.664 . . . . 1.0 109.885 -179.693 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 990' ' ' VAL . . . . . . . . . . . . . 1.4 m -81.95 -7.38 10.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.194 -0.912 . . . . 1.0 110.145 -179.175 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 991' ' ' GLY . . . . . 0.565 ' C ' ' H ' ' A' ' 993' ' ' PHE . . . 84.17 2.49 89.3 Favored Glycine 0 C--N 1.337 0.592 0 CA-C-O 119.074 -0.848 . . . . 1.0 112.672 178.613 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -53.52 -2.67 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 119.68 1.74 . . . . 1.0 112.159 -177.741 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 993' ' ' PHE . . . . . 0.565 ' H ' ' C ' ' A' ' 991' ' ' GLY . 28.3 m-85 . . . . . 0 N--CA 1.464 0.227 0 CA-C-O 123.194 1.473 . . . . 1.0 110.632 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 957' ' ' GLY . . . . . 0.534 ' O ' ' NH2' ' A' ' 962' ' ' ARG . . . . . . . . 0 N--CA 1.493 2.434 0 N-CA-C 108.93 -1.668 . . . . 10.789999999999999 108.93 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -162.88 -50.35 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.456 -0.942 . . . . 10.25 108.456 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 959' ' ' LEU . . . . . 0.633 ' H ' ' CD1' ' A' ' 959' ' ' LEU . 0.0 OUTLIER -62.64 -39.71 94.71 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 106.754 -1.573 . . . . 9.5199999999999996 106.754 178.031 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 960' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -43.73 146.03 0.6 Allowed 'General case' 0 CA--C 1.511 -0.548 0 CA-C-N 114.776 -1.102 . . . . 10.19 108.726 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 961' ' ' GLU . . . . . 0.489 ' C ' ' N ' ' A' ' 963' ' ' ALA . 0.0 OUTLIER -94.3 70.71 3.78 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.993 -0.549 . . . . 9.0299999999999994 110.753 -179.383 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 962' ' ' ARG . . . . . 0.575 ' C ' ' H ' ' A' ' 964' ' ' ILE . 1.0 OUTLIER -56.09 -28.52 58.03 Favored 'General case' 0 CA--C 1.503 -0.864 0 N-CA-C 102.284 -3.228 . . . . 9.9700000000000006 102.284 174.042 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 963' ' ' ALA . . . . . 0.671 ' O ' ' C ' ' A' ' 964' ' ' ILE . . . 72.16 -14.85 0.51 Allowed 'General case' 0 N--CA 1.412 -2.332 0 CA-C-N 109.944 -3.298 . . . . 4.7999999999999998 107.977 -178.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 964' ' ' ILE . . . . . 0.671 ' C ' ' O ' ' A' ' 963' ' ' ALA . 0.3 OUTLIER 17.29 61.12 0.19 Allowed Pre-proline 0 C--N 1.386 2.167 0 N-CA-C 104.008 -2.59 . . . . 6.5700000000000003 104.008 -177.736 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 965' ' ' PRO . . . . . 0.543 ' N ' ' O ' ' A' ' 963' ' ' ALA . 14.1 Cg_endo -63.57 68.34 0.18 Allowed 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 121.006 1.137 . . . . 3.0 111.173 -169.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 966' ' ' ILE . . . . . 0.58 ' N ' ' O ' ' A' ' 964' ' ' ILE . 0.2 OUTLIER -46.21 -34.67 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.211 0 CA-C-N 112.768 -2.014 . . . . 1.97 108.003 178.301 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 967' ' ' TRP . . . . . 0.427 ' O ' ' CG2' ' A' ' 971' ' ' VAL . 98.4 m95 -65.45 -46.4 79.99 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.238 -0.892 . . . . 0.72999999999999998 110.658 178.023 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 968' ' ' TRP . . . . . 0.519 ' HB2' ' HB2' ' A' ' 965' ' ' PRO . 64.4 m95 -65.33 -32.73 74.53 Favored 'General case' 0 CA--C 1.518 -0.272 0 C-N-CA 120.277 -0.569 . . . . 1.1299999999999999 110.144 178.268 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 95.5 t -67.79 -47.24 80.39 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.391 0 N-CA-C 108.248 -1.019 . . . . 1.28 108.248 178.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 2.0 tp -61.84 -42.35 98.93 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 114.088 -1.415 . . . . 2.4500000000000002 107.414 178.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 971' ' ' VAL . . . . . 0.427 ' CG2' ' O ' ' A' ' 967' ' ' TRP . 99.4 t -62.03 -46.06 97.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.872 0.368 . . . . 1.28 110.299 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -59.15 -42.32 97.07 Favored Glycine 0 C--N 1.338 0.644 0 N-CA-C 111.736 -0.546 . . . . 0.16 111.736 -179.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 63.6 t -67.31 -48.48 77.84 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.512 0 CA-C-N 114.94 -0.63 . . . . 1.53 109.48 -178.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 89.5 mt -61.99 -42.0 98.66 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 115.37 -0.832 . . . . 1.8200000000000001 109.15 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -67.88 -47.5 60.19 Favored Glycine 0 C--N 1.335 0.478 0 N-CA-C 110.342 -1.103 . . . . 0.16 110.342 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -60.59 -37.98 94.26 Favored Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 108.805 -1.718 . . . . 0.17000000000000001 108.805 178.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 46.0 tp -66.11 -44.4 84.39 Favored 'General case' 0 C--O 1.225 -0.197 0 N-CA-C 109.364 -0.606 . . . . 2.23 109.364 178.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 1.1 mt -61.52 -46.27 90.66 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.689 -0.486 . . . . 2.4300000000000002 109.689 178.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 57.2 mt -61.67 -43.62 98.51 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.186 -0.606 . . . . 1.5700000000000001 109.884 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 980' ' ' LEU . . . . . 0.459 ' O ' ' CG2' ' A' ' 984' ' ' VAL . 22.7 mt -63.69 -41.45 98.13 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 119.981 -0.688 . . . . 1.8899999999999999 109.971 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 7.2 m -63.15 -47.4 82.85 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.254 -0.885 . . . . 1.0700000000000001 110.928 -179.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 93.6 mt -64.38 -44.54 97.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.655 0.264 . . . . 1.3700000000000001 110.598 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 13.1 mt -63.31 -36.81 84.91 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.978 -0.749 . . . . 2.3199999999999998 108.978 179.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 984' ' ' VAL . . . . . 0.459 ' CG2' ' O ' ' A' ' 980' ' ' LEU . 23.0 t -69.14 -50.37 53.61 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 CA-C-N 115.321 -0.854 . . . . 1.1000000000000001 110.92 -178.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 94.9 mt -65.45 -40.22 92.98 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.39 -0.823 . . . . 1.1499999999999999 109.329 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 986' ' ' ALA . . . . . . . . . . . . . . . -64.54 -45.4 87.31 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 121.509 0.671 . . . . 1.03 110.273 -179.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 987' ' ' MET . . . . . 0.45 ' O ' ' N ' ' A' ' 992' ' ' PHE . 25.6 mtp -63.25 -28.63 70.16 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 122.174 0.988 . . . . 1.21 109.582 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 988' ' ' TRP . . . . . . . . . . . . . 7.8 t90 -77.64 -35.41 52.57 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.016 -1.447 . . . . 2.9100000000000001 108.014 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.5 -41.08 76.55 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.514 0.673 . . . . 1.3400000000000001 109.874 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 990' ' ' VAL . . . . . . . . . . . . . 2.4 m -79.42 -8.91 11.91 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 CA-C-N 115.124 -0.944 . . . . 1.04 109.72 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 991' ' ' GLY . . . . . . . . . . . . . . . 85.87 3.66 85.47 Favored Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 114.772 -1.104 . . . . 0.17000000000000001 112.19 179.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 992' ' ' PHE . . . . . 0.45 ' N ' ' O ' ' A' ' 987' ' ' MET . 0.3 OUTLIER -55.07 -37.92 67.38 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 120.133 1.966 . . . . 0.51000000000000001 113.762 -176.232 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 993' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -73.22 -13.92 61.24 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-O 124.684 2.183 . . . . 2.3900000000000001 109.293 178.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 994' ' ' LYS . . . . . . . . . . . . . 3.7 tttt -86.0 154.87 21.13 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 108.401 -4.0 . . . . 6.2199999999999998 110.843 178.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 995' ' ' ARG . . . . . 0.497 ' O ' ' N ' ' A' ' 997' ' ' ARG . 15.1 mtm105 -115.63 -78.67 0.58 Allowed 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 118.491 0.587 . . . . 8.1300000000000008 110.856 -177.268 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 996' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 45.56 17.66 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.128 -0.629 . . . . 7.5599999999999996 110.297 179.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 997' ' ' ARG . . . . . 0.497 ' N ' ' O ' ' A' ' 995' ' ' ARG . 0.2 OUTLIER -56.26 158.56 7.36 Favored Pre-proline 0 CA--C 1.531 0.248 0 N-CA-C 108.774 -0.825 . . . . 9.7300000000000004 108.774 179.872 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 998' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo . . . . . 0 C--N 1.308 -1.591 0 C-N-CA 122.289 1.992 . . . . 10.52 111.712 -179.229 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 957' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.542 0 N-CA-C 109.29 -1.524 . . . . 1.0 109.29 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -62.5 -41.43 98.82 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.971 -0.292 . . . . 1.0 110.62 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 94.1 mt -115.19 125.42 53.37 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.597 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 960' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -80.78 140.83 35.27 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.991 -0.549 . . . . 1.0 111.227 -179.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 961' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -67.12 137.54 56.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.831 -0.622 . . . . 1.0 110.365 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 962' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -125.89 149.02 49.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.941 -0.572 . . . . 1.0 110.872 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 963' ' ' ALA . . . . . . . . . . . . . . . -154.82 0.78 0.18 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.752 -0.658 . . . . 1.0 110.084 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 964' ' ' ILE . . . . . . . . . . . . . 5.1 pt -141.95 76.3 19.84 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.028 -0.533 . . . . 1.0 110.895 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -61.79 147.86 94.35 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.811 2.341 . . . . 1.0 111.734 179.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 83.2 mt -63.44 -44.36 98.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.007 -0.542 . . . . 1.0 111.675 -179.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 967' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -58.03 -38.33 76.02 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 112.03 0.381 . . . . 1.0 112.03 -178.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 31.3 m95 -69.3 -35.54 76.09 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 110.279 -0.267 . . . . 1.0 110.279 179.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 67.5 t -66.31 -45.01 90.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 109.097 -0.705 . . . . 1.0 109.097 178.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 92.4 mt -63.79 -41.81 97.85 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.997 -1.002 . . . . 1.0 109.961 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 971' ' ' VAL . . . . . . . . . . . . . 76.0 t -62.71 -45.27 99.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.965 0.412 . . . . 1.0 110.855 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.14 -41.78 98.27 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.665 -0.574 . . . . 1.0 111.665 -179.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 72.2 t -65.57 -46.78 88.63 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.541 0 CA-C-O 120.998 0.428 . . . . 1.0 110.574 -179.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 88.9 mt -62.24 -41.18 98.2 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.921 -0.77 . . . . 1.0 108.921 179.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -65.92 -46.18 83.41 Favored Glycine 0 C--N 1.329 0.163 0 N-CA-C 110.284 -1.126 . . . . 1.0 110.284 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -61.25 -37.93 94.82 Favored Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 109.141 -1.584 . . . . 1.0 109.141 179.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 55.4 tp -65.49 -42.53 92.07 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.196 -0.668 . . . . 1.0 109.196 178.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 42.9 tp -63.66 -45.47 90.0 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.304 -0.558 . . . . 1.0 110.694 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 90.9 mt -61.89 -42.8 99.5 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.017 -0.673 . . . . 1.0 109.908 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 980' ' ' LEU . . . . . . . . . . . . . 84.6 mt -63.99 -41.41 97.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.988 0.423 . . . . 1.0 110.437 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 7.7 m -62.65 -46.41 88.34 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.738 -0.664 . . . . 1.0 110.29 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 94.5 mt -63.65 -43.75 98.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 C-N-CA 120.781 -0.368 . . . . 1.0 110.838 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 33.0 mt -64.72 -41.04 96.26 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.867 -0.333 . . . . 1.0 111.236 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 984' ' ' VAL . . . . . . . . . . . . . 88.3 t -67.83 -49.07 72.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.25 0.548 . . . . 1.0 110.033 -179.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 81.6 mt -63.22 -43.32 98.45 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.433 -0.803 . . . . 1.0 109.698 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 986' ' ' ALA . . . . . . . . . . . . . . . -61.72 -43.48 98.78 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 108.918 -0.771 . . . . 1.0 108.918 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 27.3 mtp -62.29 -30.79 71.38 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 114.804 -1.089 . . . . 1.0 109.648 179.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 988' ' ' TRP . . . . . . . . . . . . . 1.8 t90 -75.3 -37.79 60.65 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.035 -1.438 . . . . 1.0 108.271 179.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.22 -39.11 78.76 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.766 0.793 . . . . 1.0 110.048 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 990' ' ' VAL . . . . . . . . . . . . . 1.4 m -83.39 -8.78 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-N 115.052 -0.976 . . . . 1.0 110.756 -178.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 991' ' ' GLY . . . . . 0.563 ' C ' ' H ' ' A' ' 993' ' ' PHE . . . 83.53 2.55 90.05 Favored Glycine 0 C--N 1.337 0.591 0 CA-C-O 119.222 -0.766 . . . . 1.0 112.594 178.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -52.64 -1.64 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 119.644 1.722 . . . . 1.0 112.386 -177.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 993' ' ' PHE . . . . . 0.563 ' H ' ' C ' ' A' ' 991' ' ' GLY . 12.2 m-85 -87.0 4.08 43.31 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.426 -0.51 . . . . 1.0 110.975 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 994' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -59.06 -43.74 91.76 Favored 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 108.238 -1.023 . . . . 1.0 108.238 177.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -91.82 140.22 29.9 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.099 -0.5 . . . . 1.0 110.61 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 996' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -100.5 7.54 44.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.141 -0.482 . . . . 1.0 111.708 -179.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 997' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -110.9 160.44 28.82 Favored Pre-proline 0 N--CA 1.464 0.228 0 CA-C-N 116.605 -0.27 . . . . 1.0 110.454 179.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 998' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo . . . . . 0 N--CA 1.493 1.449 0 C-N-CA 122.307 2.005 . . . . 1.0 111.824 179.816 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 957' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.356 0 N-CA-C 109.377 -1.489 . . . . 1.0 109.377 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -63.76 -37.23 86.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.0 0.429 . . . . 1.0 109.858 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 62.4 mt -103.41 132.45 49.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.824 -0.625 . . . . 1.0 110.231 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 960' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -65.71 -34.32 77.93 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.064 -0.517 . . . . 1.0 110.182 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 961' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -64.56 -35.95 82.63 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.726 -0.67 . . . . 1.0 111.112 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 962' ' ' ARG . . . . . . . . . . . . . 59.3 ttt85 -62.29 137.32 58.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.938 0.399 . . . . 1.0 110.236 -179.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 963' ' ' ALA . . . . . . . . . . . . . . . -66.41 145.78 55.3 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.993 -0.549 . . . . 1.0 111.124 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 964' ' ' ILE . . . . . . . . . . . . . 1.3 pt -132.52 66.08 76.06 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.76 -0.655 . . . . 1.0 110.11 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -68.4 -12.26 34.38 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.325 2.016 . . . . 1.0 112.748 -179.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 97.5 mt -63.65 -44.77 98.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.526 -0.306 . . . . 1.0 111.336 -179.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 967' ' ' TRP . . . . . . . . . . . . . 91.5 m95 -67.25 -35.87 80.43 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.31 -0.556 . . . . 1.0 110.704 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 87.0 m95 -68.37 -37.03 80.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.74 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 96.2 t -66.78 -42.78 89.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 109.046 -0.724 . . . . 1.0 109.046 178.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 87.4 mt -62.9 -41.77 99.56 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.209 -0.905 . . . . 1.0 109.796 178.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 971' ' ' VAL . . . . . . . . . . . . . 76.2 t -62.5 -45.57 98.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.819 0.342 . . . . 1.0 110.829 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -61.24 -40.96 99.31 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 111.837 -0.505 . . . . 1.0 111.837 -179.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 62.6 t -65.87 -46.22 89.18 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.376 0 CA-C-N 115.092 -0.554 . . . . 1.0 110.037 -179.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 86.7 mt -63.26 -41.4 99.03 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 121.327 0.584 . . . . 1.0 109.432 178.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -66.44 -46.8 74.79 Favored Glycine 0 C--N 1.332 0.341 0 N-CA-C 110.489 -1.044 . . . . 1.0 110.489 -179.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -60.18 -36.74 91.5 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 108.886 -1.686 . . . . 1.0 108.886 178.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 50.5 tp -66.41 -43.4 85.84 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.263 -0.575 . . . . 1.0 109.912 178.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 53.0 mt -61.94 -44.13 97.41 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 119.739 -0.784 . . . . 1.0 109.726 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 84.5 mt -62.5 -43.41 98.89 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 119.744 -0.782 . . . . 1.0 110.297 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 980' ' ' LEU . . . . . . . . . . . . . 66.6 mt -64.56 -42.19 95.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.075 0.464 . . . . 1.0 110.606 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 5.9 m -64.18 -47.1 81.12 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.558 -0.747 . . . . 1.0 110.109 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 94.3 mt -64.07 -44.49 97.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 120.74 -0.384 . . . . 1.0 111.433 -179.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 6.4 mp -64.55 -40.27 95.27 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.638 -0.425 . . . . 1.0 111.087 179.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 984' ' ' VAL . . . . . . . . . . . . . 54.1 t -68.5 -48.98 69.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.21 0.529 . . . . 1.0 109.843 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 85.3 mt -63.33 -43.27 98.24 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.574 -0.739 . . . . 1.0 109.451 178.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 986' ' ' ALA . . . . . . . . . . . . . . . -62.08 -42.7 99.48 Favored 'General case' 0 CA--C 1.511 -0.544 0 N-CA-C 108.997 -0.742 . . . . 1.0 108.997 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 30.9 mtp -62.1 -31.69 72.17 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 114.729 -1.123 . . . . 1.0 109.238 178.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 988' ' ' TRP . . . . . . . . . . . . . 1.8 t90 -73.23 -38.57 66.0 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 113.884 -1.507 . . . . 1.0 108.166 179.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.26 -39.6 78.34 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.434 -0.803 . . . . 1.0 110.39 -179.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 990' ' ' VAL . . . . . . . . . . . . . 1.4 m -83.58 -8.66 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 CA-C-N 115.003 -0.998 . . . . 1.0 110.204 -178.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 991' ' ' GLY . . . . . 0.543 ' C ' ' H ' ' A' ' 993' ' ' PHE . . . 81.43 5.07 90.25 Favored Glycine 0 C--N 1.339 0.713 0 CA-C-O 119.199 -0.779 . . . . 1.0 112.508 179.148 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -52.5 -1.24 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 119.74 1.77 . . . . 1.0 112.932 -177.031 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 993' ' ' PHE . . . . . 0.543 ' H ' ' C ' ' A' ' 991' ' ' GLY . 16.1 m-85 -88.42 3.63 49.29 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 120.646 -0.422 . . . . 1.0 111.18 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 994' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -50.35 145.31 6.41 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.938 -0.764 . . . . 1.0 108.938 178.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 89.6 mtm180 -63.43 -42.52 98.7 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.137 -0.483 . . . . 1.0 111.297 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 996' ' ' ASN . . . . . . . . . . . . . 57.0 t-20 -91.62 104.94 17.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.908 0.385 . . . . 1.0 111.006 -179.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 997' ' ' ARG . . . . . . . . . . . . . 23.8 mtt85 -63.72 153.17 84.56 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.116 -0.493 . . . . 1.0 109.994 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 998' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo . . . . . 0 C--N 1.313 -1.305 0 C-N-CA 122.441 2.094 . . . . 1.0 112.051 179.523 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 957' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.41 0 N-CA-C 109.356 -1.498 . . . . 1.0 109.356 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 958' ' ' ALA . . . . . 0.413 ' O ' ' N ' ' A' ' 962' ' ' ARG . . . -69.92 141.69 53.06 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.542 -0.463 . . . . 1.0 110.297 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 57.9 tp -62.04 -40.71 96.67 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.175 -0.466 . . . . 1.0 109.885 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 960' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -65.45 -36.4 83.79 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.892 -0.595 . . . . 1.0 110.814 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 961' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -117.32 39.45 3.28 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-O 121.142 0.496 . . . . 1.0 110.195 178.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 962' ' ' ARG . . . . . 0.413 ' N ' ' O ' ' A' ' 958' ' ' ALA . 77.6 ttt-85 -59.46 -43.41 93.22 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.594 -0.73 . . . . 1.0 109.139 179.32 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 963' ' ' ALA . . . . . . . . . . . . . . . -72.76 -13.83 61.41 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.361 -0.836 . . . . 1.0 110.071 179.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 964' ' ' ILE . . . . . . . . . . . . . 57.2 mt 49.01 77.35 0.47 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.923 -0.58 . . . . 1.0 110.791 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -59.36 145.52 97.65 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 C-N-CA 122.672 2.248 . . . . 1.0 111.822 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 36.8 pt -69.46 -25.4 28.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.729 -0.669 . . . . 1.0 111.152 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 967' ' ' TRP . . . . . . . . . . . . . 98.9 m95 -54.38 -38.66 66.4 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 116.147 -0.478 . . . . 1.0 111.447 -178.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 90.9 m95 -70.53 -36.42 73.71 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.474 -0.33 . . . . 1.0 110.367 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 95.2 t -66.81 -45.12 88.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 N-CA-C 108.389 -0.967 . . . . 1.0 108.389 178.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 58.9 tp -63.2 -42.51 99.32 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 114.564 -1.198 . . . . 1.0 109.199 178.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 971' ' ' VAL . . . . . . . . . . . . . 79.3 t -62.29 -45.08 99.6 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.087 0 N-CA-C 109.727 -0.472 . . . . 1.0 109.727 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.23 -43.25 98.66 Favored Glycine 0 CA--C 1.526 0.736 0 CA-C-N 116.151 -0.477 . . . . 1.0 112.127 -179.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 58.2 t -65.24 -46.72 89.9 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.416 0 CA-C-N 115.169 -0.515 . . . . 1.0 110.066 -179.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 88.8 mt -62.11 -41.98 98.76 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 109.038 -0.727 . . . . 1.0 109.038 178.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -65.98 -47.4 74.45 Favored Glycine 0 C--O 1.225 -0.418 0 N-CA-C 110.248 -1.141 . . . . 1.0 110.248 -179.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -59.13 -37.46 91.73 Favored Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 109.144 -1.582 . . . . 1.0 109.144 178.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 35.7 mt -65.49 -42.97 91.56 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 119.982 -0.687 . . . . 1.0 110.257 178.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 35.7 mt -61.98 -44.05 97.55 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.021 -0.671 . . . . 1.0 110.304 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 10.7 mp -63.82 -43.57 95.82 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 119.555 -0.858 . . . . 1.0 111.501 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 980' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -63.66 -39.58 94.68 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.731 -0.388 . . . . 1.0 110.966 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 6.7 m -64.64 -47.74 77.38 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.137 -0.483 . . . . 1.0 110.853 -179.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 92.9 mt -63.27 -44.48 99.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.385 -0.371 . . . . 1.0 111.265 -178.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -64.83 -40.83 95.82 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.333 -0.394 . . . . 1.0 111.564 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 984' ' ' VAL . . . . . . . . . . . . . 41.2 t -67.48 -48.48 77.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.425 0.631 . . . . 1.0 110.277 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 85.9 mt -64.45 -42.78 95.78 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.136 -0.938 . . . . 1.0 109.894 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 986' ' ' ALA . . . . . . . . . . . . . . . -62.92 -45.74 91.06 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.351 0.596 . . . . 1.0 109.825 -179.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 26.8 mtp -62.0 -32.56 73.05 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.966 -1.016 . . . . 1.0 109.522 179.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 988' ' ' TRP . . . . . 0.471 ' O ' ' CD1' ' A' ' 988' ' ' TRP . 11.4 t90 -74.47 -37.52 63.19 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.315 -1.311 . . . . 1.0 108.838 178.433 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.98 -40.58 78.72 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.797 0.808 . . . . 1.0 110.071 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 990' ' ' VAL . . . . . . . . . . . . . 1.4 m -81.43 -8.08 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-N 114.639 -1.164 . . . . 1.0 110.1 -179.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 991' ' ' GLY . . . . . 0.568 ' C ' ' H ' ' A' ' 993' ' ' PHE . . . 83.28 2.83 90.33 Favored Glycine 0 C--N 1.338 0.654 0 CA-C-O 119.116 -0.825 . . . . 1.0 112.479 178.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -52.98 -1.95 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 119.722 1.761 . . . . 1.0 112.132 -177.306 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 993' ' ' PHE . . . . . 0.568 ' H ' ' C ' ' A' ' 991' ' ' GLY . 11.0 m-85 -86.43 2.48 47.54 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.398 -0.364 . . . . 1.0 110.961 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 994' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -54.65 132.78 46.17 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.052 -1.092 . . . . 1.0 108.052 177.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -63.75 -38.92 92.9 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.158 -0.473 . . . . 1.0 110.594 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 996' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -93.44 110.82 22.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.095 -0.502 . . . . 1.0 111.201 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 997' ' ' ARG . . . . . . . . . . . . . 19.7 mtt85 -52.85 152.78 6.64 Favored Pre-proline 0 CA--C 1.534 0.356 0 C-N-CA 120.765 -0.374 . . . . 1.0 110.047 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 998' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo . . . . . 0 N--CA 1.499 1.845 0 C-N-CA 122.661 2.24 . . . . 1.0 112.254 179.999 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 957' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.231 0 N-CA-C 109.317 -1.513 . . . . 1.0 109.317 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -64.75 -39.26 93.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.885 0.374 . . . . 1.0 110.504 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 87.1 mt -107.88 132.0 53.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.908 -0.587 . . . . 1.0 110.481 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 960' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -56.27 -76.33 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.145 -0.48 . . . . 1.0 110.793 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 961' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 55.32 38.07 29.82 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.06 -0.518 . . . . 1.0 111.047 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 962' ' ' ARG . . . . . . . . . . . . . 85.4 mtp180 -103.51 133.97 47.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.438 -0.346 . . . . 1.0 110.264 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 963' ' ' ALA . . . . . . . . . . . . . . . -66.78 141.81 57.58 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.325 -0.398 . . . . 1.0 110.742 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 964' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -86.6 156.03 56.25 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 1.0 109.905 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -77.47 44.13 1.46 Allowed 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.106 1.87 . . . . 1.0 111.819 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 19.7 tt -66.1 -40.87 88.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.996 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 967' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -53.94 -37.96 64.41 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.716 -179.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -69.05 -35.49 76.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.166 -0.47 . . . . 1.0 109.98 178.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 77.6 t -67.33 -44.6 87.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.539 0.685 . . . . 1.0 109.284 178.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 57.3 tp -63.61 -43.16 97.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.702 -1.135 . . . . 1.0 109.468 179.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 971' ' ' VAL . . . . . . . . . . . . . 46.7 t -62.08 -45.01 99.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.998 0.428 . . . . 1.0 110.469 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.08 -39.42 95.74 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 111.348 -0.701 . . . . 1.0 111.348 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 74.5 t -66.61 -47.51 83.14 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.29 0 CA-C-N 114.999 -0.6 . . . . 1.0 110.585 -179.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 92.9 mt -62.91 -41.69 99.54 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.191 -0.67 . . . . 1.0 109.191 179.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -66.28 -46.71 76.88 Favored Glycine 0 C--N 1.329 0.175 0 N-CA-C 110.74 -0.944 . . . . 1.0 110.74 -179.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -60.29 -37.03 92.41 Favored Glycine 0 N--CA 1.448 -0.505 0 N-CA-C 109.181 -1.568 . . . . 1.0 109.181 179.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 38.2 mt -65.97 -42.54 89.74 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.119 -0.632 . . . . 1.0 110.158 179.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 76.7 mt -62.38 -44.46 96.41 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.149 -0.62 . . . . 1.0 110.496 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 96.7 mt -63.1 -43.61 98.0 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.248 -0.581 . . . . 1.0 110.676 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 980' ' ' LEU . . . . . . . . . . . . . 81.3 mt -64.35 -40.38 95.75 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.079 0.466 . . . . 1.0 110.417 -179.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 7.1 m -63.54 -45.79 88.94 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.525 -0.761 . . . . 1.0 109.748 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 89.7 mt -63.57 -44.18 98.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.318 -0.401 . . . . 1.0 111.366 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 85.1 mt -64.48 -42.63 95.77 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 121.125 -0.23 . . . . 1.0 111.347 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 984' ' ' VAL . . . . . . . . . . . . . 47.3 t -67.9 -47.96 77.12 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.374 0 CA-C-O 121.223 0.535 . . . . 1.0 109.968 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 89.3 mt -63.49 -42.75 98.53 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.458 -0.792 . . . . 1.0 109.348 179.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 986' ' ' ALA . . . . . . . . . . . . . . . -63.18 -45.64 90.84 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 121.513 0.673 . . . . 1.0 109.621 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 32.6 mtp -62.34 -33.44 74.71 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.614 -1.175 . . . . 1.0 109.188 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 988' ' ' TRP . . . . . 0.489 ' O ' ' CD1' ' A' ' 988' ' ' TRP . 12.9 t90 -73.2 -35.2 66.32 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.473 -1.239 . . . . 1.0 108.379 178.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.04 -40.14 75.32 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.589 -0.732 . . . . 1.0 109.795 -179.412 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 990' ' ' VAL . . . . . . . . . . . . . 1.2 m -81.91 -7.12 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 CA-C-N 114.989 -1.005 . . . . 1.0 110.063 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 991' ' ' GLY . . . . . 0.538 ' C ' ' H ' ' A' ' 993' ' ' PHE . . . 82.15 3.77 90.45 Favored Glycine 0 C--N 1.34 0.784 0 CA-C-O 119.011 -0.883 . . . . 1.0 112.666 178.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -54.13 -0.93 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 119.607 1.704 . . . . 1.0 112.839 -177.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 993' ' ' PHE . . . . . 0.538 ' H ' ' C ' ' A' ' 991' ' ' GLY . 13.1 m-85 -88.5 1.78 54.17 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.051 0.453 . . . . 1.0 110.135 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 994' ' ' LYS . . . . . 0.402 ' O ' ' O ' ' A' ' 993' ' ' PHE . 15.5 mttt 60.28 129.52 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.68 -0.691 . . . . 1.0 110.975 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 88.5 mtm-85 -92.23 146.8 23.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.063 -0.517 . . . . 1.0 110.74 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 996' ' ' ASN . . . . . . . . . . . . . 60.3 t-20 53.99 41.66 31.95 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.002 0.43 . . . . 1.0 110.345 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 997' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -41.39 163.4 0.11 Allowed Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 115.974 -0.557 . . . . 1.0 110.764 -179.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 998' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo . . . . . 0 C--N 1.31 -1.479 0 C-N-CA 122.708 2.272 . . . . 1.0 112.094 179.89 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 957' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.351 0 N-CA-C 109.507 -1.437 . . . . 1.0 109.507 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -142.38 147.1 35.68 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.906 0.384 . . . . 1.0 111.085 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 959' ' ' LEU . . . . . 0.44 ' N ' ' CD1' ' A' ' 959' ' ' LEU . 10.3 mp -62.99 -42.55 99.88 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.138 179.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 960' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -121.84 121.74 37.88 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.116 -0.493 . . . . 1.0 109.789 179.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 961' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -118.02 125.85 51.15 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 121.032 0.444 . . . . 1.0 110.97 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 962' ' ' ARG . . . . . . . . . . . . . 90.7 mtt180 -64.62 -40.42 95.47 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.817 -0.629 . . . . 1.0 111.226 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 963' ' ' ALA . . . . . . . . . . . . . . . -152.3 154.85 36.53 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.768 0.318 . . . . 1.0 111.115 -179.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 964' ' ' ILE . . . . . . . . . . . . . 2.8 pt -130.0 75.12 79.89 Favored Pre-proline 0 N--CA 1.463 0.203 0 CA-C-N 116.104 -0.498 . . . . 1.0 110.656 179.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -80.03 -3.0 12.47 Favored 'Trans proline' 0 C--N 1.303 -1.839 0 C-N-CA 122.789 2.326 . . . . 1.0 112.572 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 20.1 tt -64.19 -41.62 92.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 C-N-CA 120.787 -0.365 . . . . 1.0 110.725 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 967' ' ' TRP . . . . . . . . . . . . . 99.5 m95 -70.8 -35.58 72.59 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.578 -0.449 . . . . 1.0 110.98 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 94.0 m95 -69.56 -34.47 74.23 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.361 -0.382 . . . . 1.0 110.247 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 73.9 t -65.83 -43.22 93.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 C-N-CA 119.889 -0.724 . . . . 1.0 109.175 177.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 93.2 mt -62.74 -42.35 99.63 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.145 -0.934 . . . . 1.0 109.923 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 971' ' ' VAL . . . . . . . . . . . . . 47.5 t -61.87 -46.23 96.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.864 0.364 . . . . 1.0 110.175 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -59.79 -43.55 97.81 Favored Glycine 0 CA--C 1.521 0.418 0 CA-C-N 116.095 -0.502 . . . . 1.0 112.016 -179.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 71.6 t -65.17 -46.45 90.94 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.555 0 CA-C-O 120.996 0.426 . . . . 1.0 110.703 -178.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 91.5 mt -63.12 -40.38 97.43 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 109.17 -0.678 . . . . 1.0 109.17 179.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -67.76 -45.35 76.01 Favored Glycine 0 CA--C 1.518 0.236 0 N-CA-C 110.415 -1.074 . . . . 1.0 110.415 -179.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -61.24 -37.54 94.17 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 109.622 -1.391 . . . . 1.0 109.622 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 57.9 tp -67.52 -41.68 84.01 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 119.698 -0.801 . . . . 1.0 109.874 179.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 65.9 mt -62.04 -43.77 98.13 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 119.86 -0.736 . . . . 1.0 110.298 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 82.3 mt -62.59 -44.03 97.32 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.323 -0.551 . . . . 1.0 110.825 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 980' ' ' LEU . . . . . . . . . . . . . 88.6 mt -63.96 -40.26 96.0 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.067 0.461 . . . . 1.0 110.168 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 6.8 m -64.09 -46.65 83.31 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.612 -0.722 . . . . 1.0 110.293 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 93.9 mt -64.07 -44.57 97.73 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 C-N-CA 120.827 -0.349 . . . . 1.0 111.118 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 59.7 tp -63.96 -40.88 97.43 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.624 -0.43 . . . . 1.0 110.21 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 984' ' ' VAL . . . . . . . . . . . . . 77.8 t -65.7 -47.69 85.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.311 0.577 . . . . 1.0 110.252 -179.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 64.7 mt -63.71 -41.38 98.11 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.37 -0.832 . . . . 1.0 109.533 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 986' ' ' ALA . . . . . . . . . . . . . . . -62.96 -47.13 84.5 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.107 0.48 . . . . 1.0 110.511 -179.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 13.3 mtm -64.09 -32.35 73.87 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 122.112 0.958 . . . . 1.0 109.622 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 988' ' ' TRP . . . . . 0.483 ' O ' ' CD1' ' A' ' 988' ' ' TRP . 9.4 t90 -69.27 -36.46 77.11 Favored 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 107.499 -1.297 . . . . 1.0 107.499 178.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.81 -39.56 76.47 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.117 -0.947 . . . . 1.0 110.321 -179.366 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 990' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -84.88 -9.89 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 CA-C-N 115.198 -0.91 . . . . 1.0 110.651 -178.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 991' ' ' GLY . . . . . 0.5 ' C ' ' H ' ' A' ' 993' ' ' PHE . . . 82.47 6.53 88.55 Favored Glycine 0 C--N 1.336 0.56 0 CA-C-O 118.744 -1.031 . . . . 1.0 112.876 179.171 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -57.45 0.26 0.05 Allowed 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 120.056 1.928 . . . . 1.0 112.997 -177.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 993' ' ' PHE . . . . . 0.5 ' H ' ' C ' ' A' ' 991' ' ' GLY . 10.3 m-85 -92.12 7.74 41.09 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.379 0.609 . . . . 1.0 109.688 179.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 994' ' ' LYS . . . . . . . . . . . . . 6.6 tttp 62.71 105.22 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.182 -0.917 . . . . 1.0 110.866 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 92.4 mtm-85 -64.98 -40.57 95.16 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.898 -0.592 . . . . 1.0 110.903 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 996' ' ' ASN . . . . . . . . . . . . . 43.5 p-10 -157.05 171.93 19.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.114 -0.494 . . . . 1.0 110.549 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 997' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.73 160.17 26.98 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 115.88 -0.6 . . . . 1.0 110.205 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 998' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo . . . . . 0 C--N 1.308 -1.581 0 C-N-CA 122.415 2.076 . . . . 1.0 112.033 179.529 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 957' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.216 0 N-CA-C 109.402 -1.479 . . . . 1.0 109.402 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -70.15 140.05 52.54 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.757 -0.377 . . . . 1.0 110.318 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 78.7 mt -61.72 -41.62 97.87 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.29 -0.414 . . . . 1.0 110.696 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 960' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -64.81 -41.57 95.68 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.992 -0.549 . . . . 1.0 111.074 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 961' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -127.94 111.68 13.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.31 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 962' ' ' ARG . . . . . . . . . . . . . 77.4 ttt180 -76.49 142.04 41.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.321 -0.4 . . . . 1.0 110.374 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 963' ' ' ALA . . . . . . . . . . . . . . . -68.03 138.97 56.26 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.397 -0.365 . . . . 1.0 110.147 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 964' ' ' ILE . . . . . 0.422 HG21 HD12 ' A' ' 964' ' ' ILE . 0.6 OUTLIER -135.95 155.29 77.87 Favored Pre-proline 0 CA--C 1.534 0.36 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.449 179.93 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.42 -10.55 27.16 Favored 'Trans proline' 0 N--CA 1.498 1.755 0 C-N-CA 122.87 2.38 . . . . 1.0 113.205 -179.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 42.3 mm -60.46 -48.94 86.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.666 -0.243 . . . . 1.0 111.058 -179.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 967' ' ' TRP . . . . . . . . . . . . . 81.7 m95 -63.1 -36.37 83.37 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.636 -0.425 . . . . 1.0 110.621 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 95.3 m95 -68.73 -36.72 78.77 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.3 178.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 56.1 t -66.02 -43.88 92.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.149 -0.685 . . . . 1.0 109.149 178.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 62.9 tp -62.72 -41.94 99.41 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.179 -0.919 . . . . 1.0 109.484 179.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 971' ' ' VAL . . . . . . . . . . . . . 41.6 t -63.47 -45.79 96.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.165 -0.47 . . . . 1.0 111.321 -179.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -62.51 -44.17 97.96 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-N 116.253 -0.43 . . . . 1.0 113.532 -178.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 35.0 m -68.29 -42.96 84.8 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 CA-C-O 120.787 0.327 . . . . 1.0 110.861 -178.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 97.9 mt -63.09 -40.17 96.86 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.444 -0.947 . . . . 1.0 108.444 178.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -66.13 -46.75 78.05 Favored Glycine 0 C--N 1.33 0.222 0 N-CA-C 110.447 -1.061 . . . . 1.0 110.447 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -59.33 -36.16 87.83 Favored Glycine 0 N--CA 1.448 -0.514 0 N-CA-C 108.804 -1.718 . . . . 1.0 108.804 178.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 58.9 tp -65.54 -43.64 89.32 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.17 -0.612 . . . . 1.0 109.719 178.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 45.7 tp -61.84 -45.45 93.77 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.653 -0.419 . . . . 1.0 110.436 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 10.8 mp -63.18 -43.16 99.0 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 119.935 -0.706 . . . . 1.0 110.719 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 980' ' ' LEU . . . . . . . . . . . . . 80.7 mt -63.94 -40.85 97.4 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 121.186 0.517 . . . . 1.0 110.149 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 8.2 m -62.75 -46.79 86.42 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.37 -0.832 . . . . 1.0 110.015 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 88.9 mt -63.84 -43.83 97.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 C-N-CA 120.633 -0.427 . . . . 1.0 111.203 -179.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 91.1 mt -65.2 -41.07 94.88 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.519 -0.309 . . . . 1.0 111.03 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 984' ' ' VAL . . . . . . . . . . . . . 72.0 t -70.02 -50.16 50.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.064 0.459 . . . . 1.0 110.449 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 89.8 mt -63.79 -42.92 97.63 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.783 -0.644 . . . . 1.0 109.622 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 986' ' ' ALA . . . . . . . . . . . . . . . -62.53 -43.28 99.2 Favored 'General case' 0 CA--C 1.511 -0.531 0 N-CA-C 108.926 -0.768 . . . . 1.0 108.926 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 31.5 mtp -61.95 -30.53 70.97 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 122.512 1.148 . . . . 1.0 109.073 178.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 988' ' ' TRP . . . . . . . . . . . . . 1.6 t90 -74.02 -36.98 64.48 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 113.64 -1.618 . . . . 1.0 107.874 179.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.71 -39.05 73.64 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.595 0.712 . . . . 1.0 110.248 -179.359 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 990' ' ' VAL . . . . . . . . . . . . . 1.1 m -81.76 -7.28 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-N 114.967 -1.015 . . . . 1.0 110.09 -179.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 991' ' ' GLY . . . . . 0.54 ' C ' ' H ' ' A' ' 993' ' ' PHE . . . 81.85 3.73 90.51 Favored Glycine 0 C--N 1.34 0.79 0 CA-C-O 119.136 -0.813 . . . . 1.0 112.414 178.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -52.63 -1.56 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 119.45 1.625 . . . . 1.0 112.932 -177.016 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 993' ' ' PHE . . . . . 0.54 ' H ' ' C ' ' A' ' 991' ' ' GLY . 15.4 m-85 -90.45 -1.88 57.92 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.287 0.565 . . . . 1.0 110.433 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 994' ' ' LYS . . . . . 0.406 ' CG ' ' O ' ' A' ' 993' ' ' PHE . 96.9 mttt -161.58 -39.64 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 114.948 -1.024 . . . . 1.0 112.253 -179.421 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 71.4 ttt180 -72.82 134.68 44.99 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.125 -0.488 . . . . 1.0 109.877 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 996' ' ' ASN . . . . . . . . . . . . . 60.0 t30 58.66 41.32 22.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.348 -0.387 . . . . 1.0 111.056 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 997' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -50.13 157.66 1.1 Allowed Pre-proline 0 C--N 1.329 -0.284 0 N-CA-C 109.942 -0.392 . . . . 1.0 109.942 179.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 998' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo . . . . . 0 C--N 1.308 -1.556 0 C-N-CA 122.507 2.138 . . . . 1.0 111.898 179.84 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 957' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.321 0 N-CA-C 109.94 -1.264 . . . . 1.0 109.94 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -62.49 -34.85 77.68 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.679 0.276 . . . . 1.0 110.726 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 52.8 tp -64.09 -39.84 94.93 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.956 0.408 . . . . 1.0 110.45 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 960' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -66.37 -37.52 85.47 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.964 -0.562 . . . . 1.0 110.047 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 961' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -66.04 137.86 57.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.949 -0.569 . . . . 1.0 110.757 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 962' ' ' ARG . . . . . . . . . . . . . 74.7 ttt180 -60.1 -43.81 95.3 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.661 -0.7 . . . . 1.0 110.338 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 963' ' ' ALA . . . . . . . . . . . . . . . -107.37 132.59 52.98 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.991 -0.55 . . . . 1.0 109.78 179.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 964' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -87.63 156.06 53.33 Favored Pre-proline 0 C--N 1.324 -0.505 0 N-CA-C 109.375 -0.602 . . . . 1.0 109.375 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -76.83 48.33 2.43 Favored 'Trans proline' 0 N--CA 1.496 1.637 0 C-N-CA 122.407 2.071 . . . . 1.0 112.21 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 966' ' ' ILE . . . . . 0.407 ' CG2' ' N ' ' A' ' 967' ' ' TRP . 20.5 tt -66.16 -43.29 92.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.736 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 967' ' ' TRP . . . . . 0.407 ' N ' ' CG2' ' A' ' 966' ' ' ILE . 98.7 m95 -54.83 -37.24 65.92 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.516 -0.311 . . . . 1.0 110.877 -179.411 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -69.25 -34.88 75.47 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 110.029 -0.36 . . . . 1.0 110.029 179.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 75.3 t -68.52 -47.02 79.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.203 0.525 . . . . 1.0 110.489 178.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 8.8 mp -64.01 -41.68 97.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.509 -0.768 . . . . 1.0 110.18 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 971' ' ' VAL . . . . . . . . . . . . . 59.1 t -62.3 -44.53 99.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.879 0.371 . . . . 1.0 110.541 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -61.43 -40.49 98.74 Favored Glycine 0 CA--C 1.529 0.915 0 CA-C-N 116.064 -0.516 . . . . 1.0 112.006 -179.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 75.9 t -67.0 -45.26 87.46 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.519 0 CA-C-N 115.445 -0.378 . . . . 1.0 110.735 -178.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 9.2 mp -62.5 -40.23 96.06 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.597 -0.89 . . . . 1.0 108.597 178.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -65.07 -45.8 90.78 Favored Glycine 0 N--CA 1.46 0.247 0 N-CA-C 110.29 -1.124 . . . . 1.0 110.29 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -59.69 -36.73 90.74 Favored Glycine 0 N--CA 1.444 -0.767 0 N-CA-C 108.771 -1.731 . . . . 1.0 108.771 178.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 55.7 tp -66.86 -44.11 81.83 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.187 -0.605 . . . . 1.0 110.514 179.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 83.2 mt -62.54 -44.94 95.09 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.091 -0.643 . . . . 1.0 110.757 -179.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 10.2 mp -63.51 -44.11 95.22 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 119.675 -0.81 . . . . 1.0 111.924 -179.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 980' ' ' LEU . . . . . . . . . . . . . 7.1 mp -63.83 -37.65 88.15 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.156 -0.618 . . . . 1.0 110.79 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 5.4 m -65.5 -46.61 79.04 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.521 -179.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 80.1 mt -63.11 -43.41 98.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 120.495 -0.482 . . . . 1.0 110.732 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 57.1 mt -63.66 -41.78 98.17 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 121.153 -0.219 . . . . 1.0 110.722 179.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 984' ' ' VAL . . . . . . . . . . . . . 56.6 t -68.38 -47.99 75.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 120.928 0.394 . . . . 1.0 110.052 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 84.3 mt -62.63 -42.41 99.58 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.937 -0.574 . . . . 1.0 109.524 179.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 986' ' ' ALA . . . . . . . . . . . . . . . -63.26 -44.32 95.48 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 121.696 0.76 . . . . 1.0 108.981 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 30.7 mtp -62.11 -32.44 73.01 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 114.566 -1.197 . . . . 1.0 109.159 178.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 988' ' ' TRP . . . . . . . . . . . . . 2.0 t90 -72.32 -38.25 68.73 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.292 -1.322 . . . . 1.0 108.104 178.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.58 -39.62 84.85 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.335 -0.848 . . . . 1.0 110.306 -179.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 990' ' ' VAL . . . . . . . . . . . . . 1.2 m -83.88 -8.94 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-N 115.286 -0.87 . . . . 1.0 110.956 -178.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 991' ' ' GLY . . . . . 0.584 ' C ' ' H ' ' A' ' 993' ' ' PHE . . . 82.58 4.24 90.19 Favored Glycine 0 C--N 1.338 0.671 0 CA-C-O 119.245 -0.753 . . . . 1.0 112.703 178.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -53.02 -2.91 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 119.259 1.529 . . . . 1.0 111.867 -177.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 993' ' ' PHE . . . . . 0.584 ' H ' ' C ' ' A' ' 991' ' ' GLY . 11.7 m-85 -84.88 -1.57 56.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.037 0.446 . . . . 1.0 109.916 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 994' ' ' LYS . . . . . . . . . . . . . 14.2 mttt 54.8 -178.93 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.671 -0.695 . . . . 1.0 111.656 179.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 97.1 mtt-85 -81.94 147.01 29.47 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.36 -0.837 . . . . 1.0 110.355 -179.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 996' ' ' ASN . . . . . . . . . . . . . 63.3 t-20 -95.85 106.05 18.14 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.135 0.493 . . . . 1.0 111.511 -179.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 997' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.4 159.57 65.75 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 115.791 -0.64 . . . . 1.0 110.211 179.452 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 998' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo . . . . . 0 N--CA 1.498 1.79 0 C-N-CA 122.947 2.431 . . . . 1.0 112.689 -179.79 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 957' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.351 0 N-CA-C 109.941 -1.263 . . . . 1.0 109.941 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -71.9 148.45 46.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.001 0.429 . . . . 1.0 111.385 -179.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 84.7 mt -110.23 140.33 44.48 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.755 -0.657 . . . . 1.0 109.832 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 960' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -63.22 -35.2 79.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.532 -0.304 . . . . 1.0 110.923 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 961' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -63.63 -39.33 94.08 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 120.776 -0.37 . . . . 1.0 110.677 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 962' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -62.86 -40.83 98.67 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.886 0.374 . . . . 1.0 110.261 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 963' ' ' ALA . . . . . . . . . . . . . . . 44.19 -158.85 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.468 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 964' ' ' ILE . . . . . 0.446 ' O ' ' CG2' ' A' ' 964' ' ' ILE . 3.7 tt -172.37 74.63 0.45 Allowed Pre-proline 0 C--N 1.328 -0.33 0 C-N-CA 120.875 -0.33 . . . . 1.0 110.889 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -80.19 47.54 2.57 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.893 2.395 . . . . 1.0 112.19 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 966' ' ' ILE . . . . . 0.438 ' CG2' ' N ' ' A' ' 967' ' ' TRP . 19.9 tt -66.13 -41.43 89.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.627 -0.715 . . . . 1.0 111.236 -179.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 967' ' ' TRP . . . . . 0.438 ' N ' ' CG2' ' A' ' 966' ' ' ILE . 98.3 m95 -55.82 -36.5 67.54 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 120.895 -0.322 . . . . 1.0 111.498 -178.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -70.24 -36.84 74.78 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.605 -0.27 . . . . 1.0 110.475 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 73.8 t -66.66 -44.35 89.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 108.937 -0.764 . . . . 1.0 108.937 178.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 60.9 tp -62.96 -43.2 99.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.817 -1.083 . . . . 1.0 109.499 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 971' ' ' VAL . . . . . . . . . . . . . 56.2 t -61.93 -46.19 97.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.391 -0.368 . . . . 1.0 111.102 -179.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.15 -40.6 97.43 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 111.612 -0.595 . . . . 1.0 111.612 -179.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 64.8 t -66.8 -48.37 80.05 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.483 0 CA-C-O 121.028 0.442 . . . . 1.0 111.068 -178.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -62.74 -41.2 99.08 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 109.297 -0.631 . . . . 1.0 109.297 179.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -65.16 -43.52 95.37 Favored Glycine 0 C--O 1.229 -0.172 0 N-CA-C 109.456 -1.457 . . . . 1.0 109.456 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -62.01 -37.24 94.09 Favored Glycine 0 CA--C 1.521 0.462 0 N-CA-C 109.759 -1.336 . . . . 1.0 109.759 179.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 60.7 tp -67.81 -44.53 77.06 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 109.856 -0.424 . . . . 1.0 109.856 179.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -62.16 -43.81 98.0 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.329 -0.548 . . . . 1.0 110.28 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 86.3 mt -62.88 -43.67 98.18 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.07 -0.652 . . . . 1.0 110.62 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 980' ' ' LEU . . . . . . . . . . . . . 64.4 mt -63.99 -40.62 96.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.123 0.487 . . . . 1.0 110.269 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 7.5 m -63.4 -45.78 89.46 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.439 -0.801 . . . . 1.0 109.725 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 85.6 mt -63.97 -44.71 97.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.266 -0.425 . . . . 1.0 111.118 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 56.9 tp -64.89 -43.55 92.54 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.171 -0.468 . . . . 1.0 111.397 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 984' ' ' VAL . . . . . . . . . . . . . 51.9 t -66.71 -47.97 81.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.438 0.637 . . . . 1.0 110.134 -179.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 81.6 mt -63.22 -42.9 99.32 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.07 -0.968 . . . . 1.0 109.605 178.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 986' ' ' ALA . . . . . . . . . . . . . . . -61.98 -44.92 95.74 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-O 121.348 0.594 . . . . 1.0 109.487 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 19.6 mtp -62.17 -30.29 70.96 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 122.349 1.071 . . . . 1.0 109.563 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 988' ' ' TRP . . . . . . . . . . . . . 1.7 t90 -74.75 -38.09 62.33 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.018 -1.446 . . . . 1.0 108.396 178.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.88 -39.94 79.53 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.467 -0.788 . . . . 1.0 109.741 -179.068 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 990' ' ' VAL . . . . . . . . . . . . . 1.4 m -82.14 -7.9 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 CA-C-N 114.829 -1.078 . . . . 1.0 110.408 -179.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 991' ' ' GLY . . . . . 0.574 ' C ' ' H ' ' A' ' 993' ' ' PHE . . . 82.4 3.41 90.55 Favored Glycine 0 C--N 1.336 0.567 0 CA-C-O 119.366 -0.685 . . . . 1.0 112.385 178.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -52.67 -1.37 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 119.624 1.712 . . . . 1.0 112.418 -177.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 993' ' ' PHE . . . . . 0.574 ' H ' ' C ' ' A' ' 991' ' ' GLY . 14.0 m-85 -89.3 4.91 47.27 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 120.713 -0.395 . . . . 1.0 111.497 -179.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 994' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -51.75 134.88 30.22 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 108.764 -0.828 . . . . 1.0 108.764 178.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -101.04 0.09 37.38 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.366 -0.379 . . . . 1.0 111.363 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 996' ' ' ASN . . . . . . . . . . . . . 63.2 t-20 -65.36 -40.0 93.04 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.815 0.34 . . . . 1.0 110.875 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 997' ' ' ARG . . . . . . . . . . . . . 10.0 mpt_? -44.5 154.9 0.39 Allowed Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.184 -0.462 . . . . 1.0 111.198 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 998' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo . . . . . 0 N--CA 1.494 1.51 0 C-N-CA 122.626 2.217 . . . . 1.0 112.056 179.061 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 957' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.258 0 N-CA-C 109.498 -1.441 . . . . 1.0 109.498 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -65.74 151.26 47.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.752 0.31 . . . . 1.0 110.606 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 72.9 mt -101.64 126.17 48.43 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.136 0.494 . . . . 1.0 111.1 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 960' ' ' GLU . . . . . . . . . . . . . 51.0 tp10 -71.23 -37.98 72.01 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.436 -0.802 . . . . 1.0 109.724 178.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 961' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -71.15 139.53 50.26 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.994 -0.548 . . . . 1.0 110.502 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 962' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -72.18 149.73 44.39 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.052 0.453 . . . . 1.0 110.571 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 963' ' ' ALA . . . . . . . . . . . . . . . -64.62 -40.35 95.32 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.796 -0.638 . . . . 1.0 110.837 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 964' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -114.49 169.58 6.45 Favored Pre-proline 0 CA--C 1.535 0.373 0 CA-C-N 116.154 -0.476 . . . . 1.0 109.899 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -59.42 145.44 97.93 Favored 'Trans proline' 0 N--CA 1.496 1.651 0 C-N-CA 121.558 1.505 . . . . 1.0 112.275 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 966' ' ' ILE . . . . . 0.424 ' CG2' ' N ' ' A' ' 967' ' ' TRP . 18.7 tt -66.63 -39.82 84.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.888 -0.597 . . . . 1.0 110.598 -179.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 967' ' ' TRP . . . . . 0.424 ' N ' ' CG2' ' A' ' 966' ' ' ILE . 97.7 m95 -53.84 -38.85 65.06 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.016 -0.538 . . . . 1.0 111.101 -179.051 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 23.9 m95 -69.3 -34.66 75.03 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.569 -0.287 . . . . 1.0 110.557 178.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 93.8 t -66.97 -44.61 88.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 108.715 -0.846 . . . . 1.0 108.715 178.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 80.1 mt -63.16 -41.43 99.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.728 -1.124 . . . . 1.0 109.39 178.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 971' ' ' VAL . . . . . . . . . . . . . 66.8 t -61.88 -45.0 99.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 CA-C-O 120.989 0.423 . . . . 1.0 109.978 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -59.83 -41.05 97.49 Favored Glycine 0 CA--C 1.523 0.594 0 N-CA-C 111.301 -0.72 . . . . 1.0 111.301 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 54.1 t -65.63 -45.16 93.0 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.374 0 CA-C-N 115.333 -0.434 . . . . 1.0 109.882 -179.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 86.9 mt -62.25 -42.18 99.1 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.197 -0.668 . . . . 1.0 109.197 178.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -65.96 -45.74 85.95 Favored Glycine 0 N--CA 1.459 0.175 0 N-CA-C 110.26 -1.136 . . . . 1.0 110.26 -179.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -60.92 -37.98 94.66 Favored Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 109.142 -1.583 . . . . 1.0 109.142 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 56.2 tp -65.82 -44.46 85.55 Favored 'General case' 0 C--O 1.226 -0.172 0 N-CA-C 109.736 -0.468 . . . . 1.0 109.736 178.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 50.6 tp -62.42 -46.04 90.38 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.375 -0.53 . . . . 1.0 110.642 -179.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 87.8 mt -62.58 -44.5 96.15 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.281 -0.567 . . . . 1.0 110.952 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 980' ' ' LEU . . . . . . . . . . . . . 80.7 mt -63.58 -40.92 98.19 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.852 -0.425 . . . . 1.0 109.852 -179.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 6.8 m -63.96 -46.84 82.9 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.718 -0.674 . . . . 1.0 110.64 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 93.4 mt -63.59 -44.41 98.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 120.807 -0.357 . . . . 1.0 111.562 -178.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 93.9 mt -64.76 -40.18 94.86 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.727 -0.389 . . . . 1.0 110.976 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 984' ' ' VAL . . . . . . . . . . . . . 38.9 t -69.02 -48.05 72.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.257 0.551 . . . . 1.0 111.014 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 86.5 mt -62.96 -42.63 99.88 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.037 -0.727 . . . . 1.0 109.037 178.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 986' ' ' ALA . . . . . . . . . . . . . . . -63.52 -44.6 93.78 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.265 0.555 . . . . 1.0 110.11 -179.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 21.5 mtp -63.52 -31.12 72.19 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 122.527 1.156 . . . . 1.0 110.153 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 988' ' ' TRP . . . . . 0.439 ' O ' ' CD1' ' A' ' 988' ' ' TRP . 14.0 t90 -75.89 -35.03 59.98 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.163 -1.38 . . . . 1.0 108.313 179.128 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.5 -38.36 74.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.468 0.651 . . . . 1.0 109.807 -179.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 990' ' ' VAL . . . . . . . . . . . . . 1.6 m -78.96 0.2 3.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.19 -0.913 . . . . 1.0 109.394 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 991' ' ' GLY . . . . . 0.446 ' O ' ' N ' ' A' ' 994' ' ' LYS . . . 79.69 1.13 86.44 Favored Glycine 0 CA--C 1.506 -0.502 0 CA-C-O 119.478 -0.623 . . . . 1.0 112.252 177.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -48.38 -41.45 28.89 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-N 118.88 1.34 . . . . 1.0 111.256 -176.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 993' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -81.85 -6.21 58.89 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.819 0.819 . . . . 1.0 111.009 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 994' ' ' LYS . . . . . 0.446 ' N ' ' O ' ' A' ' 991' ' ' GLY . 98.2 mttt -95.74 145.8 25.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.161 -1.381 . . . . 1.0 108.222 176.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -66.58 -39.39 88.44 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.949 -0.568 . . . . 1.0 110.448 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 996' ' ' ASN . . . . . . . . . . . . . 29.7 t-20 -95.45 107.45 19.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.984 -0.553 . . . . 1.0 111.014 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 997' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.72 160.37 82.09 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.07 -0.513 . . . . 1.0 109.937 179.247 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 998' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo . . . . . 0 C--N 1.309 -1.536 0 C-N-CA 122.347 2.032 . . . . 1.0 111.875 179.922 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 957' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.202 0 N-CA-C 109.22 -1.552 . . . . 1.0 109.22 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -64.41 -37.81 88.83 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.044 0.45 . . . . 1.0 109.869 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 41.7 tp -114.47 124.86 52.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.482 -0.781 . . . . 1.0 109.797 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 960' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -72.03 141.79 49.3 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.594 -0.443 . . . . 1.0 110.565 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 961' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -68.75 -28.23 66.62 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.786 -0.643 . . . . 1.0 111.029 -179.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 962' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -91.37 16.55 9.92 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.531 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 963' ' ' ALA . . . . . . . . . . . . . . . -58.92 -42.55 89.94 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.093 -0.503 . . . . 1.0 110.98 -179.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 964' ' ' ILE . . . . . . . . . . . . . 42.0 mt 46.89 84.52 0.19 Allowed Pre-proline 0 C--N 1.327 -0.388 0 C-N-CA 120.825 -0.35 . . . . 1.0 111.106 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -58.25 147.21 85.53 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.197 1.931 . . . . 1.0 111.846 179.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 45.2 pt -67.7 -24.45 30.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 116.318 -0.401 . . . . 1.0 111.312 -179.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 967' ' ' TRP . . . . . . . . . . . . . 98.2 m95 -52.03 -37.68 54.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.254 -0.43 . . . . 1.0 111.181 -179.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 99.7 m95 -70.29 -35.58 73.81 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.571 -0.286 . . . . 1.0 110.334 179.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 86.2 t -67.31 -45.63 85.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 N-CA-C 109.107 -0.701 . . . . 1.0 109.107 178.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 10.0 mp -63.29 -43.01 99.1 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.656 -0.702 . . . . 1.0 109.866 178.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 971' ' ' VAL . . . . . . . . . . . . . 77.8 t -62.37 -45.06 99.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.378 -0.374 . . . . 1.0 110.922 -179.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.45 -41.48 98.62 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 112.074 -0.41 . . . . 1.0 112.074 -179.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 84.5 t -66.61 -45.97 87.22 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.306 0 CA-C-N 115.195 -0.503 . . . . 1.0 110.392 -178.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 90.7 mt -62.41 -41.38 98.63 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 109.042 -0.725 . . . . 1.0 109.042 178.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -65.77 -46.0 85.54 Favored Glycine 0 C--N 1.331 0.299 0 N-CA-C 110.26 -1.136 . . . . 1.0 110.26 -179.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -60.77 -37.48 93.68 Favored Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 109.195 -1.562 . . . . 1.0 109.195 179.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 56.0 tp -66.97 -43.28 83.44 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.49 -0.484 . . . . 1.0 109.936 178.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 39.9 mt -61.94 -44.94 95.73 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.359 -0.382 . . . . 1.0 110.223 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 94.8 mt -62.86 -42.96 99.95 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 119.669 -0.812 . . . . 1.0 110.315 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 980' ' ' LEU . . . . . . . . . . . . . 81.1 mt -64.17 -41.57 97.08 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.964 0.411 . . . . 1.0 111.093 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 7.5 m -62.81 -47.63 82.61 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.693 -0.685 . . . . 1.0 110.188 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 84.7 mt -63.61 -44.28 98.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 116.111 -0.495 . . . . 1.0 111.117 -179.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 15.1 tp -64.19 -43.14 95.99 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.498 -0.319 . . . . 1.0 110.955 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 984' ' ' VAL . . . . . . . . . . . . . 54.1 t -68.57 -48.7 70.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.171 0.51 . . . . 1.0 110.974 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 83.5 mt -62.15 -42.61 99.43 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.805 -0.813 . . . . 1.0 108.805 179.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 986' ' ' ALA . . . . . . . . . . . . . . . -61.69 -44.01 97.76 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 109.062 -0.718 . . . . 1.0 109.062 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 27.4 mtp -61.59 -30.87 70.95 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.761 -1.108 . . . . 1.0 108.964 178.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 988' ' ' TRP . . . . . . . . . . . . . 1.7 t90 -73.46 -38.64 65.4 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 113.928 -1.487 . . . . 1.0 108.455 179.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.2 -37.79 78.29 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.594 -0.73 . . . . 1.0 110.378 -179.204 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 990' ' ' VAL . . . . . . . . . . . . . 1.3 m -85.16 -7.56 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 CA-C-N 115.116 -0.947 . . . . 1.0 110.668 -178.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 991' ' ' GLY . . . . . 0.532 ' C ' ' H ' ' A' ' 993' ' ' PHE . . . 80.02 6.51 89.11 Favored Glycine 0 C--N 1.339 0.719 0 CA-C-O 119.264 -0.742 . . . . 1.0 112.192 179.307 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -53.0 -1.58 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 119.32 1.56 . . . . 1.0 112.736 -176.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 993' ' ' PHE . . . . . 0.532 ' H ' ' C ' ' A' ' 991' ' ' GLY . 17.1 m-85 -93.15 0.7 57.26 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.401 0.62 . . . . 1.0 110.704 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 994' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -158.22 140.52 14.27 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 114.823 -1.08 . . . . 1.0 113.01 -179.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 92.0 mtm-85 -80.17 148.58 30.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 1.0 111.022 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 996' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -101.07 141.55 33.8 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.958 -0.565 . . . . 1.0 109.819 179.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 997' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.02 159.0 44.65 Favored Pre-proline 0 N--CA 1.463 0.222 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.587 -179.566 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 998' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_exo . . . . . 0 C--N 1.313 -1.322 0 C-N-CA 122.549 2.166 . . . . 1.0 112.339 179.817 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 957' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.283 0 N-CA-C 109.557 -1.417 . . . . 1.0 109.557 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -68.46 132.43 46.98 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.976 0.417 . . . . 1.0 110.707 -179.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 93.4 mt -61.4 -41.97 97.99 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.824 -0.626 . . . . 1.0 110.532 -179.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 960' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -56.84 140.5 47.88 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.081 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 961' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -72.26 140.75 48.79 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.343 -0.39 . . . . 1.0 110.473 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 962' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -69.05 -39.82 78.94 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.492 -0.322 . . . . 1.0 111.039 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 963' ' ' ALA . . . . . . . . . . . . . . . 43.01 -165.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 1.0 111.11 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 964' ' ' ILE . . . . . . . . . . . . . 2.1 pt -130.11 59.35 44.64 Favored Pre-proline 0 N--CA 1.464 0.248 0 CA-C-N 116.2 -0.454 . . . . 1.0 111.191 -179.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -67.66 -20.02 47.17 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 122.504 2.136 . . . . 1.0 112.487 179.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 45.7 mm -64.01 -48.05 87.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.638 -0.256 . . . . 1.0 111.461 -179.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 967' ' ' TRP . . . . . . . . . . . . . 89.7 m95 -61.08 -36.59 80.05 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.589 0.233 . . . . 1.0 111.559 -179.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 88.8 m95 -71.04 -35.18 71.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.724 -0.216 . . . . 1.0 110.837 179.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 76.0 t -67.14 -44.88 87.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 108.808 -0.812 . . . . 1.0 108.808 178.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 59.4 tp -64.07 -43.02 96.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.039 -0.982 . . . . 1.0 110.199 179.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 971' ' ' VAL . . . . . . . . . . . . . 51.0 t -62.99 -45.14 99.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.959 0.409 . . . . 1.0 111.294 -179.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.29 -41.03 98.2 Favored Glycine 0 CA--C 1.528 0.882 0 CA-C-N 116.025 -0.534 . . . . 1.0 111.853 -179.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 74.8 t -66.95 -47.5 82.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.115 0.483 . . . . 1.0 111.092 -178.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -62.87 -40.88 98.85 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.88 -0.6 . . . . 1.0 109.499 178.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -65.97 -45.27 88.86 Favored Glycine 0 CA--C 1.513 -0.051 0 N-CA-C 109.869 -1.292 . . . . 1.0 109.869 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -61.26 -37.39 93.94 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 109.233 -1.547 . . . . 1.0 109.233 178.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 53.5 tp -64.87 -42.48 94.8 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 109.433 -0.581 . . . . 1.0 109.433 178.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 60.3 tp -62.28 -44.82 95.64 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.894 -0.409 . . . . 1.0 109.894 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 92.3 mt -62.59 -45.09 94.51 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.462 -0.495 . . . . 1.0 111.355 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 980' ' ' LEU . . . . . . . . . . . . . 9.2 mp -63.05 -39.28 94.28 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.322 -0.551 . . . . 1.0 110.217 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 7.8 m -62.5 -47.3 84.58 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.839 -0.619 . . . . 1.0 110.846 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 96.4 mt -64.21 -44.6 97.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.39 -0.368 . . . . 1.0 111.863 -178.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 7.5 mp -65.08 -40.09 94.13 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 120.663 -0.415 . . . . 1.0 110.943 179.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 984' ' ' VAL . . . . . . . . . . . . . 55.7 t -68.47 -48.85 70.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.288 -0.414 . . . . 1.0 110.367 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 86.3 mt -64.4 -41.77 96.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.959 -0.564 . . . . 1.0 109.53 178.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 986' ' ' ALA . . . . . . . . . . . . . . . -62.96 -43.87 97.6 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-O 121.689 0.757 . . . . 1.0 109.032 -179.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 32.7 mtp -62.57 -31.13 71.89 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 114.415 -1.266 . . . . 1.0 109.174 178.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 988' ' ' TRP . . . . . . . . . . . . . 1.6 t90 -74.22 -37.82 63.73 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 113.957 -1.474 . . . . 1.0 108.037 179.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.24 -39.43 78.49 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.944 0.878 . . . . 1.0 110.303 -179.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 990' ' ' VAL . . . . . . . . . . . . . 1.4 m -82.57 -7.94 11.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 114.92 -1.036 . . . . 1.0 110.57 -178.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 991' ' ' GLY . . . . . 0.59 ' C ' ' H ' ' A' ' 993' ' ' PHE . . . 82.68 2.94 90.69 Favored Glycine 0 C--N 1.339 0.698 0 CA-C-O 119.145 -0.808 . . . . 1.0 112.439 178.758 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -52.63 -1.37 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 119.723 1.762 . . . . 1.0 112.112 -177.505 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 993' ' ' PHE . . . . . 0.59 ' H ' ' C ' ' A' ' 991' ' ' GLY . 10.4 m-85 -87.33 2.53 50.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.567 -0.288 . . . . 1.0 111.44 -179.053 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 994' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -55.11 135.51 49.12 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.419 -0.956 . . . . 1.0 108.419 177.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 93.1 mtt180 -103.41 135.91 44.14 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.897 -0.321 . . . . 1.0 110.66 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 996' ' ' ASN . . . . . . . . . . . . . 66.1 t30 56.98 47.48 17.54 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 116.022 -0.535 . . . . 1.0 111.191 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 997' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -49.57 153.48 1.95 Allowed Pre-proline 0 N--CA 1.466 0.34 0 CA-C-N 116.423 -0.353 . . . . 1.0 110.52 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 998' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo . . . . . 0 N--CA 1.495 1.572 0 C-N-CA 122.338 2.026 . . . . 1.0 112.43 -179.96 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 957' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.327 0 N-CA-C 109.968 -1.253 . . . . 1.0 109.968 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -62.87 -38.21 89.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.998 0.427 . . . . 1.0 110.711 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 96.9 mt -61.64 -43.25 99.21 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.852 -0.613 . . . . 1.0 110.628 -179.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 960' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -70.13 133.34 47.03 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.836 0.351 . . . . 1.0 110.148 179.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 961' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -68.97 -40.49 78.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.038 -0.528 . . . . 1.0 111.092 -179.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 962' ' ' ARG . . . . . . . . . . . . . 94.5 mtt-85 -74.71 143.66 44.07 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.377 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 963' ' ' ALA . . . . . . . . . . . . . . . -148.32 13.2 0.96 Allowed 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.855 -0.338 . . . . 1.0 111.291 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 964' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -134.53 82.87 44.44 Favored Pre-proline 0 CA--C 1.536 0.423 0 CA-C-O 120.917 0.389 . . . . 1.0 110.351 -179.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -85.57 11.51 3.33 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.891 2.394 . . . . 1.0 112.588 -179.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 966' ' ' ILE . . . . . 0.439 ' CG2' ' N ' ' A' ' 967' ' ' TRP . 20.7 tt -65.52 -39.68 85.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.243 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 967' ' ' TRP . . . . . 0.439 ' N ' ' CG2' ' A' ' 966' ' ' ILE . 88.5 m95 -56.22 -39.68 72.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.178 -0.464 . . . . 1.0 111.358 -179.239 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 96.1 m95 -68.43 -34.91 76.83 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 110.117 -0.327 . . . . 1.0 110.117 179.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 57.1 t -67.14 -43.96 88.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 CA-C-O 121.649 0.737 . . . . 1.0 109.06 178.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 98.2 mt -63.34 -42.55 98.94 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 114.749 -1.114 . . . . 1.0 109.675 179.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 971' ' ' VAL . . . . . . . . . . . . . 71.0 t -62.27 -45.31 99.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.064 0.459 . . . . 1.0 110.507 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.49 -41.34 98.63 Favored Glycine 0 C--N 1.332 0.306 0 N-CA-C 111.271 -0.732 . . . . 1.0 111.271 -179.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 84.4 t -65.57 -47.56 85.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 114.971 -0.615 . . . . 1.0 110.678 -179.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 78.3 mt -61.36 -40.43 94.27 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.697 -0.853 . . . . 1.0 108.697 178.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -64.54 -46.04 91.35 Favored Glycine 0 N--CA 1.461 0.305 0 N-CA-C 110.843 -0.903 . . . . 1.0 110.843 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -60.86 -36.93 92.86 Favored Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 109.474 -1.45 . . . . 1.0 109.474 179.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 82.2 mt -67.3 -43.21 82.29 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 120.4 -0.52 . . . . 1.0 110.619 179.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 55.7 tp -61.94 -44.89 95.82 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.673 -0.411 . . . . 1.0 110.178 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 97.2 mt -63.77 -42.92 97.7 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 120.187 -0.605 . . . . 1.0 110.91 -179.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 980' ' ' LEU . . . . . . . . . . . . . 76.2 mt -64.03 -39.52 94.27 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.918 0.39 . . . . 1.0 110.362 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 7.1 m -64.12 -46.67 83.16 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.877 -0.601 . . . . 1.0 109.764 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 90.9 mt -62.65 -44.46 99.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.052 -0.522 . . . . 1.0 111.145 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 97.6 mt -64.72 -40.69 95.77 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.728 -0.389 . . . . 1.0 111.143 179.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 984' ' ' VAL . . . . . . . . . . . . . 46.7 t -67.99 -48.09 76.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.04 0.448 . . . . 1.0 110.323 179.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 85.2 mt -64.17 -43.83 93.91 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.733 -0.667 . . . . 1.0 109.564 179.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 986' ' ' ALA . . . . . . . . . . . . . . . -62.09 -44.94 95.57 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-O 121.361 0.601 . . . . 1.0 109.397 -179.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 30.9 mtp -61.99 -34.19 75.72 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 114.885 -1.052 . . . . 1.0 109.537 179.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 988' ' ' TRP . . . . . 0.463 ' O ' ' CD1' ' A' ' 988' ' ' TRP . 13.0 t90 -73.25 -36.02 66.32 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 114.137 -1.392 . . . . 1.0 108.527 179.33 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.22 -41.38 77.13 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 115.402 -0.817 . . . . 1.0 109.912 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 990' ' ' VAL . . . . . . . . . . . . . 1.2 m -82.42 -8.7 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 CA-C-N 114.811 -1.086 . . . . 1.0 110.062 -179.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 991' ' ' GLY . . . . . 0.553 ' C ' ' H ' ' A' ' 993' ' ' PHE . . . 82.2 5.14 89.9 Favored Glycine 0 C--N 1.342 0.91 0 CA-C-O 119.15 -0.805 . . . . 1.0 112.692 179.022 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -51.93 -2.17 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 119.543 1.672 . . . . 1.0 112.851 -177.384 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 993' ' ' PHE . . . . . 0.553 ' H ' ' C ' ' A' ' 991' ' ' GLY . 13.6 m-85 -85.4 -0.12 53.88 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.992 -0.283 . . . . 1.0 110.399 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 994' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -59.18 -44.03 92.19 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 108.687 -0.857 . . . . 1.0 108.687 178.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 995' ' ' ARG . . . . . 0.613 ' NH1' ' NH2' ' A' ' 997' ' ' ARG . 78.9 mtp85 -88.62 -126.47 0.06 Allowed 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 110.021 -0.363 . . . . 1.0 110.021 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 996' ' ' ASN . . . . . . . . . . . . . 59.9 t30 52.74 39.07 27.96 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.552 -0.459 . . . . 1.0 110.444 179.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 997' ' ' ARG . . . . . 0.613 ' NH2' ' NH1' ' A' ' 995' ' ' ARG . 0.0 OUTLIER -66.97 161.39 62.98 Favored Pre-proline 0 C--N 1.328 -0.368 0 N-CA-C 109.473 -0.566 . . . . 1.0 109.473 -179.999 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 998' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo . . . . . 0 C--N 1.304 -1.801 0 C-N-CA 121.885 1.723 . . . . 1.0 111.609 -179.648 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 957' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.278 0 N-CA-C 109.681 -1.367 . . . . 1.0 109.681 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . 46.15 94.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.921 -0.311 . . . . 1.0 110.671 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 11.0 mp -98.78 126.41 44.41 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.118 0.485 . . . . 1.0 110.411 179.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 960' ' ' GLU . . . . . 0.553 ' OE1' ' N ' ' A' ' 960' ' ' GLU . 55.9 mp0 -66.09 -33.59 76.14 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.552 -0.749 . . . . 1.0 110.339 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 961' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -63.0 -35.26 79.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.866 -0.606 . . . . 1.0 110.621 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 962' ' ' ARG . . . . . . . . . . . . . 96.0 mtt-85 53.96 56.57 6.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.487 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 963' ' ' ALA . . . . . . . . . . . . . . . -126.05 156.36 40.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.776 -179.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 964' ' ' ILE . . . . . . . . . . . . . 16.2 mm 60.35 79.16 0.3 Allowed Pre-proline 0 CA--C 1.534 0.334 0 CA-C-N 115.89 -0.596 . . . . 1.0 110.9 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -59.05 147.47 90.12 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 122.458 2.105 . . . . 1.0 112.268 179.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 21.1 tt -65.97 -26.58 38.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.69 -0.686 . . . . 1.0 110.824 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 967' ' ' TRP . . . . . . . . . . . . . 97.1 m95 -54.16 -38.07 65.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.251 -0.431 . . . . 1.0 111.304 -179.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 93.1 m95 -69.1 -35.69 76.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.462 . . . . 1.0 110.38 179.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 71.4 t -65.3 -43.87 94.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 108.396 -0.964 . . . . 1.0 108.396 177.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 89.9 mt -62.33 -42.86 99.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 114.513 -1.221 . . . . 1.0 109.688 179.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 971' ' ' VAL . . . . . . . . . . . . . 49.9 t -60.99 -44.87 99.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.865 0.364 . . . . 1.0 110.128 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.88 -39.01 96.3 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 111.538 -0.625 . . . . 1.0 111.538 -179.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 56.8 t -66.67 -47.47 83.09 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.382 0 CA-C-N 114.92 -0.64 . . . . 1.0 110.439 -179.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 7.9 mp -62.95 -41.1 99.4 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.663 -0.866 . . . . 1.0 108.663 179.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -66.08 -45.58 86.27 Favored Glycine 0 CA--C 1.518 0.258 0 N-CA-C 110.308 -1.117 . . . . 1.0 110.308 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -60.19 -38.72 94.91 Favored Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 108.903 -1.679 . . . . 1.0 108.903 178.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 52.7 tp -66.66 -44.32 82.16 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.313 -0.555 . . . . 1.0 110.26 179.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 59.1 tp -62.29 -45.86 91.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.619 -0.264 . . . . 1.0 110.364 -179.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 93.5 mt -63.26 -43.53 97.73 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 119.976 -0.69 . . . . 1.0 110.765 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 980' ' ' LEU . . . . . . . . . . . . . 8.5 mp -63.99 -39.06 93.26 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.74 -0.384 . . . . 1.0 110.708 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 6.9 m -64.35 -45.98 85.45 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.963 -0.562 . . . . 1.0 110.188 -179.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 97.5 mt -63.45 -44.01 98.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 C-N-CA 120.938 -0.305 . . . . 1.0 111.539 -179.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 91.0 mt -65.07 -41.08 95.42 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 120.954 -0.298 . . . . 1.0 110.788 179.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 984' ' ' VAL . . . . . . . . . . . . . 54.4 t -66.39 -47.78 82.94 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.426 0 CA-C-O 121.472 0.653 . . . . 1.0 109.538 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 87.1 mt -63.4 -43.71 96.77 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.058 -0.974 . . . . 1.0 109.739 178.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 986' ' ' ALA . . . . . . . . . . . . . . . -61.49 -45.12 95.57 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-O 121.595 0.712 . . . . 1.0 109.406 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 29.5 mtp -61.62 -30.19 70.53 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.651 -1.158 . . . . 1.0 108.778 179.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 988' ' ' TRP . . . . . . . . . . . . . 1.7 t90 -74.29 -38.85 63.26 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 113.912 -1.495 . . . . 1.0 108.424 179.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.22 -38.55 82.02 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.357 -0.838 . . . . 1.0 110.223 -179.05 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 990' ' ' VAL . . . . . . . . . . . . . 1.4 m -84.55 -7.96 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 115.075 -0.966 . . . . 1.0 110.747 -178.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 991' ' ' GLY . . . . . 0.544 ' C ' ' H ' ' A' ' 993' ' ' PHE . . . 81.27 5.33 90.12 Favored Glycine 0 C--N 1.338 0.655 0 CA-C-O 119.17 -0.794 . . . . 1.0 112.453 179.056 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -53.4 -1.81 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 119.34 1.57 . . . . 1.0 112.532 -177.323 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 993' ' ' PHE . . . . . 0.544 ' H ' ' C ' ' A' ' 991' ' ' GLY . 10.2 m-85 -92.54 0.11 57.39 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.584 0.707 . . . . 1.0 110.501 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 994' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -156.08 145.1 20.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.663 -1.153 . . . . 1.0 113.566 -178.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -78.46 144.76 35.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.892 -0.595 . . . . 1.0 110.953 -179.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 996' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -62.61 -41.8 99.2 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 109.821 -0.437 . . . . 1.0 109.821 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 997' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.7 158.22 71.11 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.025 -0.534 . . . . 1.0 109.72 179.474 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 998' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo . . . . . 0 C--N 1.309 -1.527 0 C-N-CA 122.277 1.985 . . . . 1.0 112.19 -179.315 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 957' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.479 0 N-CA-C 109.5 -1.44 . . . . 1.0 109.5 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -132.12 150.56 52.13 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.019 0.438 . . . . 1.0 110.72 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 959' ' ' LEU . . . . . 0.407 ' O ' ' C ' ' A' ' 960' ' ' GLU . 85.4 mt -116.92 132.61 56.66 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.829 -0.623 . . . . 1.0 110.588 -179.607 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 960' ' ' GLU . . . . . 0.407 ' C ' ' O ' ' A' ' 959' ' ' LEU . 94.4 mt-10 37.78 82.83 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.901 -0.59 . . . . 1.0 110.676 179.294 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 961' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -64.07 139.37 58.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.977 -0.556 . . . . 1.0 110.975 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 962' ' ' ARG . . . . . . . . . . . . . 94.9 mtt-85 -63.11 -38.69 92.19 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.308 -0.627 . . . . 1.0 109.308 179.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 963' ' ' ALA . . . . . . . . . . . . . . . -65.81 144.16 57.03 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.052 -0.976 . . . . 1.0 111.76 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 964' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -74.78 167.42 36.65 Favored Pre-proline 0 CA--C 1.536 0.408 0 CA-C-N 116.043 -0.526 . . . . 1.0 110.578 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -60.61 147.61 94.08 Favored 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 121.609 1.54 . . . . 1.0 111.367 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 71.9 mt -66.67 -25.88 35.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.013 -0.539 . . . . 1.0 110.927 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 967' ' ' TRP . . . . . . . . . . . . . 94.2 m95 -53.1 -37.41 61.69 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.821 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 83.9 m95 -72.06 -36.27 69.54 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.695 -0.229 . . . . 1.0 111.113 179.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 62.1 t -67.03 -44.82 88.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 108.691 -0.855 . . . . 1.0 108.691 178.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 56.4 tp -63.3 -44.22 95.64 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.738 -1.119 . . . . 1.0 110.204 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 971' ' ' VAL . . . . . . . . . . . . . 54.4 t -61.85 -45.44 98.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 120.625 -0.43 . . . . 1.0 111.367 -178.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.23 -36.93 92.1 Favored Glycine 0 CA--C 1.529 0.959 0 CA-C-O 121.659 0.588 . . . . 1.0 111.679 -179.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 53.5 t -68.28 -49.08 70.05 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.492 0 CA-C-N 114.87 -0.665 . . . . 1.0 109.948 -179.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 69.4 mt -62.21 -42.23 99.1 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 115.493 -0.776 . . . . 1.0 109.008 179.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -65.96 -45.55 87.08 Favored Glycine 0 N--CA 1.46 0.259 0 N-CA-C 110.061 -1.216 . . . . 1.0 110.061 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -59.62 -38.7 94.11 Favored Glycine 0 C--O 1.226 -0.366 0 N-CA-C 108.642 -1.783 . . . . 1.0 108.642 178.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 49.1 tp -65.55 -42.93 91.33 Favored 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 120.717 -0.393 . . . . 1.0 110.188 179.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 76.3 mt -64.52 -44.32 91.24 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.457 -0.497 . . . . 1.0 111.054 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 80.6 mt -63.29 -44.28 95.49 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.325 -0.55 . . . . 1.0 110.732 -179.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 980' ' ' LEU . . . . . . . . . . . . . 83.8 mt -63.51 -39.47 94.52 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.08 0.467 . . . . 1.0 110.115 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 7.3 m -64.59 -46.2 83.7 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.474 -0.785 . . . . 1.0 110.225 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 3.2 mm -64.09 -43.62 97.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.296 -0.411 . . . . 1.0 111.854 -178.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 98.2 mt -66.71 -40.72 88.55 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.093 -0.503 . . . . 1.0 111.377 -179.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 984' ' ' VAL . . . . . . . . . . . . . 65.8 t -68.61 -46.65 79.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.438 0.637 . . . . 1.0 109.492 179.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 80.9 mt -63.08 -43.44 98.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.261 -0.881 . . . . 1.0 109.039 178.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 986' ' ' ALA . . . . . . . . . . . . . . . -62.01 -43.84 97.98 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.141 -0.688 . . . . 1.0 109.141 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 29.5 mtp -64.07 -32.58 74.19 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 114.955 -1.021 . . . . 1.0 110.367 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 988' ' ' TRP . . . . . 0.477 ' O ' ' CD1' ' A' ' 988' ' ' TRP . 12.7 t90 -73.48 -34.08 65.16 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.171 -1.377 . . . . 1.0 107.75 178.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.37 -39.37 71.27 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 114.866 -1.061 . . . . 1.0 110.478 -179.558 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 990' ' ' VAL . . . . . . . . . . . . . 1.4 m -85.26 -7.6 10.96 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 CA-C-N 115.128 -0.942 . . . . 1.0 110.339 -178.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 991' ' ' GLY . . . . . 0.529 ' C ' ' H ' ' A' ' 993' ' ' PHE . . . 81.54 5.09 90.19 Favored Glycine 0 C--N 1.331 0.304 0 CA-C-O 118.813 -0.993 . . . . 1.0 112.76 179.35 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -52.79 -1.87 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 120.07 1.935 . . . . 1.0 112.729 -178.036 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 993' ' ' PHE . . . . . 0.529 ' H ' ' C ' ' A' ' 991' ' ' GLY . 17.5 m-85 -90.67 -1.48 57.87 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 121.03 0.443 . . . . 1.0 110.37 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 994' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -157.5 152.72 26.0 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 113.671 0.989 . . . . 1.0 113.671 -178.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 86.6 mtm-85 -88.83 36.03 0.8 Allowed 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.937 -0.574 . . . . 1.0 110.637 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 996' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -63.56 -42.85 98.33 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.208 -0.451 . . . . 1.0 109.791 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 997' ' ' ARG . . . . . . . . . . . . . 3.5 mtt180 -117.28 152.54 49.29 Favored Pre-proline 0 CA--C 1.535 0.398 0 CA-C-N 116.255 -0.43 . . . . 1.0 110.346 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 998' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo . . . . . 0 N--CA 1.491 1.368 0 C-N-CA 122.58 2.186 . . . . 1.0 112.841 -179.342 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 957' ' ' GLY . . . . . 0.448 ' N ' ' OE2' ' A' ' 960' ' ' GLU . . . . . . . . 0 N--CA 1.491 2.349 0 N-CA-C 109.498 -1.441 . . . . 1.0 109.498 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -62.93 -36.72 84.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.564 0.221 . . . . 1.0 110.659 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 73.3 mt -113.08 140.25 48.02 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.671 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 960' ' ' GLU . . . . . 0.448 ' OE2' ' N ' ' A' ' 957' ' ' GLY . 73.7 mm-40 -128.72 143.15 50.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.969 -0.559 . . . . 1.0 109.902 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 961' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -66.91 -39.93 87.53 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.912 0.386 . . . . 1.0 110.308 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 962' ' ' ARG . . . . . . . . . . . . . 83.6 mtp180 -99.72 140.27 34.16 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.987 -0.551 . . . . 1.0 111.369 -179.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 963' ' ' ALA . . . . . 0.448 ' O ' ' C ' ' A' ' 964' ' ' ILE . . . -150.21 150.13 31.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.775 -0.648 . . . . 1.0 110.482 179.623 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 964' ' ' ILE . . . . . 0.448 ' C ' ' O ' ' A' ' 963' ' ' ALA . 1.2 tt 29.94 72.28 0.5 Allowed Pre-proline 0 N--CA 1.462 0.174 0 O-C-N 123.896 0.747 . . . . 1.0 111.131 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -63.23 145.27 93.15 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 122.383 2.055 . . . . 1.0 111.756 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 87.4 mt -64.39 -43.97 97.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.018 -0.537 . . . . 1.0 110.697 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 967' ' ' TRP . . . . . . . . . . . . . 89.7 m95 -58.37 -40.47 82.34 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 113.293 0.849 . . . . 1.0 113.293 -178.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 39.3 m95 -71.57 -39.61 70.49 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 112.957 0.725 . . . . 1.0 112.957 -178.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 17.3 m -66.86 -41.3 87.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 119.536 -0.866 . . . . 1.0 109.23 179.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 61.9 tp -64.35 -42.78 96.04 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.246 -0.888 . . . . 1.0 109.973 179.052 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 971' ' ' VAL . . . . . . . . . . . . . 70.2 t -62.79 -44.83 99.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 120.523 -0.471 . . . . 1.0 110.668 -179.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -59.34 -41.65 97.02 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.555 -0.618 . . . . 1.0 111.555 -179.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 77.0 t -64.63 -46.9 91.05 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.593 0 CA-C-O 121.038 0.447 . . . . 1.0 110.623 -179.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 98.7 mt -61.99 -40.67 96.44 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 108.595 -0.891 . . . . 1.0 108.595 179.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -67.13 -48.21 60.65 Favored Glycine 0 C--N 1.334 0.419 0 CA-C-N 115.1 -0.955 . . . . 1.0 110.943 -179.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -60.12 -36.41 90.47 Favored Glycine 0 N--CA 1.449 -0.446 0 N-CA-C 108.915 -1.674 . . . . 1.0 108.915 179.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 54.1 tp -66.97 -43.22 83.63 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.179 -0.608 . . . . 1.0 109.993 179.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 4.3 tt -61.64 -45.24 94.88 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.348 -0.541 . . . . 1.0 110.33 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 96.1 mt -62.17 -45.16 94.65 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.487 -0.485 . . . . 1.0 111.315 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 980' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -64.13 -39.97 95.16 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.083 0.468 . . . . 1.0 111.163 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 6.9 m -64.11 -46.71 83.01 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.487 -0.778 . . . . 1.0 110.121 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 4.0 mm -63.68 -43.82 98.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.499 -0.319 . . . . 1.0 111.477 -179.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 83.7 mt -63.67 -41.58 98.17 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.381 -0.372 . . . . 1.0 110.366 179.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 984' ' ' VAL . . . . . . . . . . . . . 40.0 t -66.7 -47.1 84.11 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.332 0 CA-C-O 121.345 0.593 . . . . 1.0 110.356 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 82.2 mt -64.43 -43.04 95.6 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.292 -0.867 . . . . 1.0 109.919 179.134 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 986' ' ' ALA . . . . . . . . . . . . . . . -63.85 -46.05 86.76 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 121.371 0.605 . . . . 1.0 109.726 -179.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 30.2 mtp -61.8 -33.75 74.68 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.817 -1.083 . . . . 1.0 109.286 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 988' ' ' TRP . . . . . 0.505 ' O ' ' CD1' ' A' ' 988' ' ' TRP . 12.8 t90 -72.1 -37.27 69.57 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.338 -1.301 . . . . 1.0 108.57 178.186 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.91 -40.3 79.19 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 121.717 0.77 . . . . 1.0 110.204 -179.501 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 990' ' ' VAL . . . . . . . . . . . . . 1.2 m -82.63 -6.63 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 CA-C-N 114.707 -1.133 . . . . 1.0 109.989 -178.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 991' ' ' GLY . . . . . 0.568 ' C ' ' H ' ' A' ' 993' ' ' PHE . . . 83.58 2.6 89.99 Favored Glycine 0 C--N 1.337 0.586 0 CA-C-O 119.296 -0.724 . . . . 1.0 112.317 178.693 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -52.16 -2.5 0.02 OUTLIER 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 119.418 1.609 . . . . 1.0 112.145 -177.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 993' ' ' PHE . . . . . 0.568 ' H ' ' C ' ' A' ' 991' ' ' GLY . 11.6 m-85 -88.29 -5.29 58.43 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.077 0.465 . . . . 1.0 110.101 179.509 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 994' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -158.9 154.68 26.38 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.247 -0.888 . . . . 1.0 113.302 -179.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 89.0 mtm180 -64.57 -39.94 94.65 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.302 -0.408 . . . . 1.0 110.765 179.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 996' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -75.33 148.0 39.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.149 0.499 . . . . 1.0 110.712 -179.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 997' ' ' ARG . . . . . . . . . . . . . 46.4 mtp85 -68.19 155.11 92.94 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.625 -0.716 . . . . 1.0 110.96 -179.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 998' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo . . . . . 0 C--N 1.31 -1.45 0 C-N-CA 122.306 2.004 . . . . 1.0 112.334 -179.961 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 957' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.274 0 N-CA-C 109.795 -1.322 . . . . 1.0 109.795 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -153.2 159.49 42.66 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.988 0.423 . . . . 1.0 110.794 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 959' ' ' LEU . . . . . 0.427 ' N ' ' CD2' ' A' ' 959' ' ' LEU . 4.3 mm? -95.02 131.19 41.25 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.088 -0.505 . . . . 1.0 110.246 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 960' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -65.67 142.79 57.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.943 -0.571 . . . . 1.0 110.281 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 961' ' ' GLU . . . . . . . . . . . . . 89.0 mt-10 -65.77 -41.84 91.56 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.5 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 962' ' ' ARG . . . . . . . . . . . . . 28.1 mmt180 -107.33 132.35 53.23 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 120.889 0.376 . . . . 1.0 110.719 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 963' ' ' ALA . . . . . . . . . . . . . . . -75.38 142.62 43.08 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.046 -0.525 . . . . 1.0 110.038 179.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 964' ' ' ILE . . . . . 0.408 ' O ' ' CG2' ' A' ' 964' ' ' ILE . 1.3 tt -173.15 72.45 0.39 Allowed Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.144 -179.38 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -65.8 147.93 85.95 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.685 2.257 . . . . 1.0 111.753 -179.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 96.0 mt -64.86 -43.19 96.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.955 -0.566 . . . . 1.0 111.334 -179.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 967' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -55.7 -38.64 69.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 1.0 111.578 -178.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 24.7 m95 -70.33 -34.66 72.95 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.577 -0.283 . . . . 1.0 110.479 179.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 74.1 t -67.38 -43.93 87.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 108.99 -0.744 . . . . 1.0 108.99 178.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 51.6 tp -63.91 -41.33 97.71 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.232 -0.894 . . . . 1.0 109.104 179.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 971' ' ' VAL . . . . . . . . . . . . . 53.2 t -62.29 -45.33 99.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 C-N-CA 120.895 -0.322 . . . . 1.0 111.372 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.63 -41.31 98.83 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 112.161 -0.376 . . . . 1.0 112.161 -178.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 72.8 t -67.22 -47.23 82.15 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.517 0 CA-C-O 120.94 0.4 . . . . 1.0 110.668 -178.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 6.9 mp -63.44 -41.04 98.66 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.974 -0.557 . . . . 1.0 109.522 179.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -66.08 -44.95 90.29 Favored Glycine 0 C--N 1.334 0.433 0 N-CA-C 110.348 -1.101 . . . . 1.0 110.348 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -61.32 -36.11 91.98 Favored Glycine 0 N--CA 1.448 -0.527 0 N-CA-C 109.061 -1.615 . . . . 1.0 109.061 179.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 54.2 tp -67.37 -43.72 80.74 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.443 -0.503 . . . . 1.0 110.075 178.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 50.9 tp -62.43 -44.82 95.51 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.289 -0.564 . . . . 1.0 109.998 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 87.5 mt -61.94 -42.93 99.67 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 119.783 -0.767 . . . . 1.0 110.118 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 980' ' ' LEU . . . . . . . . . . . . . 33.2 mt -63.42 -40.41 97.1 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.058 0.456 . . . . 1.0 110.334 -179.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 6.9 m -64.16 -46.27 84.79 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.409 -0.814 . . . . 1.0 110.17 -179.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 90.8 mt -64.29 -44.27 97.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.332 -0.394 . . . . 1.0 111.236 -179.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 983' ' ' LEU . . . . . 0.487 ' CD1' ' SD ' ' A' ' 987' ' ' MET . 39.1 tp -65.67 -42.74 90.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.544 -0.298 . . . . 1.0 111.454 -179.773 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 984' ' ' VAL . . . . . . . . . . . . . 53.1 t -66.81 -47.64 82.19 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.402 0 CA-C-O 121.411 0.624 . . . . 1.0 110.341 -179.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 84.0 mt -63.58 -41.59 98.36 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.134 -0.939 . . . . 1.0 109.132 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 986' ' ' ALA . . . . . . . . . . . . . . . -62.65 -47.77 82.23 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.275 0.559 . . . . 1.0 110.38 -179.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 987' ' ' MET . . . . . 0.487 ' SD ' ' CD1' ' A' ' 983' ' ' LEU . 16.2 mtp -62.81 -30.26 71.35 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 122.632 1.206 . . . . 1.0 110.313 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 988' ' ' TRP . . . . . 0.467 ' O ' ' CD1' ' A' ' 988' ' ' TRP . 12.1 t90 -75.64 -35.34 60.48 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 113.976 -1.465 . . . . 1.0 107.926 178.523 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.25 -39.57 74.94 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-O 121.516 0.674 . . . . 1.0 109.902 -179.447 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 990' ' ' VAL . . . . . . . . . . . . . 1.4 m -78.28 -3.45 5.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 114.946 -1.025 . . . . 1.0 109.221 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 991' ' ' GLY . . . . . 0.489 ' O ' ' N ' ' A' ' 994' ' ' LYS . . . 82.83 1.44 90.59 Favored Glycine 0 C--N 1.333 0.414 0 CA-C-O 119.404 -0.664 . . . . 1.0 112.397 177.643 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -47.22 -41.92 19.26 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-N 119.046 1.423 . . . . 1.0 110.926 -176.712 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 993' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -82.19 0.16 42.31 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.861 0.838 . . . . 1.0 111.1 179.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 994' ' ' LYS . . . . . 0.489 ' N ' ' O ' ' A' ' 991' ' ' GLY . 75.5 mmtt -111.68 151.09 29.28 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 113.992 -1.458 . . . . 1.0 108.394 177.485 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 59.6 ttp180 -131.97 127.12 35.63 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.435 -0.58 . . . . 1.0 109.435 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 996' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -94.89 144.35 25.73 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.893 -0.323 . . . . 1.0 110.249 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 997' ' ' ARG . . . . . . . . . . . . . 29.8 mtt180 -91.41 156.93 43.03 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.239 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 998' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo . . . . . 0 C--N 1.309 -1.515 0 C-N-CA 122.733 2.289 . . . . 1.0 112.35 179.944 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 957' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.271 0 N-CA-C 109.235 -1.546 . . . . 1.0 109.235 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -64.83 -37.09 86.47 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.868 -0.333 . . . . 1.0 110.2 179.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 10.5 mp -96.66 129.64 44.02 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.231 0.538 . . . . 1.0 110.256 179.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 960' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -61.75 -35.0 76.84 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.379 -0.828 . . . . 1.0 110.383 -179.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 961' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -98.54 137.41 37.24 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.814 0.34 . . . . 1.0 110.41 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 962' ' ' ARG . . . . . 0.466 ' O ' ' CB ' ' A' ' 963' ' ' ALA . 94.9 mtt-85 -61.44 -41.75 97.68 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.76 -179.42 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 963' ' ' ALA . . . . . 0.466 ' CB ' ' O ' ' A' ' 962' ' ' ARG . . . 165.88 80.16 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.03 0.443 . . . . 1.0 111.541 179.248 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 964' ' ' ILE . . . . . . . . . . . . . 6.4 mt 41.1 70.41 1.61 Allowed Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.98 -0.554 . . . . 1.0 111.177 178.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -81.2 1.68 9.12 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 123.156 2.57 . . . . 1.0 112.628 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 94.5 mt -62.67 -44.61 99.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.266 -0.424 . . . . 1.0 110.927 -179.261 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 967' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -56.69 -38.49 72.33 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.948 -0.301 . . . . 1.0 110.313 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 87.4 m95 -68.58 -36.6 78.94 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.462 -0.335 . . . . 1.0 111.4 179.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 72.6 t -66.3 -44.56 91.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.307 0.575 . . . . 1.0 109.551 178.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 90.4 mt -62.82 -42.19 99.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.04 -0.982 . . . . 1.0 109.597 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 971' ' ' VAL . . . . . . . . . . . . . 54.1 t -61.6 -45.33 98.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.51 -0.314 . . . . 1.0 111.14 -179.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.78 -41.67 99.19 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 121.377 -0.44 . . . . 1.0 112.331 -178.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 57.2 t -65.82 -47.45 85.63 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.534 0 CA-C-O 121.145 0.497 . . . . 1.0 110.605 -178.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 86.9 mt -62.59 -41.58 99.04 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.556 -0.747 . . . . 1.0 109.365 179.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -66.02 -46.25 82.28 Favored Glycine 0 N--CA 1.452 -0.243 0 N-CA-C 110.421 -1.072 . . . . 1.0 110.421 -179.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -61.0 -37.33 93.69 Favored Glycine 0 N--CA 1.451 -0.339 0 N-CA-C 109.244 -1.542 . . . . 1.0 109.244 179.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 30.1 mt -64.34 -42.4 96.29 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.437 -0.505 . . . . 1.0 109.753 178.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -62.98 -43.78 97.86 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 119.628 -0.829 . . . . 1.0 110.144 179.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 98.4 mt -61.72 -43.66 98.43 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.17 -0.612 . . . . 1.0 109.906 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 980' ' ' LEU . . . . . . . . . . . . . 31.1 mt -62.82 -41.93 99.51 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.56 -0.456 . . . . 1.0 109.891 179.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 7.3 m -62.69 -47.32 84.13 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.646 -0.707 . . . . 1.0 111.183 -179.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 92.7 mt -64.26 -43.94 97.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 C-N-CA 120.775 -0.37 . . . . 1.0 111.152 -179.389 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 983' ' ' LEU . . . . . 0.403 ' O ' ' SD ' ' A' ' 987' ' ' MET . 83.0 mt -65.04 -41.76 94.92 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.329 -0.396 . . . . 1.0 111.307 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 984' ' ' VAL . . . . . . . . . . . . . 42.2 t -69.15 -49.86 58.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.208 0.528 . . . . 1.0 110.793 -179.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 90.7 mt -63.37 -42.53 98.87 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.47 -0.786 . . . . 1.0 109.44 179.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 986' ' ' ALA . . . . . . . . . . . . . . . -61.87 -43.97 97.77 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 109.18 -0.674 . . . . 1.0 109.18 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 987' ' ' MET . . . . . 0.403 ' SD ' ' O ' ' A' ' 983' ' ' LEU . 21.9 mtp -62.14 -30.29 70.94 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 114.653 -1.158 . . . . 1.0 109.387 179.028 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 988' ' ' TRP . . . . . . . . . . . . . 1.8 t90 -74.87 -36.12 62.31 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 113.797 -1.547 . . . . 1.0 108.28 178.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.44 -38.92 71.29 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.599 0.714 . . . . 1.0 110.0 -179.374 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 990' ' ' VAL . . . . . . . . . . . . . 1.3 m -80.41 -5.33 8.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 114.957 -1.02 . . . . 1.0 109.873 -179.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 991' ' ' GLY . . . . . 0.578 ' C ' ' H ' ' A' ' 993' ' ' PHE . . . 85.05 0.38 88.93 Favored Glycine 0 C--N 1.338 0.686 0 CA-C-O 119.466 -0.63 . . . . 1.0 112.546 177.576 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -51.92 -2.98 0.02 OUTLIER 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 118.901 1.35 . . . . 1.0 112.386 -177.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 993' ' ' PHE . . . . . 0.578 ' H ' ' C ' ' A' ' 991' ' ' GLY . 32.8 m-85 -118.75 -6.3 10.61 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 122.511 1.148 . . . . 1.0 110.543 179.756 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 994' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -93.8 -7.27 43.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 112.693 -2.049 . . . . 1.0 108.514 177.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -68.3 143.29 55.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.643 -0.708 . . . . 1.0 109.512 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 996' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -77.53 148.51 35.23 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.782 -0.367 . . . . 1.0 110.666 -179.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 997' ' ' ARG . . . . . . . . . . . . . 45.3 mtt85 -141.37 153.09 65.59 Favored Pre-proline 0 CA--C 1.534 0.33 0 CA-C-N 116.418 -0.355 . . . . 1.0 110.648 -179.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 998' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo . . . . . 0 N--CA 1.495 1.582 0 C-N-CA 122.211 1.941 . . . . 1.0 112.01 179.854 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 957' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.275 0 N-CA-C 109.792 -1.323 . . . . 1.0 109.792 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -155.65 152.79 29.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.841 0.353 . . . . 1.0 110.51 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 91.5 mt -79.58 141.44 36.58 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.353 -0.385 . . . . 1.0 110.445 179.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 960' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 49.46 -167.95 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.437 -0.347 . . . . 1.0 111.294 179.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 961' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -118.06 140.66 49.44 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.112 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 962' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 -112.36 150.9 30.41 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.217 0.532 . . . . 1.0 111.407 -179.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 963' ' ' ALA . . . . . . . . . . . . . . . -141.87 154.27 45.02 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.393 -0.821 . . . . 1.0 110.484 -179.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 964' ' ' ILE . . . . . 0.45 ' N ' ' CD ' ' A' ' 965' ' ' PRO . 4.4 pt -142.8 52.75 2.39 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.083 -0.508 . . . . 1.0 110.452 179.798 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 965' ' ' PRO . . . . . 0.45 ' CD ' ' N ' ' A' ' 964' ' ' ILE . 47.6 Cg_endo -68.91 -15.7 40.49 Favored 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 122.902 2.401 . . . . 1.0 112.863 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 87.2 mt -63.56 -44.03 98.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 111.953 0.353 . . . . 1.0 111.953 -178.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 967' ' ' TRP . . . . . . . . . . . . . 99.4 m95 -69.43 -36.62 76.83 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.643 -0.423 . . . . 1.0 110.569 179.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 90.9 m95 -70.01 -34.3 73.12 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.614 -0.434 . . . . 1.0 110.426 179.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 53.9 t -66.94 -45.59 86.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.694 -0.484 . . . . 1.0 109.694 178.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 80.7 mt -63.72 -40.83 97.73 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.285 -0.871 . . . . 1.0 109.908 179.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 971' ' ' VAL . . . . . . . . . . . . . 45.2 t -64.77 -45.18 95.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 C-N-CA 120.694 -0.403 . . . . 1.0 111.309 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -63.05 -43.76 98.32 Favored Glycine 0 CA--C 1.529 0.932 0 CA-C-N 116.365 -0.38 . . . . 1.0 113.49 -177.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 31.6 m -67.48 -43.12 87.61 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.403 0 CA-C-O 120.897 0.38 . . . . 1.0 110.352 -178.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 93.3 mt -63.39 -41.24 98.76 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.962 -0.755 . . . . 1.0 108.962 178.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -66.21 -46.16 81.49 Favored Glycine 0 C--N 1.329 0.151 0 N-CA-C 110.338 -1.105 . . . . 1.0 110.338 -179.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -59.2 -38.51 93.29 Favored Glycine 0 N--CA 1.446 -0.64 0 N-CA-C 108.647 -1.781 . . . . 1.0 108.647 178.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 38.3 mt -63.87 -42.17 97.58 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.135 -0.626 . . . . 1.0 109.518 178.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 55.6 tp -62.44 -46.22 89.53 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.713 -0.395 . . . . 1.0 110.408 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 9.5 mp -62.29 -42.49 99.39 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 119.724 -0.79 . . . . 1.0 110.148 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 980' ' ' LEU . . . . . . . . . . . . . 86.7 mt -63.04 -40.25 97.17 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.486 -0.486 . . . . 1.0 110.11 179.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 7.1 m -63.86 -46.72 83.73 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.667 -0.697 . . . . 1.0 110.808 -179.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 97.6 mt -63.56 -44.52 98.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.396 -0.365 . . . . 1.0 110.815 -179.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -65.73 -40.18 91.89 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.168 -0.469 . . . . 1.0 111.309 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 984' ' ' VAL . . . . . . . . . . . . . 45.6 t -67.24 -48.66 77.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.301 0.572 . . . . 1.0 110.337 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 88.2 mt -63.67 -42.29 98.07 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.224 -0.898 . . . . 1.0 109.407 178.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 986' ' ' ALA . . . . . . . . . . . . . . . -63.01 -46.93 85.33 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-O 121.384 0.611 . . . . 1.0 110.487 -179.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 19.2 mtp -63.18 -32.23 73.57 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 122.601 1.191 . . . . 1.0 109.607 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 988' ' ' TRP . . . . . 0.68 ' HE1' ' NZ ' ' A' ' 994' ' ' LYS . 14.2 t90 -72.99 -36.96 67.16 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 114.202 -1.363 . . . . 1.0 107.554 178.408 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 989' ' ' LYS . . . . . 0.543 ' O ' ' NZ ' ' A' ' 989' ' ' LYS . 0.1 OUTLIER -66.7 -41.18 88.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.224 -0.898 . . . . 1.0 109.816 -179.875 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 990' ' ' VAL . . . . . . . . . . . . . 1.3 m -79.15 -3.03 5.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.112 -0.949 . . . . 1.0 109.518 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 991' ' ' GLY . . . . . 0.477 ' O ' ' N ' ' A' ' 994' ' ' LYS . . . 82.97 1.21 90.64 Favored Glycine 0 C--N 1.338 0.668 0 CA-C-O 119.28 -0.733 . . . . 1.0 112.565 177.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -45.87 -42.81 12.99 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 118.953 1.377 . . . . 1.0 111.332 -177.157 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 993' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -83.25 -3.44 57.42 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.684 0.754 . . . . 1.0 111.454 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 994' ' ' LYS . . . . . 0.68 ' NZ ' ' HE1' ' A' ' 988' ' ' TRP . 98.9 mttt -131.12 98.58 4.61 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.453 -1.249 . . . . 1.0 108.723 177.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 83.5 mtp180 -65.28 -40.96 94.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.454 . . . . 1.0 110.642 179.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 996' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -85.49 115.52 23.26 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.129 -0.487 . . . . 1.0 111.482 -179.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 997' ' ' ARG . . . . . . . . . . . . . 3.9 ttt180 -74.17 129.97 83.47 Favored Pre-proline 0 CA--C 1.536 0.418 0 CA-C-N 115.871 -0.604 . . . . 1.0 109.406 179.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 998' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_exo . . . . . 0 N--CA 1.49 1.278 0 C-N-CA 121.86 1.707 . . . . 1.0 112.416 -179.898 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 957' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.422 0 N-CA-C 109.742 -1.343 . . . . 1.0 109.742 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -73.45 140.98 46.86 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 110.171 -0.307 . . . . 1.0 110.171 179.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 97.3 mt 56.11 -169.04 0.09 Allowed 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 120.899 -0.32 . . . . 1.0 110.433 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 960' ' ' GLU . . . . . 0.414 ' O ' ' C ' ' A' ' 961' ' ' GLU . 99.9 mt-10 -125.08 137.54 54.2 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.589 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 961' ' ' GLU . . . . . 0.414 ' C ' ' O ' ' A' ' 960' ' ' GLU . 95.7 mt-10 36.45 68.14 0.27 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.998 -0.546 . . . . 1.0 111.293 178.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 962' ' ' ARG . . . . . . . . . . . . . 91.0 mtm180 -63.52 -42.29 98.47 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.995 -0.548 . . . . 1.0 110.02 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 963' ' ' ALA . . . . . . . . . . . . . . . -65.24 140.94 58.78 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.134 -0.485 . . . . 1.0 110.372 179.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 964' ' ' ILE . . . . . . . . . . . . . 1.7 pt -135.76 75.15 56.71 Favored Pre-proline 0 N--CA 1.469 0.484 0 CA-C-O 120.902 0.382 . . . . 1.0 111.268 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -59.92 145.38 98.44 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 123.07 2.513 . . . . 1.0 112.437 179.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 93.2 mt -64.28 -43.85 97.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.551 -0.749 . . . . 1.0 111.335 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 967' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -57.14 -36.59 70.9 Favored 'General case' 0 N--CA 1.46 0.075 0 C-N-CA 120.625 -0.43 . . . . 1.0 110.677 -179.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 24.6 m95 -70.16 -35.25 73.88 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.636 -0.256 . . . . 1.0 110.422 179.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 91.2 t -67.03 -45.93 85.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.682 0.753 . . . . 1.0 109.201 178.015 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 57.1 tp -63.0 -42.74 99.93 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.75 -1.114 . . . . 1.0 109.207 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 971' ' ' VAL . . . . . . . . . . . . . 55.6 t -62.4 -45.4 98.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.952 0.406 . . . . 1.0 110.756 -179.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.35 -42.06 98.7 Favored Glycine 0 CA--C 1.524 0.603 0 CA-C-N 115.928 -0.578 . . . . 1.0 111.891 -179.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 63.6 t -66.1 -44.78 91.71 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.458 0 CA-C-O 120.909 0.385 . . . . 1.0 110.662 -178.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 80.9 mt -61.94 -40.49 95.71 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.402 -0.962 . . . . 1.0 108.402 178.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -66.63 -43.82 91.17 Favored Glycine 0 N--CA 1.46 0.261 0 N-CA-C 110.22 -1.152 . . . . 1.0 110.22 -179.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -61.29 -37.09 93.45 Favored Glycine 0 N--CA 1.447 -0.624 0 N-CA-C 109.297 -1.521 . . . . 1.0 109.297 179.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 76.2 mt -67.38 -42.53 83.21 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 119.815 -0.754 . . . . 1.0 110.207 178.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 70.8 mt -62.04 -44.75 96.03 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.26 -0.576 . . . . 1.0 110.507 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 90.3 mt -63.5 -44.59 93.89 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 119.815 -0.754 . . . . 1.0 110.855 -179.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 980' ' ' LEU . . . . . . . . . . . . . 6.2 mp -64.1 -40.76 96.9 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.232 -0.587 . . . . 1.0 110.606 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 7.4 m -62.35 -47.8 82.6 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.883 -0.599 . . . . 1.0 110.352 -179.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 96.6 mt -64.56 -44.85 96.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 C-N-CA 120.403 -0.519 . . . . 1.0 111.563 -178.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 7.1 mp -64.74 -41.93 95.57 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 111.801 0.297 . . . . 1.0 111.801 -179.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 984' ' ' VAL . . . . . . . . . . . . . 51.1 t -65.64 -48.68 81.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-O 121.313 0.578 . . . . 1.0 110.383 -179.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 82.5 mt -62.28 -41.9 98.88 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.967 -1.015 . . . . 1.0 109.478 178.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 986' ' ' ALA . . . . . . . . . . . . . . . -61.58 -46.34 90.28 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.314 0.578 . . . . 1.0 110.106 -179.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 22.7 mtp -63.33 -29.77 71.02 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 122.679 1.228 . . . . 1.0 110.043 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 988' ' ' TRP . . . . . . . . . . . . . 1.6 t90 -76.31 -34.87 59.05 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 113.57 -1.65 . . . . 1.0 107.549 179.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.22 -38.67 68.92 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.113 -0.949 . . . . 1.0 110.14 -179.43 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 990' ' ' VAL . . . . . . . . . . . . . 1.5 m -79.37 -0.69 3.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.118 -0.946 . . . . 1.0 109.129 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 991' ' ' GLY . . . . . 0.466 ' O ' ' O ' ' A' ' 994' ' ' LYS . . . 80.8 1.0 89.18 Favored Glycine 0 C--N 1.337 0.585 0 CA-C-O 119.137 -0.813 . . . . 1.0 112.783 177.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -47.04 -40.88 15.71 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 119.263 1.531 . . . . 1.0 111.53 -177.075 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 993' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -81.48 -3.93 54.45 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.981 0.896 . . . . 1.0 111.673 -179.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 994' ' ' LYS . . . . . 0.466 ' O ' ' O ' ' A' ' 991' ' ' GLY . 68.7 mttm -113.1 140.1 48.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 113.53 -1.668 . . . . 1.0 109.153 177.069 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 34.2 ttm180 43.15 51.59 5.58 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.933 0.397 . . . . 1.0 110.597 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 996' ' ' ASN . . . . . 0.404 ' OD1' ' O ' ' A' ' 996' ' ' ASN . 47.2 t-20 -63.3 -40.77 98.28 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.629 -0.428 . . . . 1.0 110.663 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 997' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.18 159.86 32.23 Favored Pre-proline 0 C--N 1.332 -0.171 0 CA-C-N 116.187 -0.46 . . . . 1.0 110.707 -179.404 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 998' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo . . . . . 0 C--N 1.311 -1.415 0 C-N-CA 122.244 1.962 . . . . 1.0 111.562 179.419 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 957' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.203 0 N-CA-C 109.526 -1.43 . . . . 1.0 109.526 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -64.74 -36.55 84.67 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 121.197 -0.201 . . . . 1.0 110.816 -179.917 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 34.1 tp -113.55 123.51 50.16 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 110.051 -0.351 . . . . 1.0 110.051 179.572 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 960' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -94.79 124.41 38.81 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.966 0.413 . . . . 1.0 110.411 -179.925 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 961' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -90.58 131.22 36.43 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.144 -0.48 . . . . 1.0 111.56 -178.781 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 962' ' ' ARG . . . . . . . . . . . . . 81.6 mtm-85 -65.02 -40.87 95.5 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.835 -0.62 . . . . 1.0 110.458 179.421 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 963' ' ' ALA . . . . . . . . . . . . . . . -72.94 153.51 40.94 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.873 -0.603 . . . . 1.0 110.854 -179.735 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 964' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -97.71 169.35 8.66 Favored Pre-proline 0 CA--C 1.533 0.29 0 CA-C-N 116.007 -0.542 . . . . 1.0 109.6 179.666 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -59.26 143.28 99.8 Favored 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 121.763 1.642 . . . . 1.0 112.738 -179.934 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 93.9 mt -64.35 -43.91 97.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.456 -0.793 . . . . 1.0 111.425 -179.737 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 967' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -56.73 -40.0 74.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.639 -0.71 . . . . 1.0 112.407 -178.317 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 38.9 m95 -69.67 -33.89 73.2 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.903 -0.406 . . . . 1.0 109.903 179.501 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 90.7 t -68.34 -46.04 81.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 C-N-CA 119.925 -0.71 . . . . 1.0 110.032 178.092 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 61.5 tp -66.15 -46.35 77.77 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 115.372 -0.831 . . . . 1.0 112.389 -179.165 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 971' ' ' VAL . . . . . . . . . . . . . 26.9 m -63.69 -41.56 93.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 119.732 -0.787 . . . . 1.0 110.614 -177.974 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.51 -40.45 97.77 Favored Glycine 0 CA--C 1.525 0.657 0 CA-C-N 115.569 -0.741 . . . . 1.0 111.541 -179.459 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 92.2 t -66.09 -47.08 86.11 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.34 0 CA-C-O 121.007 0.432 . . . . 1.0 110.364 -179.048 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 92.9 mt -62.27 -40.38 96.03 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 108.655 -0.869 . . . . 1.0 108.655 179.312 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -65.36 -45.19 91.66 Favored Glycine 0 CA--C 1.516 0.146 0 N-CA-C 109.866 -1.294 . . . . 1.0 109.866 -179.84 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -61.03 -38.05 94.89 Favored Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 109.417 -1.473 . . . . 1.0 109.417 178.864 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.24 -43.97 85.04 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 120.24 -0.584 . . . . 1.0 109.556 179.51 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 39.1 mt -61.56 -44.77 96.42 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.352 -0.539 . . . . 1.0 110.208 -179.724 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 97.1 mt -62.63 -43.47 98.73 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.419 -0.512 . . . . 1.0 110.368 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 980' ' ' LEU . . . . . . . . . . . . . 56.0 mt -63.48 -39.88 95.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.111 0.482 . . . . 1.0 109.847 -179.86 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 5.6 m -64.26 -47.1 80.89 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.592 -0.731 . . . . 1.0 110.248 -179.633 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 97.4 mt -64.23 -45.25 96.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.473 -0.331 . . . . 1.0 111.66 -178.608 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -64.89 -40.75 95.6 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.869 -0.332 . . . . 1.0 110.775 179.575 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 984' ' ' VAL . . . . . . . . . . . . . 55.5 t -67.2 -48.08 79.57 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.402 0 CA-C-O 121.441 0.638 . . . . 1.0 110.024 179.904 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 84.4 mt -63.55 -42.29 98.38 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.172 -0.922 . . . . 1.0 109.584 179.175 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 986' ' ' ALA . . . . . . . . . . . . . . . -62.99 -42.49 99.86 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-O 121.66 0.743 . . . . 1.0 109.34 -179.716 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 28.9 mtp -63.87 -30.06 71.19 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 114.643 -1.162 . . . . 1.0 109.426 179.677 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 988' ' ' TRP . . . . . . . . . . . . . 1.7 t90 -76.11 -35.86 59.13 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.073 -1.421 . . . . 1.0 108.042 178.734 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.02 -38.98 76.05 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.494 0.664 . . . . 1.0 109.885 -179.693 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 990' ' ' VAL . . . . . . . . . . . . . 1.4 m -81.95 -7.38 10.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.194 -0.912 . . . . 1.0 110.145 -179.175 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 991' ' ' GLY . . . . . 0.565 ' C ' ' H ' ' A' ' 993' ' ' PHE . . . 84.17 2.49 89.3 Favored Glycine 0 C--N 1.337 0.592 0 CA-C-O 119.074 -0.848 . . . . 1.0 112.672 178.613 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -53.52 -2.67 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 119.68 1.74 . . . . 1.0 112.159 -177.741 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 993' ' ' PHE . . . . . 0.565 ' H ' ' C ' ' A' ' 991' ' ' GLY . 28.3 m-85 -112.25 6.23 18.81 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 123.194 1.473 . . . . 1.0 110.632 179.781 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 994' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -127.11 133.31 50.42 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 111.703 -2.499 . . . . 1.0 112.74 -178.893 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 94.2 mtt-85 -67.19 -37.04 83.01 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.866 -1.061 . . . . 1.0 110.359 178.65 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 996' ' ' ASN . . . . . . . . . . . . . 31.2 m120 55.97 34.87 24.49 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.98 -0.555 . . . . 1.0 110.509 -179.464 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 997' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.62 160.05 0.41 Allowed Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.287 -179.895 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 998' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo . . . . . 0 C--N 1.31 -1.493 0 C-N-CA 122.461 2.107 . . . . 1.0 112.052 -179.656 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 967' ' ' TRP . . . . . 0.895 ' O ' HG23 ' A' ' 971' ' ' VAL . 98.4 m95 . . . . . 0 N--CA 1.448 -0.547 0 N-CA-C 110.658 -0.127 . . . . 0.64000000000000001 110.658 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 64.4 m95 -65.33 -32.73 74.53 Favored 'General case' 0 CA--C 1.518 -0.272 0 C-N-CA 120.277 -0.569 . . . . 0.93999999999999995 110.144 178.268 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 969' ' ' VAL . . . . . 0.726 ' O ' HG23 ' A' ' 973' ' ' VAL . 95.5 t -67.79 -47.24 80.39 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.391 0 N-CA-C 108.248 -1.019 . . . . 0.58999999999999997 108.248 178.559 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 2.0 tp -61.84 -42.35 98.93 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 114.088 -1.415 . . . . 1.76 107.414 178.117 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 971' ' ' VAL . . . . . 0.895 HG23 ' O ' ' A' ' 967' ' ' TRP . 99.4 t -62.03 -46.06 97.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.872 0.368 . . . . 0.65000000000000002 110.299 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -59.15 -42.32 97.07 Favored Glycine 0 C--N 1.338 0.644 0 N-CA-C 111.736 -0.546 . . . . 0.13 111.736 -179.072 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 973' ' ' VAL . . . . . 0.726 HG23 ' O ' ' A' ' 969' ' ' VAL . 63.6 t -67.31 -48.48 77.84 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.512 0 CA-C-N 114.94 -0.63 . . . . 0.85999999999999999 109.48 -178.894 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 89.5 mt -61.99 -42.0 98.66 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 115.37 -0.832 . . . . 1.1799999999999999 109.15 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -67.88 -47.5 60.19 Favored Glycine 0 C--N 1.335 0.478 0 N-CA-C 110.342 -1.103 . . . . 0.13 110.342 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -60.59 -37.98 94.26 Favored Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 108.805 -1.718 . . . . 0.14000000000000001 108.805 178.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 977' ' ' LEU . . . . . 0.466 ' O ' ' OG1' ' A' ' 981' ' ' THR . 46.0 tp -66.11 -44.4 84.39 Favored 'General case' 0 C--O 1.225 -0.197 0 N-CA-C 109.364 -0.606 . . . . 1.5600000000000001 109.364 178.631 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 1.1 mt -61.52 -46.27 90.66 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.689 -0.486 . . . . 1.73 109.689 178.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 57.2 mt -61.67 -43.62 98.51 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.186 -0.606 . . . . 0.89000000000000001 109.884 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 980' ' ' LEU . . . . . 0.682 ' O ' HG23 ' A' ' 984' ' ' VAL . 22.7 mt -63.69 -41.45 98.13 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 119.981 -0.688 . . . . 1.23 109.971 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 981' ' ' THR . . . . . 0.466 ' OG1' ' O ' ' A' ' 977' ' ' LEU . 7.2 m -63.15 -47.4 82.85 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.254 -0.885 . . . . 0.19 110.928 -179.462 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 93.6 mt -64.38 -44.54 97.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.655 0.264 . . . . 0.70999999999999996 110.598 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 13.1 mt -63.31 -36.81 84.91 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.978 -0.749 . . . . 1.6599999999999999 108.978 179.042 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 984' ' ' VAL . . . . . 0.682 HG23 ' O ' ' A' ' 980' ' ' LEU . 23.0 t -69.14 -50.37 53.61 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 CA-C-N 115.321 -0.854 . . . . 0.28000000000000003 110.92 -178.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 94.9 mt -65.45 -40.22 92.98 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.39 -0.823 . . . . 0.33000000000000002 109.329 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 986' ' ' ALA . . . . . 0.678 ' O ' HG13 ' A' ' 990' ' ' VAL . . . -64.54 -45.4 87.31 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 121.509 0.671 . . . . 0.11 110.273 -179.002 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 987' ' ' MET . . . . . 0.45 ' O ' ' N ' ' A' ' 992' ' ' PHE . 25.6 mtp -63.25 -28.63 70.16 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 122.174 0.988 . . . . 0.53000000000000003 109.582 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 988' ' ' TRP . . . . . . . . . . . . . 7.8 t90 -77.64 -35.41 52.57 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.016 -1.447 . . . . 2.4199999999999999 108.014 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.5 -41.08 76.55 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.514 0.673 . . . . 0.73999999999999999 109.874 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 990' ' ' VAL . . . . . 0.678 HG13 ' O ' ' A' ' 986' ' ' ALA . 2.4 m -79.42 -8.91 11.91 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 CA-C-N 115.124 -0.944 . . . . 0.14999999999999999 109.72 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 991' ' ' GLY . . . . . . . . . . . . . . . 85.87 3.66 85.47 Favored Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 114.772 -1.104 . . . . 0.16 112.19 179.167 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 992' ' ' PHE . . . . . 0.45 ' N ' ' O ' ' A' ' 987' ' ' MET . 0.3 OUTLIER -55.07 -37.92 67.38 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 120.133 1.966 . . . . 0.51000000000000001 113.762 -176.232 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 993' ' ' PHE . . . . . 0.407 ' CE2' ' HE2' ' A' ' 987' ' ' MET . 4.0 m-85 . . . . . 0 N--CA 1.479 0.987 0 CA-C-O 124.684 2.183 . . . . 1.53 109.293 178.177 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 967' ' ' TRP . . . . . 0.759 ' O ' HG23 ' A' ' 971' ' ' VAL . 98.7 m95 . . . . . 0 N--CA 1.463 0.213 0 N-CA-C 112.03 0.381 . . . . 1.0 112.03 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 31.3 m95 -69.3 -35.54 76.09 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 110.279 -0.267 . . . . 1.0 110.279 179.097 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 969' ' ' VAL . . . . . 0.451 ' O ' HG23 ' A' ' 973' ' ' VAL . 67.5 t -66.31 -45.01 90.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 109.097 -0.705 . . . . 1.0 109.097 178.127 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 92.4 mt -63.79 -41.81 97.85 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.997 -1.002 . . . . 1.0 109.961 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 971' ' ' VAL . . . . . 0.759 HG23 ' O ' ' A' ' 967' ' ' TRP . 76.0 t -62.71 -45.27 99.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.965 0.412 . . . . 1.0 110.855 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.14 -41.78 98.27 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.665 -0.574 . . . . 1.0 111.665 -179.095 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 973' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 969' ' ' VAL . 72.2 t -65.57 -46.78 88.63 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.541 0 CA-C-O 120.998 0.428 . . . . 1.0 110.574 -179.045 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 88.9 mt -62.24 -41.18 98.2 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.921 -0.77 . . . . 1.0 108.921 179.419 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -65.92 -46.18 83.41 Favored Glycine 0 C--N 1.329 0.163 0 N-CA-C 110.284 -1.126 . . . . 1.0 110.284 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -61.25 -37.93 94.82 Favored Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 109.141 -1.584 . . . . 1.0 109.141 179.171 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 55.4 tp -65.49 -42.53 92.07 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.196 -0.668 . . . . 1.0 109.196 178.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 42.9 tp -63.66 -45.47 90.0 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.304 -0.558 . . . . 1.0 110.694 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 90.9 mt -61.89 -42.8 99.5 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.017 -0.673 . . . . 1.0 109.908 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 980' ' ' LEU . . . . . 0.649 ' O ' HG23 ' A' ' 984' ' ' VAL . 84.6 mt -63.99 -41.41 97.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.988 0.423 . . . . 1.0 110.437 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 7.7 m -62.65 -46.41 88.34 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.738 -0.664 . . . . 1.0 110.29 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 94.5 mt -63.65 -43.75 98.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 C-N-CA 120.781 -0.368 . . . . 1.0 110.838 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 33.0 mt -64.72 -41.04 96.26 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.867 -0.333 . . . . 1.0 111.236 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 984' ' ' VAL . . . . . 0.649 HG23 ' O ' ' A' ' 980' ' ' LEU . 88.3 t -67.83 -49.07 72.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.25 0.548 . . . . 1.0 110.033 -179.535 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 81.6 mt -63.22 -43.32 98.45 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.433 -0.803 . . . . 1.0 109.698 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 986' ' ' ALA . . . . . 0.927 ' O ' HG13 ' A' ' 990' ' ' VAL . . . -61.72 -43.48 98.78 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 108.918 -0.771 . . . . 1.0 108.918 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 27.3 mtp -62.29 -30.79 71.38 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 114.804 -1.089 . . . . 1.0 109.648 179.109 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 988' ' ' TRP . . . . . . . . . . . . . 1.8 t90 -75.3 -37.79 60.65 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.035 -1.438 . . . . 1.0 108.271 179.117 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.22 -39.11 78.76 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.766 0.793 . . . . 1.0 110.048 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 990' ' ' VAL . . . . . 0.927 HG13 ' O ' ' A' ' 986' ' ' ALA . 1.4 m -83.39 -8.78 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-N 115.052 -0.976 . . . . 1.0 110.756 -178.467 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 991' ' ' GLY . . . . . 0.537 ' C ' ' H ' ' A' ' 993' ' ' PHE . . . 83.53 2.55 90.05 Favored Glycine 0 C--N 1.337 0.591 0 CA-C-O 119.222 -0.766 . . . . 1.0 112.594 178.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -52.64 -1.64 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 119.644 1.722 . . . . 1.0 112.386 -177.464 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 993' ' ' PHE . . . . . 0.537 ' H ' ' C ' ' A' ' 991' ' ' GLY . 12.2 m-85 . . . . . 0 C--N 1.332 -0.186 0 C-N-CA 120.426 -0.51 . . . . 1.0 110.975 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 967' ' ' TRP . . . . . 0.676 ' O ' HG23 ' A' ' 971' ' ' VAL . 91.5 m95 . . . . . 0 CA--C 1.522 -0.126 0 CA-C-O 120.859 0.361 . . . . 1.0 110.704 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 87.0 m95 -68.37 -37.03 80.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.74 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 969' ' ' VAL . . . . . 0.407 ' O ' HG23 ' A' ' 973' ' ' VAL . 96.2 t -66.78 -42.78 89.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 109.046 -0.724 . . . . 1.0 109.046 178.528 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 87.4 mt -62.9 -41.77 99.56 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.209 -0.905 . . . . 1.0 109.796 178.762 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 971' ' ' VAL . . . . . 0.676 HG23 ' O ' ' A' ' 967' ' ' TRP . 76.2 t -62.5 -45.57 98.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.819 0.342 . . . . 1.0 110.829 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -61.24 -40.96 99.31 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 111.837 -0.505 . . . . 1.0 111.837 -179.251 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 973' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 969' ' ' VAL . 62.6 t -65.87 -46.22 89.18 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.376 0 CA-C-N 115.092 -0.554 . . . . 1.0 110.037 -179.194 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 86.7 mt -63.26 -41.4 99.03 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 121.327 0.584 . . . . 1.0 109.432 178.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -66.44 -46.8 74.79 Favored Glycine 0 C--N 1.332 0.341 0 N-CA-C 110.489 -1.044 . . . . 1.0 110.489 -179.122 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -60.18 -36.74 91.5 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 108.886 -1.686 . . . . 1.0 108.886 178.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 977' ' ' LEU . . . . . 0.433 ' O ' ' OG1' ' A' ' 981' ' ' THR . 50.5 tp -66.41 -43.4 85.84 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.263 -0.575 . . . . 1.0 109.912 178.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 978' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' A' ' 978' ' ' LEU . 53.0 mt -61.94 -44.13 97.41 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 119.739 -0.784 . . . . 1.0 109.726 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 84.5 mt -62.5 -43.41 98.89 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 119.744 -0.782 . . . . 1.0 110.297 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 980' ' ' LEU . . . . . 0.527 ' O ' HG23 ' A' ' 984' ' ' VAL . 66.6 mt -64.56 -42.19 95.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.075 0.464 . . . . 1.0 110.606 -179.516 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 981' ' ' THR . . . . . 0.433 ' OG1' ' O ' ' A' ' 977' ' ' LEU . 5.9 m -64.18 -47.1 81.12 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.558 -0.747 . . . . 1.0 110.109 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 94.3 mt -64.07 -44.49 97.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 120.74 -0.384 . . . . 1.0 111.433 -179.091 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 6.4 mp -64.55 -40.27 95.27 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.638 -0.425 . . . . 1.0 111.087 179.387 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 984' ' ' VAL . . . . . 0.527 HG23 ' O ' ' A' ' 980' ' ' LEU . 54.1 t -68.5 -48.98 69.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.21 0.529 . . . . 1.0 109.843 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 85.3 mt -63.33 -43.27 98.24 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.574 -0.739 . . . . 1.0 109.451 178.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 986' ' ' ALA . . . . . 0.906 ' O ' HG13 ' A' ' 990' ' ' VAL . . . -62.08 -42.7 99.48 Favored 'General case' 0 CA--C 1.511 -0.544 0 N-CA-C 108.997 -0.742 . . . . 1.0 108.997 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 987' ' ' MET . . . . . 0.414 ' HA ' HG22 ' A' ' 990' ' ' VAL . 30.9 mtp -62.1 -31.69 72.17 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 114.729 -1.123 . . . . 1.0 109.238 178.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 988' ' ' TRP . . . . . . . . . . . . . 1.8 t90 -73.23 -38.57 66.0 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 113.884 -1.507 . . . . 1.0 108.166 179.205 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.26 -39.6 78.34 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.434 -0.803 . . . . 1.0 110.39 -179.434 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 990' ' ' VAL . . . . . 0.906 HG13 ' O ' ' A' ' 986' ' ' ALA . 1.4 m -83.58 -8.66 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 CA-C-N 115.003 -0.998 . . . . 1.0 110.204 -178.736 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 991' ' ' GLY . . . . . 0.51 ' C ' ' H ' ' A' ' 993' ' ' PHE . . . 81.43 5.07 90.25 Favored Glycine 0 C--N 1.339 0.713 0 CA-C-O 119.199 -0.779 . . . . 1.0 112.508 179.148 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -52.5 -1.24 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 119.74 1.77 . . . . 1.0 112.932 -177.031 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 993' ' ' PHE . . . . . 0.51 ' H ' ' C ' ' A' ' 991' ' ' GLY . 16.1 m-85 . . . . . 0 N--CA 1.465 0.315 0 C-N-CA 120.646 -0.422 . . . . 1.0 111.18 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 967' ' ' TRP . . . . . 0.825 ' O ' HG23 ' A' ' 971' ' ' VAL . 98.9 m95 . . . . . 0 CA--C 1.514 -0.41 0 CA-C-O 120.572 0.225 . . . . 1.0 111.447 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 90.9 m95 -70.53 -36.42 73.71 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.474 -0.33 . . . . 1.0 110.367 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 95.2 t -66.81 -45.12 88.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 N-CA-C 108.389 -0.967 . . . . 1.0 108.389 178.206 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 58.9 tp -63.2 -42.51 99.32 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 114.564 -1.198 . . . . 1.0 109.199 178.703 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 971' ' ' VAL . . . . . 0.825 HG23 ' O ' ' A' ' 967' ' ' TRP . 79.3 t -62.29 -45.08 99.6 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.087 0 N-CA-C 109.727 -0.472 . . . . 1.0 109.727 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.23 -43.25 98.66 Favored Glycine 0 CA--C 1.526 0.736 0 CA-C-N 116.151 -0.477 . . . . 1.0 112.127 -179.258 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 58.2 t -65.24 -46.72 89.9 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.416 0 CA-C-N 115.169 -0.515 . . . . 1.0 110.066 -179.266 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 974' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 974' ' ' LEU . 88.8 mt -62.11 -41.98 98.76 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 109.038 -0.727 . . . . 1.0 109.038 178.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -65.98 -47.4 74.45 Favored Glycine 0 C--O 1.225 -0.418 0 N-CA-C 110.248 -1.141 . . . . 1.0 110.248 -179.396 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -59.13 -37.46 91.73 Favored Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 109.144 -1.582 . . . . 1.0 109.144 178.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 977' ' ' LEU . . . . . 0.431 HD23 ' HA ' ' A' ' 977' ' ' LEU . 35.7 mt -65.49 -42.97 91.56 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 119.982 -0.687 . . . . 1.0 110.257 178.888 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 35.7 mt -61.98 -44.05 97.55 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.021 -0.671 . . . . 1.0 110.304 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 10.7 mp -63.82 -43.57 95.82 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 119.555 -0.858 . . . . 1.0 111.501 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 980' ' ' LEU . . . . . 0.433 ' O ' HG23 ' A' ' 984' ' ' VAL . 2.6 mm? -63.66 -39.58 94.68 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.731 -0.388 . . . . 1.0 110.966 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 6.7 m -64.64 -47.74 77.38 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.137 -0.483 . . . . 1.0 110.853 -179.499 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 92.9 mt -63.27 -44.48 99.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.385 -0.371 . . . . 1.0 111.265 -178.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -64.83 -40.83 95.82 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.333 -0.394 . . . . 1.0 111.564 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 984' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 980' ' ' LEU . 41.2 t -67.48 -48.48 77.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.425 0.631 . . . . 1.0 110.277 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 85.9 mt -64.45 -42.78 95.78 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.136 -0.938 . . . . 1.0 109.894 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 986' ' ' ALA . . . . . 0.941 ' O ' HG13 ' A' ' 990' ' ' VAL . . . -62.92 -45.74 91.06 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.351 0.596 . . . . 1.0 109.825 -179.448 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 26.8 mtp -62.0 -32.56 73.05 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.966 -1.016 . . . . 1.0 109.522 179.318 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 988' ' ' TRP . . . . . 0.471 ' O ' ' CD1' ' A' ' 988' ' ' TRP . 11.4 t90 -74.47 -37.52 63.19 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.315 -1.311 . . . . 1.0 108.838 178.433 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.98 -40.58 78.72 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.797 0.808 . . . . 1.0 110.071 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 990' ' ' VAL . . . . . 0.941 HG13 ' O ' ' A' ' 986' ' ' ALA . 1.4 m -81.43 -8.08 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-N 114.639 -1.164 . . . . 1.0 110.1 -179.134 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 991' ' ' GLY . . . . . 0.551 ' C ' ' H ' ' A' ' 993' ' ' PHE . . . 83.28 2.83 90.33 Favored Glycine 0 C--N 1.338 0.654 0 CA-C-O 119.116 -0.825 . . . . 1.0 112.479 178.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -52.98 -1.95 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 119.722 1.761 . . . . 1.0 112.132 -177.306 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 993' ' ' PHE . . . . . 0.551 ' H ' ' C ' ' A' ' 991' ' ' GLY . 11.0 m-85 . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 116.398 -0.364 . . . . 1.0 110.961 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 967' ' ' TRP . . . . . 0.568 ' O ' HG23 ' A' ' 971' ' ' VAL . 97.6 m95 . . . . . 0 N--CA 1.455 -0.195 0 CA-C-O 120.857 0.36 . . . . 1.0 110.716 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -69.05 -35.49 76.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.166 -0.47 . . . . 1.0 109.98 178.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 969' ' ' VAL . . . . . 0.566 ' O ' HG23 ' A' ' 973' ' ' VAL . 77.6 t -67.33 -44.6 87.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.539 0.685 . . . . 1.0 109.284 178.263 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 57.3 tp -63.61 -43.16 97.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.702 -1.135 . . . . 1.0 109.468 179.304 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 971' ' ' VAL . . . . . 0.568 HG23 ' O ' ' A' ' 967' ' ' TRP . 46.7 t -62.08 -45.01 99.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.998 0.428 . . . . 1.0 110.469 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.08 -39.42 95.74 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 111.348 -0.701 . . . . 1.0 111.348 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 973' ' ' VAL . . . . . 0.566 HG23 ' O ' ' A' ' 969' ' ' VAL . 74.5 t -66.61 -47.51 83.14 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.29 0 CA-C-N 114.999 -0.6 . . . . 1.0 110.585 -179.243 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 92.9 mt -62.91 -41.69 99.54 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.191 -0.67 . . . . 1.0 109.191 179.116 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -66.28 -46.71 76.88 Favored Glycine 0 C--N 1.329 0.175 0 N-CA-C 110.74 -0.944 . . . . 1.0 110.74 -179.265 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -60.29 -37.03 92.41 Favored Glycine 0 N--CA 1.448 -0.505 0 N-CA-C 109.181 -1.568 . . . . 1.0 109.181 179.121 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 38.2 mt -65.97 -42.54 89.74 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.119 -0.632 . . . . 1.0 110.158 179.013 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 76.7 mt -62.38 -44.46 96.41 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.149 -0.62 . . . . 1.0 110.496 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 96.7 mt -63.1 -43.61 98.0 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.248 -0.581 . . . . 1.0 110.676 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 980' ' ' LEU . . . . . . . . . . . . . 81.3 mt -64.35 -40.38 95.75 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.079 0.466 . . . . 1.0 110.417 -179.686 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 981' ' ' THR . . . . . 0.43 HG22 ' CD1' ' A' ' 985' ' ' LEU . 7.1 m -63.54 -45.79 88.94 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.525 -0.761 . . . . 1.0 109.748 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 89.7 mt -63.57 -44.18 98.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.318 -0.401 . . . . 1.0 111.366 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 85.1 mt -64.48 -42.63 95.77 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 121.125 -0.23 . . . . 1.0 111.347 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 984' ' ' VAL . . . . . . . . . . . . . 47.3 t -67.9 -47.96 77.12 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.374 0 CA-C-O 121.223 0.535 . . . . 1.0 109.968 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 985' ' ' LEU . . . . . 0.43 ' CD1' HG22 ' A' ' 981' ' ' THR . 89.3 mt -63.49 -42.75 98.53 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.458 -0.792 . . . . 1.0 109.348 179.362 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 986' ' ' ALA . . . . . 0.881 ' O ' HG13 ' A' ' 990' ' ' VAL . . . -63.18 -45.64 90.84 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 121.513 0.673 . . . . 1.0 109.621 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 32.6 mtp -62.34 -33.44 74.71 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.614 -1.175 . . . . 1.0 109.188 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 988' ' ' TRP . . . . . 0.489 ' O ' ' CD1' ' A' ' 988' ' ' TRP . 12.9 t90 -73.2 -35.2 66.32 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.473 -1.239 . . . . 1.0 108.379 178.61 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.04 -40.14 75.32 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.589 -0.732 . . . . 1.0 109.795 -179.412 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 990' ' ' VAL . . . . . 0.881 HG13 ' O ' ' A' ' 986' ' ' ALA . 1.2 m -81.91 -7.12 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 CA-C-N 114.989 -1.005 . . . . 1.0 110.063 -179.237 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 991' ' ' GLY . . . . . 0.517 ' C ' ' H ' ' A' ' 993' ' ' PHE . . . 82.15 3.77 90.45 Favored Glycine 0 C--N 1.34 0.784 0 CA-C-O 119.011 -0.883 . . . . 1.0 112.666 178.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -54.13 -0.93 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 119.607 1.704 . . . . 1.0 112.839 -177.216 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 993' ' ' PHE . . . . . 0.517 ' H ' ' C ' ' A' ' 991' ' ' GLY . 13.1 m-85 . . . . . 0 N--CA 1.465 0.28 0 CA-C-O 121.051 0.453 . . . . 1.0 110.135 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 967' ' ' TRP . . . . . 0.441 ' O ' HG23 ' A' ' 971' ' ' VAL . 99.5 m95 . . . . . 0 N--CA 1.457 -0.101 0 CA-C-O 120.867 0.365 . . . . 1.0 110.98 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 94.0 m95 -69.56 -34.47 74.23 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.361 -0.382 . . . . 1.0 110.247 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 969' ' ' VAL . . . . . 0.411 ' O ' HG23 ' A' ' 973' ' ' VAL . 73.9 t -65.83 -43.22 93.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 C-N-CA 119.889 -0.724 . . . . 1.0 109.175 177.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 93.2 mt -62.74 -42.35 99.63 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.145 -0.934 . . . . 1.0 109.923 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 971' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 967' ' ' TRP . 47.5 t -61.87 -46.23 96.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.864 0.364 . . . . 1.0 110.175 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -59.79 -43.55 97.81 Favored Glycine 0 CA--C 1.521 0.418 0 CA-C-N 116.095 -0.502 . . . . 1.0 112.016 -179.379 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 973' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 969' ' ' VAL . 71.6 t -65.17 -46.45 90.94 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.555 0 CA-C-O 120.996 0.426 . . . . 1.0 110.703 -178.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 91.5 mt -63.12 -40.38 97.43 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 109.17 -0.678 . . . . 1.0 109.17 179.519 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -67.76 -45.35 76.01 Favored Glycine 0 CA--C 1.518 0.236 0 N-CA-C 110.415 -1.074 . . . . 1.0 110.415 -179.012 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -61.24 -37.54 94.17 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 109.622 -1.391 . . . . 1.0 109.622 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 57.9 tp -67.52 -41.68 84.01 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 119.698 -0.801 . . . . 1.0 109.874 179.336 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 65.9 mt -62.04 -43.77 98.13 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 119.86 -0.736 . . . . 1.0 110.298 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 82.3 mt -62.59 -44.03 97.32 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.323 -0.551 . . . . 1.0 110.825 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 980' ' ' LEU . . . . . 0.724 ' O ' HG23 ' A' ' 984' ' ' VAL . 88.6 mt -63.96 -40.26 96.0 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.067 0.461 . . . . 1.0 110.168 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 6.8 m -64.09 -46.65 83.31 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.612 -0.722 . . . . 1.0 110.293 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 93.9 mt -64.07 -44.57 97.73 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 C-N-CA 120.827 -0.349 . . . . 1.0 111.118 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 59.7 tp -63.96 -40.88 97.43 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.624 -0.43 . . . . 1.0 110.21 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 984' ' ' VAL . . . . . 0.724 HG23 ' O ' ' A' ' 980' ' ' LEU . 77.8 t -65.7 -47.69 85.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.311 0.577 . . . . 1.0 110.252 -179.312 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 64.7 mt -63.71 -41.38 98.11 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.37 -0.832 . . . . 1.0 109.533 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 986' ' ' ALA . . . . . 0.87 ' O ' HG13 ' A' ' 990' ' ' VAL . . . -62.96 -47.13 84.5 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.107 0.48 . . . . 1.0 110.511 -179.136 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 13.3 mtm -64.09 -32.35 73.87 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 122.112 0.958 . . . . 1.0 109.622 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 988' ' ' TRP . . . . . 0.483 ' O ' ' CD1' ' A' ' 988' ' ' TRP . 9.4 t90 -69.27 -36.46 77.11 Favored 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 107.499 -1.297 . . . . 1.0 107.499 178.635 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.81 -39.56 76.47 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.117 -0.947 . . . . 1.0 110.321 -179.366 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 990' ' ' VAL . . . . . 0.87 HG13 ' O ' ' A' ' 986' ' ' ALA . 1.0 OUTLIER -84.88 -9.89 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 CA-C-N 115.198 -0.91 . . . . 1.0 110.651 -178.892 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 991' ' ' GLY . . . . . 0.484 ' C ' ' H ' ' A' ' 993' ' ' PHE . . . 82.47 6.53 88.55 Favored Glycine 0 C--N 1.336 0.56 0 CA-C-O 118.744 -1.031 . . . . 1.0 112.876 179.171 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -57.45 0.26 0.05 Allowed 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 120.056 1.928 . . . . 1.0 112.997 -177.381 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 993' ' ' PHE . . . . . 0.484 ' H ' ' C ' ' A' ' 991' ' ' GLY . 10.3 m-85 . . . . . 0 C--N 1.326 -0.445 0 CA-C-O 121.379 0.609 . . . . 1.0 109.688 179.591 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 967' ' ' TRP . . . . . 0.515 ' O ' HG23 ' A' ' 971' ' ' VAL . 81.7 m95 . . . . . 0 N--CA 1.454 -0.241 0 CA-C-O 120.763 0.316 . . . . 1.0 110.621 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 95.3 m95 -68.73 -36.72 78.77 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.3 178.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 56.1 t -66.02 -43.88 92.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.149 -0.685 . . . . 1.0 109.149 178.327 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 62.9 tp -62.72 -41.94 99.41 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.179 -0.919 . . . . 1.0 109.484 179.331 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 971' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 967' ' ' TRP . 41.6 t -63.47 -45.79 96.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.165 -0.47 . . . . 1.0 111.321 -179.379 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -62.51 -44.17 97.96 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-N 116.253 -0.43 . . . . 1.0 113.532 -178.187 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 35.0 m -68.29 -42.96 84.8 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 CA-C-O 120.787 0.327 . . . . 1.0 110.861 -178.017 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 97.9 mt -63.09 -40.17 96.86 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.444 -0.947 . . . . 1.0 108.444 178.445 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -66.13 -46.75 78.05 Favored Glycine 0 C--N 1.33 0.222 0 N-CA-C 110.447 -1.061 . . . . 1.0 110.447 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -59.33 -36.16 87.83 Favored Glycine 0 N--CA 1.448 -0.514 0 N-CA-C 108.804 -1.718 . . . . 1.0 108.804 178.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 977' ' ' LEU . . . . . 0.427 ' O ' ' OG1' ' A' ' 981' ' ' THR . 58.9 tp -65.54 -43.64 89.32 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.17 -0.612 . . . . 1.0 109.719 178.668 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 45.7 tp -61.84 -45.45 93.77 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.653 -0.419 . . . . 1.0 110.436 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 10.8 mp -63.18 -43.16 99.0 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 119.935 -0.706 . . . . 1.0 110.719 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 980' ' ' LEU . . . . . 0.53 ' O ' HG23 ' A' ' 984' ' ' VAL . 80.7 mt -63.94 -40.85 97.4 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 121.186 0.517 . . . . 1.0 110.149 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 981' ' ' THR . . . . . 0.444 HG22 HD12 ' A' ' 985' ' ' LEU . 8.2 m -62.75 -46.79 86.42 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.37 -0.832 . . . . 1.0 110.015 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 88.9 mt -63.84 -43.83 97.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 C-N-CA 120.633 -0.427 . . . . 1.0 111.203 -179.553 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 91.1 mt -65.2 -41.07 94.88 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.519 -0.309 . . . . 1.0 111.03 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 984' ' ' VAL . . . . . 0.53 HG23 ' O ' ' A' ' 980' ' ' LEU . 72.0 t -70.02 -50.16 50.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.064 0.459 . . . . 1.0 110.449 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 985' ' ' LEU . . . . . 0.444 HD12 HG22 ' A' ' 981' ' ' THR . 89.8 mt -63.79 -42.92 97.63 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.783 -0.644 . . . . 1.0 109.622 179.482 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 986' ' ' ALA . . . . . 0.863 ' O ' HG13 ' A' ' 990' ' ' VAL . . . -62.53 -43.28 99.2 Favored 'General case' 0 CA--C 1.511 -0.531 0 N-CA-C 108.926 -0.768 . . . . 1.0 108.926 -179.56 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 31.5 mtp -61.95 -30.53 70.97 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 122.512 1.148 . . . . 1.0 109.073 178.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 988' ' ' TRP . . . . . . . . . . . . . 1.6 t90 -74.02 -36.98 64.48 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 113.64 -1.618 . . . . 1.0 107.874 179.125 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.71 -39.05 73.64 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.595 0.712 . . . . 1.0 110.248 -179.359 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 990' ' ' VAL . . . . . 0.863 HG13 ' O ' ' A' ' 986' ' ' ALA . 1.1 m -81.76 -7.28 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-N 114.967 -1.015 . . . . 1.0 110.09 -179.258 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 991' ' ' GLY . . . . . 0.51 ' C ' ' H ' ' A' ' 993' ' ' PHE . . . 81.85 3.73 90.51 Favored Glycine 0 C--N 1.34 0.79 0 CA-C-O 119.136 -0.813 . . . . 1.0 112.414 178.88 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -52.63 -1.56 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 119.45 1.625 . . . . 1.0 112.932 -177.016 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 993' ' ' PHE . . . . . 0.51 ' H ' ' C ' ' A' ' 991' ' ' GLY . 15.4 m-85 . . . . . 0 C--N 1.327 -0.389 0 CA-C-O 121.287 0.565 . . . . 1.0 110.433 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 967' ' ' TRP . . . . . 0.684 ' O ' HG23 ' A' ' 971' ' ' VAL . 98.7 m95 . . . . . 0 CA--C 1.52 -0.174 0 CA-C-O 120.677 0.275 . . . . 1.0 110.877 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -69.25 -34.88 75.47 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 110.029 -0.36 . . . . 1.0 110.029 179.439 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 969' ' ' VAL . . . . . 0.458 ' O ' HG23 ' A' ' 973' ' ' VAL . 75.3 t -68.52 -47.02 79.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.203 0.525 . . . . 1.0 110.489 178.598 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 8.8 mp -64.01 -41.68 97.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.509 -0.768 . . . . 1.0 110.18 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 971' ' ' VAL . . . . . 0.684 HG23 ' O ' ' A' ' 967' ' ' TRP . 59.1 t -62.3 -44.53 99.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.879 0.371 . . . . 1.0 110.541 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -61.43 -40.49 98.74 Favored Glycine 0 CA--C 1.529 0.915 0 CA-C-N 116.064 -0.516 . . . . 1.0 112.006 -179.198 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 973' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 969' ' ' VAL . 75.9 t -67.0 -45.26 87.46 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.519 0 CA-C-N 115.445 -0.378 . . . . 1.0 110.735 -178.798 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 9.2 mp -62.5 -40.23 96.06 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.597 -0.89 . . . . 1.0 108.597 178.377 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -65.07 -45.8 90.78 Favored Glycine 0 N--CA 1.46 0.247 0 N-CA-C 110.29 -1.124 . . . . 1.0 110.29 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -59.69 -36.73 90.74 Favored Glycine 0 N--CA 1.444 -0.767 0 N-CA-C 108.771 -1.731 . . . . 1.0 108.771 178.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 55.7 tp -66.86 -44.11 81.83 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.187 -0.605 . . . . 1.0 110.514 179.32 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 83.2 mt -62.54 -44.94 95.09 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.091 -0.643 . . . . 1.0 110.757 -179.273 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 10.2 mp -63.51 -44.11 95.22 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 119.675 -0.81 . . . . 1.0 111.924 -179.433 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 980' ' ' LEU . . . . . . . . . . . . . 7.1 mp -63.83 -37.65 88.15 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.156 -0.618 . . . . 1.0 110.79 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 5.4 m -65.5 -46.61 79.04 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.521 -179.478 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 80.1 mt -63.11 -43.41 98.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 120.495 -0.482 . . . . 1.0 110.732 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 57.1 mt -63.66 -41.78 98.17 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 121.153 -0.219 . . . . 1.0 110.722 179.392 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 984' ' ' VAL . . . . . . . . . . . . . 56.6 t -68.38 -47.99 75.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 120.928 0.394 . . . . 1.0 110.052 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 84.3 mt -62.63 -42.41 99.58 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.937 -0.574 . . . . 1.0 109.524 179.005 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 986' ' ' ALA . . . . . 0.869 ' O ' HG13 ' A' ' 990' ' ' VAL . . . -63.26 -44.32 95.48 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 121.696 0.76 . . . . 1.0 108.981 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 30.7 mtp -62.11 -32.44 73.01 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 114.566 -1.197 . . . . 1.0 109.159 178.723 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 988' ' ' TRP . . . . . . . . . . . . . 2.0 t90 -72.32 -38.25 68.73 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.292 -1.322 . . . . 1.0 108.104 178.712 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.58 -39.62 84.85 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.335 -0.848 . . . . 1.0 110.306 -179.619 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 990' ' ' VAL . . . . . 0.869 HG13 ' O ' ' A' ' 986' ' ' ALA . 1.2 m -83.88 -8.94 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-N 115.286 -0.87 . . . . 1.0 110.956 -178.245 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 991' ' ' GLY . . . . . 0.556 ' C ' ' H ' ' A' ' 993' ' ' PHE . . . 82.58 4.24 90.19 Favored Glycine 0 C--N 1.338 0.671 0 CA-C-O 119.245 -0.753 . . . . 1.0 112.703 178.319 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -53.02 -2.91 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 119.259 1.529 . . . . 1.0 111.867 -177.812 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 993' ' ' PHE . . . . . 0.556 ' H ' ' C ' ' A' ' 991' ' ' GLY . 11.7 m-85 . . . . . 0 C--N 1.329 -0.292 0 CA-C-O 121.037 0.446 . . . . 1.0 109.916 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 967' ' ' TRP . . . . . 0.786 ' O ' HG23 ' A' ' 971' ' ' VAL . 98.3 m95 . . . . . 0 N--CA 1.463 0.181 0 CA-C-O 120.637 0.256 . . . . 1.0 111.498 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -70.24 -36.84 74.78 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.605 -0.27 . . . . 1.0 110.475 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 969' ' ' VAL . . . . . 0.445 ' O ' HG23 ' A' ' 973' ' ' VAL . 73.8 t -66.66 -44.35 89.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 108.937 -0.764 . . . . 1.0 108.937 178.551 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 60.9 tp -62.96 -43.2 99.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.817 -1.083 . . . . 1.0 109.499 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 971' ' ' VAL . . . . . 0.786 HG23 ' O ' ' A' ' 967' ' ' TRP . 56.2 t -61.93 -46.19 97.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.391 -0.368 . . . . 1.0 111.102 -179.517 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.15 -40.6 97.43 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 111.612 -0.595 . . . . 1.0 111.612 -179.286 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 973' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 969' ' ' VAL . 64.8 t -66.8 -48.37 80.05 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.483 0 CA-C-O 121.028 0.442 . . . . 1.0 111.068 -178.738 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 974' ' ' LEU . . . . . 0.406 HD13 ' HA ' ' A' ' 974' ' ' LEU . 3.9 mm? -62.74 -41.2 99.08 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 109.297 -0.631 . . . . 1.0 109.297 179.224 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -65.16 -43.52 95.37 Favored Glycine 0 C--O 1.229 -0.172 0 N-CA-C 109.456 -1.457 . . . . 1.0 109.456 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -62.01 -37.24 94.09 Favored Glycine 0 CA--C 1.521 0.462 0 N-CA-C 109.759 -1.336 . . . . 1.0 109.759 179.082 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 977' ' ' LEU . . . . . 0.41 ' O ' ' OG1' ' A' ' 981' ' ' THR . 60.7 tp -67.81 -44.53 77.06 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 109.856 -0.424 . . . . 1.0 109.856 179.18 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -62.16 -43.81 98.0 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.329 -0.548 . . . . 1.0 110.28 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 86.3 mt -62.88 -43.67 98.18 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.07 -0.652 . . . . 1.0 110.62 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 980' ' ' LEU . . . . . . . . . . . . . 64.4 mt -63.99 -40.62 96.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.123 0.487 . . . . 1.0 110.269 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 981' ' ' THR . . . . . 0.439 HG22 ' CD1' ' A' ' 985' ' ' LEU . 7.5 m -63.4 -45.78 89.46 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.439 -0.801 . . . . 1.0 109.725 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 85.6 mt -63.97 -44.71 97.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.266 -0.425 . . . . 1.0 111.118 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 56.9 tp -64.89 -43.55 92.54 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.171 -0.468 . . . . 1.0 111.397 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 984' ' ' VAL . . . . . . . . . . . . . 51.9 t -66.71 -47.97 81.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.438 0.637 . . . . 1.0 110.134 -179.497 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 985' ' ' LEU . . . . . 0.439 ' CD1' HG22 ' A' ' 981' ' ' THR . 81.6 mt -63.22 -42.9 99.32 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.07 -0.968 . . . . 1.0 109.605 178.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 986' ' ' ALA . . . . . 0.879 ' O ' HG13 ' A' ' 990' ' ' VAL . . . -61.98 -44.92 95.74 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-O 121.348 0.594 . . . . 1.0 109.487 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 987' ' ' MET . . . . . 0.431 ' HA ' HG22 ' A' ' 990' ' ' VAL . 19.6 mtp -62.17 -30.29 70.96 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 122.349 1.071 . . . . 1.0 109.563 179.199 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 988' ' ' TRP . . . . . . . . . . . . . 1.7 t90 -74.75 -38.09 62.33 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.018 -1.446 . . . . 1.0 108.396 178.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.88 -39.94 79.53 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.467 -0.788 . . . . 1.0 109.741 -179.068 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 990' ' ' VAL . . . . . 0.879 HG13 ' O ' ' A' ' 986' ' ' ALA . 1.4 m -82.14 -7.9 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 CA-C-N 114.829 -1.078 . . . . 1.0 110.408 -179.11 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 991' ' ' GLY . . . . . 0.549 ' C ' ' H ' ' A' ' 993' ' ' PHE . . . 82.4 3.41 90.55 Favored Glycine 0 C--N 1.336 0.567 0 CA-C-O 119.366 -0.685 . . . . 1.0 112.385 178.814 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -52.67 -1.37 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 119.624 1.712 . . . . 1.0 112.418 -177.369 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 993' ' ' PHE . . . . . 0.549 ' H ' ' C ' ' A' ' 991' ' ' GLY . 14.0 m-85 . . . . . 0 C--O 1.233 0.207 0 C-N-CA 120.713 -0.395 . . . . 1.0 111.497 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 967' ' ' TRP . . . . . 0.733 ' O ' HG23 ' A' ' 971' ' ' VAL . 97.7 m95 . . . . . 0 N--CA 1.454 -0.236 0 CA-C-O 120.614 0.245 . . . . 1.0 111.101 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 23.9 m95 -69.3 -34.66 75.03 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.569 -0.287 . . . . 1.0 110.557 178.684 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 93.8 t -66.97 -44.61 88.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 108.715 -0.846 . . . . 1.0 108.715 178.152 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 80.1 mt -63.16 -41.43 99.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.728 -1.124 . . . . 1.0 109.39 178.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 971' ' ' VAL . . . . . 0.733 HG23 ' O ' ' A' ' 967' ' ' TRP . 66.8 t -61.88 -45.0 99.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 CA-C-O 120.989 0.423 . . . . 1.0 109.978 179.456 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -59.83 -41.05 97.49 Favored Glycine 0 CA--C 1.523 0.594 0 N-CA-C 111.301 -0.72 . . . . 1.0 111.301 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 54.1 t -65.63 -45.16 93.0 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.374 0 CA-C-N 115.333 -0.434 . . . . 1.0 109.882 -179.454 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 974' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 974' ' ' LEU . 86.9 mt -62.25 -42.18 99.1 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.197 -0.668 . . . . 1.0 109.197 178.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -65.96 -45.74 85.95 Favored Glycine 0 N--CA 1.459 0.175 0 N-CA-C 110.26 -1.136 . . . . 1.0 110.26 -179.376 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -60.92 -37.98 94.66 Favored Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 109.142 -1.583 . . . . 1.0 109.142 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 977' ' ' LEU . . . . . 0.473 ' O ' ' OG1' ' A' ' 981' ' ' THR . 56.2 tp -65.82 -44.46 85.55 Favored 'General case' 0 C--O 1.226 -0.172 0 N-CA-C 109.736 -0.468 . . . . 1.0 109.736 178.86 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 50.6 tp -62.42 -46.04 90.38 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.375 -0.53 . . . . 1.0 110.642 -179.417 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 87.8 mt -62.58 -44.5 96.15 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.281 -0.567 . . . . 1.0 110.952 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 980' ' ' LEU . . . . . . . . . . . . . 80.7 mt -63.58 -40.92 98.19 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.852 -0.425 . . . . 1.0 109.852 -179.552 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 981' ' ' THR . . . . . 0.473 ' OG1' ' O ' ' A' ' 977' ' ' LEU . 6.8 m -63.96 -46.84 82.9 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.718 -0.674 . . . . 1.0 110.64 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 93.4 mt -63.59 -44.41 98.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 120.807 -0.357 . . . . 1.0 111.562 -178.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 983' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 983' ' ' LEU . 93.9 mt -64.76 -40.18 94.86 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.727 -0.389 . . . . 1.0 110.976 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 984' ' ' VAL . . . . . . . . . . . . . 38.9 t -69.02 -48.05 72.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.257 0.551 . . . . 1.0 111.014 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 86.5 mt -62.96 -42.63 99.88 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.037 -0.727 . . . . 1.0 109.037 178.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 986' ' ' ALA . . . . . 0.871 ' O ' HG13 ' A' ' 990' ' ' VAL . . . -63.52 -44.6 93.78 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.265 0.555 . . . . 1.0 110.11 -179.045 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 21.5 mtp -63.52 -31.12 72.19 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 122.527 1.156 . . . . 1.0 110.153 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 988' ' ' TRP . . . . . 0.439 ' O ' ' CD1' ' A' ' 988' ' ' TRP . 14.0 t90 -75.89 -35.03 59.98 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.163 -1.38 . . . . 1.0 108.313 179.128 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.5 -38.36 74.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.468 0.651 . . . . 1.0 109.807 -179.578 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 990' ' ' VAL . . . . . 0.871 HG13 ' O ' ' A' ' 986' ' ' ALA . 1.6 m -78.96 0.2 3.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.19 -0.913 . . . . 1.0 109.394 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 991' ' ' GLY . . . . . . . . . . . . . . . 79.69 1.13 86.44 Favored Glycine 0 CA--C 1.506 -0.502 0 CA-C-O 119.478 -0.623 . . . . 1.0 112.252 177.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -48.38 -41.45 28.89 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-N 118.88 1.34 . . . . 1.0 111.256 -176.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 993' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 . . . . . 0 N--CA 1.463 0.198 0 CA-C-O 121.819 0.819 . . . . 1.0 111.009 179.937 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 967' ' ' TRP . . . . . 0.755 ' O ' HG23 ' A' ' 971' ' ' VAL . 98.2 m95 . . . . . 0 C--O 1.229 0.023 0 CA-C-O 120.603 0.24 . . . . 1.0 111.181 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 99.7 m95 -70.29 -35.58 73.81 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.571 -0.286 . . . . 1.0 110.334 179.265 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 969' ' ' VAL . . . . . 0.545 ' O ' HG23 ' A' ' 973' ' ' VAL . 86.2 t -67.31 -45.63 85.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 N-CA-C 109.107 -0.701 . . . . 1.0 109.107 178.588 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 10.0 mp -63.29 -43.01 99.1 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.656 -0.702 . . . . 1.0 109.866 178.774 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 971' ' ' VAL . . . . . 0.755 HG23 ' O ' ' A' ' 967' ' ' TRP . 77.8 t -62.37 -45.06 99.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.378 -0.374 . . . . 1.0 110.922 -179.413 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.45 -41.48 98.62 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 112.074 -0.41 . . . . 1.0 112.074 -179.069 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 973' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 969' ' ' VAL . 84.5 t -66.61 -45.97 87.22 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.306 0 CA-C-N 115.195 -0.503 . . . . 1.0 110.392 -178.867 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 90.7 mt -62.41 -41.38 98.63 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 109.042 -0.725 . . . . 1.0 109.042 178.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -65.77 -46.0 85.54 Favored Glycine 0 C--N 1.331 0.299 0 N-CA-C 110.26 -1.136 . . . . 1.0 110.26 -179.634 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -60.77 -37.48 93.68 Favored Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 109.195 -1.562 . . . . 1.0 109.195 179.058 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 56.0 tp -66.97 -43.28 83.44 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.49 -0.484 . . . . 1.0 109.936 178.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 978' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 978' ' ' LEU . 39.9 mt -61.94 -44.94 95.73 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.359 -0.382 . . . . 1.0 110.223 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 94.8 mt -62.86 -42.96 99.95 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 119.669 -0.812 . . . . 1.0 110.315 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 980' ' ' LEU . . . . . . . . . . . . . 81.1 mt -64.17 -41.57 97.08 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.964 0.411 . . . . 1.0 111.093 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 7.5 m -62.81 -47.63 82.61 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.693 -0.685 . . . . 1.0 110.188 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 84.7 mt -63.61 -44.28 98.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 116.111 -0.495 . . . . 1.0 111.117 -179.653 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 15.1 tp -64.19 -43.14 95.99 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.498 -0.319 . . . . 1.0 110.955 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 984' ' ' VAL . . . . . . . . . . . . . 54.1 t -68.57 -48.7 70.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.171 0.51 . . . . 1.0 110.974 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 83.5 mt -62.15 -42.61 99.43 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.805 -0.813 . . . . 1.0 108.805 179.34 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 986' ' ' ALA . . . . . 0.831 ' O ' HG13 ' A' ' 990' ' ' VAL . . . -61.69 -44.01 97.76 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 109.062 -0.718 . . . . 1.0 109.062 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 27.4 mtp -61.59 -30.87 70.95 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.761 -1.108 . . . . 1.0 108.964 178.65 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 988' ' ' TRP . . . . . . . . . . . . . 1.7 t90 -73.46 -38.64 65.4 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 113.928 -1.487 . . . . 1.0 108.455 179.023 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.2 -37.79 78.29 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.594 -0.73 . . . . 1.0 110.378 -179.204 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 990' ' ' VAL . . . . . 0.831 HG13 ' O ' ' A' ' 986' ' ' ALA . 1.3 m -85.16 -7.56 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 CA-C-N 115.116 -0.947 . . . . 1.0 110.668 -178.528 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 991' ' ' GLY . . . . . 0.499 ' C ' ' H ' ' A' ' 993' ' ' PHE . . . 80.02 6.51 89.11 Favored Glycine 0 C--N 1.339 0.719 0 CA-C-O 119.264 -0.742 . . . . 1.0 112.192 179.307 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -53.0 -1.58 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 119.32 1.56 . . . . 1.0 112.736 -176.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 993' ' ' PHE . . . . . 0.499 ' H ' ' C ' ' A' ' 991' ' ' GLY . 17.1 m-85 . . . . . 0 N--CA 1.465 0.298 0 CA-C-O 121.401 0.62 . . . . 1.0 110.704 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 967' ' ' TRP . . . . . 0.567 ' O ' HG23 ' A' ' 971' ' ' VAL . 89.7 m95 . . . . . 0 N--CA 1.463 0.195 0 CA-C-O 120.589 0.233 . . . . 1.0 111.559 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 88.8 m95 -71.04 -35.18 71.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.724 -0.216 . . . . 1.0 110.837 179.669 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 969' ' ' VAL . . . . . 0.424 ' O ' HG23 ' A' ' 973' ' ' VAL . 76.0 t -67.14 -44.88 87.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 108.808 -0.812 . . . . 1.0 108.808 178.403 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 59.4 tp -64.07 -43.02 96.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.039 -0.982 . . . . 1.0 110.199 179.193 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 971' ' ' VAL . . . . . 0.567 HG23 ' O ' ' A' ' 967' ' ' TRP . 51.0 t -62.99 -45.14 99.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.959 0.409 . . . . 1.0 111.294 -179.368 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.29 -41.03 98.2 Favored Glycine 0 CA--C 1.528 0.882 0 CA-C-N 116.025 -0.534 . . . . 1.0 111.853 -179.443 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 973' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 969' ' ' VAL . 74.8 t -66.95 -47.5 82.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.115 0.483 . . . . 1.0 111.092 -178.709 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -62.87 -40.88 98.85 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.88 -0.6 . . . . 1.0 109.499 178.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -65.97 -45.27 88.86 Favored Glycine 0 CA--C 1.513 -0.051 0 N-CA-C 109.869 -1.292 . . . . 1.0 109.869 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 976' ' ' GLY . . . . . 0.468 ' O ' HD13 ' A' ' 980' ' ' LEU . . . -61.26 -37.39 93.94 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 109.233 -1.547 . . . . 1.0 109.233 178.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 53.5 tp -64.87 -42.48 94.8 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 109.433 -0.581 . . . . 1.0 109.433 178.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 60.3 tp -62.28 -44.82 95.64 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.894 -0.409 . . . . 1.0 109.894 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 92.3 mt -62.59 -45.09 94.51 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.462 -0.495 . . . . 1.0 111.355 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 980' ' ' LEU . . . . . 0.468 HD13 ' O ' ' A' ' 976' ' ' GLY . 9.2 mp -63.05 -39.28 94.28 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.322 -0.551 . . . . 1.0 110.217 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 7.8 m -62.5 -47.3 84.58 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.839 -0.619 . . . . 1.0 110.846 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 96.4 mt -64.21 -44.6 97.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.39 -0.368 . . . . 1.0 111.863 -178.491 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 7.5 mp -65.08 -40.09 94.13 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 120.663 -0.415 . . . . 1.0 110.943 179.636 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 984' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 980' ' ' LEU . 55.7 t -68.47 -48.85 70.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.288 -0.414 . . . . 1.0 110.367 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 86.3 mt -64.4 -41.77 96.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.959 -0.564 . . . . 1.0 109.53 178.761 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 986' ' ' ALA . . . . . 0.89 ' O ' HG13 ' A' ' 990' ' ' VAL . . . -62.96 -43.87 97.6 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-O 121.689 0.757 . . . . 1.0 109.032 -179.498 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 32.7 mtp -62.57 -31.13 71.89 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 114.415 -1.266 . . . . 1.0 109.174 178.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 988' ' ' TRP . . . . . . . . . . . . . 1.6 t90 -74.22 -37.82 63.73 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 113.957 -1.474 . . . . 1.0 108.037 179.15 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.24 -39.43 78.49 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.944 0.878 . . . . 1.0 110.303 -179.687 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 990' ' ' VAL . . . . . 0.89 HG13 ' O ' ' A' ' 986' ' ' ALA . 1.4 m -82.57 -7.94 11.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 114.92 -1.036 . . . . 1.0 110.57 -178.805 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 991' ' ' GLY . . . . . 0.574 ' C ' ' H ' ' A' ' 993' ' ' PHE . . . 82.68 2.94 90.69 Favored Glycine 0 C--N 1.339 0.698 0 CA-C-O 119.145 -0.808 . . . . 1.0 112.439 178.758 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -52.63 -1.37 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 119.723 1.762 . . . . 1.0 112.112 -177.505 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 993' ' ' PHE . . . . . 0.574 ' H ' ' C ' ' A' ' 991' ' ' GLY . 10.4 m-85 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.567 -0.288 . . . . 1.0 111.44 -179.053 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 967' ' ' TRP . . . . . 0.659 ' O ' HG23 ' A' ' 971' ' ' VAL . 88.5 m95 . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.484 0.183 . . . . 1.0 111.358 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 96.1 m95 -68.43 -34.91 76.83 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 110.117 -0.327 . . . . 1.0 110.117 179.319 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 969' ' ' VAL . . . . . 0.638 ' O ' HG23 ' A' ' 973' ' ' VAL . 57.1 t -67.14 -43.96 88.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 CA-C-O 121.649 0.737 . . . . 1.0 109.06 178.26 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 98.2 mt -63.34 -42.55 98.94 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 114.749 -1.114 . . . . 1.0 109.675 179.197 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 971' ' ' VAL . . . . . 0.659 HG23 ' O ' ' A' ' 967' ' ' TRP . 71.0 t -62.27 -45.31 99.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.064 0.459 . . . . 1.0 110.507 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.49 -41.34 98.63 Favored Glycine 0 C--N 1.332 0.306 0 N-CA-C 111.271 -0.732 . . . . 1.0 111.271 -179.228 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 973' ' ' VAL . . . . . 0.638 HG23 ' O ' ' A' ' 969' ' ' VAL . 84.4 t -65.57 -47.56 85.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 114.971 -0.615 . . . . 1.0 110.678 -179.151 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 78.3 mt -61.36 -40.43 94.27 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.697 -0.853 . . . . 1.0 108.697 178.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -64.54 -46.04 91.35 Favored Glycine 0 N--CA 1.461 0.305 0 N-CA-C 110.843 -0.903 . . . . 1.0 110.843 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -60.86 -36.93 92.86 Favored Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 109.474 -1.45 . . . . 1.0 109.474 179.012 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 82.2 mt -67.3 -43.21 82.29 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 120.4 -0.52 . . . . 1.0 110.619 179.14 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 55.7 tp -61.94 -44.89 95.82 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.673 -0.411 . . . . 1.0 110.178 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 97.2 mt -63.77 -42.92 97.7 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 120.187 -0.605 . . . . 1.0 110.91 -179.637 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 980' ' ' LEU . . . . . . . . . . . . . 76.2 mt -64.03 -39.52 94.27 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.918 0.39 . . . . 1.0 110.362 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 7.1 m -64.12 -46.67 83.16 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.877 -0.601 . . . . 1.0 109.764 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 90.9 mt -62.65 -44.46 99.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.052 -0.522 . . . . 1.0 111.145 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 97.6 mt -64.72 -40.69 95.77 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.728 -0.389 . . . . 1.0 111.143 179.749 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 984' ' ' VAL . . . . . . . . . . . . . 46.7 t -67.99 -48.09 76.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.04 0.448 . . . . 1.0 110.323 179.576 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 85.2 mt -64.17 -43.83 93.91 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.733 -0.667 . . . . 1.0 109.564 179.297 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 986' ' ' ALA . . . . . 0.936 ' O ' HG13 ' A' ' 990' ' ' VAL . . . -62.09 -44.94 95.57 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-O 121.361 0.601 . . . . 1.0 109.397 -179.375 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 30.9 mtp -61.99 -34.19 75.72 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 114.885 -1.052 . . . . 1.0 109.537 179.5 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 988' ' ' TRP . . . . . 0.463 ' O ' ' CD1' ' A' ' 988' ' ' TRP . 13.0 t90 -73.25 -36.02 66.32 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 114.137 -1.392 . . . . 1.0 108.527 179.33 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.22 -41.38 77.13 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 115.402 -0.817 . . . . 1.0 109.912 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 990' ' ' VAL . . . . . 0.936 HG13 ' O ' ' A' ' 986' ' ' ALA . 1.2 m -82.42 -8.7 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 CA-C-N 114.811 -1.086 . . . . 1.0 110.062 -179.122 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 991' ' ' GLY . . . . . 0.529 ' C ' ' H ' ' A' ' 993' ' ' PHE . . . 82.2 5.14 89.9 Favored Glycine 0 C--N 1.342 0.91 0 CA-C-O 119.15 -0.805 . . . . 1.0 112.692 179.022 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -51.93 -2.17 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 119.543 1.672 . . . . 1.0 112.851 -177.384 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 993' ' ' PHE . . . . . 0.529 ' H ' ' C ' ' A' ' 991' ' ' GLY . 13.6 m-85 . . . . . 0 C--N 1.327 -0.385 0 C-N-CA 120.992 -0.283 . . . . 1.0 110.399 179.812 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 967' ' ' TRP . . . . . 0.537 ' O ' HG23 ' A' ' 971' ' ' VAL . 97.1 m95 . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.821 0.343 . . . . 1.0 111.304 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 93.1 m95 -69.1 -35.69 76.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.462 . . . . 1.0 110.38 179.361 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 969' ' ' VAL . . . . . 0.476 ' O ' HG23 ' A' ' 973' ' ' VAL . 71.4 t -65.3 -43.87 94.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 108.396 -0.964 . . . . 1.0 108.396 177.881 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 970' ' ' LEU . . . . . 0.444 ' O ' HD13 ' A' ' 974' ' ' LEU . 89.9 mt -62.33 -42.86 99.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 114.513 -1.221 . . . . 1.0 109.688 179.615 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 971' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 967' ' ' TRP . 49.9 t -60.99 -44.87 99.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.865 0.364 . . . . 1.0 110.128 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.88 -39.01 96.3 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 111.538 -0.625 . . . . 1.0 111.538 -179.562 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 973' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 969' ' ' VAL . 56.8 t -66.67 -47.47 83.09 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.382 0 CA-C-N 114.92 -0.64 . . . . 1.0 110.439 -179.398 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 974' ' ' LEU . . . . . 0.444 HD13 ' O ' ' A' ' 970' ' ' LEU . 7.9 mp -62.95 -41.1 99.4 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.663 -0.866 . . . . 1.0 108.663 179.087 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -66.08 -45.58 86.27 Favored Glycine 0 CA--C 1.518 0.258 0 N-CA-C 110.308 -1.117 . . . . 1.0 110.308 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 976' ' ' GLY . . . . . 0.558 ' O ' HD13 ' A' ' 980' ' ' LEU . . . -60.19 -38.72 94.91 Favored Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 108.903 -1.679 . . . . 1.0 108.903 178.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 52.7 tp -66.66 -44.32 82.16 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.313 -0.555 . . . . 1.0 110.26 179.03 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 59.1 tp -62.29 -45.86 91.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.619 -0.264 . . . . 1.0 110.364 -179.662 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 93.5 mt -63.26 -43.53 97.73 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 119.976 -0.69 . . . . 1.0 110.765 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 980' ' ' LEU . . . . . 0.558 HD13 ' O ' ' A' ' 976' ' ' GLY . 8.5 mp -63.99 -39.06 93.26 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.74 -0.384 . . . . 1.0 110.708 -179.718 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 6.9 m -64.35 -45.98 85.45 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.963 -0.562 . . . . 1.0 110.188 -179.642 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 97.5 mt -63.45 -44.01 98.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 C-N-CA 120.938 -0.305 . . . . 1.0 111.539 -179.114 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 91.0 mt -65.07 -41.08 95.42 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 120.954 -0.298 . . . . 1.0 110.788 179.598 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 984' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 980' ' ' LEU . 54.4 t -66.39 -47.78 82.94 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.426 0 CA-C-O 121.472 0.653 . . . . 1.0 109.538 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 87.1 mt -63.4 -43.71 96.77 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.058 -0.974 . . . . 1.0 109.739 178.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 986' ' ' ALA . . . . . 0.824 ' O ' HG13 ' A' ' 990' ' ' VAL . . . -61.49 -45.12 95.57 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-O 121.595 0.712 . . . . 1.0 109.406 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 29.5 mtp -61.62 -30.19 70.53 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.651 -1.158 . . . . 1.0 108.778 179.053 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 988' ' ' TRP . . . . . . . . . . . . . 1.7 t90 -74.29 -38.85 63.26 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 113.912 -1.495 . . . . 1.0 108.424 179.207 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.22 -38.55 82.02 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.357 -0.838 . . . . 1.0 110.223 -179.05 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 990' ' ' VAL . . . . . 0.824 HG13 ' O ' ' A' ' 986' ' ' ALA . 1.4 m -84.55 -7.96 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 115.075 -0.966 . . . . 1.0 110.747 -178.48 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 991' ' ' GLY . . . . . 0.524 ' C ' ' H ' ' A' ' 993' ' ' PHE . . . 81.27 5.33 90.12 Favored Glycine 0 C--N 1.338 0.655 0 CA-C-O 119.17 -0.794 . . . . 1.0 112.453 179.056 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -53.4 -1.81 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 119.34 1.57 . . . . 1.0 112.532 -177.323 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 993' ' ' PHE . . . . . 0.524 ' H ' ' C ' ' A' ' 991' ' ' GLY . 10.2 m-85 . . . . . 0 C--N 1.326 -0.421 0 CA-C-O 121.584 0.707 . . . . 1.0 110.501 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 967' ' ' TRP . . . . . 0.722 ' O ' HG23 ' A' ' 971' ' ' VAL . 94.2 m95 . . . . . 0 N--CA 1.453 -0.289 0 CA-C-O 120.564 0.221 . . . . 1.0 110.821 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 83.9 m95 -72.06 -36.27 69.54 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.695 -0.229 . . . . 1.0 111.113 179.654 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 969' ' ' VAL . . . . . 0.408 ' O ' HG23 ' A' ' 973' ' ' VAL . 62.1 t -67.03 -44.82 88.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 108.691 -0.855 . . . . 1.0 108.691 178.497 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 56.4 tp -63.3 -44.22 95.64 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.738 -1.119 . . . . 1.0 110.204 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 971' ' ' VAL . . . . . 0.722 HG23 ' O ' ' A' ' 967' ' ' TRP . 54.4 t -61.85 -45.44 98.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 120.625 -0.43 . . . . 1.0 111.367 -178.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.23 -36.93 92.1 Favored Glycine 0 CA--C 1.529 0.959 0 CA-C-O 121.659 0.588 . . . . 1.0 111.679 -179.407 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 973' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 969' ' ' VAL . 53.5 t -68.28 -49.08 70.05 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.492 0 CA-C-N 114.87 -0.665 . . . . 1.0 109.948 -179.093 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 69.4 mt -62.21 -42.23 99.1 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 115.493 -0.776 . . . . 1.0 109.008 179.3 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -65.96 -45.55 87.08 Favored Glycine 0 N--CA 1.46 0.259 0 N-CA-C 110.061 -1.216 . . . . 1.0 110.061 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -59.62 -38.7 94.11 Favored Glycine 0 C--O 1.226 -0.366 0 N-CA-C 108.642 -1.783 . . . . 1.0 108.642 178.095 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 977' ' ' LEU . . . . . 0.42 ' O ' ' OG1' ' A' ' 981' ' ' THR . 49.1 tp -65.55 -42.93 91.33 Favored 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 120.717 -0.393 . . . . 1.0 110.188 179.313 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 76.3 mt -64.52 -44.32 91.24 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.457 -0.497 . . . . 1.0 111.054 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 80.6 mt -63.29 -44.28 95.49 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.325 -0.55 . . . . 1.0 110.732 -179.25 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 980' ' ' LEU . . . . . 0.417 ' O ' HG23 ' A' ' 984' ' ' VAL . 83.8 mt -63.51 -39.47 94.52 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.08 0.467 . . . . 1.0 110.115 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 981' ' ' THR . . . . . 0.508 HG22 ' CD1' ' A' ' 985' ' ' LEU . 7.3 m -64.59 -46.2 83.7 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.474 -0.785 . . . . 1.0 110.225 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 3.2 mm -64.09 -43.62 97.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.296 -0.411 . . . . 1.0 111.854 -178.686 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 98.2 mt -66.71 -40.72 88.55 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.093 -0.503 . . . . 1.0 111.377 -179.371 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 984' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 980' ' ' LEU . 65.8 t -68.61 -46.65 79.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.438 0.637 . . . . 1.0 109.492 179.465 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 985' ' ' LEU . . . . . 0.508 ' CD1' HG22 ' A' ' 981' ' ' THR . 80.9 mt -63.08 -43.44 98.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.261 -0.881 . . . . 1.0 109.039 178.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 986' ' ' ALA . . . . . 0.872 ' O ' HG13 ' A' ' 990' ' ' VAL . . . -62.01 -43.84 97.98 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.141 -0.688 . . . . 1.0 109.141 179.636 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 987' ' ' MET . . . . . 0.431 ' HA ' HG22 ' A' ' 990' ' ' VAL . 29.5 mtp -64.07 -32.58 74.19 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 114.955 -1.021 . . . . 1.0 110.367 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 988' ' ' TRP . . . . . 0.477 ' O ' ' CD1' ' A' ' 988' ' ' TRP . 12.7 t90 -73.48 -34.08 65.16 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.171 -1.377 . . . . 1.0 107.75 178.879 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.37 -39.37 71.27 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 114.866 -1.061 . . . . 1.0 110.478 -179.558 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 990' ' ' VAL . . . . . 0.872 HG13 ' O ' ' A' ' 986' ' ' ALA . 1.4 m -85.26 -7.6 10.96 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 CA-C-N 115.128 -0.942 . . . . 1.0 110.339 -178.478 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 991' ' ' GLY . . . . . 0.504 ' C ' ' H ' ' A' ' 993' ' ' PHE . . . 81.54 5.09 90.19 Favored Glycine 0 C--N 1.331 0.304 0 CA-C-O 118.813 -0.993 . . . . 1.0 112.76 179.35 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -52.79 -1.87 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 120.07 1.935 . . . . 1.0 112.729 -178.036 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 993' ' ' PHE . . . . . 0.504 ' H ' ' C ' ' A' ' 991' ' ' GLY . 17.5 m-85 . . . . . 0 C--O 1.236 0.383 0 CA-C-O 121.03 0.443 . . . . 1.0 110.37 179.824 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 967' ' ' TRP . . . . . 0.784 ' O ' HG23 ' A' ' 971' ' ' VAL . 89.7 m95 . . . . . 0 C--O 1.226 -0.172 0 N-CA-C 113.293 0.849 . . . . 1.0 113.293 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 39.3 m95 -71.57 -39.61 70.49 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 112.957 0.725 . . . . 1.0 112.957 -178.523 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 969' ' ' VAL . . . . . 0.445 ' O ' HG23 ' A' ' 973' ' ' VAL . 17.3 m -66.86 -41.3 87.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 119.536 -0.866 . . . . 1.0 109.23 179.355 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 61.9 tp -64.35 -42.78 96.04 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.246 -0.888 . . . . 1.0 109.973 179.052 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 971' ' ' VAL . . . . . 0.784 HG23 ' O ' ' A' ' 967' ' ' TRP . 70.2 t -62.79 -44.83 99.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 120.523 -0.471 . . . . 1.0 110.668 -179.1 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -59.34 -41.65 97.02 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.555 -0.618 . . . . 1.0 111.555 -179.508 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 973' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 969' ' ' VAL . 77.0 t -64.63 -46.9 91.05 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.593 0 CA-C-O 121.038 0.447 . . . . 1.0 110.623 -179.303 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 98.7 mt -61.99 -40.67 96.44 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 108.595 -0.891 . . . . 1.0 108.595 179.476 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -67.13 -48.21 60.65 Favored Glycine 0 C--N 1.334 0.419 0 CA-C-N 115.1 -0.955 . . . . 1.0 110.943 -179.43 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -60.12 -36.41 90.47 Favored Glycine 0 N--CA 1.449 -0.446 0 N-CA-C 108.915 -1.674 . . . . 1.0 108.915 179.233 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 977' ' ' LEU . . . . . 0.455 ' O ' ' OG1' ' A' ' 981' ' ' THR . 54.1 tp -66.97 -43.22 83.63 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.179 -0.608 . . . . 1.0 109.993 179.138 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 4.3 tt -61.64 -45.24 94.88 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.348 -0.541 . . . . 1.0 110.33 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 96.1 mt -62.17 -45.16 94.65 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.487 -0.485 . . . . 1.0 111.315 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 980' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -64.13 -39.97 95.16 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.083 0.468 . . . . 1.0 111.163 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 981' ' ' THR . . . . . 0.455 ' OG1' ' O ' ' A' ' 977' ' ' LEU . 6.9 m -64.11 -46.71 83.01 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.487 -0.778 . . . . 1.0 110.121 -179.647 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 4.0 mm -63.68 -43.82 98.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.499 -0.319 . . . . 1.0 111.477 -179.169 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 83.7 mt -63.67 -41.58 98.17 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.381 -0.372 . . . . 1.0 110.366 179.49 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 984' ' ' VAL . . . . . . . . . . . . . 40.0 t -66.7 -47.1 84.11 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.332 0 CA-C-O 121.345 0.593 . . . . 1.0 110.356 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 82.2 mt -64.43 -43.04 95.6 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.292 -0.867 . . . . 1.0 109.919 179.134 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 986' ' ' ALA . . . . . 0.939 ' O ' HG13 ' A' ' 990' ' ' VAL . . . -63.85 -46.05 86.76 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 121.371 0.605 . . . . 1.0 109.726 -179.344 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 30.2 mtp -61.8 -33.75 74.68 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.817 -1.083 . . . . 1.0 109.286 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 988' ' ' TRP . . . . . 0.505 ' O ' ' CD1' ' A' ' 988' ' ' TRP . 12.8 t90 -72.1 -37.27 69.57 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.338 -1.301 . . . . 1.0 108.57 178.186 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.91 -40.3 79.19 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 121.717 0.77 . . . . 1.0 110.204 -179.501 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 990' ' ' VAL . . . . . 0.939 HG13 ' O ' ' A' ' 986' ' ' ALA . 1.2 m -82.63 -6.63 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 CA-C-N 114.707 -1.133 . . . . 1.0 109.989 -178.617 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 991' ' ' GLY . . . . . 0.543 ' C ' ' H ' ' A' ' 993' ' ' PHE . . . 83.58 2.6 89.99 Favored Glycine 0 C--N 1.337 0.586 0 CA-C-O 119.296 -0.724 . . . . 1.0 112.317 178.693 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -52.16 -2.5 0.02 OUTLIER 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 119.418 1.609 . . . . 1.0 112.145 -177.66 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 993' ' ' PHE . . . . . 0.543 ' H ' ' C ' ' A' ' 991' ' ' GLY . 11.6 m-85 . . . . . 0 C--N 1.332 -0.191 0 CA-C-O 121.077 0.465 . . . . 1.0 110.101 179.509 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 967' ' ' TRP . . . . . 0.635 ' O ' HG23 ' A' ' 971' ' ' VAL . 96.9 m95 . . . . . 0 N--CA 1.456 -0.147 0 CA-C-O 120.573 0.225 . . . . 1.0 111.578 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 24.7 m95 -70.33 -34.66 72.95 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.577 -0.283 . . . . 1.0 110.479 179.188 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 74.1 t -67.38 -43.93 87.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 108.99 -0.744 . . . . 1.0 108.99 178.258 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 51.6 tp -63.91 -41.33 97.71 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.232 -0.894 . . . . 1.0 109.104 179.062 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 971' ' ' VAL . . . . . 0.635 HG23 ' O ' ' A' ' 967' ' ' TRP . 53.2 t -62.29 -45.33 99.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 C-N-CA 120.895 -0.322 . . . . 1.0 111.372 -179.705 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.63 -41.31 98.83 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 112.161 -0.376 . . . . 1.0 112.161 -178.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 72.8 t -67.22 -47.23 82.15 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.517 0 CA-C-O 120.94 0.4 . . . . 1.0 110.668 -178.636 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 6.9 mp -63.44 -41.04 98.66 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.974 -0.557 . . . . 1.0 109.522 179.426 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -66.08 -44.95 90.29 Favored Glycine 0 C--N 1.334 0.433 0 N-CA-C 110.348 -1.101 . . . . 1.0 110.348 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -61.32 -36.11 91.98 Favored Glycine 0 N--CA 1.448 -0.527 0 N-CA-C 109.061 -1.615 . . . . 1.0 109.061 179.036 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 54.2 tp -67.37 -43.72 80.74 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.443 -0.503 . . . . 1.0 110.075 178.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 50.9 tp -62.43 -44.82 95.51 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.289 -0.564 . . . . 1.0 109.998 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 87.5 mt -61.94 -42.93 99.67 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 119.783 -0.767 . . . . 1.0 110.118 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 980' ' ' LEU . . . . . 0.428 ' O ' HG23 ' A' ' 984' ' ' VAL . 33.2 mt -63.42 -40.41 97.1 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.058 0.456 . . . . 1.0 110.334 -179.637 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 6.9 m -64.16 -46.27 84.79 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.409 -0.814 . . . . 1.0 110.17 -179.724 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 90.8 mt -64.29 -44.27 97.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.332 -0.394 . . . . 1.0 111.236 -179.439 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 983' ' ' LEU . . . . . 0.57 HD11 ' SD ' ' A' ' 987' ' ' MET . 39.1 tp -65.67 -42.74 90.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.544 -0.298 . . . . 1.0 111.454 -179.773 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 984' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 980' ' ' LEU . 53.1 t -66.81 -47.64 82.19 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.402 0 CA-C-O 121.411 0.624 . . . . 1.0 110.341 -179.404 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 84.0 mt -63.58 -41.59 98.36 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.134 -0.939 . . . . 1.0 109.132 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 986' ' ' ALA . . . . . 0.836 ' O ' HG13 ' A' ' 990' ' ' VAL . . . -62.65 -47.77 82.23 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.275 0.559 . . . . 1.0 110.38 -179.491 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 987' ' ' MET . . . . . 0.57 ' SD ' HD11 ' A' ' 983' ' ' LEU . 16.2 mtp -62.81 -30.26 71.35 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 122.632 1.206 . . . . 1.0 110.313 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 988' ' ' TRP . . . . . 0.467 ' O ' ' CD1' ' A' ' 988' ' ' TRP . 12.1 t90 -75.64 -35.34 60.48 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 113.976 -1.465 . . . . 1.0 107.926 178.523 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.25 -39.57 74.94 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-O 121.516 0.674 . . . . 1.0 109.902 -179.447 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 990' ' ' VAL . . . . . 0.836 HG13 ' O ' ' A' ' 986' ' ' ALA . 1.4 m -78.28 -3.45 5.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 114.946 -1.025 . . . . 1.0 109.221 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 991' ' ' GLY . . . . . . . . . . . . . . . 82.83 1.44 90.59 Favored Glycine 0 C--N 1.333 0.414 0 CA-C-O 119.404 -0.664 . . . . 1.0 112.397 177.643 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -47.22 -41.92 19.26 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-N 119.046 1.423 . . . . 1.0 110.926 -176.712 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 993' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 . . . . . 0 N--CA 1.466 0.344 0 CA-C-O 121.861 0.838 . . . . 1.0 111.1 179.479 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 967' ' ' TRP . . . . . 0.638 ' O ' HG23 ' A' ' 971' ' ' VAL . 98.8 m95 . . . . . 0 N--CA 1.455 -0.195 0 CA-C-O 120.688 0.28 . . . . 1.0 110.313 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 87.4 m95 -68.58 -36.6 78.94 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.462 -0.335 . . . . 1.0 111.4 179.003 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 72.6 t -66.3 -44.56 91.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.307 0.575 . . . . 1.0 109.551 178.651 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 90.4 mt -62.82 -42.19 99.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.04 -0.982 . . . . 1.0 109.597 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 971' ' ' VAL . . . . . 0.638 HG23 ' O ' ' A' ' 967' ' ' TRP . 54.1 t -61.6 -45.33 98.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.51 -0.314 . . . . 1.0 111.14 -179.402 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.78 -41.67 99.19 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 121.377 -0.44 . . . . 1.0 112.331 -178.779 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 57.2 t -65.82 -47.45 85.63 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.534 0 CA-C-O 121.145 0.497 . . . . 1.0 110.605 -178.687 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 86.9 mt -62.59 -41.58 99.04 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.556 -0.747 . . . . 1.0 109.365 179.286 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -66.02 -46.25 82.28 Favored Glycine 0 N--CA 1.452 -0.243 0 N-CA-C 110.421 -1.072 . . . . 1.0 110.421 -179.446 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -61.0 -37.33 93.69 Favored Glycine 0 N--CA 1.451 -0.339 0 N-CA-C 109.244 -1.542 . . . . 1.0 109.244 179.238 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 977' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' A' ' 977' ' ' LEU . 30.1 mt -64.34 -42.4 96.29 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.437 -0.505 . . . . 1.0 109.753 178.677 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -62.98 -43.78 97.86 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 119.628 -0.829 . . . . 1.0 110.144 179.513 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 98.4 mt -61.72 -43.66 98.43 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.17 -0.612 . . . . 1.0 109.906 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 980' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 980' ' ' LEU . 31.1 mt -62.82 -41.93 99.51 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.56 -0.456 . . . . 1.0 109.891 179.628 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 981' ' ' THR . . . . . 0.496 HG22 HD12 ' A' ' 985' ' ' LEU . 7.3 m -62.69 -47.32 84.13 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.646 -0.707 . . . . 1.0 111.183 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 92.7 mt -64.26 -43.94 97.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 C-N-CA 120.775 -0.37 . . . . 1.0 111.152 -179.389 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 983' ' ' LEU . . . . . 0.403 ' O ' ' SD ' ' A' ' 987' ' ' MET . 83.0 mt -65.04 -41.76 94.92 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.329 -0.396 . . . . 1.0 111.307 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 984' ' ' VAL . . . . . . . . . . . . . 42.2 t -69.15 -49.86 58.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.208 0.528 . . . . 1.0 110.793 -179.302 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 985' ' ' LEU . . . . . 0.496 HD12 HG22 ' A' ' 981' ' ' THR . 90.7 mt -63.37 -42.53 98.87 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.47 -0.786 . . . . 1.0 109.44 179.32 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 986' ' ' ALA . . . . . 0.874 ' O ' HG13 ' A' ' 990' ' ' VAL . . . -61.87 -43.97 97.77 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 109.18 -0.674 . . . . 1.0 109.18 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 987' ' ' MET . . . . . 0.403 ' SD ' ' O ' ' A' ' 983' ' ' LEU . 21.9 mtp -62.14 -30.29 70.94 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 114.653 -1.158 . . . . 1.0 109.387 179.028 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 988' ' ' TRP . . . . . . . . . . . . . 1.8 t90 -74.87 -36.12 62.31 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 113.797 -1.547 . . . . 1.0 108.28 178.536 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.44 -38.92 71.29 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.599 0.714 . . . . 1.0 110.0 -179.374 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 990' ' ' VAL . . . . . 0.874 HG13 ' O ' ' A' ' 986' ' ' ALA . 1.3 m -80.41 -5.33 8.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 114.957 -1.02 . . . . 1.0 109.873 -179.333 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 991' ' ' GLY . . . . . 0.547 ' C ' ' H ' ' A' ' 993' ' ' PHE . . . 85.05 0.38 88.93 Favored Glycine 0 C--N 1.338 0.686 0 CA-C-O 119.466 -0.63 . . . . 1.0 112.546 177.576 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -51.92 -2.98 0.02 OUTLIER 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 118.901 1.35 . . . . 1.0 112.386 -177.651 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 993' ' ' PHE . . . . . 0.547 ' H ' ' C ' ' A' ' 991' ' ' GLY . 32.8 m-85 . . . . . 0 N--CA 1.463 0.202 0 CA-C-O 122.511 1.148 . . . . 1.0 110.543 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 967' ' ' TRP . . . . . 0.519 ' O ' HG23 ' A' ' 971' ' ' VAL . 99.4 m95 . . . . . 0 N--CA 1.46 0.056 0 CA-C-O 120.556 0.217 . . . . 1.0 110.569 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 90.9 m95 -70.01 -34.3 73.12 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.614 -0.434 . . . . 1.0 110.426 179.003 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 969' ' ' VAL . . . . . 0.439 ' O ' HG22 ' A' ' 973' ' ' VAL . 53.9 t -66.94 -45.59 86.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.694 -0.484 . . . . 1.0 109.694 178.31 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 80.7 mt -63.72 -40.83 97.73 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.285 -0.871 . . . . 1.0 109.908 179.271 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 971' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 967' ' ' TRP . 45.2 t -64.77 -45.18 95.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 C-N-CA 120.694 -0.403 . . . . 1.0 111.309 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -63.05 -43.76 98.32 Favored Glycine 0 CA--C 1.529 0.932 0 CA-C-N 116.365 -0.38 . . . . 1.0 113.49 -177.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 973' ' ' VAL . . . . . 0.439 HG22 ' O ' ' A' ' 969' ' ' VAL . 31.6 m -67.48 -43.12 87.61 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.403 0 CA-C-O 120.897 0.38 . . . . 1.0 110.352 -178.24 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 974' ' ' LEU . . . . . 0.419 HD23 ' HA ' ' A' ' 974' ' ' LEU . 93.3 mt -63.39 -41.24 98.76 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.962 -0.755 . . . . 1.0 108.962 178.385 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -66.21 -46.16 81.49 Favored Glycine 0 C--N 1.329 0.151 0 N-CA-C 110.338 -1.105 . . . . 1.0 110.338 -179.406 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -59.2 -38.51 93.29 Favored Glycine 0 N--CA 1.446 -0.64 0 N-CA-C 108.647 -1.781 . . . . 1.0 108.647 178.826 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 977' ' ' LEU . . . . . 0.424 HD23 ' HA ' ' A' ' 977' ' ' LEU . 38.3 mt -63.87 -42.17 97.58 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.135 -0.626 . . . . 1.0 109.518 178.538 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 55.6 tp -62.44 -46.22 89.53 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.713 -0.395 . . . . 1.0 110.408 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 9.5 mp -62.29 -42.49 99.39 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 119.724 -0.79 . . . . 1.0 110.148 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 980' ' ' LEU . . . . . 0.526 ' O ' HG23 ' A' ' 984' ' ' VAL . 86.7 mt -63.04 -40.25 97.17 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.486 -0.486 . . . . 1.0 110.11 179.765 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 7.1 m -63.86 -46.72 83.73 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.667 -0.697 . . . . 1.0 110.808 -179.495 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 97.6 mt -63.56 -44.52 98.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.396 -0.365 . . . . 1.0 110.815 -179.022 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -65.73 -40.18 91.89 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.168 -0.469 . . . . 1.0 111.309 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 984' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 980' ' ' LEU . 45.6 t -67.24 -48.66 77.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.301 0.572 . . . . 1.0 110.337 -179.571 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 88.2 mt -63.67 -42.29 98.07 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.224 -0.898 . . . . 1.0 109.407 178.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 986' ' ' ALA . . . . . 0.827 ' O ' HG13 ' A' ' 990' ' ' VAL . . . -63.01 -46.93 85.33 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-O 121.384 0.611 . . . . 1.0 110.487 -179.081 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 19.2 mtp -63.18 -32.23 73.57 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 122.601 1.191 . . . . 1.0 109.607 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 988' ' ' TRP . . . . . . . . . . . . . 14.2 t90 -72.99 -36.96 67.16 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 114.202 -1.363 . . . . 1.0 107.554 178.408 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 989' ' ' LYS . . . . . 0.537 ' O ' ' NZ ' ' A' ' 989' ' ' LYS . 0.1 OUTLIER -66.7 -41.18 88.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.224 -0.898 . . . . 1.0 109.816 -179.875 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 990' ' ' VAL . . . . . 0.827 HG13 ' O ' ' A' ' 986' ' ' ALA . 1.3 m -79.15 -3.03 5.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.112 -0.949 . . . . 1.0 109.518 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 991' ' ' GLY . . . . . . . . . . . . . . . 82.97 1.21 90.64 Favored Glycine 0 C--N 1.338 0.668 0 CA-C-O 119.28 -0.733 . . . . 1.0 112.565 177.676 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -45.87 -42.81 12.99 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 118.953 1.377 . . . . 1.0 111.332 -177.157 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 993' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 . . . . . 0 N--CA 1.468 0.467 0 CA-C-O 121.684 0.754 . . . . 1.0 111.454 179.836 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 967' ' ' TRP . . . . . 0.669 ' O ' HG23 ' A' ' 971' ' ' VAL . 98.4 m95 . . . . . 0 N--CA 1.46 0.075 0 CA-C-O 120.608 0.242 . . . . 1.0 110.677 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 24.6 m95 -70.16 -35.25 73.88 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.636 -0.256 . . . . 1.0 110.422 179.32 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 91.2 t -67.03 -45.93 85.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.682 0.753 . . . . 1.0 109.201 178.015 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 57.1 tp -63.0 -42.74 99.93 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.75 -1.114 . . . . 1.0 109.207 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 971' ' ' VAL . . . . . 0.669 HG23 ' O ' ' A' ' 967' ' ' TRP . 55.6 t -62.4 -45.4 98.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.952 0.406 . . . . 1.0 110.756 -179.701 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.35 -42.06 98.7 Favored Glycine 0 CA--C 1.524 0.603 0 CA-C-N 115.928 -0.578 . . . . 1.0 111.891 -179.056 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 63.6 t -66.1 -44.78 91.71 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.458 0 CA-C-O 120.909 0.385 . . . . 1.0 110.662 -178.845 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 80.9 mt -61.94 -40.49 95.71 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.402 -0.962 . . . . 1.0 108.402 178.657 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -66.63 -43.82 91.17 Favored Glycine 0 N--CA 1.46 0.261 0 N-CA-C 110.22 -1.152 . . . . 1.0 110.22 -179.425 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -61.29 -37.09 93.45 Favored Glycine 0 N--CA 1.447 -0.624 0 N-CA-C 109.297 -1.521 . . . . 1.0 109.297 179.177 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 977' ' ' LEU . . . . . 0.444 ' O ' ' OG1' ' A' ' 981' ' ' THR . 76.2 mt -67.38 -42.53 83.21 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 119.815 -0.754 . . . . 1.0 110.207 178.68 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 70.8 mt -62.04 -44.75 96.03 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.26 -0.576 . . . . 1.0 110.507 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 90.3 mt -63.5 -44.59 93.89 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 119.815 -0.754 . . . . 1.0 110.855 -179.566 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 980' ' ' LEU . . . . . 0.486 ' O ' HG23 ' A' ' 984' ' ' VAL . 6.2 mp -64.1 -40.76 96.9 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.232 -0.587 . . . . 1.0 110.606 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 981' ' ' THR . . . . . 0.444 ' OG1' ' O ' ' A' ' 977' ' ' LEU . 7.4 m -62.35 -47.8 82.6 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.883 -0.599 . . . . 1.0 110.352 -179.718 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 96.6 mt -64.56 -44.85 96.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 C-N-CA 120.403 -0.519 . . . . 1.0 111.563 -178.798 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 7.1 mp -64.74 -41.93 95.57 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 111.801 0.297 . . . . 1.0 111.801 -179.796 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 984' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 980' ' ' LEU . 51.1 t -65.64 -48.68 81.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-O 121.313 0.578 . . . . 1.0 110.383 -179.136 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 82.5 mt -62.28 -41.9 98.88 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.967 -1.015 . . . . 1.0 109.478 178.855 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 986' ' ' ALA . . . . . 0.892 ' O ' HG13 ' A' ' 990' ' ' VAL . . . -61.58 -46.34 90.28 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.314 0.578 . . . . 1.0 110.106 -179.447 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 22.7 mtp -63.33 -29.77 71.02 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 122.679 1.228 . . . . 1.0 110.043 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 988' ' ' TRP . . . . . . . . . . . . . 1.6 t90 -76.31 -34.87 59.05 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 113.57 -1.65 . . . . 1.0 107.549 179.482 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.22 -38.67 68.92 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.113 -0.949 . . . . 1.0 110.14 -179.43 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 990' ' ' VAL . . . . . 0.892 HG13 ' O ' ' A' ' 986' ' ' ALA . 1.5 m -79.37 -0.69 3.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.118 -0.946 . . . . 1.0 109.129 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 991' ' ' GLY . . . . . . . . . . . . . . . 80.8 1.0 89.18 Favored Glycine 0 C--N 1.337 0.585 0 CA-C-O 119.137 -0.813 . . . . 1.0 112.783 177.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -47.04 -40.88 15.71 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 119.263 1.531 . . . . 1.0 111.53 -177.075 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 993' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 . . . . . 0 N--CA 1.465 0.296 0 CA-C-O 121.981 0.896 . . . . 1.0 111.673 -179.308 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 967' ' ' TRP . . . . . 0.619 ' O ' HG13 ' A' ' 971' ' ' VAL . 98.0 m95 . . . . . 0 N--CA 1.455 -0.193 0 N-CA-C 112.407 0.521 . . . . 1.0 112.407 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 38.9 m95 -69.67 -33.89 73.2 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.903 -0.406 . . . . 1.0 109.903 179.501 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 969' ' ' VAL . . . . . 0.631 ' O ' HG23 ' A' ' 973' ' ' VAL . 90.7 t -68.34 -46.04 81.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 C-N-CA 119.925 -0.71 . . . . 1.0 110.032 178.092 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 61.5 tp -66.15 -46.35 77.77 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 115.372 -0.831 . . . . 1.0 112.389 -179.165 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 971' ' ' VAL . . . . . 0.619 HG13 ' O ' ' A' ' 967' ' ' TRP . 26.9 m -63.69 -41.56 93.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 119.732 -0.787 . . . . 1.0 110.614 -177.974 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 972' ' ' GLY . . . . . 0.496 ' N ' HG23 ' A' ' 971' ' ' VAL . . . -60.51 -40.45 97.77 Favored Glycine 0 CA--C 1.525 0.657 0 CA-C-N 115.569 -0.741 . . . . 1.0 111.541 -179.459 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 973' ' ' VAL . . . . . 0.631 HG23 ' O ' ' A' ' 969' ' ' VAL . 92.2 t -66.09 -47.08 86.11 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.34 0 CA-C-O 121.007 0.432 . . . . 1.0 110.364 -179.048 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 92.9 mt -62.27 -40.38 96.03 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 108.655 -0.869 . . . . 1.0 108.655 179.312 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -65.36 -45.19 91.66 Favored Glycine 0 CA--C 1.516 0.146 0 N-CA-C 109.866 -1.294 . . . . 1.0 109.866 -179.84 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -61.03 -38.05 94.89 Favored Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 109.417 -1.473 . . . . 1.0 109.417 178.864 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 977' ' ' LEU . . . . . 0.58 HD13 ' O ' ' A' ' 977' ' ' LEU . 0.2 OUTLIER -66.24 -43.97 85.04 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 120.24 -0.584 . . . . 1.0 109.556 179.51 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 39.1 mt -61.56 -44.77 96.42 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.352 -0.539 . . . . 1.0 110.208 -179.724 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 97.1 mt -62.63 -43.47 98.73 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.419 -0.512 . . . . 1.0 110.368 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 980' ' ' LEU . . . . . 0.467 ' O ' HG23 ' A' ' 984' ' ' VAL . 56.0 mt -63.48 -39.88 95.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.111 0.482 . . . . 1.0 109.847 -179.86 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 5.6 m -64.26 -47.1 80.89 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.592 -0.731 . . . . 1.0 110.248 -179.633 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 97.4 mt -64.23 -45.25 96.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.473 -0.331 . . . . 1.0 111.66 -178.608 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -64.89 -40.75 95.6 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.869 -0.332 . . . . 1.0 110.775 179.575 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 984' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 980' ' ' LEU . 55.5 t -67.2 -48.08 79.57 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.402 0 CA-C-O 121.441 0.638 . . . . 1.0 110.024 179.904 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 985' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 985' ' ' LEU . 84.4 mt -63.55 -42.29 98.38 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.172 -0.922 . . . . 1.0 109.584 179.175 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 986' ' ' ALA . . . . . 0.886 ' O ' HG13 ' A' ' 990' ' ' VAL . . . -62.99 -42.49 99.86 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-O 121.66 0.743 . . . . 1.0 109.34 -179.716 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 28.9 mtp -63.87 -30.06 71.19 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 114.643 -1.162 . . . . 1.0 109.426 179.677 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 988' ' ' TRP . . . . . . . . . . . . . 1.7 t90 -76.11 -35.86 59.13 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.073 -1.421 . . . . 1.0 108.042 178.734 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.02 -38.98 76.05 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.494 0.664 . . . . 1.0 109.885 -179.693 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 990' ' ' VAL . . . . . 0.886 HG13 ' O ' ' A' ' 986' ' ' ALA . 1.4 m -81.95 -7.38 10.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.194 -0.912 . . . . 1.0 110.145 -179.175 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 991' ' ' GLY . . . . . 0.541 ' C ' ' H ' ' A' ' 993' ' ' PHE . . . 84.17 2.49 89.3 Favored Glycine 0 C--N 1.337 0.592 0 CA-C-O 119.074 -0.848 . . . . 1.0 112.672 178.613 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -53.52 -2.67 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 119.68 1.74 . . . . 1.0 112.159 -177.741 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 993' ' ' PHE . . . . . 0.541 ' H ' ' C ' ' A' ' 991' ' ' GLY . 28.3 m-85 . . . . . 0 N--CA 1.464 0.227 0 CA-C-O 123.194 1.473 . . . . 1.0 110.632 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 957' ' ' GLY . . . . . 0.534 ' O ' ' NH2' ' A' ' 962' ' ' ARG . . . . . . . . 0 N--CA 1.493 2.434 0 N-CA-C 108.93 -1.668 . . . . 10.49 108.93 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -162.88 -50.35 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.456 -0.942 . . . . 9.9900000000000002 108.456 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 959' ' ' LEU . . . . . 0.801 ' H ' HD12 ' A' ' 959' ' ' LEU . 0.0 OUTLIER -62.64 -39.71 94.71 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 106.754 -1.573 . . . . 9.25 106.754 178.031 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 960' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -43.73 146.03 0.6 Allowed 'General case' 0 CA--C 1.511 -0.548 0 CA-C-N 114.776 -1.102 . . . . 10.19 108.726 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 961' ' ' GLU . . . . . 0.489 ' C ' ' N ' ' A' ' 963' ' ' ALA . 0.0 OUTLIER -94.3 70.71 3.78 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.993 -0.549 . . . . 9.0299999999999994 110.753 -179.383 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 962' ' ' ARG . . . . . 0.543 ' C ' ' H ' ' A' ' 964' ' ' ILE . 1.0 OUTLIER -56.09 -28.52 58.03 Favored 'General case' 0 CA--C 1.503 -0.864 0 N-CA-C 102.284 -3.228 . . . . 9.3800000000000008 102.284 174.042 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 963' ' ' ALA . . . . . 0.671 ' O ' ' C ' ' A' ' 964' ' ' ILE . . . 72.16 -14.85 0.51 Allowed 'General case' 0 N--CA 1.412 -2.332 0 CA-C-N 109.944 -3.298 . . . . 4.3300000000000001 107.977 -178.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 964' ' ' ILE . . . . . 0.671 ' C ' ' O ' ' A' ' 963' ' ' ALA . 0.3 OUTLIER 17.29 61.12 0.19 Allowed Pre-proline 0 C--N 1.386 2.167 0 N-CA-C 104.008 -2.59 . . . . 6.1699999999999999 104.008 -177.736 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 965' ' ' PRO . . . . . 0.603 ' HB2' ' HB2' ' A' ' 968' ' ' TRP . 14.1 Cg_endo -63.57 68.34 0.18 Allowed 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 121.006 1.137 . . . . 2.1299999999999999 111.173 -169.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 966' ' ' ILE . . . . . 0.607 ' N ' ' O ' ' A' ' 964' ' ' ILE . 0.2 OUTLIER -46.21 -34.67 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.211 0 CA-C-N 112.768 -2.014 . . . . 1.54 108.003 178.301 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 967' ' ' TRP . . . . . 0.895 ' O ' HG23 ' A' ' 971' ' ' VAL . 98.4 m95 -65.45 -46.4 79.99 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.238 -0.892 . . . . 0.64000000000000001 110.658 178.023 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 968' ' ' TRP . . . . . 0.603 ' HB2' ' HB2' ' A' ' 965' ' ' PRO . 64.4 m95 -65.33 -32.73 74.53 Favored 'General case' 0 CA--C 1.518 -0.272 0 C-N-CA 120.277 -0.569 . . . . 0.93999999999999995 110.144 178.268 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 969' ' ' VAL . . . . . 0.726 ' O ' HG23 ' A' ' 973' ' ' VAL . 95.5 t -67.79 -47.24 80.39 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.391 0 N-CA-C 108.248 -1.019 . . . . 0.58999999999999997 108.248 178.559 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 2.0 tp -61.84 -42.35 98.93 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 114.088 -1.415 . . . . 1.76 107.414 178.117 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 971' ' ' VAL . . . . . 0.895 HG23 ' O ' ' A' ' 967' ' ' TRP . 99.4 t -62.03 -46.06 97.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.872 0.368 . . . . 0.65000000000000002 110.299 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -59.15 -42.32 97.07 Favored Glycine 0 C--N 1.338 0.644 0 N-CA-C 111.736 -0.546 . . . . 0.13 111.736 -179.072 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 973' ' ' VAL . . . . . 0.726 HG23 ' O ' ' A' ' 969' ' ' VAL . 63.6 t -67.31 -48.48 77.84 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.512 0 CA-C-N 114.94 -0.63 . . . . 0.85999999999999999 109.48 -178.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 89.5 mt -61.99 -42.0 98.66 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 115.37 -0.832 . . . . 1.1799999999999999 109.15 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -67.88 -47.5 60.19 Favored Glycine 0 C--N 1.335 0.478 0 N-CA-C 110.342 -1.103 . . . . 0.13 110.342 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -60.59 -37.98 94.26 Favored Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 108.805 -1.718 . . . . 0.14000000000000001 108.805 178.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 977' ' ' LEU . . . . . 0.466 ' O ' ' OG1' ' A' ' 981' ' ' THR . 46.0 tp -66.11 -44.4 84.39 Favored 'General case' 0 C--O 1.225 -0.197 0 N-CA-C 109.364 -0.606 . . . . 1.5600000000000001 109.364 178.631 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 1.1 mt -61.52 -46.27 90.66 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.689 -0.486 . . . . 1.73 109.689 178.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 57.2 mt -61.67 -43.62 98.51 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.186 -0.606 . . . . 0.89000000000000001 109.884 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 980' ' ' LEU . . . . . 0.682 ' O ' HG23 ' A' ' 984' ' ' VAL . 22.7 mt -63.69 -41.45 98.13 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 119.981 -0.688 . . . . 1.23 109.971 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 981' ' ' THR . . . . . 0.466 ' OG1' ' O ' ' A' ' 977' ' ' LEU . 7.2 m -63.15 -47.4 82.85 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.254 -0.885 . . . . 0.19 110.928 -179.462 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 93.6 mt -64.38 -44.54 97.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.655 0.264 . . . . 0.70999999999999996 110.598 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 13.1 mt -63.31 -36.81 84.91 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.978 -0.749 . . . . 1.6599999999999999 108.978 179.042 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 984' ' ' VAL . . . . . 0.682 HG23 ' O ' ' A' ' 980' ' ' LEU . 23.0 t -69.14 -50.37 53.61 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 CA-C-N 115.321 -0.854 . . . . 0.28000000000000003 110.92 -178.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 94.9 mt -65.45 -40.22 92.98 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.39 -0.823 . . . . 0.33000000000000002 109.329 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 986' ' ' ALA . . . . . 0.678 ' O ' HG13 ' A' ' 990' ' ' VAL . . . -64.54 -45.4 87.31 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 121.509 0.671 . . . . 0.11 110.273 -179.002 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 987' ' ' MET . . . . . 0.45 ' O ' ' N ' ' A' ' 992' ' ' PHE . 25.6 mtp -63.25 -28.63 70.16 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 122.174 0.988 . . . . 0.53000000000000003 109.582 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 988' ' ' TRP . . . . . . . . . . . . . 7.8 t90 -77.64 -35.41 52.57 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.016 -1.447 . . . . 2.4199999999999999 108.014 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.5 -41.08 76.55 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.514 0.673 . . . . 0.73999999999999999 109.874 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 990' ' ' VAL . . . . . 0.678 HG13 ' O ' ' A' ' 986' ' ' ALA . 2.4 m -79.42 -8.91 11.91 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 CA-C-N 115.124 -0.944 . . . . 0.14999999999999999 109.72 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 991' ' ' GLY . . . . . . . . . . . . . . . 85.87 3.66 85.47 Favored Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 114.772 -1.104 . . . . 0.16 112.19 179.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 992' ' ' PHE . . . . . 0.45 ' N ' ' O ' ' A' ' 987' ' ' MET . 0.3 OUTLIER -55.07 -37.92 67.38 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 120.133 1.966 . . . . 0.51000000000000001 113.762 -176.232 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 993' ' ' PHE . . . . . 0.407 ' CE2' ' HE2' ' A' ' 987' ' ' MET . 4.0 m-85 -73.22 -13.92 61.24 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-O 124.684 2.183 . . . . 1.53 109.293 178.177 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 994' ' ' LYS . . . . . . . . . . . . . 3.7 tttt -86.0 154.87 21.13 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 108.401 -4.0 . . . . 5.8700000000000001 110.843 178.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 995' ' ' ARG . . . . . 0.497 ' O ' ' N ' ' A' ' 997' ' ' ARG . 15.1 mtm105 -115.63 -78.67 0.58 Allowed 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 118.491 0.587 . . . . 7.3799999999999999 110.856 -177.268 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 996' ' ' ASN . . . . . . . . . . . . . 49.3 t30 45.56 17.66 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.128 -0.629 . . . . 6.9400000000000004 110.297 179.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 997' ' ' ARG . . . . . 0.497 ' N ' ' O ' ' A' ' 995' ' ' ARG . 0.2 OUTLIER -56.26 158.56 7.36 Favored Pre-proline 0 CA--C 1.531 0.248 0 N-CA-C 108.774 -0.825 . . . . 9.2400000000000002 108.774 179.872 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 998' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo . . . . . 0 C--N 1.308 -1.591 0 C-N-CA 122.289 1.992 . . . . 10.050000000000001 111.712 -179.229 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 957' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.542 0 N-CA-C 109.29 -1.524 . . . . 1.0 109.29 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -62.5 -41.43 98.82 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.971 -0.292 . . . . 1.0 110.62 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 94.1 mt -115.19 125.42 53.37 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.597 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 960' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -80.78 140.83 35.27 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.991 -0.549 . . . . 1.0 111.227 -179.391 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 961' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -67.12 137.54 56.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.831 -0.622 . . . . 1.0 110.365 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 962' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -125.89 149.02 49.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.941 -0.572 . . . . 1.0 110.872 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 963' ' ' ALA . . . . . . . . . . . . . . . -154.82 0.78 0.18 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.752 -0.658 . . . . 1.0 110.084 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 964' ' ' ILE . . . . . . . . . . . . . 5.1 pt -141.95 76.3 19.84 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.028 -0.533 . . . . 1.0 110.895 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -61.79 147.86 94.35 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.811 2.341 . . . . 1.0 111.734 179.539 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 83.2 mt -63.44 -44.36 98.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.007 -0.542 . . . . 1.0 111.675 -179.122 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 967' ' ' TRP . . . . . 0.759 ' O ' HG23 ' A' ' 971' ' ' VAL . 98.7 m95 -58.03 -38.33 76.02 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 112.03 0.381 . . . . 1.0 112.03 -178.473 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 31.3 m95 -69.3 -35.54 76.09 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 110.279 -0.267 . . . . 1.0 110.279 179.097 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 969' ' ' VAL . . . . . 0.451 ' O ' HG23 ' A' ' 973' ' ' VAL . 67.5 t -66.31 -45.01 90.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 109.097 -0.705 . . . . 1.0 109.097 178.127 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 92.4 mt -63.79 -41.81 97.85 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.997 -1.002 . . . . 1.0 109.961 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 971' ' ' VAL . . . . . 0.759 HG23 ' O ' ' A' ' 967' ' ' TRP . 76.0 t -62.71 -45.27 99.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.965 0.412 . . . . 1.0 110.855 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.14 -41.78 98.27 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.665 -0.574 . . . . 1.0 111.665 -179.095 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 973' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 969' ' ' VAL . 72.2 t -65.57 -46.78 88.63 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.541 0 CA-C-O 120.998 0.428 . . . . 1.0 110.574 -179.045 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 88.9 mt -62.24 -41.18 98.2 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.921 -0.77 . . . . 1.0 108.921 179.419 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -65.92 -46.18 83.41 Favored Glycine 0 C--N 1.329 0.163 0 N-CA-C 110.284 -1.126 . . . . 1.0 110.284 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -61.25 -37.93 94.82 Favored Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 109.141 -1.584 . . . . 1.0 109.141 179.171 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 55.4 tp -65.49 -42.53 92.07 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.196 -0.668 . . . . 1.0 109.196 178.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 42.9 tp -63.66 -45.47 90.0 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.304 -0.558 . . . . 1.0 110.694 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 90.9 mt -61.89 -42.8 99.5 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.017 -0.673 . . . . 1.0 109.908 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 980' ' ' LEU . . . . . 0.649 ' O ' HG23 ' A' ' 984' ' ' VAL . 84.6 mt -63.99 -41.41 97.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.988 0.423 . . . . 1.0 110.437 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 7.7 m -62.65 -46.41 88.34 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.738 -0.664 . . . . 1.0 110.29 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 94.5 mt -63.65 -43.75 98.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 C-N-CA 120.781 -0.368 . . . . 1.0 110.838 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 33.0 mt -64.72 -41.04 96.26 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.867 -0.333 . . . . 1.0 111.236 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 984' ' ' VAL . . . . . 0.649 HG23 ' O ' ' A' ' 980' ' ' LEU . 88.3 t -67.83 -49.07 72.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.25 0.548 . . . . 1.0 110.033 -179.535 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 81.6 mt -63.22 -43.32 98.45 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.433 -0.803 . . . . 1.0 109.698 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 986' ' ' ALA . . . . . 0.927 ' O ' HG13 ' A' ' 990' ' ' VAL . . . -61.72 -43.48 98.78 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 108.918 -0.771 . . . . 1.0 108.918 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 27.3 mtp -62.29 -30.79 71.38 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 114.804 -1.089 . . . . 1.0 109.648 179.109 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 988' ' ' TRP . . . . . . . . . . . . . 1.8 t90 -75.3 -37.79 60.65 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.035 -1.438 . . . . 1.0 108.271 179.117 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.22 -39.11 78.76 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.766 0.793 . . . . 1.0 110.048 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 990' ' ' VAL . . . . . 0.927 HG13 ' O ' ' A' ' 986' ' ' ALA . 1.4 m -83.39 -8.78 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-N 115.052 -0.976 . . . . 1.0 110.756 -178.467 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 991' ' ' GLY . . . . . 0.537 ' C ' ' H ' ' A' ' 993' ' ' PHE . . . 83.53 2.55 90.05 Favored Glycine 0 C--N 1.337 0.591 0 CA-C-O 119.222 -0.766 . . . . 1.0 112.594 178.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -52.64 -1.64 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 119.644 1.722 . . . . 1.0 112.386 -177.464 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 993' ' ' PHE . . . . . 0.537 ' H ' ' C ' ' A' ' 991' ' ' GLY . 12.2 m-85 -87.0 4.08 43.31 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.426 -0.51 . . . . 1.0 110.975 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 994' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -59.06 -43.74 91.76 Favored 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 108.238 -1.023 . . . . 1.0 108.238 177.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -91.82 140.22 29.9 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.099 -0.5 . . . . 1.0 110.61 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 996' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -100.5 7.54 44.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.141 -0.482 . . . . 1.0 111.708 -179.325 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 997' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -110.9 160.44 28.82 Favored Pre-proline 0 N--CA 1.464 0.228 0 CA-C-N 116.605 -0.27 . . . . 1.0 110.454 179.561 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 998' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo . . . . . 0 N--CA 1.493 1.449 0 C-N-CA 122.307 2.005 . . . . 1.0 111.824 179.816 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 957' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.356 0 N-CA-C 109.377 -1.489 . . . . 1.0 109.377 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -63.76 -37.23 86.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.0 0.429 . . . . 1.0 109.858 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 62.4 mt -103.41 132.45 49.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.824 -0.625 . . . . 1.0 110.231 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 960' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -65.71 -34.32 77.93 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.064 -0.517 . . . . 1.0 110.182 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 961' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -64.56 -35.95 82.63 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.726 -0.67 . . . . 1.0 111.112 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 962' ' ' ARG . . . . . . . . . . . . . 59.3 ttt85 -62.29 137.32 58.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.938 0.399 . . . . 1.0 110.236 -179.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 963' ' ' ALA . . . . . . . . . . . . . . . -66.41 145.78 55.3 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.993 -0.549 . . . . 1.0 111.124 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 964' ' ' ILE . . . . . . . . . . . . . 1.3 pt -132.52 66.08 76.06 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.76 -0.655 . . . . 1.0 110.11 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 965' ' ' PRO . . . . . 0.639 ' O ' HG23 ' A' ' 969' ' ' VAL . 30.2 Cg_endo -68.4 -12.26 34.38 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.325 2.016 . . . . 1.0 112.748 -179.197 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 97.5 mt -63.65 -44.77 98.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.526 -0.306 . . . . 1.0 111.336 -179.382 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 967' ' ' TRP . . . . . 0.676 ' O ' HG23 ' A' ' 971' ' ' VAL . 91.5 m95 -67.25 -35.87 80.43 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.31 -0.556 . . . . 1.0 110.704 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 87.0 m95 -68.37 -37.03 80.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.74 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 969' ' ' VAL . . . . . 0.639 HG23 ' O ' ' A' ' 965' ' ' PRO . 96.2 t -66.78 -42.78 89.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 109.046 -0.724 . . . . 1.0 109.046 178.528 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 87.4 mt -62.9 -41.77 99.56 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.209 -0.905 . . . . 1.0 109.796 178.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 971' ' ' VAL . . . . . 0.676 HG23 ' O ' ' A' ' 967' ' ' TRP . 76.2 t -62.5 -45.57 98.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.819 0.342 . . . . 1.0 110.829 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -61.24 -40.96 99.31 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 111.837 -0.505 . . . . 1.0 111.837 -179.251 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 973' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 969' ' ' VAL . 62.6 t -65.87 -46.22 89.18 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.376 0 CA-C-N 115.092 -0.554 . . . . 1.0 110.037 -179.194 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 86.7 mt -63.26 -41.4 99.03 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 121.327 0.584 . . . . 1.0 109.432 178.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -66.44 -46.8 74.79 Favored Glycine 0 C--N 1.332 0.341 0 N-CA-C 110.489 -1.044 . . . . 1.0 110.489 -179.122 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -60.18 -36.74 91.5 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 108.886 -1.686 . . . . 1.0 108.886 178.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 977' ' ' LEU . . . . . 0.433 ' O ' ' OG1' ' A' ' 981' ' ' THR . 50.5 tp -66.41 -43.4 85.84 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.263 -0.575 . . . . 1.0 109.912 178.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 978' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' A' ' 978' ' ' LEU . 53.0 mt -61.94 -44.13 97.41 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 119.739 -0.784 . . . . 1.0 109.726 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 84.5 mt -62.5 -43.41 98.89 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 119.744 -0.782 . . . . 1.0 110.297 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 980' ' ' LEU . . . . . 0.527 ' O ' HG23 ' A' ' 984' ' ' VAL . 66.6 mt -64.56 -42.19 95.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.075 0.464 . . . . 1.0 110.606 -179.516 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 981' ' ' THR . . . . . 0.433 ' OG1' ' O ' ' A' ' 977' ' ' LEU . 5.9 m -64.18 -47.1 81.12 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.558 -0.747 . . . . 1.0 110.109 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 94.3 mt -64.07 -44.49 97.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 120.74 -0.384 . . . . 1.0 111.433 -179.091 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 6.4 mp -64.55 -40.27 95.27 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.638 -0.425 . . . . 1.0 111.087 179.387 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 984' ' ' VAL . . . . . 0.527 HG23 ' O ' ' A' ' 980' ' ' LEU . 54.1 t -68.5 -48.98 69.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.21 0.529 . . . . 1.0 109.843 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 85.3 mt -63.33 -43.27 98.24 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.574 -0.739 . . . . 1.0 109.451 178.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 986' ' ' ALA . . . . . 0.906 ' O ' HG13 ' A' ' 990' ' ' VAL . . . -62.08 -42.7 99.48 Favored 'General case' 0 CA--C 1.511 -0.544 0 N-CA-C 108.997 -0.742 . . . . 1.0 108.997 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 987' ' ' MET . . . . . 0.414 ' HA ' HG22 ' A' ' 990' ' ' VAL . 30.9 mtp -62.1 -31.69 72.17 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 114.729 -1.123 . . . . 1.0 109.238 178.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 988' ' ' TRP . . . . . . . . . . . . . 1.8 t90 -73.23 -38.57 66.0 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 113.884 -1.507 . . . . 1.0 108.166 179.205 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.26 -39.6 78.34 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.434 -0.803 . . . . 1.0 110.39 -179.434 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 990' ' ' VAL . . . . . 0.906 HG13 ' O ' ' A' ' 986' ' ' ALA . 1.4 m -83.58 -8.66 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 CA-C-N 115.003 -0.998 . . . . 1.0 110.204 -178.736 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 991' ' ' GLY . . . . . 0.51 ' C ' ' H ' ' A' ' 993' ' ' PHE . . . 81.43 5.07 90.25 Favored Glycine 0 C--N 1.339 0.713 0 CA-C-O 119.199 -0.779 . . . . 1.0 112.508 179.148 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -52.5 -1.24 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 119.74 1.77 . . . . 1.0 112.932 -177.031 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 993' ' ' PHE . . . . . 0.51 ' H ' ' C ' ' A' ' 991' ' ' GLY . 16.1 m-85 -88.42 3.63 49.29 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 120.646 -0.422 . . . . 1.0 111.18 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 994' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -50.35 145.31 6.41 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.938 -0.764 . . . . 1.0 108.938 178.529 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 89.6 mtm180 -63.43 -42.52 98.7 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.137 -0.483 . . . . 1.0 111.297 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 996' ' ' ASN . . . . . . . . . . . . . 57.0 t-20 -91.62 104.94 17.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.908 0.385 . . . . 1.0 111.006 -179.288 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 997' ' ' ARG . . . . . . . . . . . . . 23.8 mtt85 -63.72 153.17 84.56 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.116 -0.493 . . . . 1.0 109.994 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 998' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo . . . . . 0 C--N 1.313 -1.305 0 C-N-CA 122.441 2.094 . . . . 1.0 112.051 179.523 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 957' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.41 0 N-CA-C 109.356 -1.498 . . . . 1.0 109.356 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 958' ' ' ALA . . . . . 0.413 ' O ' ' N ' ' A' ' 962' ' ' ARG . . . -69.92 141.69 53.06 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.542 -0.463 . . . . 1.0 110.297 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 57.9 tp -62.04 -40.71 96.67 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.175 -0.466 . . . . 1.0 109.885 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 960' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -65.45 -36.4 83.79 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.892 -0.595 . . . . 1.0 110.814 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 961' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -117.32 39.45 3.28 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-O 121.142 0.496 . . . . 1.0 110.195 178.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 962' ' ' ARG . . . . . 0.413 ' N ' ' O ' ' A' ' 958' ' ' ALA . 77.6 ttt-85 -59.46 -43.41 93.22 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.594 -0.73 . . . . 1.0 109.139 179.32 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 963' ' ' ALA . . . . . . . . . . . . . . . -72.76 -13.83 61.41 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.361 -0.836 . . . . 1.0 110.071 179.464 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 964' ' ' ILE . . . . . . . . . . . . . 57.2 mt 49.01 77.35 0.47 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.923 -0.58 . . . . 1.0 110.791 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -59.36 145.52 97.65 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 C-N-CA 122.672 2.248 . . . . 1.0 111.822 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 36.8 pt -69.46 -25.4 28.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.729 -0.669 . . . . 1.0 111.152 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 967' ' ' TRP . . . . . 0.825 ' O ' HG23 ' A' ' 971' ' ' VAL . 98.9 m95 -54.38 -38.66 66.4 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 116.147 -0.478 . . . . 1.0 111.447 -178.69 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 90.9 m95 -70.53 -36.42 73.71 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.474 -0.33 . . . . 1.0 110.367 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 95.2 t -66.81 -45.12 88.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 N-CA-C 108.389 -0.967 . . . . 1.0 108.389 178.206 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 58.9 tp -63.2 -42.51 99.32 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 114.564 -1.198 . . . . 1.0 109.199 178.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 971' ' ' VAL . . . . . 0.825 HG23 ' O ' ' A' ' 967' ' ' TRP . 79.3 t -62.29 -45.08 99.6 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.087 0 N-CA-C 109.727 -0.472 . . . . 1.0 109.727 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.23 -43.25 98.66 Favored Glycine 0 CA--C 1.526 0.736 0 CA-C-N 116.151 -0.477 . . . . 1.0 112.127 -179.258 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 58.2 t -65.24 -46.72 89.9 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.416 0 CA-C-N 115.169 -0.515 . . . . 1.0 110.066 -179.266 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 974' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 974' ' ' LEU . 88.8 mt -62.11 -41.98 98.76 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 109.038 -0.727 . . . . 1.0 109.038 178.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -65.98 -47.4 74.45 Favored Glycine 0 C--O 1.225 -0.418 0 N-CA-C 110.248 -1.141 . . . . 1.0 110.248 -179.396 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -59.13 -37.46 91.73 Favored Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 109.144 -1.582 . . . . 1.0 109.144 178.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 977' ' ' LEU . . . . . 0.431 HD23 ' HA ' ' A' ' 977' ' ' LEU . 35.7 mt -65.49 -42.97 91.56 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 119.982 -0.687 . . . . 1.0 110.257 178.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 35.7 mt -61.98 -44.05 97.55 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.021 -0.671 . . . . 1.0 110.304 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 10.7 mp -63.82 -43.57 95.82 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 119.555 -0.858 . . . . 1.0 111.501 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 980' ' ' LEU . . . . . 0.433 ' O ' HG23 ' A' ' 984' ' ' VAL . 2.6 mm? -63.66 -39.58 94.68 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.731 -0.388 . . . . 1.0 110.966 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 6.7 m -64.64 -47.74 77.38 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.137 -0.483 . . . . 1.0 110.853 -179.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 92.9 mt -63.27 -44.48 99.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.385 -0.371 . . . . 1.0 111.265 -178.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -64.83 -40.83 95.82 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.333 -0.394 . . . . 1.0 111.564 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 984' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 980' ' ' LEU . 41.2 t -67.48 -48.48 77.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.425 0.631 . . . . 1.0 110.277 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 85.9 mt -64.45 -42.78 95.78 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.136 -0.938 . . . . 1.0 109.894 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 986' ' ' ALA . . . . . 0.941 ' O ' HG13 ' A' ' 990' ' ' VAL . . . -62.92 -45.74 91.06 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.351 0.596 . . . . 1.0 109.825 -179.448 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 26.8 mtp -62.0 -32.56 73.05 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.966 -1.016 . . . . 1.0 109.522 179.318 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 988' ' ' TRP . . . . . 0.471 ' O ' ' CD1' ' A' ' 988' ' ' TRP . 11.4 t90 -74.47 -37.52 63.19 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.315 -1.311 . . . . 1.0 108.838 178.433 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.98 -40.58 78.72 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.797 0.808 . . . . 1.0 110.071 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 990' ' ' VAL . . . . . 0.941 HG13 ' O ' ' A' ' 986' ' ' ALA . 1.4 m -81.43 -8.08 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-N 114.639 -1.164 . . . . 1.0 110.1 -179.134 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 991' ' ' GLY . . . . . 0.551 ' C ' ' H ' ' A' ' 993' ' ' PHE . . . 83.28 2.83 90.33 Favored Glycine 0 C--N 1.338 0.654 0 CA-C-O 119.116 -0.825 . . . . 1.0 112.479 178.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -52.98 -1.95 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 119.722 1.761 . . . . 1.0 112.132 -177.306 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 993' ' ' PHE . . . . . 0.551 ' H ' ' C ' ' A' ' 991' ' ' GLY . 11.0 m-85 -86.43 2.48 47.54 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.398 -0.364 . . . . 1.0 110.961 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 994' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -54.65 132.78 46.17 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.052 -1.092 . . . . 1.0 108.052 177.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -63.75 -38.92 92.9 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.158 -0.473 . . . . 1.0 110.594 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 996' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -93.44 110.82 22.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.095 -0.502 . . . . 1.0 111.201 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 997' ' ' ARG . . . . . . . . . . . . . 19.7 mtt85 -52.85 152.78 6.64 Favored Pre-proline 0 CA--C 1.534 0.356 0 C-N-CA 120.765 -0.374 . . . . 1.0 110.047 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 998' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo . . . . . 0 N--CA 1.499 1.845 0 C-N-CA 122.661 2.24 . . . . 1.0 112.254 179.999 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 957' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.231 0 N-CA-C 109.317 -1.513 . . . . 1.0 109.317 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -64.75 -39.26 93.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.885 0.374 . . . . 1.0 110.504 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 87.1 mt -107.88 132.0 53.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.908 -0.587 . . . . 1.0 110.481 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 960' ' ' GLU . . . . . 0.446 ' HG2' ' H ' ' A' ' 962' ' ' ARG . 81.5 tt0 -56.27 -76.33 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.145 -0.48 . . . . 1.0 110.793 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 961' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 55.32 38.07 29.82 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.06 -0.518 . . . . 1.0 111.047 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 962' ' ' ARG . . . . . 0.446 ' H ' ' HG2' ' A' ' 960' ' ' GLU . 85.4 mtp180 -103.51 133.97 47.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.438 -0.346 . . . . 1.0 110.264 179.57 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 963' ' ' ALA . . . . . . . . . . . . . . . -66.78 141.81 57.58 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.325 -0.398 . . . . 1.0 110.742 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 964' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -86.6 156.03 56.25 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 1.0 109.905 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -77.47 44.13 1.46 Allowed 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.106 1.87 . . . . 1.0 111.819 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 966' ' ' ILE . . . . . 0.492 HG23 ' N ' ' A' ' 967' ' ' TRP . 19.7 tt -66.1 -40.87 88.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.996 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 967' ' ' TRP . . . . . 0.568 ' O ' HG23 ' A' ' 971' ' ' VAL . 97.6 m95 -53.94 -37.96 64.41 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.716 -179.229 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -69.05 -35.49 76.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.166 -0.47 . . . . 1.0 109.98 178.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 969' ' ' VAL . . . . . 0.566 ' O ' HG23 ' A' ' 973' ' ' VAL . 77.6 t -67.33 -44.6 87.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.539 0.685 . . . . 1.0 109.284 178.263 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 57.3 tp -63.61 -43.16 97.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.702 -1.135 . . . . 1.0 109.468 179.304 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 971' ' ' VAL . . . . . 0.568 HG23 ' O ' ' A' ' 967' ' ' TRP . 46.7 t -62.08 -45.01 99.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.998 0.428 . . . . 1.0 110.469 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.08 -39.42 95.74 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 111.348 -0.701 . . . . 1.0 111.348 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 973' ' ' VAL . . . . . 0.566 HG23 ' O ' ' A' ' 969' ' ' VAL . 74.5 t -66.61 -47.51 83.14 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.29 0 CA-C-N 114.999 -0.6 . . . . 1.0 110.585 -179.243 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 92.9 mt -62.91 -41.69 99.54 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.191 -0.67 . . . . 1.0 109.191 179.116 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -66.28 -46.71 76.88 Favored Glycine 0 C--N 1.329 0.175 0 N-CA-C 110.74 -0.944 . . . . 1.0 110.74 -179.265 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -60.29 -37.03 92.41 Favored Glycine 0 N--CA 1.448 -0.505 0 N-CA-C 109.181 -1.568 . . . . 1.0 109.181 179.121 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 38.2 mt -65.97 -42.54 89.74 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.119 -0.632 . . . . 1.0 110.158 179.013 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 76.7 mt -62.38 -44.46 96.41 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.149 -0.62 . . . . 1.0 110.496 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 96.7 mt -63.1 -43.61 98.0 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.248 -0.581 . . . . 1.0 110.676 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 980' ' ' LEU . . . . . . . . . . . . . 81.3 mt -64.35 -40.38 95.75 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.079 0.466 . . . . 1.0 110.417 -179.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 981' ' ' THR . . . . . 0.43 HG22 ' CD1' ' A' ' 985' ' ' LEU . 7.1 m -63.54 -45.79 88.94 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.525 -0.761 . . . . 1.0 109.748 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 89.7 mt -63.57 -44.18 98.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.318 -0.401 . . . . 1.0 111.366 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 85.1 mt -64.48 -42.63 95.77 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 121.125 -0.23 . . . . 1.0 111.347 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 984' ' ' VAL . . . . . . . . . . . . . 47.3 t -67.9 -47.96 77.12 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.374 0 CA-C-O 121.223 0.535 . . . . 1.0 109.968 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 985' ' ' LEU . . . . . 0.43 ' CD1' HG22 ' A' ' 981' ' ' THR . 89.3 mt -63.49 -42.75 98.53 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.458 -0.792 . . . . 1.0 109.348 179.362 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 986' ' ' ALA . . . . . 0.881 ' O ' HG13 ' A' ' 990' ' ' VAL . . . -63.18 -45.64 90.84 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 121.513 0.673 . . . . 1.0 109.621 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 32.6 mtp -62.34 -33.44 74.71 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.614 -1.175 . . . . 1.0 109.188 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 988' ' ' TRP . . . . . 0.489 ' O ' ' CD1' ' A' ' 988' ' ' TRP . 12.9 t90 -73.2 -35.2 66.32 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.473 -1.239 . . . . 1.0 108.379 178.61 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.04 -40.14 75.32 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.589 -0.732 . . . . 1.0 109.795 -179.412 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 990' ' ' VAL . . . . . 0.881 HG13 ' O ' ' A' ' 986' ' ' ALA . 1.2 m -81.91 -7.12 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 CA-C-N 114.989 -1.005 . . . . 1.0 110.063 -179.237 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 991' ' ' GLY . . . . . 0.517 ' C ' ' H ' ' A' ' 993' ' ' PHE . . . 82.15 3.77 90.45 Favored Glycine 0 C--N 1.34 0.784 0 CA-C-O 119.011 -0.883 . . . . 1.0 112.666 178.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -54.13 -0.93 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 119.607 1.704 . . . . 1.0 112.839 -177.216 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 993' ' ' PHE . . . . . 0.517 ' H ' ' C ' ' A' ' 991' ' ' GLY . 13.1 m-85 -88.5 1.78 54.17 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.051 0.453 . . . . 1.0 110.135 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 994' ' ' LYS . . . . . 0.402 ' O ' ' O ' ' A' ' 993' ' ' PHE . 15.5 mttt 60.28 129.52 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.68 -0.691 . . . . 1.0 110.975 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 88.5 mtm-85 -92.23 146.8 23.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.063 -0.517 . . . . 1.0 110.74 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 996' ' ' ASN . . . . . . . . . . . . . 60.3 t-20 53.99 41.66 31.95 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.002 0.43 . . . . 1.0 110.345 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 997' ' ' ARG . . . . . 0.418 ' HG2' ' H ' ' A' ' 997' ' ' ARG . 0.0 OUTLIER -41.39 163.4 0.11 Allowed Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 115.974 -0.557 . . . . 1.0 110.764 -179.666 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 998' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo . . . . . 0 C--N 1.31 -1.479 0 C-N-CA 122.708 2.272 . . . . 1.0 112.094 179.89 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 957' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.351 0 N-CA-C 109.507 -1.437 . . . . 1.0 109.507 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -142.38 147.1 35.68 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.906 0.384 . . . . 1.0 111.085 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 959' ' ' LEU . . . . . 0.529 ' N ' HD12 ' A' ' 959' ' ' LEU . 10.3 mp -62.99 -42.55 99.88 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.138 179.762 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 960' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -121.84 121.74 37.88 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.116 -0.493 . . . . 1.0 109.789 179.343 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 961' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -118.02 125.85 51.15 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 121.032 0.444 . . . . 1.0 110.97 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 962' ' ' ARG . . . . . . . . . . . . . 90.7 mtt180 -64.62 -40.42 95.47 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.817 -0.629 . . . . 1.0 111.226 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 963' ' ' ALA . . . . . . . . . . . . . . . -152.3 154.85 36.53 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.768 0.318 . . . . 1.0 111.115 -179.37 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 964' ' ' ILE . . . . . . . . . . . . . 2.8 pt -130.0 75.12 79.89 Favored Pre-proline 0 N--CA 1.463 0.203 0 CA-C-N 116.104 -0.498 . . . . 1.0 110.656 179.437 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 965' ' ' PRO . . . . . 0.605 ' O ' HG23 ' A' ' 969' ' ' VAL . 58.0 Cg_endo -80.03 -3.0 12.47 Favored 'Trans proline' 0 C--N 1.303 -1.839 0 C-N-CA 122.789 2.326 . . . . 1.0 112.572 -179.749 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 966' ' ' ILE . . . . . 0.499 HG23 ' N ' ' A' ' 967' ' ' TRP . 20.1 tt -64.19 -41.62 92.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 C-N-CA 120.787 -0.365 . . . . 1.0 110.725 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 967' ' ' TRP . . . . . 0.499 ' N ' HG23 ' A' ' 966' ' ' ILE . 99.5 m95 -70.8 -35.58 72.59 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.578 -0.449 . . . . 1.0 110.98 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 94.0 m95 -69.56 -34.47 74.23 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.361 -0.382 . . . . 1.0 110.247 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 969' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 965' ' ' PRO . 73.9 t -65.83 -43.22 93.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 C-N-CA 119.889 -0.724 . . . . 1.0 109.175 177.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 93.2 mt -62.74 -42.35 99.63 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.145 -0.934 . . . . 1.0 109.923 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 971' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 967' ' ' TRP . 47.5 t -61.87 -46.23 96.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.864 0.364 . . . . 1.0 110.175 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -59.79 -43.55 97.81 Favored Glycine 0 CA--C 1.521 0.418 0 CA-C-N 116.095 -0.502 . . . . 1.0 112.016 -179.379 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 973' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 969' ' ' VAL . 71.6 t -65.17 -46.45 90.94 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.555 0 CA-C-O 120.996 0.426 . . . . 1.0 110.703 -178.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 91.5 mt -63.12 -40.38 97.43 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 109.17 -0.678 . . . . 1.0 109.17 179.519 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -67.76 -45.35 76.01 Favored Glycine 0 CA--C 1.518 0.236 0 N-CA-C 110.415 -1.074 . . . . 1.0 110.415 -179.012 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -61.24 -37.54 94.17 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 109.622 -1.391 . . . . 1.0 109.622 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 57.9 tp -67.52 -41.68 84.01 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 119.698 -0.801 . . . . 1.0 109.874 179.336 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 65.9 mt -62.04 -43.77 98.13 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 119.86 -0.736 . . . . 1.0 110.298 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 82.3 mt -62.59 -44.03 97.32 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.323 -0.551 . . . . 1.0 110.825 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 980' ' ' LEU . . . . . 0.724 ' O ' HG23 ' A' ' 984' ' ' VAL . 88.6 mt -63.96 -40.26 96.0 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.067 0.461 . . . . 1.0 110.168 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 6.8 m -64.09 -46.65 83.31 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.612 -0.722 . . . . 1.0 110.293 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 93.9 mt -64.07 -44.57 97.73 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 C-N-CA 120.827 -0.349 . . . . 1.0 111.118 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 59.7 tp -63.96 -40.88 97.43 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.624 -0.43 . . . . 1.0 110.21 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 984' ' ' VAL . . . . . 0.724 HG23 ' O ' ' A' ' 980' ' ' LEU . 77.8 t -65.7 -47.69 85.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.311 0.577 . . . . 1.0 110.252 -179.312 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 64.7 mt -63.71 -41.38 98.11 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.37 -0.832 . . . . 1.0 109.533 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 986' ' ' ALA . . . . . 0.87 ' O ' HG13 ' A' ' 990' ' ' VAL . . . -62.96 -47.13 84.5 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.107 0.48 . . . . 1.0 110.511 -179.136 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 13.3 mtm -64.09 -32.35 73.87 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 122.112 0.958 . . . . 1.0 109.622 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 988' ' ' TRP . . . . . 0.483 ' O ' ' CD1' ' A' ' 988' ' ' TRP . 9.4 t90 -69.27 -36.46 77.11 Favored 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 107.499 -1.297 . . . . 1.0 107.499 178.635 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.81 -39.56 76.47 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.117 -0.947 . . . . 1.0 110.321 -179.366 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 990' ' ' VAL . . . . . 0.87 HG13 ' O ' ' A' ' 986' ' ' ALA . 1.0 OUTLIER -84.88 -9.89 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 CA-C-N 115.198 -0.91 . . . . 1.0 110.651 -178.892 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 991' ' ' GLY . . . . . 0.484 ' C ' ' H ' ' A' ' 993' ' ' PHE . . . 82.47 6.53 88.55 Favored Glycine 0 C--N 1.336 0.56 0 CA-C-O 118.744 -1.031 . . . . 1.0 112.876 179.171 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -57.45 0.26 0.05 Allowed 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 120.056 1.928 . . . . 1.0 112.997 -177.381 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 993' ' ' PHE . . . . . 0.484 ' H ' ' C ' ' A' ' 991' ' ' GLY . 10.3 m-85 -92.12 7.74 41.09 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.379 0.609 . . . . 1.0 109.688 179.591 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 994' ' ' LYS . . . . . . . . . . . . . 6.6 tttp 62.71 105.22 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.182 -0.917 . . . . 1.0 110.866 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 92.4 mtm-85 -64.98 -40.57 95.16 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.898 -0.592 . . . . 1.0 110.903 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 996' ' ' ASN . . . . . . . . . . . . . 43.5 p-10 -157.05 171.93 19.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.114 -0.494 . . . . 1.0 110.549 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 997' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.73 160.17 26.98 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 115.88 -0.6 . . . . 1.0 110.205 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 998' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo . . . . . 0 C--N 1.308 -1.581 0 C-N-CA 122.415 2.076 . . . . 1.0 112.033 179.529 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 957' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.216 0 N-CA-C 109.402 -1.479 . . . . 1.0 109.402 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -70.15 140.05 52.54 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.757 -0.377 . . . . 1.0 110.318 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 78.7 mt -61.72 -41.62 97.87 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.29 -0.414 . . . . 1.0 110.696 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 960' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -64.81 -41.57 95.68 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.992 -0.549 . . . . 1.0 111.074 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 961' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -127.94 111.68 13.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.31 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 962' ' ' ARG . . . . . . . . . . . . . 77.4 ttt180 -76.49 142.04 41.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.321 -0.4 . . . . 1.0 110.374 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 963' ' ' ALA . . . . . . . . . . . . . . . -68.03 138.97 56.26 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.397 -0.365 . . . . 1.0 110.147 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 964' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -135.95 155.29 77.87 Favored Pre-proline 0 CA--C 1.534 0.36 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.449 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 965' ' ' PRO . . . . . 0.478 ' O ' HG23 ' A' ' 969' ' ' VAL . 57.6 Cg_endo -71.42 -10.55 27.16 Favored 'Trans proline' 0 N--CA 1.498 1.755 0 C-N-CA 122.87 2.38 . . . . 1.0 113.205 -179.248 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 42.3 mm -60.46 -48.94 86.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.666 -0.243 . . . . 1.0 111.058 -179.056 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 967' ' ' TRP . . . . . 0.515 ' O ' HG23 ' A' ' 971' ' ' VAL . 81.7 m95 -63.1 -36.37 83.37 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.636 -0.425 . . . . 1.0 110.621 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 95.3 m95 -68.73 -36.72 78.77 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.3 178.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 969' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 965' ' ' PRO . 56.1 t -66.02 -43.88 92.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.149 -0.685 . . . . 1.0 109.149 178.327 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 62.9 tp -62.72 -41.94 99.41 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.179 -0.919 . . . . 1.0 109.484 179.331 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 971' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 967' ' ' TRP . 41.6 t -63.47 -45.79 96.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.165 -0.47 . . . . 1.0 111.321 -179.379 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -62.51 -44.17 97.96 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-N 116.253 -0.43 . . . . 1.0 113.532 -178.187 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 35.0 m -68.29 -42.96 84.8 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 CA-C-O 120.787 0.327 . . . . 1.0 110.861 -178.017 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 97.9 mt -63.09 -40.17 96.86 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.444 -0.947 . . . . 1.0 108.444 178.445 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -66.13 -46.75 78.05 Favored Glycine 0 C--N 1.33 0.222 0 N-CA-C 110.447 -1.061 . . . . 1.0 110.447 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -59.33 -36.16 87.83 Favored Glycine 0 N--CA 1.448 -0.514 0 N-CA-C 108.804 -1.718 . . . . 1.0 108.804 178.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 977' ' ' LEU . . . . . 0.427 ' O ' ' OG1' ' A' ' 981' ' ' THR . 58.9 tp -65.54 -43.64 89.32 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.17 -0.612 . . . . 1.0 109.719 178.668 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 45.7 tp -61.84 -45.45 93.77 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.653 -0.419 . . . . 1.0 110.436 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 10.8 mp -63.18 -43.16 99.0 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 119.935 -0.706 . . . . 1.0 110.719 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 980' ' ' LEU . . . . . 0.53 ' O ' HG23 ' A' ' 984' ' ' VAL . 80.7 mt -63.94 -40.85 97.4 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 121.186 0.517 . . . . 1.0 110.149 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 981' ' ' THR . . . . . 0.444 HG22 HD12 ' A' ' 985' ' ' LEU . 8.2 m -62.75 -46.79 86.42 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.37 -0.832 . . . . 1.0 110.015 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 88.9 mt -63.84 -43.83 97.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 C-N-CA 120.633 -0.427 . . . . 1.0 111.203 -179.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 91.1 mt -65.2 -41.07 94.88 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.519 -0.309 . . . . 1.0 111.03 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 984' ' ' VAL . . . . . 0.53 HG23 ' O ' ' A' ' 980' ' ' LEU . 72.0 t -70.02 -50.16 50.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.064 0.459 . . . . 1.0 110.449 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 985' ' ' LEU . . . . . 0.444 HD12 HG22 ' A' ' 981' ' ' THR . 89.8 mt -63.79 -42.92 97.63 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.783 -0.644 . . . . 1.0 109.622 179.482 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 986' ' ' ALA . . . . . 0.863 ' O ' HG13 ' A' ' 990' ' ' VAL . . . -62.53 -43.28 99.2 Favored 'General case' 0 CA--C 1.511 -0.531 0 N-CA-C 108.926 -0.768 . . . . 1.0 108.926 -179.56 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 31.5 mtp -61.95 -30.53 70.97 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 122.512 1.148 . . . . 1.0 109.073 178.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 988' ' ' TRP . . . . . . . . . . . . . 1.6 t90 -74.02 -36.98 64.48 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 113.64 -1.618 . . . . 1.0 107.874 179.125 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.71 -39.05 73.64 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.595 0.712 . . . . 1.0 110.248 -179.359 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 990' ' ' VAL . . . . . 0.863 HG13 ' O ' ' A' ' 986' ' ' ALA . 1.1 m -81.76 -7.28 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-N 114.967 -1.015 . . . . 1.0 110.09 -179.258 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 991' ' ' GLY . . . . . 0.51 ' C ' ' H ' ' A' ' 993' ' ' PHE . . . 81.85 3.73 90.51 Favored Glycine 0 C--N 1.34 0.79 0 CA-C-O 119.136 -0.813 . . . . 1.0 112.414 178.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -52.63 -1.56 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 119.45 1.625 . . . . 1.0 112.932 -177.016 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 993' ' ' PHE . . . . . 0.51 ' H ' ' C ' ' A' ' 991' ' ' GLY . 15.4 m-85 -90.45 -1.88 57.92 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.287 0.565 . . . . 1.0 110.433 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 994' ' ' LYS . . . . . 0.406 ' CG ' ' O ' ' A' ' 993' ' ' PHE . 96.9 mttt -161.58 -39.64 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 114.948 -1.024 . . . . 1.0 112.253 -179.421 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 71.4 ttt180 -72.82 134.68 44.99 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.125 -0.488 . . . . 1.0 109.877 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 996' ' ' ASN . . . . . . . . . . . . . 60.0 t30 58.66 41.32 22.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.348 -0.387 . . . . 1.0 111.056 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 997' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -50.13 157.66 1.1 Allowed Pre-proline 0 C--N 1.329 -0.284 0 N-CA-C 109.942 -0.392 . . . . 1.0 109.942 179.547 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 998' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo . . . . . 0 C--N 1.308 -1.556 0 C-N-CA 122.507 2.138 . . . . 1.0 111.898 179.84 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 957' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.321 0 N-CA-C 109.94 -1.264 . . . . 1.0 109.94 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -62.49 -34.85 77.68 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.679 0.276 . . . . 1.0 110.726 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 52.8 tp -64.09 -39.84 94.93 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.956 0.408 . . . . 1.0 110.45 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 960' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -66.37 -37.52 85.47 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.964 -0.562 . . . . 1.0 110.047 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 961' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -66.04 137.86 57.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.949 -0.569 . . . . 1.0 110.757 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 962' ' ' ARG . . . . . . . . . . . . . 74.7 ttt180 -60.1 -43.81 95.3 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.661 -0.7 . . . . 1.0 110.338 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 963' ' ' ALA . . . . . . . . . . . . . . . -107.37 132.59 52.98 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.991 -0.55 . . . . 1.0 109.78 179.222 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 964' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -87.63 156.06 53.33 Favored Pre-proline 0 C--N 1.324 -0.505 0 N-CA-C 109.375 -0.602 . . . . 1.0 109.375 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -76.83 48.33 2.43 Favored 'Trans proline' 0 N--CA 1.496 1.637 0 C-N-CA 122.407 2.071 . . . . 1.0 112.21 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 966' ' ' ILE . . . . . 0.506 HG23 ' N ' ' A' ' 967' ' ' TRP . 20.5 tt -66.16 -43.29 92.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.736 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 967' ' ' TRP . . . . . 0.684 ' O ' HG23 ' A' ' 971' ' ' VAL . 98.7 m95 -54.83 -37.24 65.92 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.516 -0.311 . . . . 1.0 110.877 -179.411 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -69.25 -34.88 75.47 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 110.029 -0.36 . . . . 1.0 110.029 179.439 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 969' ' ' VAL . . . . . 0.458 ' O ' HG23 ' A' ' 973' ' ' VAL . 75.3 t -68.52 -47.02 79.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.203 0.525 . . . . 1.0 110.489 178.598 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 8.8 mp -64.01 -41.68 97.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.509 -0.768 . . . . 1.0 110.18 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 971' ' ' VAL . . . . . 0.684 HG23 ' O ' ' A' ' 967' ' ' TRP . 59.1 t -62.3 -44.53 99.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.879 0.371 . . . . 1.0 110.541 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -61.43 -40.49 98.74 Favored Glycine 0 CA--C 1.529 0.915 0 CA-C-N 116.064 -0.516 . . . . 1.0 112.006 -179.198 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 973' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 969' ' ' VAL . 75.9 t -67.0 -45.26 87.46 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.519 0 CA-C-N 115.445 -0.378 . . . . 1.0 110.735 -178.798 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 9.2 mp -62.5 -40.23 96.06 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.597 -0.89 . . . . 1.0 108.597 178.377 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -65.07 -45.8 90.78 Favored Glycine 0 N--CA 1.46 0.247 0 N-CA-C 110.29 -1.124 . . . . 1.0 110.29 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -59.69 -36.73 90.74 Favored Glycine 0 N--CA 1.444 -0.767 0 N-CA-C 108.771 -1.731 . . . . 1.0 108.771 178.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 55.7 tp -66.86 -44.11 81.83 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.187 -0.605 . . . . 1.0 110.514 179.32 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 83.2 mt -62.54 -44.94 95.09 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.091 -0.643 . . . . 1.0 110.757 -179.273 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 10.2 mp -63.51 -44.11 95.22 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 119.675 -0.81 . . . . 1.0 111.924 -179.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 980' ' ' LEU . . . . . . . . . . . . . 7.1 mp -63.83 -37.65 88.15 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.156 -0.618 . . . . 1.0 110.79 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 5.4 m -65.5 -46.61 79.04 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.521 -179.478 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 80.1 mt -63.11 -43.41 98.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 120.495 -0.482 . . . . 1.0 110.732 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 57.1 mt -63.66 -41.78 98.17 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 121.153 -0.219 . . . . 1.0 110.722 179.392 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 984' ' ' VAL . . . . . . . . . . . . . 56.6 t -68.38 -47.99 75.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 120.928 0.394 . . . . 1.0 110.052 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 84.3 mt -62.63 -42.41 99.58 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.937 -0.574 . . . . 1.0 109.524 179.005 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 986' ' ' ALA . . . . . 0.869 ' O ' HG13 ' A' ' 990' ' ' VAL . . . -63.26 -44.32 95.48 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 121.696 0.76 . . . . 1.0 108.981 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 30.7 mtp -62.11 -32.44 73.01 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 114.566 -1.197 . . . . 1.0 109.159 178.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 988' ' ' TRP . . . . . . . . . . . . . 2.0 t90 -72.32 -38.25 68.73 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.292 -1.322 . . . . 1.0 108.104 178.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.58 -39.62 84.85 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.335 -0.848 . . . . 1.0 110.306 -179.619 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 990' ' ' VAL . . . . . 0.869 HG13 ' O ' ' A' ' 986' ' ' ALA . 1.2 m -83.88 -8.94 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-N 115.286 -0.87 . . . . 1.0 110.956 -178.245 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 991' ' ' GLY . . . . . 0.556 ' C ' ' H ' ' A' ' 993' ' ' PHE . . . 82.58 4.24 90.19 Favored Glycine 0 C--N 1.338 0.671 0 CA-C-O 119.245 -0.753 . . . . 1.0 112.703 178.319 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -53.02 -2.91 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 119.259 1.529 . . . . 1.0 111.867 -177.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 993' ' ' PHE . . . . . 0.556 ' H ' ' C ' ' A' ' 991' ' ' GLY . 11.7 m-85 -84.88 -1.57 56.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.037 0.446 . . . . 1.0 109.916 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 994' ' ' LYS . . . . . . . . . . . . . 14.2 mttt 54.8 -178.93 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.671 -0.695 . . . . 1.0 111.656 179.18 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 97.1 mtt-85 -81.94 147.01 29.47 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.36 -0.837 . . . . 1.0 110.355 -179.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 996' ' ' ASN . . . . . . . . . . . . . 63.3 t-20 -95.85 106.05 18.14 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.135 0.493 . . . . 1.0 111.511 -179.268 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 997' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.4 159.57 65.75 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 115.791 -0.64 . . . . 1.0 110.211 179.452 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 998' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo . . . . . 0 N--CA 1.498 1.79 0 C-N-CA 122.947 2.431 . . . . 1.0 112.689 -179.79 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 957' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.351 0 N-CA-C 109.941 -1.263 . . . . 1.0 109.941 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -71.9 148.45 46.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.001 0.429 . . . . 1.0 111.385 -179.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 84.7 mt -110.23 140.33 44.48 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.755 -0.657 . . . . 1.0 109.832 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 960' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -63.22 -35.2 79.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.532 -0.304 . . . . 1.0 110.923 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 961' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -63.63 -39.33 94.08 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 120.776 -0.37 . . . . 1.0 110.677 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 962' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -62.86 -40.83 98.67 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.886 0.374 . . . . 1.0 110.261 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 963' ' ' ALA . . . . . . . . . . . . . . . 44.19 -158.85 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.468 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 964' ' ' ILE . . . . . 0.697 HG23 ' O ' ' A' ' 964' ' ' ILE . 3.7 tt -172.37 74.63 0.45 Allowed Pre-proline 0 C--N 1.328 -0.33 0 C-N-CA 120.875 -0.33 . . . . 1.0 110.889 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -80.19 47.54 2.57 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.893 2.395 . . . . 1.0 112.19 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 966' ' ' ILE . . . . . 0.509 HG23 ' N ' ' A' ' 967' ' ' TRP . 19.9 tt -66.13 -41.43 89.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.627 -0.715 . . . . 1.0 111.236 -179.701 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 967' ' ' TRP . . . . . 0.786 ' O ' HG23 ' A' ' 971' ' ' VAL . 98.3 m95 -55.82 -36.5 67.54 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 120.895 -0.322 . . . . 1.0 111.498 -178.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -70.24 -36.84 74.78 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.605 -0.27 . . . . 1.0 110.475 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 969' ' ' VAL . . . . . 0.445 ' O ' HG23 ' A' ' 973' ' ' VAL . 73.8 t -66.66 -44.35 89.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 108.937 -0.764 . . . . 1.0 108.937 178.551 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 60.9 tp -62.96 -43.2 99.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.817 -1.083 . . . . 1.0 109.499 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 971' ' ' VAL . . . . . 0.786 HG23 ' O ' ' A' ' 967' ' ' TRP . 56.2 t -61.93 -46.19 97.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.391 -0.368 . . . . 1.0 111.102 -179.517 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.15 -40.6 97.43 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 111.612 -0.595 . . . . 1.0 111.612 -179.286 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 973' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 969' ' ' VAL . 64.8 t -66.8 -48.37 80.05 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.483 0 CA-C-O 121.028 0.442 . . . . 1.0 111.068 -178.738 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 974' ' ' LEU . . . . . 0.406 HD13 ' HA ' ' A' ' 974' ' ' LEU . 3.9 mm? -62.74 -41.2 99.08 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 109.297 -0.631 . . . . 1.0 109.297 179.224 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -65.16 -43.52 95.37 Favored Glycine 0 C--O 1.229 -0.172 0 N-CA-C 109.456 -1.457 . . . . 1.0 109.456 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -62.01 -37.24 94.09 Favored Glycine 0 CA--C 1.521 0.462 0 N-CA-C 109.759 -1.336 . . . . 1.0 109.759 179.082 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 977' ' ' LEU . . . . . 0.41 ' O ' ' OG1' ' A' ' 981' ' ' THR . 60.7 tp -67.81 -44.53 77.06 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 109.856 -0.424 . . . . 1.0 109.856 179.18 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -62.16 -43.81 98.0 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.329 -0.548 . . . . 1.0 110.28 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 86.3 mt -62.88 -43.67 98.18 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.07 -0.652 . . . . 1.0 110.62 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 980' ' ' LEU . . . . . . . . . . . . . 64.4 mt -63.99 -40.62 96.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.123 0.487 . . . . 1.0 110.269 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 981' ' ' THR . . . . . 0.439 HG22 ' CD1' ' A' ' 985' ' ' LEU . 7.5 m -63.4 -45.78 89.46 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.439 -0.801 . . . . 1.0 109.725 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 85.6 mt -63.97 -44.71 97.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.266 -0.425 . . . . 1.0 111.118 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 56.9 tp -64.89 -43.55 92.54 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.171 -0.468 . . . . 1.0 111.397 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 984' ' ' VAL . . . . . . . . . . . . . 51.9 t -66.71 -47.97 81.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.438 0.637 . . . . 1.0 110.134 -179.497 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 985' ' ' LEU . . . . . 0.439 ' CD1' HG22 ' A' ' 981' ' ' THR . 81.6 mt -63.22 -42.9 99.32 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.07 -0.968 . . . . 1.0 109.605 178.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 986' ' ' ALA . . . . . 0.879 ' O ' HG13 ' A' ' 990' ' ' VAL . . . -61.98 -44.92 95.74 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-O 121.348 0.594 . . . . 1.0 109.487 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 987' ' ' MET . . . . . 0.431 ' HA ' HG22 ' A' ' 990' ' ' VAL . 19.6 mtp -62.17 -30.29 70.96 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 122.349 1.071 . . . . 1.0 109.563 179.199 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 988' ' ' TRP . . . . . . . . . . . . . 1.7 t90 -74.75 -38.09 62.33 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.018 -1.446 . . . . 1.0 108.396 178.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.88 -39.94 79.53 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.467 -0.788 . . . . 1.0 109.741 -179.068 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 990' ' ' VAL . . . . . 0.879 HG13 ' O ' ' A' ' 986' ' ' ALA . 1.4 m -82.14 -7.9 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 CA-C-N 114.829 -1.078 . . . . 1.0 110.408 -179.11 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 991' ' ' GLY . . . . . 0.549 ' C ' ' H ' ' A' ' 993' ' ' PHE . . . 82.4 3.41 90.55 Favored Glycine 0 C--N 1.336 0.567 0 CA-C-O 119.366 -0.685 . . . . 1.0 112.385 178.814 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -52.67 -1.37 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 119.624 1.712 . . . . 1.0 112.418 -177.369 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 993' ' ' PHE . . . . . 0.549 ' H ' ' C ' ' A' ' 991' ' ' GLY . 14.0 m-85 -89.3 4.91 47.27 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 120.713 -0.395 . . . . 1.0 111.497 -179.474 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 994' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -51.75 134.88 30.22 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 108.764 -0.828 . . . . 1.0 108.764 178.322 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -101.04 0.09 37.38 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.366 -0.379 . . . . 1.0 111.363 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 996' ' ' ASN . . . . . . . . . . . . . 63.2 t-20 -65.36 -40.0 93.04 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.815 0.34 . . . . 1.0 110.875 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 997' ' ' ARG . . . . . . . . . . . . . 10.0 mpt_? -44.5 154.9 0.39 Allowed Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.184 -0.462 . . . . 1.0 111.198 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 998' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo . . . . . 0 N--CA 1.494 1.51 0 C-N-CA 122.626 2.217 . . . . 1.0 112.056 179.061 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 957' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.258 0 N-CA-C 109.498 -1.441 . . . . 1.0 109.498 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -65.74 151.26 47.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.752 0.31 . . . . 1.0 110.606 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 72.9 mt -101.64 126.17 48.43 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.136 0.494 . . . . 1.0 111.1 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 960' ' ' GLU . . . . . . . . . . . . . 51.0 tp10 -71.23 -37.98 72.01 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.436 -0.802 . . . . 1.0 109.724 178.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 961' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -71.15 139.53 50.26 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.994 -0.548 . . . . 1.0 110.502 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 962' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -72.18 149.73 44.39 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.052 0.453 . . . . 1.0 110.571 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 963' ' ' ALA . . . . . . . . . . . . . . . -64.62 -40.35 95.32 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.796 -0.638 . . . . 1.0 110.837 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 964' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -114.49 169.58 6.45 Favored Pre-proline 0 CA--C 1.535 0.373 0 CA-C-N 116.154 -0.476 . . . . 1.0 109.899 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -59.42 145.44 97.93 Favored 'Trans proline' 0 N--CA 1.496 1.651 0 C-N-CA 121.558 1.505 . . . . 1.0 112.275 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 966' ' ' ILE . . . . . 0.446 HG23 ' N ' ' A' ' 967' ' ' TRP . 18.7 tt -66.63 -39.82 84.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.888 -0.597 . . . . 1.0 110.598 -179.626 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 967' ' ' TRP . . . . . 0.733 ' O ' HG23 ' A' ' 971' ' ' VAL . 97.7 m95 -53.84 -38.85 65.06 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.016 -0.538 . . . . 1.0 111.101 -179.051 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 23.9 m95 -69.3 -34.66 75.03 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.569 -0.287 . . . . 1.0 110.557 178.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 93.8 t -66.97 -44.61 88.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 108.715 -0.846 . . . . 1.0 108.715 178.152 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 80.1 mt -63.16 -41.43 99.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.728 -1.124 . . . . 1.0 109.39 178.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 971' ' ' VAL . . . . . 0.733 HG23 ' O ' ' A' ' 967' ' ' TRP . 66.8 t -61.88 -45.0 99.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 CA-C-O 120.989 0.423 . . . . 1.0 109.978 179.456 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -59.83 -41.05 97.49 Favored Glycine 0 CA--C 1.523 0.594 0 N-CA-C 111.301 -0.72 . . . . 1.0 111.301 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 54.1 t -65.63 -45.16 93.0 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.374 0 CA-C-N 115.333 -0.434 . . . . 1.0 109.882 -179.454 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 974' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 974' ' ' LEU . 86.9 mt -62.25 -42.18 99.1 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.197 -0.668 . . . . 1.0 109.197 178.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -65.96 -45.74 85.95 Favored Glycine 0 N--CA 1.459 0.175 0 N-CA-C 110.26 -1.136 . . . . 1.0 110.26 -179.376 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -60.92 -37.98 94.66 Favored Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 109.142 -1.583 . . . . 1.0 109.142 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 977' ' ' LEU . . . . . 0.473 ' O ' ' OG1' ' A' ' 981' ' ' THR . 56.2 tp -65.82 -44.46 85.55 Favored 'General case' 0 C--O 1.226 -0.172 0 N-CA-C 109.736 -0.468 . . . . 1.0 109.736 178.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 50.6 tp -62.42 -46.04 90.38 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.375 -0.53 . . . . 1.0 110.642 -179.417 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 87.8 mt -62.58 -44.5 96.15 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.281 -0.567 . . . . 1.0 110.952 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 980' ' ' LEU . . . . . . . . . . . . . 80.7 mt -63.58 -40.92 98.19 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.852 -0.425 . . . . 1.0 109.852 -179.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 981' ' ' THR . . . . . 0.473 ' OG1' ' O ' ' A' ' 977' ' ' LEU . 6.8 m -63.96 -46.84 82.9 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.718 -0.674 . . . . 1.0 110.64 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 93.4 mt -63.59 -44.41 98.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 120.807 -0.357 . . . . 1.0 111.562 -178.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 983' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 983' ' ' LEU . 93.9 mt -64.76 -40.18 94.86 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.727 -0.389 . . . . 1.0 110.976 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 984' ' ' VAL . . . . . . . . . . . . . 38.9 t -69.02 -48.05 72.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.257 0.551 . . . . 1.0 111.014 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 86.5 mt -62.96 -42.63 99.88 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.037 -0.727 . . . . 1.0 109.037 178.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 986' ' ' ALA . . . . . 0.871 ' O ' HG13 ' A' ' 990' ' ' VAL . . . -63.52 -44.6 93.78 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.265 0.555 . . . . 1.0 110.11 -179.045 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 21.5 mtp -63.52 -31.12 72.19 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 122.527 1.156 . . . . 1.0 110.153 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 988' ' ' TRP . . . . . 0.439 ' O ' ' CD1' ' A' ' 988' ' ' TRP . 14.0 t90 -75.89 -35.03 59.98 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.163 -1.38 . . . . 1.0 108.313 179.128 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.5 -38.36 74.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.468 0.651 . . . . 1.0 109.807 -179.578 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 990' ' ' VAL . . . . . 0.871 HG13 ' O ' ' A' ' 986' ' ' ALA . 1.6 m -78.96 0.2 3.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.19 -0.913 . . . . 1.0 109.394 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 991' ' ' GLY . . . . . 0.446 ' O ' ' N ' ' A' ' 994' ' ' LYS . . . 79.69 1.13 86.44 Favored Glycine 0 CA--C 1.506 -0.502 0 CA-C-O 119.478 -0.623 . . . . 1.0 112.252 177.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -48.38 -41.45 28.89 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-N 118.88 1.34 . . . . 1.0 111.256 -176.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 993' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -81.85 -6.21 58.89 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.819 0.819 . . . . 1.0 111.009 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 994' ' ' LYS . . . . . 0.446 ' N ' ' O ' ' A' ' 991' ' ' GLY . 98.2 mttt -95.74 145.8 25.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.161 -1.381 . . . . 1.0 108.222 176.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -66.58 -39.39 88.44 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.949 -0.568 . . . . 1.0 110.448 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 996' ' ' ASN . . . . . . . . . . . . . 29.7 t-20 -95.45 107.45 19.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.984 -0.553 . . . . 1.0 111.014 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 997' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.72 160.37 82.09 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.07 -0.513 . . . . 1.0 109.937 179.247 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 998' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo . . . . . 0 C--N 1.309 -1.536 0 C-N-CA 122.347 2.032 . . . . 1.0 111.875 179.922 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 957' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.202 0 N-CA-C 109.22 -1.552 . . . . 1.0 109.22 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -64.41 -37.81 88.83 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.044 0.45 . . . . 1.0 109.869 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 41.7 tp -114.47 124.86 52.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.482 -0.781 . . . . 1.0 109.797 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 960' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -72.03 141.79 49.3 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.594 -0.443 . . . . 1.0 110.565 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 961' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -68.75 -28.23 66.62 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.786 -0.643 . . . . 1.0 111.029 -179.585 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 962' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -91.37 16.55 9.92 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.531 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 963' ' ' ALA . . . . . . . . . . . . . . . -58.92 -42.55 89.94 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.093 -0.503 . . . . 1.0 110.98 -179.192 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 964' ' ' ILE . . . . . . . . . . . . . 42.0 mt 46.89 84.52 0.19 Allowed Pre-proline 0 C--N 1.327 -0.388 0 C-N-CA 120.825 -0.35 . . . . 1.0 111.106 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -58.25 147.21 85.53 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.197 1.931 . . . . 1.0 111.846 179.152 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 45.2 pt -67.7 -24.45 30.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 116.318 -0.401 . . . . 1.0 111.312 -179.461 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 967' ' ' TRP . . . . . 0.755 ' O ' HG23 ' A' ' 971' ' ' VAL . 98.2 m95 -52.03 -37.68 54.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.254 -0.43 . . . . 1.0 111.181 -179.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 99.7 m95 -70.29 -35.58 73.81 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.571 -0.286 . . . . 1.0 110.334 179.265 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 969' ' ' VAL . . . . . 0.545 ' O ' HG23 ' A' ' 973' ' ' VAL . 86.2 t -67.31 -45.63 85.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 N-CA-C 109.107 -0.701 . . . . 1.0 109.107 178.588 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 10.0 mp -63.29 -43.01 99.1 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.656 -0.702 . . . . 1.0 109.866 178.774 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 971' ' ' VAL . . . . . 0.755 HG23 ' O ' ' A' ' 967' ' ' TRP . 77.8 t -62.37 -45.06 99.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.378 -0.374 . . . . 1.0 110.922 -179.413 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.45 -41.48 98.62 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 112.074 -0.41 . . . . 1.0 112.074 -179.069 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 973' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 969' ' ' VAL . 84.5 t -66.61 -45.97 87.22 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.306 0 CA-C-N 115.195 -0.503 . . . . 1.0 110.392 -178.867 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 90.7 mt -62.41 -41.38 98.63 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 109.042 -0.725 . . . . 1.0 109.042 178.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -65.77 -46.0 85.54 Favored Glycine 0 C--N 1.331 0.299 0 N-CA-C 110.26 -1.136 . . . . 1.0 110.26 -179.634 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -60.77 -37.48 93.68 Favored Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 109.195 -1.562 . . . . 1.0 109.195 179.058 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 56.0 tp -66.97 -43.28 83.44 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.49 -0.484 . . . . 1.0 109.936 178.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 978' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 978' ' ' LEU . 39.9 mt -61.94 -44.94 95.73 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.359 -0.382 . . . . 1.0 110.223 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 94.8 mt -62.86 -42.96 99.95 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 119.669 -0.812 . . . . 1.0 110.315 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 980' ' ' LEU . . . . . . . . . . . . . 81.1 mt -64.17 -41.57 97.08 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.964 0.411 . . . . 1.0 111.093 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 7.5 m -62.81 -47.63 82.61 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.693 -0.685 . . . . 1.0 110.188 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 84.7 mt -63.61 -44.28 98.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 116.111 -0.495 . . . . 1.0 111.117 -179.653 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 15.1 tp -64.19 -43.14 95.99 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.498 -0.319 . . . . 1.0 110.955 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 984' ' ' VAL . . . . . . . . . . . . . 54.1 t -68.57 -48.7 70.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.171 0.51 . . . . 1.0 110.974 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 83.5 mt -62.15 -42.61 99.43 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.805 -0.813 . . . . 1.0 108.805 179.34 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 986' ' ' ALA . . . . . 0.831 ' O ' HG13 ' A' ' 990' ' ' VAL . . . -61.69 -44.01 97.76 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 109.062 -0.718 . . . . 1.0 109.062 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 27.4 mtp -61.59 -30.87 70.95 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.761 -1.108 . . . . 1.0 108.964 178.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 988' ' ' TRP . . . . . . . . . . . . . 1.7 t90 -73.46 -38.64 65.4 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 113.928 -1.487 . . . . 1.0 108.455 179.023 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.2 -37.79 78.29 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.594 -0.73 . . . . 1.0 110.378 -179.204 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 990' ' ' VAL . . . . . 0.831 HG13 ' O ' ' A' ' 986' ' ' ALA . 1.3 m -85.16 -7.56 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 CA-C-N 115.116 -0.947 . . . . 1.0 110.668 -178.528 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 991' ' ' GLY . . . . . 0.499 ' C ' ' H ' ' A' ' 993' ' ' PHE . . . 80.02 6.51 89.11 Favored Glycine 0 C--N 1.339 0.719 0 CA-C-O 119.264 -0.742 . . . . 1.0 112.192 179.307 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -53.0 -1.58 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 119.32 1.56 . . . . 1.0 112.736 -176.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 993' ' ' PHE . . . . . 0.499 ' H ' ' C ' ' A' ' 991' ' ' GLY . 17.1 m-85 -93.15 0.7 57.26 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.401 0.62 . . . . 1.0 110.704 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 994' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -158.22 140.52 14.27 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 114.823 -1.08 . . . . 1.0 113.01 -179.201 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 92.0 mtm-85 -80.17 148.58 30.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 1.0 111.022 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 996' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -101.07 141.55 33.8 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.958 -0.565 . . . . 1.0 109.819 179.438 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 997' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.02 159.0 44.65 Favored Pre-proline 0 N--CA 1.463 0.222 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.587 -179.566 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 998' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_exo . . . . . 0 C--N 1.313 -1.322 0 C-N-CA 122.549 2.166 . . . . 1.0 112.339 179.817 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 957' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.283 0 N-CA-C 109.557 -1.417 . . . . 1.0 109.557 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -68.46 132.43 46.98 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.976 0.417 . . . . 1.0 110.707 -179.59 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 93.4 mt -61.4 -41.97 97.99 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.824 -0.626 . . . . 1.0 110.532 -179.425 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 960' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -56.84 140.5 47.88 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.081 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 961' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -72.26 140.75 48.79 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.343 -0.39 . . . . 1.0 110.473 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 962' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -69.05 -39.82 78.94 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.492 -0.322 . . . . 1.0 111.039 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 963' ' ' ALA . . . . . . . . . . . . . . . 43.01 -165.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 1.0 111.11 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 964' ' ' ILE . . . . . . . . . . . . . 2.1 pt -130.11 59.35 44.64 Favored Pre-proline 0 N--CA 1.464 0.248 0 CA-C-N 116.2 -0.454 . . . . 1.0 111.191 -179.485 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 965' ' ' PRO . . . . . 0.531 ' O ' HG23 ' A' ' 969' ' ' VAL . 37.5 Cg_endo -67.66 -20.02 47.17 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 122.504 2.136 . . . . 1.0 112.487 179.487 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 45.7 mm -64.01 -48.05 87.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.638 -0.256 . . . . 1.0 111.461 -179.534 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 967' ' ' TRP . . . . . 0.567 ' O ' HG23 ' A' ' 971' ' ' VAL . 89.7 m95 -61.08 -36.59 80.05 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.589 0.233 . . . . 1.0 111.559 -179.185 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 88.8 m95 -71.04 -35.18 71.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.724 -0.216 . . . . 1.0 110.837 179.669 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 969' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 965' ' ' PRO . 76.0 t -67.14 -44.88 87.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 108.808 -0.812 . . . . 1.0 108.808 178.403 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 59.4 tp -64.07 -43.02 96.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.039 -0.982 . . . . 1.0 110.199 179.193 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 971' ' ' VAL . . . . . 0.567 HG23 ' O ' ' A' ' 967' ' ' TRP . 51.0 t -62.99 -45.14 99.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.959 0.409 . . . . 1.0 111.294 -179.368 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.29 -41.03 98.2 Favored Glycine 0 CA--C 1.528 0.882 0 CA-C-N 116.025 -0.534 . . . . 1.0 111.853 -179.443 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 973' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 969' ' ' VAL . 74.8 t -66.95 -47.5 82.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.115 0.483 . . . . 1.0 111.092 -178.709 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -62.87 -40.88 98.85 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.88 -0.6 . . . . 1.0 109.499 178.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -65.97 -45.27 88.86 Favored Glycine 0 CA--C 1.513 -0.051 0 N-CA-C 109.869 -1.292 . . . . 1.0 109.869 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 976' ' ' GLY . . . . . 0.468 ' O ' HD13 ' A' ' 980' ' ' LEU . . . -61.26 -37.39 93.94 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 109.233 -1.547 . . . . 1.0 109.233 178.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 53.5 tp -64.87 -42.48 94.8 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 109.433 -0.581 . . . . 1.0 109.433 178.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 60.3 tp -62.28 -44.82 95.64 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.894 -0.409 . . . . 1.0 109.894 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 92.3 mt -62.59 -45.09 94.51 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.462 -0.495 . . . . 1.0 111.355 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 980' ' ' LEU . . . . . 0.468 HD13 ' O ' ' A' ' 976' ' ' GLY . 9.2 mp -63.05 -39.28 94.28 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.322 -0.551 . . . . 1.0 110.217 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 7.8 m -62.5 -47.3 84.58 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.839 -0.619 . . . . 1.0 110.846 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 96.4 mt -64.21 -44.6 97.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.39 -0.368 . . . . 1.0 111.863 -178.491 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 7.5 mp -65.08 -40.09 94.13 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 120.663 -0.415 . . . . 1.0 110.943 179.636 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 984' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 980' ' ' LEU . 55.7 t -68.47 -48.85 70.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.288 -0.414 . . . . 1.0 110.367 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 86.3 mt -64.4 -41.77 96.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.959 -0.564 . . . . 1.0 109.53 178.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 986' ' ' ALA . . . . . 0.89 ' O ' HG13 ' A' ' 990' ' ' VAL . . . -62.96 -43.87 97.6 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-O 121.689 0.757 . . . . 1.0 109.032 -179.498 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 32.7 mtp -62.57 -31.13 71.89 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 114.415 -1.266 . . . . 1.0 109.174 178.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 988' ' ' TRP . . . . . . . . . . . . . 1.6 t90 -74.22 -37.82 63.73 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 113.957 -1.474 . . . . 1.0 108.037 179.15 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.24 -39.43 78.49 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.944 0.878 . . . . 1.0 110.303 -179.687 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 990' ' ' VAL . . . . . 0.89 HG13 ' O ' ' A' ' 986' ' ' ALA . 1.4 m -82.57 -7.94 11.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 114.92 -1.036 . . . . 1.0 110.57 -178.805 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 991' ' ' GLY . . . . . 0.574 ' C ' ' H ' ' A' ' 993' ' ' PHE . . . 82.68 2.94 90.69 Favored Glycine 0 C--N 1.339 0.698 0 CA-C-O 119.145 -0.808 . . . . 1.0 112.439 178.758 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -52.63 -1.37 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 119.723 1.762 . . . . 1.0 112.112 -177.505 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 993' ' ' PHE . . . . . 0.574 ' H ' ' C ' ' A' ' 991' ' ' GLY . 10.4 m-85 -87.33 2.53 50.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.567 -0.288 . . . . 1.0 111.44 -179.053 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 994' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -55.11 135.51 49.12 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.419 -0.956 . . . . 1.0 108.419 177.662 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 93.1 mtt180 -103.41 135.91 44.14 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.897 -0.321 . . . . 1.0 110.66 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 996' ' ' ASN . . . . . . . . . . . . . 66.1 t30 56.98 47.48 17.54 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 116.022 -0.535 . . . . 1.0 111.191 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 997' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -49.57 153.48 1.95 Allowed Pre-proline 0 N--CA 1.466 0.34 0 CA-C-N 116.423 -0.353 . . . . 1.0 110.52 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 998' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo . . . . . 0 N--CA 1.495 1.572 0 C-N-CA 122.338 2.026 . . . . 1.0 112.43 -179.96 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 957' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.327 0 N-CA-C 109.968 -1.253 . . . . 1.0 109.968 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -62.87 -38.21 89.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.998 0.427 . . . . 1.0 110.711 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 96.9 mt -61.64 -43.25 99.21 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.852 -0.613 . . . . 1.0 110.628 -179.369 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 960' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -70.13 133.34 47.03 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.836 0.351 . . . . 1.0 110.148 179.473 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 961' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -68.97 -40.49 78.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.038 -0.528 . . . . 1.0 111.092 -179.349 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 962' ' ' ARG . . . . . . . . . . . . . 94.5 mtt-85 -74.71 143.66 44.07 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.377 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 963' ' ' ALA . . . . . . . . . . . . . . . -148.32 13.2 0.96 Allowed 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.855 -0.338 . . . . 1.0 111.291 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 964' ' ' ILE . . . . . 0.475 HG22 HG22 ' A' ' 966' ' ' ILE . 1.0 OUTLIER -134.53 82.87 44.44 Favored Pre-proline 0 CA--C 1.536 0.423 0 CA-C-O 120.917 0.389 . . . . 1.0 110.351 -179.69 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -85.57 11.51 3.33 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.891 2.394 . . . . 1.0 112.588 -179.49 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 966' ' ' ILE . . . . . 0.51 HG23 ' N ' ' A' ' 967' ' ' TRP . 20.7 tt -65.52 -39.68 85.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.243 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 967' ' ' TRP . . . . . 0.659 ' O ' HG23 ' A' ' 971' ' ' VAL . 88.5 m95 -56.22 -39.68 72.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.178 -0.464 . . . . 1.0 111.358 -179.239 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 96.1 m95 -68.43 -34.91 76.83 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 110.117 -0.327 . . . . 1.0 110.117 179.319 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 969' ' ' VAL . . . . . 0.638 ' O ' HG23 ' A' ' 973' ' ' VAL . 57.1 t -67.14 -43.96 88.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 CA-C-O 121.649 0.737 . . . . 1.0 109.06 178.26 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 98.2 mt -63.34 -42.55 98.94 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 114.749 -1.114 . . . . 1.0 109.675 179.197 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 971' ' ' VAL . . . . . 0.659 HG23 ' O ' ' A' ' 967' ' ' TRP . 71.0 t -62.27 -45.31 99.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.064 0.459 . . . . 1.0 110.507 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.49 -41.34 98.63 Favored Glycine 0 C--N 1.332 0.306 0 N-CA-C 111.271 -0.732 . . . . 1.0 111.271 -179.228 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 973' ' ' VAL . . . . . 0.638 HG23 ' O ' ' A' ' 969' ' ' VAL . 84.4 t -65.57 -47.56 85.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 114.971 -0.615 . . . . 1.0 110.678 -179.151 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 78.3 mt -61.36 -40.43 94.27 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.697 -0.853 . . . . 1.0 108.697 178.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -64.54 -46.04 91.35 Favored Glycine 0 N--CA 1.461 0.305 0 N-CA-C 110.843 -0.903 . . . . 1.0 110.843 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -60.86 -36.93 92.86 Favored Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 109.474 -1.45 . . . . 1.0 109.474 179.012 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 82.2 mt -67.3 -43.21 82.29 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 120.4 -0.52 . . . . 1.0 110.619 179.14 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 55.7 tp -61.94 -44.89 95.82 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.673 -0.411 . . . . 1.0 110.178 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 97.2 mt -63.77 -42.92 97.7 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 120.187 -0.605 . . . . 1.0 110.91 -179.637 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 980' ' ' LEU . . . . . . . . . . . . . 76.2 mt -64.03 -39.52 94.27 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.918 0.39 . . . . 1.0 110.362 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 7.1 m -64.12 -46.67 83.16 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.877 -0.601 . . . . 1.0 109.764 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 90.9 mt -62.65 -44.46 99.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.052 -0.522 . . . . 1.0 111.145 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 97.6 mt -64.72 -40.69 95.77 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.728 -0.389 . . . . 1.0 111.143 179.749 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 984' ' ' VAL . . . . . . . . . . . . . 46.7 t -67.99 -48.09 76.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.04 0.448 . . . . 1.0 110.323 179.576 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 85.2 mt -64.17 -43.83 93.91 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.733 -0.667 . . . . 1.0 109.564 179.297 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 986' ' ' ALA . . . . . 0.936 ' O ' HG13 ' A' ' 990' ' ' VAL . . . -62.09 -44.94 95.57 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-O 121.361 0.601 . . . . 1.0 109.397 -179.375 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 30.9 mtp -61.99 -34.19 75.72 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 114.885 -1.052 . . . . 1.0 109.537 179.5 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 988' ' ' TRP . . . . . 0.463 ' O ' ' CD1' ' A' ' 988' ' ' TRP . 13.0 t90 -73.25 -36.02 66.32 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 114.137 -1.392 . . . . 1.0 108.527 179.33 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.22 -41.38 77.13 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 115.402 -0.817 . . . . 1.0 109.912 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 990' ' ' VAL . . . . . 0.936 HG13 ' O ' ' A' ' 986' ' ' ALA . 1.2 m -82.42 -8.7 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 CA-C-N 114.811 -1.086 . . . . 1.0 110.062 -179.122 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 991' ' ' GLY . . . . . 0.529 ' C ' ' H ' ' A' ' 993' ' ' PHE . . . 82.2 5.14 89.9 Favored Glycine 0 C--N 1.342 0.91 0 CA-C-O 119.15 -0.805 . . . . 1.0 112.692 179.022 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -51.93 -2.17 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 119.543 1.672 . . . . 1.0 112.851 -177.384 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 993' ' ' PHE . . . . . 0.529 ' H ' ' C ' ' A' ' 991' ' ' GLY . 13.6 m-85 -85.4 -0.12 53.88 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.992 -0.283 . . . . 1.0 110.399 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 994' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -59.18 -44.03 92.19 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 108.687 -0.857 . . . . 1.0 108.687 178.353 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 995' ' ' ARG . . . . . 0.613 ' NH1' ' NH2' ' A' ' 997' ' ' ARG . 78.9 mtp85 -88.62 -126.47 0.06 Allowed 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 110.021 -0.363 . . . . 1.0 110.021 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 996' ' ' ASN . . . . . . . . . . . . . 59.9 t30 52.74 39.07 27.96 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.552 -0.459 . . . . 1.0 110.444 179.562 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 997' ' ' ARG . . . . . 0.613 ' NH2' ' NH1' ' A' ' 995' ' ' ARG . 0.0 OUTLIER -66.97 161.39 62.98 Favored Pre-proline 0 C--N 1.328 -0.368 0 N-CA-C 109.473 -0.566 . . . . 1.0 109.473 -179.999 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 998' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo . . . . . 0 C--N 1.304 -1.801 0 C-N-CA 121.885 1.723 . . . . 1.0 111.609 -179.648 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 957' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.278 0 N-CA-C 109.681 -1.367 . . . . 1.0 109.681 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . 46.15 94.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.921 -0.311 . . . . 1.0 110.671 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 959' ' ' LEU . . . . . 0.481 ' N ' HD12 ' A' ' 959' ' ' LEU . 11.0 mp -98.78 126.41 44.41 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.118 0.485 . . . . 1.0 110.411 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 960' ' ' GLU . . . . . 0.496 ' OE1' ' N ' ' A' ' 960' ' ' GLU . 55.9 mp0 -66.09 -33.59 76.14 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.552 -0.749 . . . . 1.0 110.339 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 961' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -63.0 -35.26 79.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.866 -0.606 . . . . 1.0 110.621 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 962' ' ' ARG . . . . . . . . . . . . . 96.0 mtt-85 53.96 56.57 6.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.487 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 963' ' ' ALA . . . . . . . . . . . . . . . -126.05 156.36 40.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.776 -179.468 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 964' ' ' ILE . . . . . . . . . . . . . 16.2 mm 60.35 79.16 0.3 Allowed Pre-proline 0 CA--C 1.534 0.334 0 CA-C-N 115.89 -0.596 . . . . 1.0 110.9 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -59.05 147.47 90.12 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 122.458 2.105 . . . . 1.0 112.268 179.481 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 21.1 tt -65.97 -26.58 38.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.69 -0.686 . . . . 1.0 110.824 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 967' ' ' TRP . . . . . 0.537 ' O ' HG23 ' A' ' 971' ' ' VAL . 97.1 m95 -54.16 -38.07 65.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.251 -0.431 . . . . 1.0 111.304 -179.255 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 93.1 m95 -69.1 -35.69 76.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.462 . . . . 1.0 110.38 179.361 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 969' ' ' VAL . . . . . 0.476 ' O ' HG23 ' A' ' 973' ' ' VAL . 71.4 t -65.3 -43.87 94.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 108.396 -0.964 . . . . 1.0 108.396 177.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 970' ' ' LEU . . . . . 0.444 ' O ' HD13 ' A' ' 974' ' ' LEU . 89.9 mt -62.33 -42.86 99.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 114.513 -1.221 . . . . 1.0 109.688 179.615 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 971' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 967' ' ' TRP . 49.9 t -60.99 -44.87 99.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.865 0.364 . . . . 1.0 110.128 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.88 -39.01 96.3 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 111.538 -0.625 . . . . 1.0 111.538 -179.562 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 973' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 969' ' ' VAL . 56.8 t -66.67 -47.47 83.09 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.382 0 CA-C-N 114.92 -0.64 . . . . 1.0 110.439 -179.398 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 974' ' ' LEU . . . . . 0.444 HD13 ' O ' ' A' ' 970' ' ' LEU . 7.9 mp -62.95 -41.1 99.4 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.663 -0.866 . . . . 1.0 108.663 179.087 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -66.08 -45.58 86.27 Favored Glycine 0 CA--C 1.518 0.258 0 N-CA-C 110.308 -1.117 . . . . 1.0 110.308 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 976' ' ' GLY . . . . . 0.558 ' O ' HD13 ' A' ' 980' ' ' LEU . . . -60.19 -38.72 94.91 Favored Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 108.903 -1.679 . . . . 1.0 108.903 178.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 52.7 tp -66.66 -44.32 82.16 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.313 -0.555 . . . . 1.0 110.26 179.03 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 59.1 tp -62.29 -45.86 91.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.619 -0.264 . . . . 1.0 110.364 -179.662 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 93.5 mt -63.26 -43.53 97.73 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 119.976 -0.69 . . . . 1.0 110.765 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 980' ' ' LEU . . . . . 0.558 HD13 ' O ' ' A' ' 976' ' ' GLY . 8.5 mp -63.99 -39.06 93.26 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.74 -0.384 . . . . 1.0 110.708 -179.718 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 6.9 m -64.35 -45.98 85.45 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.963 -0.562 . . . . 1.0 110.188 -179.642 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 97.5 mt -63.45 -44.01 98.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 C-N-CA 120.938 -0.305 . . . . 1.0 111.539 -179.114 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 91.0 mt -65.07 -41.08 95.42 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 120.954 -0.298 . . . . 1.0 110.788 179.598 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 984' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 980' ' ' LEU . 54.4 t -66.39 -47.78 82.94 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.426 0 CA-C-O 121.472 0.653 . . . . 1.0 109.538 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 87.1 mt -63.4 -43.71 96.77 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.058 -0.974 . . . . 1.0 109.739 178.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 986' ' ' ALA . . . . . 0.824 ' O ' HG13 ' A' ' 990' ' ' VAL . . . -61.49 -45.12 95.57 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-O 121.595 0.712 . . . . 1.0 109.406 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 29.5 mtp -61.62 -30.19 70.53 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.651 -1.158 . . . . 1.0 108.778 179.053 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 988' ' ' TRP . . . . . . . . . . . . . 1.7 t90 -74.29 -38.85 63.26 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 113.912 -1.495 . . . . 1.0 108.424 179.207 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.22 -38.55 82.02 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.357 -0.838 . . . . 1.0 110.223 -179.05 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 990' ' ' VAL . . . . . 0.824 HG13 ' O ' ' A' ' 986' ' ' ALA . 1.4 m -84.55 -7.96 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 115.075 -0.966 . . . . 1.0 110.747 -178.48 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 991' ' ' GLY . . . . . 0.524 ' C ' ' H ' ' A' ' 993' ' ' PHE . . . 81.27 5.33 90.12 Favored Glycine 0 C--N 1.338 0.655 0 CA-C-O 119.17 -0.794 . . . . 1.0 112.453 179.056 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -53.4 -1.81 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 119.34 1.57 . . . . 1.0 112.532 -177.323 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 993' ' ' PHE . . . . . 0.524 ' H ' ' C ' ' A' ' 991' ' ' GLY . 10.2 m-85 -92.54 0.11 57.39 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.584 0.707 . . . . 1.0 110.501 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 994' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -156.08 145.1 20.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.663 -1.153 . . . . 1.0 113.566 -178.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -78.46 144.76 35.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.892 -0.595 . . . . 1.0 110.953 -179.228 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 996' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -62.61 -41.8 99.2 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 109.821 -0.437 . . . . 1.0 109.821 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 997' ' ' ARG . . . . . 0.429 ' HG3' ' H ' ' A' ' 997' ' ' ARG . 0.0 OUTLIER -80.7 158.22 71.11 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.025 -0.534 . . . . 1.0 109.72 179.474 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 998' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo . . . . . 0 C--N 1.309 -1.527 0 C-N-CA 122.277 1.985 . . . . 1.0 112.19 -179.315 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 957' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.479 0 N-CA-C 109.5 -1.44 . . . . 1.0 109.5 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -132.12 150.56 52.13 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.019 0.438 . . . . 1.0 110.72 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 959' ' ' LEU . . . . . 0.407 ' O ' ' C ' ' A' ' 960' ' ' GLU . 85.4 mt -116.92 132.61 56.66 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.829 -0.623 . . . . 1.0 110.588 -179.607 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 960' ' ' GLU . . . . . 0.407 ' C ' ' O ' ' A' ' 959' ' ' LEU . 94.4 mt-10 37.78 82.83 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.901 -0.59 . . . . 1.0 110.676 179.294 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 961' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -64.07 139.37 58.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.977 -0.556 . . . . 1.0 110.975 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 962' ' ' ARG . . . . . . . . . . . . . 94.9 mtt-85 -63.11 -38.69 92.19 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.308 -0.627 . . . . 1.0 109.308 179.17 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 963' ' ' ALA . . . . . . . . . . . . . . . -65.81 144.16 57.03 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.052 -0.976 . . . . 1.0 111.76 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 964' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -74.78 167.42 36.65 Favored Pre-proline 0 CA--C 1.536 0.408 0 CA-C-N 116.043 -0.526 . . . . 1.0 110.578 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -60.61 147.61 94.08 Favored 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 121.609 1.54 . . . . 1.0 111.367 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 71.9 mt -66.67 -25.88 35.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.013 -0.539 . . . . 1.0 110.927 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 967' ' ' TRP . . . . . 0.722 ' O ' HG23 ' A' ' 971' ' ' VAL . 94.2 m95 -53.1 -37.41 61.69 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.821 -179.717 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 83.9 m95 -72.06 -36.27 69.54 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.695 -0.229 . . . . 1.0 111.113 179.654 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 969' ' ' VAL . . . . . 0.408 ' O ' HG23 ' A' ' 973' ' ' VAL . 62.1 t -67.03 -44.82 88.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 108.691 -0.855 . . . . 1.0 108.691 178.497 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 56.4 tp -63.3 -44.22 95.64 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.738 -1.119 . . . . 1.0 110.204 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 971' ' ' VAL . . . . . 0.722 HG23 ' O ' ' A' ' 967' ' ' TRP . 54.4 t -61.85 -45.44 98.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 120.625 -0.43 . . . . 1.0 111.367 -178.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.23 -36.93 92.1 Favored Glycine 0 CA--C 1.529 0.959 0 CA-C-O 121.659 0.588 . . . . 1.0 111.679 -179.407 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 973' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 969' ' ' VAL . 53.5 t -68.28 -49.08 70.05 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.492 0 CA-C-N 114.87 -0.665 . . . . 1.0 109.948 -179.093 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 69.4 mt -62.21 -42.23 99.1 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 115.493 -0.776 . . . . 1.0 109.008 179.3 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -65.96 -45.55 87.08 Favored Glycine 0 N--CA 1.46 0.259 0 N-CA-C 110.061 -1.216 . . . . 1.0 110.061 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -59.62 -38.7 94.11 Favored Glycine 0 C--O 1.226 -0.366 0 N-CA-C 108.642 -1.783 . . . . 1.0 108.642 178.095 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 977' ' ' LEU . . . . . 0.42 ' O ' ' OG1' ' A' ' 981' ' ' THR . 49.1 tp -65.55 -42.93 91.33 Favored 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 120.717 -0.393 . . . . 1.0 110.188 179.313 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 76.3 mt -64.52 -44.32 91.24 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.457 -0.497 . . . . 1.0 111.054 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 80.6 mt -63.29 -44.28 95.49 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.325 -0.55 . . . . 1.0 110.732 -179.25 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 980' ' ' LEU . . . . . 0.417 ' O ' HG23 ' A' ' 984' ' ' VAL . 83.8 mt -63.51 -39.47 94.52 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.08 0.467 . . . . 1.0 110.115 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 981' ' ' THR . . . . . 0.508 HG22 ' CD1' ' A' ' 985' ' ' LEU . 7.3 m -64.59 -46.2 83.7 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.474 -0.785 . . . . 1.0 110.225 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 3.2 mm -64.09 -43.62 97.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.296 -0.411 . . . . 1.0 111.854 -178.686 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 98.2 mt -66.71 -40.72 88.55 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.093 -0.503 . . . . 1.0 111.377 -179.371 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 984' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 980' ' ' LEU . 65.8 t -68.61 -46.65 79.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.438 0.637 . . . . 1.0 109.492 179.465 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 985' ' ' LEU . . . . . 0.508 ' CD1' HG22 ' A' ' 981' ' ' THR . 80.9 mt -63.08 -43.44 98.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.261 -0.881 . . . . 1.0 109.039 178.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 986' ' ' ALA . . . . . 0.872 ' O ' HG13 ' A' ' 990' ' ' VAL . . . -62.01 -43.84 97.98 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.141 -0.688 . . . . 1.0 109.141 179.636 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 987' ' ' MET . . . . . 0.431 ' HA ' HG22 ' A' ' 990' ' ' VAL . 29.5 mtp -64.07 -32.58 74.19 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 114.955 -1.021 . . . . 1.0 110.367 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 988' ' ' TRP . . . . . 0.477 ' O ' ' CD1' ' A' ' 988' ' ' TRP . 12.7 t90 -73.48 -34.08 65.16 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.171 -1.377 . . . . 1.0 107.75 178.879 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.37 -39.37 71.27 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 114.866 -1.061 . . . . 1.0 110.478 -179.558 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 990' ' ' VAL . . . . . 0.872 HG13 ' O ' ' A' ' 986' ' ' ALA . 1.4 m -85.26 -7.6 10.96 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 CA-C-N 115.128 -0.942 . . . . 1.0 110.339 -178.478 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 991' ' ' GLY . . . . . 0.504 ' C ' ' H ' ' A' ' 993' ' ' PHE . . . 81.54 5.09 90.19 Favored Glycine 0 C--N 1.331 0.304 0 CA-C-O 118.813 -0.993 . . . . 1.0 112.76 179.35 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -52.79 -1.87 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 120.07 1.935 . . . . 1.0 112.729 -178.036 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 993' ' ' PHE . . . . . 0.504 ' H ' ' C ' ' A' ' 991' ' ' GLY . 17.5 m-85 -90.67 -1.48 57.87 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 121.03 0.443 . . . . 1.0 110.37 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 994' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -157.5 152.72 26.0 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 113.671 0.989 . . . . 1.0 113.671 -178.801 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 86.6 mtm-85 -88.83 36.03 0.8 Allowed 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.937 -0.574 . . . . 1.0 110.637 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 996' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -63.56 -42.85 98.33 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.208 -0.451 . . . . 1.0 109.791 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 997' ' ' ARG . . . . . . . . . . . . . 3.5 mtt180 -117.28 152.54 49.29 Favored Pre-proline 0 CA--C 1.535 0.398 0 CA-C-N 116.255 -0.43 . . . . 1.0 110.346 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 998' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo . . . . . 0 N--CA 1.491 1.368 0 C-N-CA 122.58 2.186 . . . . 1.0 112.841 -179.342 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 957' ' ' GLY . . . . . 0.448 ' N ' ' OE2' ' A' ' 960' ' ' GLU . . . . . . . . 0 N--CA 1.491 2.349 0 N-CA-C 109.498 -1.441 . . . . 1.0 109.498 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -62.93 -36.72 84.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.564 0.221 . . . . 1.0 110.659 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 73.3 mt -113.08 140.25 48.02 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.671 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 960' ' ' GLU . . . . . 0.448 ' OE2' ' N ' ' A' ' 957' ' ' GLY . 73.7 mm-40 -128.72 143.15 50.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.969 -0.559 . . . . 1.0 109.902 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 961' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -66.91 -39.93 87.53 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.912 0.386 . . . . 1.0 110.308 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 962' ' ' ARG . . . . . . . . . . . . . 83.6 mtp180 -99.72 140.27 34.16 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.987 -0.551 . . . . 1.0 111.369 -179.525 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 963' ' ' ALA . . . . . 0.448 ' O ' ' C ' ' A' ' 964' ' ' ILE . . . -150.21 150.13 31.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.775 -0.648 . . . . 1.0 110.482 179.623 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 964' ' ' ILE . . . . . 0.448 ' C ' ' O ' ' A' ' 963' ' ' ALA . 1.2 tt 29.94 72.28 0.5 Allowed Pre-proline 0 N--CA 1.462 0.174 0 O-C-N 123.896 0.747 . . . . 1.0 111.131 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -63.23 145.27 93.15 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 122.383 2.055 . . . . 1.0 111.756 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 87.4 mt -64.39 -43.97 97.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.018 -0.537 . . . . 1.0 110.697 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 967' ' ' TRP . . . . . 0.784 ' O ' HG23 ' A' ' 971' ' ' VAL . 89.7 m95 -58.37 -40.47 82.34 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 113.293 0.849 . . . . 1.0 113.293 -178.416 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 39.3 m95 -71.57 -39.61 70.49 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 112.957 0.725 . . . . 1.0 112.957 -178.523 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 969' ' ' VAL . . . . . 0.445 ' O ' HG23 ' A' ' 973' ' ' VAL . 17.3 m -66.86 -41.3 87.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 119.536 -0.866 . . . . 1.0 109.23 179.355 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 61.9 tp -64.35 -42.78 96.04 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.246 -0.888 . . . . 1.0 109.973 179.052 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 971' ' ' VAL . . . . . 0.784 HG23 ' O ' ' A' ' 967' ' ' TRP . 70.2 t -62.79 -44.83 99.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 120.523 -0.471 . . . . 1.0 110.668 -179.1 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -59.34 -41.65 97.02 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.555 -0.618 . . . . 1.0 111.555 -179.508 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 973' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 969' ' ' VAL . 77.0 t -64.63 -46.9 91.05 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.593 0 CA-C-O 121.038 0.447 . . . . 1.0 110.623 -179.303 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 98.7 mt -61.99 -40.67 96.44 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 108.595 -0.891 . . . . 1.0 108.595 179.476 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -67.13 -48.21 60.65 Favored Glycine 0 C--N 1.334 0.419 0 CA-C-N 115.1 -0.955 . . . . 1.0 110.943 -179.43 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -60.12 -36.41 90.47 Favored Glycine 0 N--CA 1.449 -0.446 0 N-CA-C 108.915 -1.674 . . . . 1.0 108.915 179.233 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 977' ' ' LEU . . . . . 0.455 ' O ' ' OG1' ' A' ' 981' ' ' THR . 54.1 tp -66.97 -43.22 83.63 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.179 -0.608 . . . . 1.0 109.993 179.138 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 4.3 tt -61.64 -45.24 94.88 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.348 -0.541 . . . . 1.0 110.33 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 96.1 mt -62.17 -45.16 94.65 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.487 -0.485 . . . . 1.0 111.315 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 980' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -64.13 -39.97 95.16 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.083 0.468 . . . . 1.0 111.163 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 981' ' ' THR . . . . . 0.455 ' OG1' ' O ' ' A' ' 977' ' ' LEU . 6.9 m -64.11 -46.71 83.01 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.487 -0.778 . . . . 1.0 110.121 -179.647 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 4.0 mm -63.68 -43.82 98.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.499 -0.319 . . . . 1.0 111.477 -179.169 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 83.7 mt -63.67 -41.58 98.17 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.381 -0.372 . . . . 1.0 110.366 179.49 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 984' ' ' VAL . . . . . . . . . . . . . 40.0 t -66.7 -47.1 84.11 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.332 0 CA-C-O 121.345 0.593 . . . . 1.0 110.356 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 82.2 mt -64.43 -43.04 95.6 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.292 -0.867 . . . . 1.0 109.919 179.134 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 986' ' ' ALA . . . . . 0.939 ' O ' HG13 ' A' ' 990' ' ' VAL . . . -63.85 -46.05 86.76 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 121.371 0.605 . . . . 1.0 109.726 -179.344 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 30.2 mtp -61.8 -33.75 74.68 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.817 -1.083 . . . . 1.0 109.286 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 988' ' ' TRP . . . . . 0.505 ' O ' ' CD1' ' A' ' 988' ' ' TRP . 12.8 t90 -72.1 -37.27 69.57 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.338 -1.301 . . . . 1.0 108.57 178.186 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.91 -40.3 79.19 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 121.717 0.77 . . . . 1.0 110.204 -179.501 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 990' ' ' VAL . . . . . 0.939 HG13 ' O ' ' A' ' 986' ' ' ALA . 1.2 m -82.63 -6.63 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 CA-C-N 114.707 -1.133 . . . . 1.0 109.989 -178.617 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 991' ' ' GLY . . . . . 0.543 ' C ' ' H ' ' A' ' 993' ' ' PHE . . . 83.58 2.6 89.99 Favored Glycine 0 C--N 1.337 0.586 0 CA-C-O 119.296 -0.724 . . . . 1.0 112.317 178.693 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -52.16 -2.5 0.02 OUTLIER 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 119.418 1.609 . . . . 1.0 112.145 -177.66 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 993' ' ' PHE . . . . . 0.543 ' H ' ' C ' ' A' ' 991' ' ' GLY . 11.6 m-85 -88.29 -5.29 58.43 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.077 0.465 . . . . 1.0 110.101 179.509 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 994' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -158.9 154.68 26.38 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.247 -0.888 . . . . 1.0 113.302 -179.409 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 89.0 mtm180 -64.57 -39.94 94.65 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.302 -0.408 . . . . 1.0 110.765 179.595 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 996' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -75.33 148.0 39.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.149 0.499 . . . . 1.0 110.712 -179.475 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 997' ' ' ARG . . . . . . . . . . . . . 46.4 mtp85 -68.19 155.11 92.94 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.625 -0.716 . . . . 1.0 110.96 -179.163 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 998' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo . . . . . 0 C--N 1.31 -1.45 0 C-N-CA 122.306 2.004 . . . . 1.0 112.334 -179.961 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 957' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.274 0 N-CA-C 109.795 -1.322 . . . . 1.0 109.795 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -153.2 159.49 42.66 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.988 0.423 . . . . 1.0 110.794 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 959' ' ' LEU . . . . . 0.457 HD22 ' N ' ' A' ' 959' ' ' LEU . 4.3 mm? -95.02 131.19 41.25 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.088 -0.505 . . . . 1.0 110.246 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 960' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -65.67 142.79 57.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.943 -0.571 . . . . 1.0 110.281 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 961' ' ' GLU . . . . . . . . . . . . . 89.0 mt-10 -65.77 -41.84 91.56 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.5 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 962' ' ' ARG . . . . . . . . . . . . . 28.1 mmt180 -107.33 132.35 53.23 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 120.889 0.376 . . . . 1.0 110.719 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 963' ' ' ALA . . . . . . . . . . . . . . . -75.38 142.62 43.08 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.046 -0.525 . . . . 1.0 110.038 179.372 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 964' ' ' ILE . . . . . 0.636 HG23 ' O ' ' A' ' 964' ' ' ILE . 1.3 tt -173.15 72.45 0.39 Allowed Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.144 -179.38 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -65.8 147.93 85.95 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.685 2.257 . . . . 1.0 111.753 -179.217 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 96.0 mt -64.86 -43.19 96.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.955 -0.566 . . . . 1.0 111.334 -179.599 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 967' ' ' TRP . . . . . 0.635 ' O ' HG23 ' A' ' 971' ' ' VAL . 96.9 m95 -55.7 -38.64 69.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 1.0 111.578 -178.627 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 24.7 m95 -70.33 -34.66 72.95 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.577 -0.283 . . . . 1.0 110.479 179.188 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 74.1 t -67.38 -43.93 87.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 108.99 -0.744 . . . . 1.0 108.99 178.258 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 51.6 tp -63.91 -41.33 97.71 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.232 -0.894 . . . . 1.0 109.104 179.062 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 971' ' ' VAL . . . . . 0.635 HG23 ' O ' ' A' ' 967' ' ' TRP . 53.2 t -62.29 -45.33 99.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 C-N-CA 120.895 -0.322 . . . . 1.0 111.372 -179.705 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.63 -41.31 98.83 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 112.161 -0.376 . . . . 1.0 112.161 -178.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 72.8 t -67.22 -47.23 82.15 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.517 0 CA-C-O 120.94 0.4 . . . . 1.0 110.668 -178.636 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 6.9 mp -63.44 -41.04 98.66 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.974 -0.557 . . . . 1.0 109.522 179.426 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -66.08 -44.95 90.29 Favored Glycine 0 C--N 1.334 0.433 0 N-CA-C 110.348 -1.101 . . . . 1.0 110.348 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -61.32 -36.11 91.98 Favored Glycine 0 N--CA 1.448 -0.527 0 N-CA-C 109.061 -1.615 . . . . 1.0 109.061 179.036 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 54.2 tp -67.37 -43.72 80.74 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.443 -0.503 . . . . 1.0 110.075 178.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 50.9 tp -62.43 -44.82 95.51 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.289 -0.564 . . . . 1.0 109.998 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 87.5 mt -61.94 -42.93 99.67 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 119.783 -0.767 . . . . 1.0 110.118 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 980' ' ' LEU . . . . . 0.428 ' O ' HG23 ' A' ' 984' ' ' VAL . 33.2 mt -63.42 -40.41 97.1 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.058 0.456 . . . . 1.0 110.334 -179.637 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 6.9 m -64.16 -46.27 84.79 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.409 -0.814 . . . . 1.0 110.17 -179.724 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 90.8 mt -64.29 -44.27 97.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.332 -0.394 . . . . 1.0 111.236 -179.439 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 983' ' ' LEU . . . . . 0.57 HD11 ' SD ' ' A' ' 987' ' ' MET . 39.1 tp -65.67 -42.74 90.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.544 -0.298 . . . . 1.0 111.454 -179.773 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 984' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 980' ' ' LEU . 53.1 t -66.81 -47.64 82.19 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.402 0 CA-C-O 121.411 0.624 . . . . 1.0 110.341 -179.404 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 84.0 mt -63.58 -41.59 98.36 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.134 -0.939 . . . . 1.0 109.132 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 986' ' ' ALA . . . . . 0.836 ' O ' HG13 ' A' ' 990' ' ' VAL . . . -62.65 -47.77 82.23 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.275 0.559 . . . . 1.0 110.38 -179.491 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 987' ' ' MET . . . . . 0.57 ' SD ' HD11 ' A' ' 983' ' ' LEU . 16.2 mtp -62.81 -30.26 71.35 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 122.632 1.206 . . . . 1.0 110.313 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 988' ' ' TRP . . . . . 0.467 ' O ' ' CD1' ' A' ' 988' ' ' TRP . 12.1 t90 -75.64 -35.34 60.48 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 113.976 -1.465 . . . . 1.0 107.926 178.523 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.25 -39.57 74.94 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-O 121.516 0.674 . . . . 1.0 109.902 -179.447 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 990' ' ' VAL . . . . . 0.836 HG13 ' O ' ' A' ' 986' ' ' ALA . 1.4 m -78.28 -3.45 5.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 114.946 -1.025 . . . . 1.0 109.221 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 991' ' ' GLY . . . . . 0.439 ' O ' ' N ' ' A' ' 994' ' ' LYS . . . 82.83 1.44 90.59 Favored Glycine 0 C--N 1.333 0.414 0 CA-C-O 119.404 -0.664 . . . . 1.0 112.397 177.643 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -47.22 -41.92 19.26 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-N 119.046 1.423 . . . . 1.0 110.926 -176.712 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 993' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -82.19 0.16 42.31 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.861 0.838 . . . . 1.0 111.1 179.479 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 994' ' ' LYS . . . . . 0.439 ' N ' ' O ' ' A' ' 991' ' ' GLY . 75.5 mmtt -111.68 151.09 29.28 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 113.992 -1.458 . . . . 1.0 108.394 177.485 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 59.6 ttp180 -131.97 127.12 35.63 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.435 -0.58 . . . . 1.0 109.435 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 996' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -94.89 144.35 25.73 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.893 -0.323 . . . . 1.0 110.249 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 997' ' ' ARG . . . . . . . . . . . . . 29.8 mtt180 -91.41 156.93 43.03 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.239 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 998' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo . . . . . 0 C--N 1.309 -1.515 0 C-N-CA 122.733 2.289 . . . . 1.0 112.35 179.944 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 957' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.271 0 N-CA-C 109.235 -1.546 . . . . 1.0 109.235 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -64.83 -37.09 86.47 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.868 -0.333 . . . . 1.0 110.2 179.575 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 10.5 mp -96.66 129.64 44.02 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.231 0.538 . . . . 1.0 110.256 179.595 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 960' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -61.75 -35.0 76.84 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.379 -0.828 . . . . 1.0 110.383 -179.436 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 961' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -98.54 137.41 37.24 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.814 0.34 . . . . 1.0 110.41 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 962' ' ' ARG . . . . . 0.648 ' O ' ' HB2' ' A' ' 963' ' ' ALA . 94.9 mtt-85 -61.44 -41.75 97.68 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.76 -179.42 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 963' ' ' ALA . . . . . 0.648 ' HB2' ' O ' ' A' ' 962' ' ' ARG . . . 165.88 80.16 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.03 0.443 . . . . 1.0 111.541 179.248 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 964' ' ' ILE . . . . . . . . . . . . . 6.4 mt 41.1 70.41 1.61 Allowed Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.98 -0.554 . . . . 1.0 111.177 178.316 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -81.2 1.68 9.12 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 123.156 2.57 . . . . 1.0 112.628 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 94.5 mt -62.67 -44.61 99.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.266 -0.424 . . . . 1.0 110.927 -179.261 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 967' ' ' TRP . . . . . 0.638 ' O ' HG23 ' A' ' 971' ' ' VAL . 98.8 m95 -56.69 -38.49 72.33 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.948 -0.301 . . . . 1.0 110.313 -179.763 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 87.4 m95 -68.58 -36.6 78.94 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.462 -0.335 . . . . 1.0 111.4 179.003 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 72.6 t -66.3 -44.56 91.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.307 0.575 . . . . 1.0 109.551 178.651 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 90.4 mt -62.82 -42.19 99.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.04 -0.982 . . . . 1.0 109.597 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 971' ' ' VAL . . . . . 0.638 HG23 ' O ' ' A' ' 967' ' ' TRP . 54.1 t -61.6 -45.33 98.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.51 -0.314 . . . . 1.0 111.14 -179.402 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.78 -41.67 99.19 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 121.377 -0.44 . . . . 1.0 112.331 -178.779 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 57.2 t -65.82 -47.45 85.63 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.534 0 CA-C-O 121.145 0.497 . . . . 1.0 110.605 -178.687 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 86.9 mt -62.59 -41.58 99.04 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.556 -0.747 . . . . 1.0 109.365 179.286 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -66.02 -46.25 82.28 Favored Glycine 0 N--CA 1.452 -0.243 0 N-CA-C 110.421 -1.072 . . . . 1.0 110.421 -179.446 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -61.0 -37.33 93.69 Favored Glycine 0 N--CA 1.451 -0.339 0 N-CA-C 109.244 -1.542 . . . . 1.0 109.244 179.238 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 977' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' A' ' 977' ' ' LEU . 30.1 mt -64.34 -42.4 96.29 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.437 -0.505 . . . . 1.0 109.753 178.677 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -62.98 -43.78 97.86 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 119.628 -0.829 . . . . 1.0 110.144 179.513 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 98.4 mt -61.72 -43.66 98.43 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.17 -0.612 . . . . 1.0 109.906 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 980' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 980' ' ' LEU . 31.1 mt -62.82 -41.93 99.51 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.56 -0.456 . . . . 1.0 109.891 179.628 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 981' ' ' THR . . . . . 0.496 HG22 HD12 ' A' ' 985' ' ' LEU . 7.3 m -62.69 -47.32 84.13 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.646 -0.707 . . . . 1.0 111.183 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 92.7 mt -64.26 -43.94 97.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 C-N-CA 120.775 -0.37 . . . . 1.0 111.152 -179.389 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 983' ' ' LEU . . . . . 0.403 ' O ' ' SD ' ' A' ' 987' ' ' MET . 83.0 mt -65.04 -41.76 94.92 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.329 -0.396 . . . . 1.0 111.307 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 984' ' ' VAL . . . . . . . . . . . . . 42.2 t -69.15 -49.86 58.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.208 0.528 . . . . 1.0 110.793 -179.302 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 985' ' ' LEU . . . . . 0.496 HD12 HG22 ' A' ' 981' ' ' THR . 90.7 mt -63.37 -42.53 98.87 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.47 -0.786 . . . . 1.0 109.44 179.32 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 986' ' ' ALA . . . . . 0.874 ' O ' HG13 ' A' ' 990' ' ' VAL . . . -61.87 -43.97 97.77 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 109.18 -0.674 . . . . 1.0 109.18 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 987' ' ' MET . . . . . 0.403 ' SD ' ' O ' ' A' ' 983' ' ' LEU . 21.9 mtp -62.14 -30.29 70.94 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 114.653 -1.158 . . . . 1.0 109.387 179.028 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 988' ' ' TRP . . . . . . . . . . . . . 1.8 t90 -74.87 -36.12 62.31 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 113.797 -1.547 . . . . 1.0 108.28 178.536 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.44 -38.92 71.29 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.599 0.714 . . . . 1.0 110.0 -179.374 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 990' ' ' VAL . . . . . 0.874 HG13 ' O ' ' A' ' 986' ' ' ALA . 1.3 m -80.41 -5.33 8.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 114.957 -1.02 . . . . 1.0 109.873 -179.333 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 991' ' ' GLY . . . . . 0.547 ' C ' ' H ' ' A' ' 993' ' ' PHE . . . 85.05 0.38 88.93 Favored Glycine 0 C--N 1.338 0.686 0 CA-C-O 119.466 -0.63 . . . . 1.0 112.546 177.576 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -51.92 -2.98 0.02 OUTLIER 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 118.901 1.35 . . . . 1.0 112.386 -177.651 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 993' ' ' PHE . . . . . 0.547 ' H ' ' C ' ' A' ' 991' ' ' GLY . 32.8 m-85 -118.75 -6.3 10.61 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 122.511 1.148 . . . . 1.0 110.543 179.756 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 994' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -93.8 -7.27 43.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 112.693 -2.049 . . . . 1.0 108.514 177.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -68.3 143.29 55.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.643 -0.708 . . . . 1.0 109.512 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 996' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -77.53 148.51 35.23 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.782 -0.367 . . . . 1.0 110.666 -179.364 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 997' ' ' ARG . . . . . . . . . . . . . 45.3 mtt85 -141.37 153.09 65.59 Favored Pre-proline 0 CA--C 1.534 0.33 0 CA-C-N 116.418 -0.355 . . . . 1.0 110.648 -179.385 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 998' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo . . . . . 0 N--CA 1.495 1.582 0 C-N-CA 122.211 1.941 . . . . 1.0 112.01 179.854 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 957' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.275 0 N-CA-C 109.792 -1.323 . . . . 1.0 109.792 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -155.65 152.79 29.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.841 0.353 . . . . 1.0 110.51 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 91.5 mt -79.58 141.44 36.58 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.353 -0.385 . . . . 1.0 110.445 179.734 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 960' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 49.46 -167.95 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.437 -0.347 . . . . 1.0 111.294 179.159 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 961' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -118.06 140.66 49.44 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.112 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 962' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 -112.36 150.9 30.41 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.217 0.532 . . . . 1.0 111.407 -179.711 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 963' ' ' ALA . . . . . 0.45 ' HB1' ' HD3' ' A' ' 965' ' ' PRO . . . -141.87 154.27 45.02 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.393 -0.821 . . . . 1.0 110.484 -179.538 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 964' ' ' ILE . . . . . 0.45 ' N ' ' CD ' ' A' ' 965' ' ' PRO . 4.4 pt -142.8 52.75 2.39 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.083 -0.508 . . . . 1.0 110.452 179.798 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 965' ' ' PRO . . . . . 0.649 ' O ' HG23 ' A' ' 969' ' ' VAL . 47.6 Cg_endo -68.91 -15.7 40.49 Favored 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 122.902 2.401 . . . . 1.0 112.863 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 87.2 mt -63.56 -44.03 98.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 111.953 0.353 . . . . 1.0 111.953 -178.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 967' ' ' TRP . . . . . 0.519 ' O ' HG23 ' A' ' 971' ' ' VAL . 99.4 m95 -69.43 -36.62 76.83 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.643 -0.423 . . . . 1.0 110.569 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 90.9 m95 -70.01 -34.3 73.12 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.614 -0.434 . . . . 1.0 110.426 179.003 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 969' ' ' VAL . . . . . 0.649 HG23 ' O ' ' A' ' 965' ' ' PRO . 53.9 t -66.94 -45.59 86.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.694 -0.484 . . . . 1.0 109.694 178.31 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 80.7 mt -63.72 -40.83 97.73 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.285 -0.871 . . . . 1.0 109.908 179.271 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 971' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 967' ' ' TRP . 45.2 t -64.77 -45.18 95.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 C-N-CA 120.694 -0.403 . . . . 1.0 111.309 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -63.05 -43.76 98.32 Favored Glycine 0 CA--C 1.529 0.932 0 CA-C-N 116.365 -0.38 . . . . 1.0 113.49 -177.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 973' ' ' VAL . . . . . 0.439 HG22 ' O ' ' A' ' 969' ' ' VAL . 31.6 m -67.48 -43.12 87.61 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.403 0 CA-C-O 120.897 0.38 . . . . 1.0 110.352 -178.24 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 974' ' ' LEU . . . . . 0.419 HD23 ' HA ' ' A' ' 974' ' ' LEU . 93.3 mt -63.39 -41.24 98.76 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.962 -0.755 . . . . 1.0 108.962 178.385 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -66.21 -46.16 81.49 Favored Glycine 0 C--N 1.329 0.151 0 N-CA-C 110.338 -1.105 . . . . 1.0 110.338 -179.406 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -59.2 -38.51 93.29 Favored Glycine 0 N--CA 1.446 -0.64 0 N-CA-C 108.647 -1.781 . . . . 1.0 108.647 178.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 977' ' ' LEU . . . . . 0.424 HD23 ' HA ' ' A' ' 977' ' ' LEU . 38.3 mt -63.87 -42.17 97.58 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.135 -0.626 . . . . 1.0 109.518 178.538 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 55.6 tp -62.44 -46.22 89.53 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.713 -0.395 . . . . 1.0 110.408 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 9.5 mp -62.29 -42.49 99.39 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 119.724 -0.79 . . . . 1.0 110.148 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 980' ' ' LEU . . . . . 0.526 ' O ' HG23 ' A' ' 984' ' ' VAL . 86.7 mt -63.04 -40.25 97.17 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.486 -0.486 . . . . 1.0 110.11 179.765 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 7.1 m -63.86 -46.72 83.73 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.667 -0.697 . . . . 1.0 110.808 -179.495 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 97.6 mt -63.56 -44.52 98.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.396 -0.365 . . . . 1.0 110.815 -179.022 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -65.73 -40.18 91.89 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.168 -0.469 . . . . 1.0 111.309 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 984' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 980' ' ' LEU . 45.6 t -67.24 -48.66 77.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.301 0.572 . . . . 1.0 110.337 -179.571 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 88.2 mt -63.67 -42.29 98.07 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.224 -0.898 . . . . 1.0 109.407 178.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 986' ' ' ALA . . . . . 0.827 ' O ' HG13 ' A' ' 990' ' ' VAL . . . -63.01 -46.93 85.33 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-O 121.384 0.611 . . . . 1.0 110.487 -179.081 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 19.2 mtp -63.18 -32.23 73.57 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 122.601 1.191 . . . . 1.0 109.607 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 988' ' ' TRP . . . . . 0.711 ' HE1' ' NZ ' ' A' ' 994' ' ' LYS . 14.2 t90 -72.99 -36.96 67.16 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 114.202 -1.363 . . . . 1.0 107.554 178.408 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 989' ' ' LYS . . . . . 0.537 ' O ' ' NZ ' ' A' ' 989' ' ' LYS . 0.1 OUTLIER -66.7 -41.18 88.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.224 -0.898 . . . . 1.0 109.816 -179.875 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 990' ' ' VAL . . . . . 0.827 HG13 ' O ' ' A' ' 986' ' ' ALA . 1.3 m -79.15 -3.03 5.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.112 -0.949 . . . . 1.0 109.518 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 991' ' ' GLY . . . . . . . . . . . . . . . 82.97 1.21 90.64 Favored Glycine 0 C--N 1.338 0.668 0 CA-C-O 119.28 -0.733 . . . . 1.0 112.565 177.676 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -45.87 -42.81 12.99 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 118.953 1.377 . . . . 1.0 111.332 -177.157 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 993' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -83.25 -3.44 57.42 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.684 0.754 . . . . 1.0 111.454 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 994' ' ' LYS . . . . . 0.711 ' NZ ' ' HE1' ' A' ' 988' ' ' TRP . 98.9 mttt -131.12 98.58 4.61 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.453 -1.249 . . . . 1.0 108.723 177.858 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 83.5 mtp180 -65.28 -40.96 94.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.454 . . . . 1.0 110.642 179.643 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 996' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -85.49 115.52 23.26 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.129 -0.487 . . . . 1.0 111.482 -179.405 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 997' ' ' ARG . . . . . . . . . . . . . 3.9 ttt180 -74.17 129.97 83.47 Favored Pre-proline 0 CA--C 1.536 0.418 0 CA-C-N 115.871 -0.604 . . . . 1.0 109.406 179.226 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 998' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_exo . . . . . 0 N--CA 1.49 1.278 0 C-N-CA 121.86 1.707 . . . . 1.0 112.416 -179.898 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 957' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.422 0 N-CA-C 109.742 -1.343 . . . . 1.0 109.742 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -73.45 140.98 46.86 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 110.171 -0.307 . . . . 1.0 110.171 179.567 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 97.3 mt 56.11 -169.04 0.09 Allowed 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 120.899 -0.32 . . . . 1.0 110.433 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 960' ' ' GLU . . . . . 0.414 ' O ' ' C ' ' A' ' 961' ' ' GLU . 99.9 mt-10 -125.08 137.54 54.2 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.589 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 961' ' ' GLU . . . . . 0.414 ' C ' ' O ' ' A' ' 960' ' ' GLU . 95.7 mt-10 36.45 68.14 0.27 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.998 -0.546 . . . . 1.0 111.293 178.868 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 962' ' ' ARG . . . . . . . . . . . . . 91.0 mtm180 -63.52 -42.29 98.47 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.995 -0.548 . . . . 1.0 110.02 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 963' ' ' ALA . . . . . . . . . . . . . . . -65.24 140.94 58.78 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.134 -0.485 . . . . 1.0 110.372 179.378 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 964' ' ' ILE . . . . . . . . . . . . . 1.7 pt -135.76 75.15 56.71 Favored Pre-proline 0 N--CA 1.469 0.484 0 CA-C-O 120.902 0.382 . . . . 1.0 111.268 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 965' ' ' PRO . . . . . 0.501 ' O ' HG23 ' A' ' 969' ' ' VAL . 24.2 Cg_exo -59.92 145.38 98.44 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 123.07 2.513 . . . . 1.0 112.437 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 93.2 mt -64.28 -43.85 97.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.551 -0.749 . . . . 1.0 111.335 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 967' ' ' TRP . . . . . 0.669 ' O ' HG23 ' A' ' 971' ' ' VAL . 98.4 m95 -57.14 -36.59 70.9 Favored 'General case' 0 N--CA 1.46 0.075 0 C-N-CA 120.625 -0.43 . . . . 1.0 110.677 -179.159 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 24.6 m95 -70.16 -35.25 73.88 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.636 -0.256 . . . . 1.0 110.422 179.32 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 969' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 965' ' ' PRO . 91.2 t -67.03 -45.93 85.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.682 0.753 . . . . 1.0 109.201 178.015 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 57.1 tp -63.0 -42.74 99.93 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.75 -1.114 . . . . 1.0 109.207 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 971' ' ' VAL . . . . . 0.669 HG23 ' O ' ' A' ' 967' ' ' TRP . 55.6 t -62.4 -45.4 98.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.952 0.406 . . . . 1.0 110.756 -179.701 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.35 -42.06 98.7 Favored Glycine 0 CA--C 1.524 0.603 0 CA-C-N 115.928 -0.578 . . . . 1.0 111.891 -179.056 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 63.6 t -66.1 -44.78 91.71 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.458 0 CA-C-O 120.909 0.385 . . . . 1.0 110.662 -178.845 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 80.9 mt -61.94 -40.49 95.71 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.402 -0.962 . . . . 1.0 108.402 178.657 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -66.63 -43.82 91.17 Favored Glycine 0 N--CA 1.46 0.261 0 N-CA-C 110.22 -1.152 . . . . 1.0 110.22 -179.425 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -61.29 -37.09 93.45 Favored Glycine 0 N--CA 1.447 -0.624 0 N-CA-C 109.297 -1.521 . . . . 1.0 109.297 179.177 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 977' ' ' LEU . . . . . 0.444 ' O ' ' OG1' ' A' ' 981' ' ' THR . 76.2 mt -67.38 -42.53 83.21 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 119.815 -0.754 . . . . 1.0 110.207 178.68 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 70.8 mt -62.04 -44.75 96.03 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.26 -0.576 . . . . 1.0 110.507 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 90.3 mt -63.5 -44.59 93.89 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 119.815 -0.754 . . . . 1.0 110.855 -179.566 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 980' ' ' LEU . . . . . 0.486 ' O ' HG23 ' A' ' 984' ' ' VAL . 6.2 mp -64.1 -40.76 96.9 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.232 -0.587 . . . . 1.0 110.606 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 981' ' ' THR . . . . . 0.444 ' OG1' ' O ' ' A' ' 977' ' ' LEU . 7.4 m -62.35 -47.8 82.6 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.883 -0.599 . . . . 1.0 110.352 -179.718 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 96.6 mt -64.56 -44.85 96.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 C-N-CA 120.403 -0.519 . . . . 1.0 111.563 -178.798 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 7.1 mp -64.74 -41.93 95.57 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 111.801 0.297 . . . . 1.0 111.801 -179.796 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 984' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 980' ' ' LEU . 51.1 t -65.64 -48.68 81.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-O 121.313 0.578 . . . . 1.0 110.383 -179.136 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 82.5 mt -62.28 -41.9 98.88 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.967 -1.015 . . . . 1.0 109.478 178.855 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 986' ' ' ALA . . . . . 0.892 ' O ' HG13 ' A' ' 990' ' ' VAL . . . -61.58 -46.34 90.28 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.314 0.578 . . . . 1.0 110.106 -179.447 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 22.7 mtp -63.33 -29.77 71.02 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 122.679 1.228 . . . . 1.0 110.043 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 988' ' ' TRP . . . . . . . . . . . . . 1.6 t90 -76.31 -34.87 59.05 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 113.57 -1.65 . . . . 1.0 107.549 179.482 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.22 -38.67 68.92 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.113 -0.949 . . . . 1.0 110.14 -179.43 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 990' ' ' VAL . . . . . 0.892 HG13 ' O ' ' A' ' 986' ' ' ALA . 1.5 m -79.37 -0.69 3.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.118 -0.946 . . . . 1.0 109.129 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 991' ' ' GLY . . . . . 0.466 ' O ' ' O ' ' A' ' 994' ' ' LYS . . . 80.8 1.0 89.18 Favored Glycine 0 C--N 1.337 0.585 0 CA-C-O 119.137 -0.813 . . . . 1.0 112.783 177.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -47.04 -40.88 15.71 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 119.263 1.531 . . . . 1.0 111.53 -177.075 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 993' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -81.48 -3.93 54.45 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.981 0.896 . . . . 1.0 111.673 -179.308 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 994' ' ' LYS . . . . . 0.466 ' O ' ' O ' ' A' ' 991' ' ' GLY . 68.7 mttm -113.1 140.1 48.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 113.53 -1.668 . . . . 1.0 109.153 177.069 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 34.2 ttm180 43.15 51.59 5.58 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.933 0.397 . . . . 1.0 110.597 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 996' ' ' ASN . . . . . 0.404 ' OD1' ' O ' ' A' ' 996' ' ' ASN . 47.2 t-20 -63.3 -40.77 98.28 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.629 -0.428 . . . . 1.0 110.663 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 997' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.18 159.86 32.23 Favored Pre-proline 0 C--N 1.332 -0.171 0 CA-C-N 116.187 -0.46 . . . . 1.0 110.707 -179.404 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 998' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo . . . . . 0 C--N 1.311 -1.415 0 C-N-CA 122.244 1.962 . . . . 1.0 111.562 179.419 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 957' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.203 0 N-CA-C 109.526 -1.43 . . . . 1.0 109.526 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -64.74 -36.55 84.67 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 121.197 -0.201 . . . . 1.0 110.816 -179.917 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 959' ' ' LEU . . . . . 0.404 ' HA ' HD12 ' A' ' 959' ' ' LEU . 34.1 tp -113.55 123.51 50.16 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 110.051 -0.351 . . . . 1.0 110.051 179.572 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 960' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -94.79 124.41 38.81 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.966 0.413 . . . . 1.0 110.411 -179.925 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 961' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -90.58 131.22 36.43 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.144 -0.48 . . . . 1.0 111.56 -178.781 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 962' ' ' ARG . . . . . . . . . . . . . 81.6 mtm-85 -65.02 -40.87 95.5 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.835 -0.62 . . . . 1.0 110.458 179.421 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 963' ' ' ALA . . . . . . . . . . . . . . . -72.94 153.51 40.94 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.873 -0.603 . . . . 1.0 110.854 -179.735 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 964' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -97.71 169.35 8.66 Favored Pre-proline 0 CA--C 1.533 0.29 0 CA-C-N 116.007 -0.542 . . . . 1.0 109.6 179.666 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -59.26 143.28 99.8 Favored 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 121.763 1.642 . . . . 1.0 112.738 -179.934 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 93.9 mt -64.35 -43.91 97.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.456 -0.793 . . . . 1.0 111.425 -179.737 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 967' ' ' TRP . . . . . 0.619 ' O ' HG13 ' A' ' 971' ' ' VAL . 98.0 m95 -56.73 -40.0 74.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.639 -0.71 . . . . 1.0 112.407 -178.317 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 38.9 m95 -69.67 -33.89 73.2 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.903 -0.406 . . . . 1.0 109.903 179.501 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 969' ' ' VAL . . . . . 0.631 ' O ' HG23 ' A' ' 973' ' ' VAL . 90.7 t -68.34 -46.04 81.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 C-N-CA 119.925 -0.71 . . . . 1.0 110.032 178.092 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 61.5 tp -66.15 -46.35 77.77 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 115.372 -0.831 . . . . 1.0 112.389 -179.165 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 971' ' ' VAL . . . . . 0.619 HG13 ' O ' ' A' ' 967' ' ' TRP . 26.9 m -63.69 -41.56 93.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 119.732 -0.787 . . . . 1.0 110.614 -177.974 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 972' ' ' GLY . . . . . 0.496 ' N ' HG23 ' A' ' 971' ' ' VAL . . . -60.51 -40.45 97.77 Favored Glycine 0 CA--C 1.525 0.657 0 CA-C-N 115.569 -0.741 . . . . 1.0 111.541 -179.459 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 973' ' ' VAL . . . . . 0.631 HG23 ' O ' ' A' ' 969' ' ' VAL . 92.2 t -66.09 -47.08 86.11 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.34 0 CA-C-O 121.007 0.432 . . . . 1.0 110.364 -179.048 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 92.9 mt -62.27 -40.38 96.03 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 108.655 -0.869 . . . . 1.0 108.655 179.312 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -65.36 -45.19 91.66 Favored Glycine 0 CA--C 1.516 0.146 0 N-CA-C 109.866 -1.294 . . . . 1.0 109.866 -179.84 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -61.03 -38.05 94.89 Favored Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 109.417 -1.473 . . . . 1.0 109.417 178.864 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 977' ' ' LEU . . . . . 0.58 HD13 ' O ' ' A' ' 977' ' ' LEU . 0.2 OUTLIER -66.24 -43.97 85.04 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 120.24 -0.584 . . . . 1.0 109.556 179.51 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 39.1 mt -61.56 -44.77 96.42 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.352 -0.539 . . . . 1.0 110.208 -179.724 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 97.1 mt -62.63 -43.47 98.73 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.419 -0.512 . . . . 1.0 110.368 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 980' ' ' LEU . . . . . 0.467 ' O ' HG23 ' A' ' 984' ' ' VAL . 56.0 mt -63.48 -39.88 95.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.111 0.482 . . . . 1.0 109.847 -179.86 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 5.6 m -64.26 -47.1 80.89 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.592 -0.731 . . . . 1.0 110.248 -179.633 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 97.4 mt -64.23 -45.25 96.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.473 -0.331 . . . . 1.0 111.66 -178.608 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -64.89 -40.75 95.6 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.869 -0.332 . . . . 1.0 110.775 179.575 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 984' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 980' ' ' LEU . 55.5 t -67.2 -48.08 79.57 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.402 0 CA-C-O 121.441 0.638 . . . . 1.0 110.024 179.904 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 985' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 985' ' ' LEU . 84.4 mt -63.55 -42.29 98.38 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.172 -0.922 . . . . 1.0 109.584 179.175 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 986' ' ' ALA . . . . . 0.886 ' O ' HG13 ' A' ' 990' ' ' VAL . . . -62.99 -42.49 99.86 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-O 121.66 0.743 . . . . 1.0 109.34 -179.716 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 28.9 mtp -63.87 -30.06 71.19 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 114.643 -1.162 . . . . 1.0 109.426 179.677 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 988' ' ' TRP . . . . . . . . . . . . . 1.7 t90 -76.11 -35.86 59.13 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.073 -1.421 . . . . 1.0 108.042 178.734 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.02 -38.98 76.05 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.494 0.664 . . . . 1.0 109.885 -179.693 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 990' ' ' VAL . . . . . 0.886 HG13 ' O ' ' A' ' 986' ' ' ALA . 1.4 m -81.95 -7.38 10.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.194 -0.912 . . . . 1.0 110.145 -179.175 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 991' ' ' GLY . . . . . 0.541 ' C ' ' H ' ' A' ' 993' ' ' PHE . . . 84.17 2.49 89.3 Favored Glycine 0 C--N 1.337 0.592 0 CA-C-O 119.074 -0.848 . . . . 1.0 112.672 178.613 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -53.52 -2.67 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 119.68 1.74 . . . . 1.0 112.159 -177.741 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 993' ' ' PHE . . . . . 0.541 ' H ' ' C ' ' A' ' 991' ' ' GLY . 28.3 m-85 -112.25 6.23 18.81 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 123.194 1.473 . . . . 1.0 110.632 179.781 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 994' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -127.11 133.31 50.42 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 111.703 -2.499 . . . . 1.0 112.74 -178.893 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 94.2 mtt-85 -67.19 -37.04 83.01 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.866 -1.061 . . . . 1.0 110.359 178.65 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 996' ' ' ASN . . . . . . . . . . . . . 31.2 m120 55.97 34.87 24.49 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.98 -0.555 . . . . 1.0 110.509 -179.464 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 997' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.62 160.05 0.41 Allowed Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.287 -179.895 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 998' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo . . . . . 0 C--N 1.31 -1.493 0 C-N-CA 122.461 2.107 . . . . 1.0 112.052 -179.656 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 967' ' ' TRP . . . . . 0.895 ' O ' HG23 ' A' ' 971' ' ' VAL . 98.4 m95 . . . . . 0 N--CA 1.448 -0.547 0 N-CA-C 110.658 -0.127 . . . . 0.64 110.658 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 64.4 m95 -65.33 -32.73 74.53 Favored 'General case' 0 CA--C 1.518 -0.272 0 C-N-CA 120.277 -0.569 . . . . 0.94 110.144 178.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 969' ' ' VAL . . . . . 0.726 ' O ' HG23 ' A' ' 973' ' ' VAL . 95.5 t -67.79 -47.24 80.39 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.391 0 N-CA-C 108.248 -1.019 . . . . 0.59 108.248 178.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 2.0 tp -61.84 -42.35 98.93 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 114.088 -1.415 . . . . 1.76 107.414 178.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 971' ' ' VAL . . . . . 0.895 HG23 ' O ' ' A' ' 967' ' ' TRP . 99.4 t -62.03 -46.06 97.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.872 0.368 . . . . 0.65 110.299 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -59.15 -42.32 97.07 Favored Glycine 0 C--N 1.338 0.644 0 N-CA-C 111.736 -0.546 . . . . 0.13 111.736 -179.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 973' ' ' VAL . . . . . 0.726 HG23 ' O ' ' A' ' 969' ' ' VAL . 63.6 t -67.31 -48.48 77.84 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.512 0 CA-C-N 114.94 -0.63 . . . . 0.86 109.48 -178.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 89.5 mt -61.99 -42.0 98.66 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 115.37 -0.832 . . . . 1.18 109.15 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -67.88 -47.5 60.19 Favored Glycine 0 C--N 1.335 0.478 0 N-CA-C 110.342 -1.103 . . . . 0.13 110.342 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -60.59 -37.98 94.26 Favored Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 108.805 -1.718 . . . . 0.14 108.805 178.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 977' ' ' LEU . . . . . 0.466 ' O ' ' OG1' ' A' ' 981' ' ' THR . 46.0 tp -66.11 -44.4 84.39 Favored 'General case' 0 C--O 1.225 -0.197 0 N-CA-C 109.364 -0.606 . . . . 1.56 109.364 178.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 1.1 mt -61.52 -46.27 90.66 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.689 -0.486 . . . . 1.73 109.689 178.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 57.2 mt -61.67 -43.62 98.51 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.186 -0.606 . . . . 0.89 109.884 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 980' ' ' LEU . . . . . 0.682 ' O ' HG23 ' A' ' 984' ' ' VAL . 22.7 mt -63.69 -41.45 98.13 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 119.981 -0.688 . . . . 1.23 109.971 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 981' ' ' THR . . . . . 0.466 ' OG1' ' O ' ' A' ' 977' ' ' LEU . 7.2 m -63.15 -47.4 82.85 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.254 -0.885 . . . . 0.19 110.928 -179.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 93.6 mt -64.38 -44.54 97.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.655 0.264 . . . . 0.71 110.598 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 13.1 mt -63.31 -36.81 84.91 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.978 -0.749 . . . . 1.66 108.978 179.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 984' ' ' VAL . . . . . 0.682 HG23 ' O ' ' A' ' 980' ' ' LEU . 23.0 t -69.14 -50.37 53.61 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 CA-C-N 115.321 -0.854 . . . . 0.28 110.92 -178.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 94.9 mt -65.45 -40.22 92.98 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.39 -0.823 . . . . 0.33 109.329 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 986' ' ' ALA . . . . . 0.678 ' O ' HG13 ' A' ' 990' ' ' VAL . . . -64.54 -45.4 87.31 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 121.509 0.671 . . . . 0.11 110.273 -179.002 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 987' ' ' MET . . . . . 0.45 ' O ' ' N ' ' A' ' 992' ' ' PHE . 25.6 mtp -63.25 -28.63 70.16 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 122.174 0.988 . . . . 0.53 109.582 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 988' ' ' TRP . . . . . . . . . . . . . 7.8 t90 -77.64 -35.41 52.57 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.016 -1.447 . . . . 2.42 108.014 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.5 -41.08 76.55 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.514 0.673 . . . . 0.74 109.874 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 990' ' ' VAL . . . . . 0.678 HG13 ' O ' ' A' ' 986' ' ' ALA . 2.4 m -79.42 -8.91 11.91 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 CA-C-N 115.124 -0.944 . . . . 0.15 109.72 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 991' ' ' GLY . . . . . . . . . . . . . . . 85.87 3.66 85.47 Favored Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 114.772 -1.104 . . . . 0.16 112.19 179.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 992' ' ' PHE . . . . . 0.45 ' N ' ' O ' ' A' ' 987' ' ' MET . 0.3 OUTLIER -55.07 -37.92 67.38 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 120.133 1.966 . . . . 0.51 113.762 -176.232 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 993' ' ' PHE . . . . . 0.407 ' CE2' ' HE2' ' A' ' 987' ' ' MET . 4.0 m-85 . . . . . 0 N--CA 1.479 0.987 0 CA-C-O 124.684 2.183 . . . . 1.53 109.293 178.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 967' ' ' TRP . . . . . 0.759 ' O ' HG23 ' A' ' 971' ' ' VAL . 98.7 m95 . . . . . 0 N--CA 1.463 0.213 0 N-CA-C 112.03 0.381 . . . . 1.0 112.03 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 31.3 m95 -69.3 -35.54 76.09 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 110.279 -0.267 . . . . 1.0 110.279 179.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 969' ' ' VAL . . . . . 0.451 ' O ' HG23 ' A' ' 973' ' ' VAL . 67.5 t -66.31 -45.01 90.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 109.097 -0.705 . . . . 1.0 109.097 178.127 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 92.4 mt -63.79 -41.81 97.85 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.997 -1.002 . . . . 1.0 109.961 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 971' ' ' VAL . . . . . 0.759 HG23 ' O ' ' A' ' 967' ' ' TRP . 76.0 t -62.71 -45.27 99.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.965 0.412 . . . . 1.0 110.855 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.14 -41.78 98.27 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.665 -0.574 . . . . 1.0 111.665 -179.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 973' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 969' ' ' VAL . 72.2 t -65.57 -46.78 88.63 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.541 0 CA-C-O 120.998 0.428 . . . . 1.0 110.574 -179.045 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 88.9 mt -62.24 -41.18 98.2 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.921 -0.77 . . . . 1.0 108.921 179.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -65.92 -46.18 83.41 Favored Glycine 0 C--N 1.329 0.163 0 N-CA-C 110.284 -1.126 . . . . 1.0 110.284 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -61.25 -37.93 94.82 Favored Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 109.141 -1.584 . . . . 1.0 109.141 179.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 55.4 tp -65.49 -42.53 92.07 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.196 -0.668 . . . . 1.0 109.196 178.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 42.9 tp -63.66 -45.47 90.0 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.304 -0.558 . . . . 1.0 110.694 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 90.9 mt -61.89 -42.8 99.5 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.017 -0.673 . . . . 1.0 109.908 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 980' ' ' LEU . . . . . 0.649 ' O ' HG23 ' A' ' 984' ' ' VAL . 84.6 mt -63.99 -41.41 97.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.988 0.423 . . . . 1.0 110.437 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 7.7 m -62.65 -46.41 88.34 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.738 -0.664 . . . . 1.0 110.29 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 94.5 mt -63.65 -43.75 98.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 C-N-CA 120.781 -0.368 . . . . 1.0 110.838 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 33.0 mt -64.72 -41.04 96.26 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.867 -0.333 . . . . 1.0 111.236 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 984' ' ' VAL . . . . . 0.649 HG23 ' O ' ' A' ' 980' ' ' LEU . 88.3 t -67.83 -49.07 72.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.25 0.548 . . . . 1.0 110.033 -179.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 81.6 mt -63.22 -43.32 98.45 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.433 -0.803 . . . . 1.0 109.698 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 986' ' ' ALA . . . . . 0.927 ' O ' HG13 ' A' ' 990' ' ' VAL . . . -61.72 -43.48 98.78 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 108.918 -0.771 . . . . 1.0 108.918 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 27.3 mtp -62.29 -30.79 71.38 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 114.804 -1.089 . . . . 1.0 109.648 179.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 988' ' ' TRP . . . . . . . . . . . . . 1.8 t90 -75.3 -37.79 60.65 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.035 -1.438 . . . . 1.0 108.271 179.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.22 -39.11 78.76 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.766 0.793 . . . . 1.0 110.048 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 990' ' ' VAL . . . . . 0.927 HG13 ' O ' ' A' ' 986' ' ' ALA . 1.4 m -83.39 -8.78 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-N 115.052 -0.976 . . . . 1.0 110.756 -178.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 991' ' ' GLY . . . . . 0.537 ' C ' ' H ' ' A' ' 993' ' ' PHE . . . 83.53 2.55 90.05 Favored Glycine 0 C--N 1.337 0.591 0 CA-C-O 119.222 -0.766 . . . . 1.0 112.594 178.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -52.64 -1.64 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 119.644 1.722 . . . . 1.0 112.386 -177.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 993' ' ' PHE . . . . . 0.537 ' H ' ' C ' ' A' ' 991' ' ' GLY . 12.2 m-85 . . . . . 0 C--N 1.332 -0.186 0 C-N-CA 120.426 -0.51 . . . . 1.0 110.975 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 967' ' ' TRP . . . . . 0.676 ' O ' HG23 ' A' ' 971' ' ' VAL . 91.5 m95 . . . . . 0 CA--C 1.522 -0.126 0 CA-C-O 120.859 0.361 . . . . 1.0 110.704 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 87.0 m95 -68.37 -37.03 80.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.74 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 969' ' ' VAL . . . . . 0.407 ' O ' HG23 ' A' ' 973' ' ' VAL . 96.2 t -66.78 -42.78 89.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 109.046 -0.724 . . . . 1.0 109.046 178.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 87.4 mt -62.9 -41.77 99.56 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.209 -0.905 . . . . 1.0 109.796 178.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 971' ' ' VAL . . . . . 0.676 HG23 ' O ' ' A' ' 967' ' ' TRP . 76.2 t -62.5 -45.57 98.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.819 0.342 . . . . 1.0 110.829 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -61.24 -40.96 99.31 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 111.837 -0.505 . . . . 1.0 111.837 -179.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 973' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 969' ' ' VAL . 62.6 t -65.87 -46.22 89.18 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.376 0 CA-C-N 115.092 -0.554 . . . . 1.0 110.037 -179.194 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 86.7 mt -63.26 -41.4 99.03 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 121.327 0.584 . . . . 1.0 109.432 178.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -66.44 -46.8 74.79 Favored Glycine 0 C--N 1.332 0.341 0 N-CA-C 110.489 -1.044 . . . . 1.0 110.489 -179.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -60.18 -36.74 91.5 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 108.886 -1.686 . . . . 1.0 108.886 178.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 977' ' ' LEU . . . . . 0.433 ' O ' ' OG1' ' A' ' 981' ' ' THR . 50.5 tp -66.41 -43.4 85.84 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.263 -0.575 . . . . 1.0 109.912 178.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 978' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' A' ' 978' ' ' LEU . 53.0 mt -61.94 -44.13 97.41 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 119.739 -0.784 . . . . 1.0 109.726 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 84.5 mt -62.5 -43.41 98.89 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 119.744 -0.782 . . . . 1.0 110.297 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 980' ' ' LEU . . . . . 0.527 ' O ' HG23 ' A' ' 984' ' ' VAL . 66.6 mt -64.56 -42.19 95.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.075 0.464 . . . . 1.0 110.606 -179.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 981' ' ' THR . . . . . 0.433 ' OG1' ' O ' ' A' ' 977' ' ' LEU . 5.9 m -64.18 -47.1 81.12 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.558 -0.747 . . . . 1.0 110.109 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 94.3 mt -64.07 -44.49 97.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 120.74 -0.384 . . . . 1.0 111.433 -179.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 6.4 mp -64.55 -40.27 95.27 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.638 -0.425 . . . . 1.0 111.087 179.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 984' ' ' VAL . . . . . 0.527 HG23 ' O ' ' A' ' 980' ' ' LEU . 54.1 t -68.5 -48.98 69.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.21 0.529 . . . . 1.0 109.843 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 85.3 mt -63.33 -43.27 98.24 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.574 -0.739 . . . . 1.0 109.451 178.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 986' ' ' ALA . . . . . 0.906 ' O ' HG13 ' A' ' 990' ' ' VAL . . . -62.08 -42.7 99.48 Favored 'General case' 0 CA--C 1.511 -0.544 0 N-CA-C 108.997 -0.742 . . . . 1.0 108.997 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 987' ' ' MET . . . . . 0.414 ' HA ' HG22 ' A' ' 990' ' ' VAL . 30.9 mtp -62.1 -31.69 72.17 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 114.729 -1.123 . . . . 1.0 109.238 178.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 988' ' ' TRP . . . . . . . . . . . . . 1.8 t90 -73.23 -38.57 66.0 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 113.884 -1.507 . . . . 1.0 108.166 179.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.26 -39.6 78.34 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.434 -0.803 . . . . 1.0 110.39 -179.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 990' ' ' VAL . . . . . 0.906 HG13 ' O ' ' A' ' 986' ' ' ALA . 1.4 m -83.58 -8.66 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 CA-C-N 115.003 -0.998 . . . . 1.0 110.204 -178.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 991' ' ' GLY . . . . . 0.51 ' C ' ' H ' ' A' ' 993' ' ' PHE . . . 81.43 5.07 90.25 Favored Glycine 0 C--N 1.339 0.713 0 CA-C-O 119.199 -0.779 . . . . 1.0 112.508 179.148 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -52.5 -1.24 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 119.74 1.77 . . . . 1.0 112.932 -177.031 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 993' ' ' PHE . . . . . 0.51 ' H ' ' C ' ' A' ' 991' ' ' GLY . 16.1 m-85 . . . . . 0 N--CA 1.465 0.315 0 C-N-CA 120.646 -0.422 . . . . 1.0 111.18 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 967' ' ' TRP . . . . . 0.825 ' O ' HG23 ' A' ' 971' ' ' VAL . 98.9 m95 . . . . . 0 CA--C 1.514 -0.41 0 CA-C-O 120.572 0.225 . . . . 1.0 111.447 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 90.9 m95 -70.53 -36.42 73.71 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.474 -0.33 . . . . 1.0 110.367 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 95.2 t -66.81 -45.12 88.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 N-CA-C 108.389 -0.967 . . . . 1.0 108.389 178.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 58.9 tp -63.2 -42.51 99.32 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 114.564 -1.198 . . . . 1.0 109.199 178.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 971' ' ' VAL . . . . . 0.825 HG23 ' O ' ' A' ' 967' ' ' TRP . 79.3 t -62.29 -45.08 99.6 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.087 0 N-CA-C 109.727 -0.472 . . . . 1.0 109.727 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.23 -43.25 98.66 Favored Glycine 0 CA--C 1.526 0.736 0 CA-C-N 116.151 -0.477 . . . . 1.0 112.127 -179.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 58.2 t -65.24 -46.72 89.9 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.416 0 CA-C-N 115.169 -0.515 . . . . 1.0 110.066 -179.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 974' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 974' ' ' LEU . 88.8 mt -62.11 -41.98 98.76 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 109.038 -0.727 . . . . 1.0 109.038 178.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -65.98 -47.4 74.45 Favored Glycine 0 C--O 1.225 -0.418 0 N-CA-C 110.248 -1.141 . . . . 1.0 110.248 -179.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -59.13 -37.46 91.73 Favored Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 109.144 -1.582 . . . . 1.0 109.144 178.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 977' ' ' LEU . . . . . 0.431 HD23 ' HA ' ' A' ' 977' ' ' LEU . 35.7 mt -65.49 -42.97 91.56 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 119.982 -0.687 . . . . 1.0 110.257 178.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 35.7 mt -61.98 -44.05 97.55 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.021 -0.671 . . . . 1.0 110.304 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 10.7 mp -63.82 -43.57 95.82 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 119.555 -0.858 . . . . 1.0 111.501 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 980' ' ' LEU . . . . . 0.433 ' O ' HG23 ' A' ' 984' ' ' VAL . 2.6 mm? -63.66 -39.58 94.68 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.731 -0.388 . . . . 1.0 110.966 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 6.7 m -64.64 -47.74 77.38 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.137 -0.483 . . . . 1.0 110.853 -179.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 92.9 mt -63.27 -44.48 99.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.385 -0.371 . . . . 1.0 111.265 -178.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -64.83 -40.83 95.82 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.333 -0.394 . . . . 1.0 111.564 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 984' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 980' ' ' LEU . 41.2 t -67.48 -48.48 77.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.425 0.631 . . . . 1.0 110.277 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 85.9 mt -64.45 -42.78 95.78 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.136 -0.938 . . . . 1.0 109.894 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 986' ' ' ALA . . . . . 0.941 ' O ' HG13 ' A' ' 990' ' ' VAL . . . -62.92 -45.74 91.06 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.351 0.596 . . . . 1.0 109.825 -179.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 26.8 mtp -62.0 -32.56 73.05 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.966 -1.016 . . . . 1.0 109.522 179.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 988' ' ' TRP . . . . . 0.471 ' O ' ' CD1' ' A' ' 988' ' ' TRP . 11.4 t90 -74.47 -37.52 63.19 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.315 -1.311 . . . . 1.0 108.838 178.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.98 -40.58 78.72 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.797 0.808 . . . . 1.0 110.071 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 990' ' ' VAL . . . . . 0.941 HG13 ' O ' ' A' ' 986' ' ' ALA . 1.4 m -81.43 -8.08 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-N 114.639 -1.164 . . . . 1.0 110.1 -179.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 991' ' ' GLY . . . . . 0.551 ' C ' ' H ' ' A' ' 993' ' ' PHE . . . 83.28 2.83 90.33 Favored Glycine 0 C--N 1.338 0.654 0 CA-C-O 119.116 -0.825 . . . . 1.0 112.479 178.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -52.98 -1.95 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 119.722 1.761 . . . . 1.0 112.132 -177.306 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 993' ' ' PHE . . . . . 0.551 ' H ' ' C ' ' A' ' 991' ' ' GLY . 11.0 m-85 . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 116.398 -0.364 . . . . 1.0 110.961 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 967' ' ' TRP . . . . . 0.568 ' O ' HG23 ' A' ' 971' ' ' VAL . 97.6 m95 . . . . . 0 N--CA 1.455 -0.195 0 CA-C-O 120.857 0.36 . . . . 1.0 110.716 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -69.05 -35.49 76.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.166 -0.47 . . . . 1.0 109.98 178.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 969' ' ' VAL . . . . . 0.566 ' O ' HG23 ' A' ' 973' ' ' VAL . 77.6 t -67.33 -44.6 87.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.539 0.685 . . . . 1.0 109.284 178.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 57.3 tp -63.61 -43.16 97.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.702 -1.135 . . . . 1.0 109.468 179.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 971' ' ' VAL . . . . . 0.568 HG23 ' O ' ' A' ' 967' ' ' TRP . 46.7 t -62.08 -45.01 99.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.998 0.428 . . . . 1.0 110.469 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.08 -39.42 95.74 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 111.348 -0.701 . . . . 1.0 111.348 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 973' ' ' VAL . . . . . 0.566 HG23 ' O ' ' A' ' 969' ' ' VAL . 74.5 t -66.61 -47.51 83.14 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.29 0 CA-C-N 114.999 -0.6 . . . . 1.0 110.585 -179.243 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 92.9 mt -62.91 -41.69 99.54 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.191 -0.67 . . . . 1.0 109.191 179.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -66.28 -46.71 76.88 Favored Glycine 0 C--N 1.329 0.175 0 N-CA-C 110.74 -0.944 . . . . 1.0 110.74 -179.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -60.29 -37.03 92.41 Favored Glycine 0 N--CA 1.448 -0.505 0 N-CA-C 109.181 -1.568 . . . . 1.0 109.181 179.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 38.2 mt -65.97 -42.54 89.74 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.119 -0.632 . . . . 1.0 110.158 179.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 76.7 mt -62.38 -44.46 96.41 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.149 -0.62 . . . . 1.0 110.496 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 96.7 mt -63.1 -43.61 98.0 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.248 -0.581 . . . . 1.0 110.676 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 980' ' ' LEU . . . . . . . . . . . . . 81.3 mt -64.35 -40.38 95.75 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.079 0.466 . . . . 1.0 110.417 -179.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 981' ' ' THR . . . . . 0.43 HG22 ' CD1' ' A' ' 985' ' ' LEU . 7.1 m -63.54 -45.79 88.94 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.525 -0.761 . . . . 1.0 109.748 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 89.7 mt -63.57 -44.18 98.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.318 -0.401 . . . . 1.0 111.366 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 85.1 mt -64.48 -42.63 95.77 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 121.125 -0.23 . . . . 1.0 111.347 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 984' ' ' VAL . . . . . . . . . . . . . 47.3 t -67.9 -47.96 77.12 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.374 0 CA-C-O 121.223 0.535 . . . . 1.0 109.968 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 985' ' ' LEU . . . . . 0.43 ' CD1' HG22 ' A' ' 981' ' ' THR . 89.3 mt -63.49 -42.75 98.53 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.458 -0.792 . . . . 1.0 109.348 179.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 986' ' ' ALA . . . . . 0.881 ' O ' HG13 ' A' ' 990' ' ' VAL . . . -63.18 -45.64 90.84 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 121.513 0.673 . . . . 1.0 109.621 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 32.6 mtp -62.34 -33.44 74.71 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.614 -1.175 . . . . 1.0 109.188 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 988' ' ' TRP . . . . . 0.489 ' O ' ' CD1' ' A' ' 988' ' ' TRP . 12.9 t90 -73.2 -35.2 66.32 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.473 -1.239 . . . . 1.0 108.379 178.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.04 -40.14 75.32 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.589 -0.732 . . . . 1.0 109.795 -179.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 990' ' ' VAL . . . . . 0.881 HG13 ' O ' ' A' ' 986' ' ' ALA . 1.2 m -81.91 -7.12 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 CA-C-N 114.989 -1.005 . . . . 1.0 110.063 -179.237 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 991' ' ' GLY . . . . . 0.517 ' C ' ' H ' ' A' ' 993' ' ' PHE . . . 82.15 3.77 90.45 Favored Glycine 0 C--N 1.34 0.784 0 CA-C-O 119.011 -0.883 . . . . 1.0 112.666 178.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -54.13 -0.93 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 119.607 1.704 . . . . 1.0 112.839 -177.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 993' ' ' PHE . . . . . 0.517 ' H ' ' C ' ' A' ' 991' ' ' GLY . 13.1 m-85 . . . . . 0 N--CA 1.465 0.28 0 CA-C-O 121.051 0.453 . . . . 1.0 110.135 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 967' ' ' TRP . . . . . 0.441 ' O ' HG23 ' A' ' 971' ' ' VAL . 99.5 m95 . . . . . 0 N--CA 1.457 -0.101 0 CA-C-O 120.867 0.365 . . . . 1.0 110.98 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 94.0 m95 -69.56 -34.47 74.23 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.361 -0.382 . . . . 1.0 110.247 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 969' ' ' VAL . . . . . 0.411 ' O ' HG23 ' A' ' 973' ' ' VAL . 73.9 t -65.83 -43.22 93.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 C-N-CA 119.889 -0.724 . . . . 1.0 109.175 177.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 93.2 mt -62.74 -42.35 99.63 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.145 -0.934 . . . . 1.0 109.923 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 971' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 967' ' ' TRP . 47.5 t -61.87 -46.23 96.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.864 0.364 . . . . 1.0 110.175 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -59.79 -43.55 97.81 Favored Glycine 0 CA--C 1.521 0.418 0 CA-C-N 116.095 -0.502 . . . . 1.0 112.016 -179.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 973' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 969' ' ' VAL . 71.6 t -65.17 -46.45 90.94 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.555 0 CA-C-O 120.996 0.426 . . . . 1.0 110.703 -178.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 91.5 mt -63.12 -40.38 97.43 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 109.17 -0.678 . . . . 1.0 109.17 179.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -67.76 -45.35 76.01 Favored Glycine 0 CA--C 1.518 0.236 0 N-CA-C 110.415 -1.074 . . . . 1.0 110.415 -179.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -61.24 -37.54 94.17 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 109.622 -1.391 . . . . 1.0 109.622 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 57.9 tp -67.52 -41.68 84.01 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 119.698 -0.801 . . . . 1.0 109.874 179.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 65.9 mt -62.04 -43.77 98.13 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 119.86 -0.736 . . . . 1.0 110.298 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 82.3 mt -62.59 -44.03 97.32 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.323 -0.551 . . . . 1.0 110.825 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 980' ' ' LEU . . . . . 0.724 ' O ' HG23 ' A' ' 984' ' ' VAL . 88.6 mt -63.96 -40.26 96.0 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.067 0.461 . . . . 1.0 110.168 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 6.8 m -64.09 -46.65 83.31 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.612 -0.722 . . . . 1.0 110.293 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 93.9 mt -64.07 -44.57 97.73 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 C-N-CA 120.827 -0.349 . . . . 1.0 111.118 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 59.7 tp -63.96 -40.88 97.43 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.624 -0.43 . . . . 1.0 110.21 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 984' ' ' VAL . . . . . 0.724 HG23 ' O ' ' A' ' 980' ' ' LEU . 77.8 t -65.7 -47.69 85.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.311 0.577 . . . . 1.0 110.252 -179.312 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 64.7 mt -63.71 -41.38 98.11 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.37 -0.832 . . . . 1.0 109.533 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 986' ' ' ALA . . . . . 0.87 ' O ' HG13 ' A' ' 990' ' ' VAL . . . -62.96 -47.13 84.5 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.107 0.48 . . . . 1.0 110.511 -179.136 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 13.3 mtm -64.09 -32.35 73.87 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 122.112 0.958 . . . . 1.0 109.622 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 988' ' ' TRP . . . . . 0.483 ' O ' ' CD1' ' A' ' 988' ' ' TRP . 9.4 t90 -69.27 -36.46 77.11 Favored 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 107.499 -1.297 . . . . 1.0 107.499 178.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.81 -39.56 76.47 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.117 -0.947 . . . . 1.0 110.321 -179.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 990' ' ' VAL . . . . . 0.87 HG13 ' O ' ' A' ' 986' ' ' ALA . 1.0 OUTLIER -84.88 -9.89 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 CA-C-N 115.198 -0.91 . . . . 1.0 110.651 -178.892 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 991' ' ' GLY . . . . . 0.484 ' C ' ' H ' ' A' ' 993' ' ' PHE . . . 82.47 6.53 88.55 Favored Glycine 0 C--N 1.336 0.56 0 CA-C-O 118.744 -1.031 . . . . 1.0 112.876 179.171 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -57.45 0.26 0.05 Allowed 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 120.056 1.928 . . . . 1.0 112.997 -177.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 993' ' ' PHE . . . . . 0.484 ' H ' ' C ' ' A' ' 991' ' ' GLY . 10.3 m-85 . . . . . 0 C--N 1.326 -0.445 0 CA-C-O 121.379 0.609 . . . . 1.0 109.688 179.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 967' ' ' TRP . . . . . 0.515 ' O ' HG23 ' A' ' 971' ' ' VAL . 81.7 m95 . . . . . 0 N--CA 1.454 -0.241 0 CA-C-O 120.763 0.316 . . . . 1.0 110.621 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 95.3 m95 -68.73 -36.72 78.77 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.3 178.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 56.1 t -66.02 -43.88 92.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.149 -0.685 . . . . 1.0 109.149 178.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 62.9 tp -62.72 -41.94 99.41 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.179 -0.919 . . . . 1.0 109.484 179.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 971' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 967' ' ' TRP . 41.6 t -63.47 -45.79 96.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.165 -0.47 . . . . 1.0 111.321 -179.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -62.51 -44.17 97.96 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-N 116.253 -0.43 . . . . 1.0 113.532 -178.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 35.0 m -68.29 -42.96 84.8 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 CA-C-O 120.787 0.327 . . . . 1.0 110.861 -178.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 97.9 mt -63.09 -40.17 96.86 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.444 -0.947 . . . . 1.0 108.444 178.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -66.13 -46.75 78.05 Favored Glycine 0 C--N 1.33 0.222 0 N-CA-C 110.447 -1.061 . . . . 1.0 110.447 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -59.33 -36.16 87.83 Favored Glycine 0 N--CA 1.448 -0.514 0 N-CA-C 108.804 -1.718 . . . . 1.0 108.804 178.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 977' ' ' LEU . . . . . 0.427 ' O ' ' OG1' ' A' ' 981' ' ' THR . 58.9 tp -65.54 -43.64 89.32 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.17 -0.612 . . . . 1.0 109.719 178.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 45.7 tp -61.84 -45.45 93.77 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.653 -0.419 . . . . 1.0 110.436 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 10.8 mp -63.18 -43.16 99.0 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 119.935 -0.706 . . . . 1.0 110.719 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 980' ' ' LEU . . . . . 0.53 ' O ' HG23 ' A' ' 984' ' ' VAL . 80.7 mt -63.94 -40.85 97.4 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 121.186 0.517 . . . . 1.0 110.149 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 981' ' ' THR . . . . . 0.444 HG22 HD12 ' A' ' 985' ' ' LEU . 8.2 m -62.75 -46.79 86.42 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.37 -0.832 . . . . 1.0 110.015 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 88.9 mt -63.84 -43.83 97.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 C-N-CA 120.633 -0.427 . . . . 1.0 111.203 -179.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 91.1 mt -65.2 -41.07 94.88 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.519 -0.309 . . . . 1.0 111.03 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 984' ' ' VAL . . . . . 0.53 HG23 ' O ' ' A' ' 980' ' ' LEU . 72.0 t -70.02 -50.16 50.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.064 0.459 . . . . 1.0 110.449 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 985' ' ' LEU . . . . . 0.444 HD12 HG22 ' A' ' 981' ' ' THR . 89.8 mt -63.79 -42.92 97.63 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.783 -0.644 . . . . 1.0 109.622 179.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 986' ' ' ALA . . . . . 0.863 ' O ' HG13 ' A' ' 990' ' ' VAL . . . -62.53 -43.28 99.2 Favored 'General case' 0 CA--C 1.511 -0.531 0 N-CA-C 108.926 -0.768 . . . . 1.0 108.926 -179.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 31.5 mtp -61.95 -30.53 70.97 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 122.512 1.148 . . . . 1.0 109.073 178.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 988' ' ' TRP . . . . . . . . . . . . . 1.6 t90 -74.02 -36.98 64.48 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 113.64 -1.618 . . . . 1.0 107.874 179.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.71 -39.05 73.64 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.595 0.712 . . . . 1.0 110.248 -179.359 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 990' ' ' VAL . . . . . 0.863 HG13 ' O ' ' A' ' 986' ' ' ALA . 1.1 m -81.76 -7.28 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-N 114.967 -1.015 . . . . 1.0 110.09 -179.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 991' ' ' GLY . . . . . 0.51 ' C ' ' H ' ' A' ' 993' ' ' PHE . . . 81.85 3.73 90.51 Favored Glycine 0 C--N 1.34 0.79 0 CA-C-O 119.136 -0.813 . . . . 1.0 112.414 178.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -52.63 -1.56 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 119.45 1.625 . . . . 1.0 112.932 -177.016 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 993' ' ' PHE . . . . . 0.51 ' H ' ' C ' ' A' ' 991' ' ' GLY . 15.4 m-85 . . . . . 0 C--N 1.327 -0.389 0 CA-C-O 121.287 0.565 . . . . 1.0 110.433 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 967' ' ' TRP . . . . . 0.684 ' O ' HG23 ' A' ' 971' ' ' VAL . 98.7 m95 . . . . . 0 CA--C 1.52 -0.174 0 CA-C-O 120.677 0.275 . . . . 1.0 110.877 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -69.25 -34.88 75.47 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 110.029 -0.36 . . . . 1.0 110.029 179.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 969' ' ' VAL . . . . . 0.458 ' O ' HG23 ' A' ' 973' ' ' VAL . 75.3 t -68.52 -47.02 79.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.203 0.525 . . . . 1.0 110.489 178.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 8.8 mp -64.01 -41.68 97.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.509 -0.768 . . . . 1.0 110.18 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 971' ' ' VAL . . . . . 0.684 HG23 ' O ' ' A' ' 967' ' ' TRP . 59.1 t -62.3 -44.53 99.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.879 0.371 . . . . 1.0 110.541 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -61.43 -40.49 98.74 Favored Glycine 0 CA--C 1.529 0.915 0 CA-C-N 116.064 -0.516 . . . . 1.0 112.006 -179.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 973' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 969' ' ' VAL . 75.9 t -67.0 -45.26 87.46 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.519 0 CA-C-N 115.445 -0.378 . . . . 1.0 110.735 -178.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 9.2 mp -62.5 -40.23 96.06 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.597 -0.89 . . . . 1.0 108.597 178.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -65.07 -45.8 90.78 Favored Glycine 0 N--CA 1.46 0.247 0 N-CA-C 110.29 -1.124 . . . . 1.0 110.29 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -59.69 -36.73 90.74 Favored Glycine 0 N--CA 1.444 -0.767 0 N-CA-C 108.771 -1.731 . . . . 1.0 108.771 178.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 55.7 tp -66.86 -44.11 81.83 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.187 -0.605 . . . . 1.0 110.514 179.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 83.2 mt -62.54 -44.94 95.09 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.091 -0.643 . . . . 1.0 110.757 -179.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 10.2 mp -63.51 -44.11 95.22 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 119.675 -0.81 . . . . 1.0 111.924 -179.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 980' ' ' LEU . . . . . . . . . . . . . 7.1 mp -63.83 -37.65 88.15 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.156 -0.618 . . . . 1.0 110.79 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 5.4 m -65.5 -46.61 79.04 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.521 -179.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 80.1 mt -63.11 -43.41 98.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 120.495 -0.482 . . . . 1.0 110.732 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 57.1 mt -63.66 -41.78 98.17 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 121.153 -0.219 . . . . 1.0 110.722 179.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 984' ' ' VAL . . . . . . . . . . . . . 56.6 t -68.38 -47.99 75.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 120.928 0.394 . . . . 1.0 110.052 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 84.3 mt -62.63 -42.41 99.58 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.937 -0.574 . . . . 1.0 109.524 179.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 986' ' ' ALA . . . . . 0.869 ' O ' HG13 ' A' ' 990' ' ' VAL . . . -63.26 -44.32 95.48 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 121.696 0.76 . . . . 1.0 108.981 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 30.7 mtp -62.11 -32.44 73.01 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 114.566 -1.197 . . . . 1.0 109.159 178.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 988' ' ' TRP . . . . . . . . . . . . . 2.0 t90 -72.32 -38.25 68.73 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.292 -1.322 . . . . 1.0 108.104 178.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.58 -39.62 84.85 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.335 -0.848 . . . . 1.0 110.306 -179.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 990' ' ' VAL . . . . . 0.869 HG13 ' O ' ' A' ' 986' ' ' ALA . 1.2 m -83.88 -8.94 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-N 115.286 -0.87 . . . . 1.0 110.956 -178.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 991' ' ' GLY . . . . . 0.556 ' C ' ' H ' ' A' ' 993' ' ' PHE . . . 82.58 4.24 90.19 Favored Glycine 0 C--N 1.338 0.671 0 CA-C-O 119.245 -0.753 . . . . 1.0 112.703 178.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -53.02 -2.91 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 119.259 1.529 . . . . 1.0 111.867 -177.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 993' ' ' PHE . . . . . 0.556 ' H ' ' C ' ' A' ' 991' ' ' GLY . 11.7 m-85 . . . . . 0 C--N 1.329 -0.292 0 CA-C-O 121.037 0.446 . . . . 1.0 109.916 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 967' ' ' TRP . . . . . 0.786 ' O ' HG23 ' A' ' 971' ' ' VAL . 98.3 m95 . . . . . 0 N--CA 1.463 0.181 0 CA-C-O 120.637 0.256 . . . . 1.0 111.498 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -70.24 -36.84 74.78 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.605 -0.27 . . . . 1.0 110.475 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 969' ' ' VAL . . . . . 0.445 ' O ' HG23 ' A' ' 973' ' ' VAL . 73.8 t -66.66 -44.35 89.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 108.937 -0.764 . . . . 1.0 108.937 178.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 60.9 tp -62.96 -43.2 99.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.817 -1.083 . . . . 1.0 109.499 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 971' ' ' VAL . . . . . 0.786 HG23 ' O ' ' A' ' 967' ' ' TRP . 56.2 t -61.93 -46.19 97.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.391 -0.368 . . . . 1.0 111.102 -179.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.15 -40.6 97.43 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 111.612 -0.595 . . . . 1.0 111.612 -179.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 973' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 969' ' ' VAL . 64.8 t -66.8 -48.37 80.05 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.483 0 CA-C-O 121.028 0.442 . . . . 1.0 111.068 -178.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 974' ' ' LEU . . . . . 0.406 HD13 ' HA ' ' A' ' 974' ' ' LEU . 3.9 mm? -62.74 -41.2 99.08 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 109.297 -0.631 . . . . 1.0 109.297 179.224 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -65.16 -43.52 95.37 Favored Glycine 0 C--O 1.229 -0.172 0 N-CA-C 109.456 -1.457 . . . . 1.0 109.456 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -62.01 -37.24 94.09 Favored Glycine 0 CA--C 1.521 0.462 0 N-CA-C 109.759 -1.336 . . . . 1.0 109.759 179.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 977' ' ' LEU . . . . . 0.41 ' O ' ' OG1' ' A' ' 981' ' ' THR . 60.7 tp -67.81 -44.53 77.06 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 109.856 -0.424 . . . . 1.0 109.856 179.18 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -62.16 -43.81 98.0 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.329 -0.548 . . . . 1.0 110.28 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 86.3 mt -62.88 -43.67 98.18 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.07 -0.652 . . . . 1.0 110.62 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 980' ' ' LEU . . . . . . . . . . . . . 64.4 mt -63.99 -40.62 96.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.123 0.487 . . . . 1.0 110.269 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 981' ' ' THR . . . . . 0.439 HG22 ' CD1' ' A' ' 985' ' ' LEU . 7.5 m -63.4 -45.78 89.46 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.439 -0.801 . . . . 1.0 109.725 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 85.6 mt -63.97 -44.71 97.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.266 -0.425 . . . . 1.0 111.118 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 56.9 tp -64.89 -43.55 92.54 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.171 -0.468 . . . . 1.0 111.397 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 984' ' ' VAL . . . . . . . . . . . . . 51.9 t -66.71 -47.97 81.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.438 0.637 . . . . 1.0 110.134 -179.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 985' ' ' LEU . . . . . 0.439 ' CD1' HG22 ' A' ' 981' ' ' THR . 81.6 mt -63.22 -42.9 99.32 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.07 -0.968 . . . . 1.0 109.605 178.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 986' ' ' ALA . . . . . 0.879 ' O ' HG13 ' A' ' 990' ' ' VAL . . . -61.98 -44.92 95.74 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-O 121.348 0.594 . . . . 1.0 109.487 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 987' ' ' MET . . . . . 0.431 ' HA ' HG22 ' A' ' 990' ' ' VAL . 19.6 mtp -62.17 -30.29 70.96 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 122.349 1.071 . . . . 1.0 109.563 179.199 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 988' ' ' TRP . . . . . . . . . . . . . 1.7 t90 -74.75 -38.09 62.33 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.018 -1.446 . . . . 1.0 108.396 178.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.88 -39.94 79.53 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.467 -0.788 . . . . 1.0 109.741 -179.068 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 990' ' ' VAL . . . . . 0.879 HG13 ' O ' ' A' ' 986' ' ' ALA . 1.4 m -82.14 -7.9 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 CA-C-N 114.829 -1.078 . . . . 1.0 110.408 -179.11 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 991' ' ' GLY . . . . . 0.549 ' C ' ' H ' ' A' ' 993' ' ' PHE . . . 82.4 3.41 90.55 Favored Glycine 0 C--N 1.336 0.567 0 CA-C-O 119.366 -0.685 . . . . 1.0 112.385 178.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -52.67 -1.37 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 119.624 1.712 . . . . 1.0 112.418 -177.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 993' ' ' PHE . . . . . 0.549 ' H ' ' C ' ' A' ' 991' ' ' GLY . 14.0 m-85 . . . . . 0 C--O 1.233 0.207 0 C-N-CA 120.713 -0.395 . . . . 1.0 111.497 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 967' ' ' TRP . . . . . 0.733 ' O ' HG23 ' A' ' 971' ' ' VAL . 97.7 m95 . . . . . 0 N--CA 1.454 -0.236 0 CA-C-O 120.614 0.245 . . . . 1.0 111.101 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 23.9 m95 -69.3 -34.66 75.03 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.569 -0.287 . . . . 1.0 110.557 178.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 93.8 t -66.97 -44.61 88.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 108.715 -0.846 . . . . 1.0 108.715 178.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 80.1 mt -63.16 -41.43 99.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.728 -1.124 . . . . 1.0 109.39 178.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 971' ' ' VAL . . . . . 0.733 HG23 ' O ' ' A' ' 967' ' ' TRP . 66.8 t -61.88 -45.0 99.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 CA-C-O 120.989 0.423 . . . . 1.0 109.978 179.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -59.83 -41.05 97.49 Favored Glycine 0 CA--C 1.523 0.594 0 N-CA-C 111.301 -0.72 . . . . 1.0 111.301 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 54.1 t -65.63 -45.16 93.0 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.374 0 CA-C-N 115.333 -0.434 . . . . 1.0 109.882 -179.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 974' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 974' ' ' LEU . 86.9 mt -62.25 -42.18 99.1 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.197 -0.668 . . . . 1.0 109.197 178.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -65.96 -45.74 85.95 Favored Glycine 0 N--CA 1.459 0.175 0 N-CA-C 110.26 -1.136 . . . . 1.0 110.26 -179.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -60.92 -37.98 94.66 Favored Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 109.142 -1.583 . . . . 1.0 109.142 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 977' ' ' LEU . . . . . 0.473 ' O ' ' OG1' ' A' ' 981' ' ' THR . 56.2 tp -65.82 -44.46 85.55 Favored 'General case' 0 C--O 1.226 -0.172 0 N-CA-C 109.736 -0.468 . . . . 1.0 109.736 178.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 50.6 tp -62.42 -46.04 90.38 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.375 -0.53 . . . . 1.0 110.642 -179.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 87.8 mt -62.58 -44.5 96.15 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.281 -0.567 . . . . 1.0 110.952 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 980' ' ' LEU . . . . . . . . . . . . . 80.7 mt -63.58 -40.92 98.19 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.852 -0.425 . . . . 1.0 109.852 -179.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 981' ' ' THR . . . . . 0.473 ' OG1' ' O ' ' A' ' 977' ' ' LEU . 6.8 m -63.96 -46.84 82.9 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.718 -0.674 . . . . 1.0 110.64 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 93.4 mt -63.59 -44.41 98.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 120.807 -0.357 . . . . 1.0 111.562 -178.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 983' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 983' ' ' LEU . 93.9 mt -64.76 -40.18 94.86 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.727 -0.389 . . . . 1.0 110.976 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 984' ' ' VAL . . . . . . . . . . . . . 38.9 t -69.02 -48.05 72.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.257 0.551 . . . . 1.0 111.014 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 86.5 mt -62.96 -42.63 99.88 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.037 -0.727 . . . . 1.0 109.037 178.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 986' ' ' ALA . . . . . 0.871 ' O ' HG13 ' A' ' 990' ' ' VAL . . . -63.52 -44.6 93.78 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.265 0.555 . . . . 1.0 110.11 -179.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 21.5 mtp -63.52 -31.12 72.19 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 122.527 1.156 . . . . 1.0 110.153 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 988' ' ' TRP . . . . . 0.439 ' O ' ' CD1' ' A' ' 988' ' ' TRP . 14.0 t90 -75.89 -35.03 59.98 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.163 -1.38 . . . . 1.0 108.313 179.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.5 -38.36 74.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.468 0.651 . . . . 1.0 109.807 -179.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 990' ' ' VAL . . . . . 0.871 HG13 ' O ' ' A' ' 986' ' ' ALA . 1.6 m -78.96 0.2 3.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.19 -0.913 . . . . 1.0 109.394 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 991' ' ' GLY . . . . . . . . . . . . . . . 79.69 1.13 86.44 Favored Glycine 0 CA--C 1.506 -0.502 0 CA-C-O 119.478 -0.623 . . . . 1.0 112.252 177.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -48.38 -41.45 28.89 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-N 118.88 1.34 . . . . 1.0 111.256 -176.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 993' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 . . . . . 0 N--CA 1.463 0.198 0 CA-C-O 121.819 0.819 . . . . 1.0 111.009 179.937 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 967' ' ' TRP . . . . . 0.755 ' O ' HG23 ' A' ' 971' ' ' VAL . 98.2 m95 . . . . . 0 C--O 1.229 0.023 0 CA-C-O 120.603 0.24 . . . . 1.0 111.181 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 99.7 m95 -70.29 -35.58 73.81 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.571 -0.286 . . . . 1.0 110.334 179.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 969' ' ' VAL . . . . . 0.545 ' O ' HG23 ' A' ' 973' ' ' VAL . 86.2 t -67.31 -45.63 85.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 N-CA-C 109.107 -0.701 . . . . 1.0 109.107 178.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 10.0 mp -63.29 -43.01 99.1 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.656 -0.702 . . . . 1.0 109.866 178.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 971' ' ' VAL . . . . . 0.755 HG23 ' O ' ' A' ' 967' ' ' TRP . 77.8 t -62.37 -45.06 99.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.378 -0.374 . . . . 1.0 110.922 -179.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.45 -41.48 98.62 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 112.074 -0.41 . . . . 1.0 112.074 -179.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 973' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 969' ' ' VAL . 84.5 t -66.61 -45.97 87.22 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.306 0 CA-C-N 115.195 -0.503 . . . . 1.0 110.392 -178.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 90.7 mt -62.41 -41.38 98.63 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 109.042 -0.725 . . . . 1.0 109.042 178.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -65.77 -46.0 85.54 Favored Glycine 0 C--N 1.331 0.299 0 N-CA-C 110.26 -1.136 . . . . 1.0 110.26 -179.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -60.77 -37.48 93.68 Favored Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 109.195 -1.562 . . . . 1.0 109.195 179.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 56.0 tp -66.97 -43.28 83.44 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.49 -0.484 . . . . 1.0 109.936 178.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 978' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 978' ' ' LEU . 39.9 mt -61.94 -44.94 95.73 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.359 -0.382 . . . . 1.0 110.223 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 94.8 mt -62.86 -42.96 99.95 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 119.669 -0.812 . . . . 1.0 110.315 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 980' ' ' LEU . . . . . . . . . . . . . 81.1 mt -64.17 -41.57 97.08 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.964 0.411 . . . . 1.0 111.093 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 7.5 m -62.81 -47.63 82.61 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.693 -0.685 . . . . 1.0 110.188 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 84.7 mt -63.61 -44.28 98.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 116.111 -0.495 . . . . 1.0 111.117 -179.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 15.1 tp -64.19 -43.14 95.99 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.498 -0.319 . . . . 1.0 110.955 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 984' ' ' VAL . . . . . . . . . . . . . 54.1 t -68.57 -48.7 70.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.171 0.51 . . . . 1.0 110.974 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 83.5 mt -62.15 -42.61 99.43 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.805 -0.813 . . . . 1.0 108.805 179.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 986' ' ' ALA . . . . . 0.831 ' O ' HG13 ' A' ' 990' ' ' VAL . . . -61.69 -44.01 97.76 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 109.062 -0.718 . . . . 1.0 109.062 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 27.4 mtp -61.59 -30.87 70.95 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.761 -1.108 . . . . 1.0 108.964 178.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 988' ' ' TRP . . . . . . . . . . . . . 1.7 t90 -73.46 -38.64 65.4 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 113.928 -1.487 . . . . 1.0 108.455 179.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.2 -37.79 78.29 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.594 -0.73 . . . . 1.0 110.378 -179.204 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 990' ' ' VAL . . . . . 0.831 HG13 ' O ' ' A' ' 986' ' ' ALA . 1.3 m -85.16 -7.56 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 CA-C-N 115.116 -0.947 . . . . 1.0 110.668 -178.528 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 991' ' ' GLY . . . . . 0.499 ' C ' ' H ' ' A' ' 993' ' ' PHE . . . 80.02 6.51 89.11 Favored Glycine 0 C--N 1.339 0.719 0 CA-C-O 119.264 -0.742 . . . . 1.0 112.192 179.307 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -53.0 -1.58 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 119.32 1.56 . . . . 1.0 112.736 -176.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 993' ' ' PHE . . . . . 0.499 ' H ' ' C ' ' A' ' 991' ' ' GLY . 17.1 m-85 . . . . . 0 N--CA 1.465 0.298 0 CA-C-O 121.401 0.62 . . . . 1.0 110.704 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 967' ' ' TRP . . . . . 0.567 ' O ' HG23 ' A' ' 971' ' ' VAL . 89.7 m95 . . . . . 0 N--CA 1.463 0.195 0 CA-C-O 120.589 0.233 . . . . 1.0 111.559 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 88.8 m95 -71.04 -35.18 71.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.724 -0.216 . . . . 1.0 110.837 179.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 969' ' ' VAL . . . . . 0.424 ' O ' HG23 ' A' ' 973' ' ' VAL . 76.0 t -67.14 -44.88 87.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 108.808 -0.812 . . . . 1.0 108.808 178.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 59.4 tp -64.07 -43.02 96.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.039 -0.982 . . . . 1.0 110.199 179.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 971' ' ' VAL . . . . . 0.567 HG23 ' O ' ' A' ' 967' ' ' TRP . 51.0 t -62.99 -45.14 99.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.959 0.409 . . . . 1.0 111.294 -179.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.29 -41.03 98.2 Favored Glycine 0 CA--C 1.528 0.882 0 CA-C-N 116.025 -0.534 . . . . 1.0 111.853 -179.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 973' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 969' ' ' VAL . 74.8 t -66.95 -47.5 82.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.115 0.483 . . . . 1.0 111.092 -178.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -62.87 -40.88 98.85 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.88 -0.6 . . . . 1.0 109.499 178.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -65.97 -45.27 88.86 Favored Glycine 0 CA--C 1.513 -0.051 0 N-CA-C 109.869 -1.292 . . . . 1.0 109.869 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 976' ' ' GLY . . . . . 0.468 ' O ' HD13 ' A' ' 980' ' ' LEU . . . -61.26 -37.39 93.94 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 109.233 -1.547 . . . . 1.0 109.233 178.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 53.5 tp -64.87 -42.48 94.8 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 109.433 -0.581 . . . . 1.0 109.433 178.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 60.3 tp -62.28 -44.82 95.64 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.894 -0.409 . . . . 1.0 109.894 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 92.3 mt -62.59 -45.09 94.51 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.462 -0.495 . . . . 1.0 111.355 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 980' ' ' LEU . . . . . 0.468 HD13 ' O ' ' A' ' 976' ' ' GLY . 9.2 mp -63.05 -39.28 94.28 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.322 -0.551 . . . . 1.0 110.217 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 7.8 m -62.5 -47.3 84.58 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.839 -0.619 . . . . 1.0 110.846 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 96.4 mt -64.21 -44.6 97.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.39 -0.368 . . . . 1.0 111.863 -178.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 7.5 mp -65.08 -40.09 94.13 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 120.663 -0.415 . . . . 1.0 110.943 179.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 984' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 980' ' ' LEU . 55.7 t -68.47 -48.85 70.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.288 -0.414 . . . . 1.0 110.367 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 86.3 mt -64.4 -41.77 96.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.959 -0.564 . . . . 1.0 109.53 178.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 986' ' ' ALA . . . . . 0.89 ' O ' HG13 ' A' ' 990' ' ' VAL . . . -62.96 -43.87 97.6 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-O 121.689 0.757 . . . . 1.0 109.032 -179.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 32.7 mtp -62.57 -31.13 71.89 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 114.415 -1.266 . . . . 1.0 109.174 178.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 988' ' ' TRP . . . . . . . . . . . . . 1.6 t90 -74.22 -37.82 63.73 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 113.957 -1.474 . . . . 1.0 108.037 179.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.24 -39.43 78.49 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.944 0.878 . . . . 1.0 110.303 -179.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 990' ' ' VAL . . . . . 0.89 HG13 ' O ' ' A' ' 986' ' ' ALA . 1.4 m -82.57 -7.94 11.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 114.92 -1.036 . . . . 1.0 110.57 -178.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 991' ' ' GLY . . . . . 0.574 ' C ' ' H ' ' A' ' 993' ' ' PHE . . . 82.68 2.94 90.69 Favored Glycine 0 C--N 1.339 0.698 0 CA-C-O 119.145 -0.808 . . . . 1.0 112.439 178.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -52.63 -1.37 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 119.723 1.762 . . . . 1.0 112.112 -177.505 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 993' ' ' PHE . . . . . 0.574 ' H ' ' C ' ' A' ' 991' ' ' GLY . 10.4 m-85 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.567 -0.288 . . . . 1.0 111.44 -179.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 967' ' ' TRP . . . . . 0.659 ' O ' HG23 ' A' ' 971' ' ' VAL . 88.5 m95 . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.484 0.183 . . . . 1.0 111.358 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 96.1 m95 -68.43 -34.91 76.83 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 110.117 -0.327 . . . . 1.0 110.117 179.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 969' ' ' VAL . . . . . 0.638 ' O ' HG23 ' A' ' 973' ' ' VAL . 57.1 t -67.14 -43.96 88.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 CA-C-O 121.649 0.737 . . . . 1.0 109.06 178.26 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 98.2 mt -63.34 -42.55 98.94 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 114.749 -1.114 . . . . 1.0 109.675 179.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 971' ' ' VAL . . . . . 0.659 HG23 ' O ' ' A' ' 967' ' ' TRP . 71.0 t -62.27 -45.31 99.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.064 0.459 . . . . 1.0 110.507 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.49 -41.34 98.63 Favored Glycine 0 C--N 1.332 0.306 0 N-CA-C 111.271 -0.732 . . . . 1.0 111.271 -179.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 973' ' ' VAL . . . . . 0.638 HG23 ' O ' ' A' ' 969' ' ' VAL . 84.4 t -65.57 -47.56 85.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 114.971 -0.615 . . . . 1.0 110.678 -179.151 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 78.3 mt -61.36 -40.43 94.27 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.697 -0.853 . . . . 1.0 108.697 178.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -64.54 -46.04 91.35 Favored Glycine 0 N--CA 1.461 0.305 0 N-CA-C 110.843 -0.903 . . . . 1.0 110.843 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -60.86 -36.93 92.86 Favored Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 109.474 -1.45 . . . . 1.0 109.474 179.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 82.2 mt -67.3 -43.21 82.29 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 120.4 -0.52 . . . . 1.0 110.619 179.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 55.7 tp -61.94 -44.89 95.82 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.673 -0.411 . . . . 1.0 110.178 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 97.2 mt -63.77 -42.92 97.7 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 120.187 -0.605 . . . . 1.0 110.91 -179.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 980' ' ' LEU . . . . . . . . . . . . . 76.2 mt -64.03 -39.52 94.27 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.918 0.39 . . . . 1.0 110.362 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 7.1 m -64.12 -46.67 83.16 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.877 -0.601 . . . . 1.0 109.764 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 90.9 mt -62.65 -44.46 99.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.052 -0.522 . . . . 1.0 111.145 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 97.6 mt -64.72 -40.69 95.77 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.728 -0.389 . . . . 1.0 111.143 179.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 984' ' ' VAL . . . . . . . . . . . . . 46.7 t -67.99 -48.09 76.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.04 0.448 . . . . 1.0 110.323 179.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 85.2 mt -64.17 -43.83 93.91 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.733 -0.667 . . . . 1.0 109.564 179.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 986' ' ' ALA . . . . . 0.936 ' O ' HG13 ' A' ' 990' ' ' VAL . . . -62.09 -44.94 95.57 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-O 121.361 0.601 . . . . 1.0 109.397 -179.375 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 30.9 mtp -61.99 -34.19 75.72 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 114.885 -1.052 . . . . 1.0 109.537 179.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 988' ' ' TRP . . . . . 0.463 ' O ' ' CD1' ' A' ' 988' ' ' TRP . 13.0 t90 -73.25 -36.02 66.32 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 114.137 -1.392 . . . . 1.0 108.527 179.33 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.22 -41.38 77.13 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 115.402 -0.817 . . . . 1.0 109.912 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 990' ' ' VAL . . . . . 0.936 HG13 ' O ' ' A' ' 986' ' ' ALA . 1.2 m -82.42 -8.7 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 CA-C-N 114.811 -1.086 . . . . 1.0 110.062 -179.122 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 991' ' ' GLY . . . . . 0.529 ' C ' ' H ' ' A' ' 993' ' ' PHE . . . 82.2 5.14 89.9 Favored Glycine 0 C--N 1.342 0.91 0 CA-C-O 119.15 -0.805 . . . . 1.0 112.692 179.022 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -51.93 -2.17 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 119.543 1.672 . . . . 1.0 112.851 -177.384 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 993' ' ' PHE . . . . . 0.529 ' H ' ' C ' ' A' ' 991' ' ' GLY . 13.6 m-85 . . . . . 0 C--N 1.327 -0.385 0 C-N-CA 120.992 -0.283 . . . . 1.0 110.399 179.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 967' ' ' TRP . . . . . 0.537 ' O ' HG23 ' A' ' 971' ' ' VAL . 97.1 m95 . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.821 0.343 . . . . 1.0 111.304 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 93.1 m95 -69.1 -35.69 76.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.462 . . . . 1.0 110.38 179.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 969' ' ' VAL . . . . . 0.476 ' O ' HG23 ' A' ' 973' ' ' VAL . 71.4 t -65.3 -43.87 94.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 108.396 -0.964 . . . . 1.0 108.396 177.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 970' ' ' LEU . . . . . 0.444 ' O ' HD13 ' A' ' 974' ' ' LEU . 89.9 mt -62.33 -42.86 99.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 114.513 -1.221 . . . . 1.0 109.688 179.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 971' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 967' ' ' TRP . 49.9 t -60.99 -44.87 99.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.865 0.364 . . . . 1.0 110.128 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.88 -39.01 96.3 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 111.538 -0.625 . . . . 1.0 111.538 -179.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 973' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 969' ' ' VAL . 56.8 t -66.67 -47.47 83.09 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.382 0 CA-C-N 114.92 -0.64 . . . . 1.0 110.439 -179.398 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 974' ' ' LEU . . . . . 0.444 HD13 ' O ' ' A' ' 970' ' ' LEU . 7.9 mp -62.95 -41.1 99.4 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.663 -0.866 . . . . 1.0 108.663 179.087 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -66.08 -45.58 86.27 Favored Glycine 0 CA--C 1.518 0.258 0 N-CA-C 110.308 -1.117 . . . . 1.0 110.308 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 976' ' ' GLY . . . . . 0.558 ' O ' HD13 ' A' ' 980' ' ' LEU . . . -60.19 -38.72 94.91 Favored Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 108.903 -1.679 . . . . 1.0 108.903 178.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 52.7 tp -66.66 -44.32 82.16 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.313 -0.555 . . . . 1.0 110.26 179.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 59.1 tp -62.29 -45.86 91.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.619 -0.264 . . . . 1.0 110.364 -179.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 93.5 mt -63.26 -43.53 97.73 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 119.976 -0.69 . . . . 1.0 110.765 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 980' ' ' LEU . . . . . 0.558 HD13 ' O ' ' A' ' 976' ' ' GLY . 8.5 mp -63.99 -39.06 93.26 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.74 -0.384 . . . . 1.0 110.708 -179.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 6.9 m -64.35 -45.98 85.45 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.963 -0.562 . . . . 1.0 110.188 -179.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 97.5 mt -63.45 -44.01 98.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 C-N-CA 120.938 -0.305 . . . . 1.0 111.539 -179.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 91.0 mt -65.07 -41.08 95.42 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 120.954 -0.298 . . . . 1.0 110.788 179.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 984' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 980' ' ' LEU . 54.4 t -66.39 -47.78 82.94 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.426 0 CA-C-O 121.472 0.653 . . . . 1.0 109.538 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 87.1 mt -63.4 -43.71 96.77 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.058 -0.974 . . . . 1.0 109.739 178.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 986' ' ' ALA . . . . . 0.824 ' O ' HG13 ' A' ' 990' ' ' VAL . . . -61.49 -45.12 95.57 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-O 121.595 0.712 . . . . 1.0 109.406 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 29.5 mtp -61.62 -30.19 70.53 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.651 -1.158 . . . . 1.0 108.778 179.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 988' ' ' TRP . . . . . . . . . . . . . 1.7 t90 -74.29 -38.85 63.26 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 113.912 -1.495 . . . . 1.0 108.424 179.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.22 -38.55 82.02 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.357 -0.838 . . . . 1.0 110.223 -179.05 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 990' ' ' VAL . . . . . 0.824 HG13 ' O ' ' A' ' 986' ' ' ALA . 1.4 m -84.55 -7.96 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 115.075 -0.966 . . . . 1.0 110.747 -178.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 991' ' ' GLY . . . . . 0.524 ' C ' ' H ' ' A' ' 993' ' ' PHE . . . 81.27 5.33 90.12 Favored Glycine 0 C--N 1.338 0.655 0 CA-C-O 119.17 -0.794 . . . . 1.0 112.453 179.056 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -53.4 -1.81 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 119.34 1.57 . . . . 1.0 112.532 -177.323 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 993' ' ' PHE . . . . . 0.524 ' H ' ' C ' ' A' ' 991' ' ' GLY . 10.2 m-85 . . . . . 0 C--N 1.326 -0.421 0 CA-C-O 121.584 0.707 . . . . 1.0 110.501 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 967' ' ' TRP . . . . . 0.722 ' O ' HG23 ' A' ' 971' ' ' VAL . 94.2 m95 . . . . . 0 N--CA 1.453 -0.289 0 CA-C-O 120.564 0.221 . . . . 1.0 110.821 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 83.9 m95 -72.06 -36.27 69.54 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.695 -0.229 . . . . 1.0 111.113 179.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 969' ' ' VAL . . . . . 0.408 ' O ' HG23 ' A' ' 973' ' ' VAL . 62.1 t -67.03 -44.82 88.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 108.691 -0.855 . . . . 1.0 108.691 178.497 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 56.4 tp -63.3 -44.22 95.64 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.738 -1.119 . . . . 1.0 110.204 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 971' ' ' VAL . . . . . 0.722 HG23 ' O ' ' A' ' 967' ' ' TRP . 54.4 t -61.85 -45.44 98.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 120.625 -0.43 . . . . 1.0 111.367 -178.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.23 -36.93 92.1 Favored Glycine 0 CA--C 1.529 0.959 0 CA-C-O 121.659 0.588 . . . . 1.0 111.679 -179.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 973' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 969' ' ' VAL . 53.5 t -68.28 -49.08 70.05 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.492 0 CA-C-N 114.87 -0.665 . . . . 1.0 109.948 -179.093 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 69.4 mt -62.21 -42.23 99.1 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 115.493 -0.776 . . . . 1.0 109.008 179.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -65.96 -45.55 87.08 Favored Glycine 0 N--CA 1.46 0.259 0 N-CA-C 110.061 -1.216 . . . . 1.0 110.061 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -59.62 -38.7 94.11 Favored Glycine 0 C--O 1.226 -0.366 0 N-CA-C 108.642 -1.783 . . . . 1.0 108.642 178.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 977' ' ' LEU . . . . . 0.42 ' O ' ' OG1' ' A' ' 981' ' ' THR . 49.1 tp -65.55 -42.93 91.33 Favored 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 120.717 -0.393 . . . . 1.0 110.188 179.313 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 76.3 mt -64.52 -44.32 91.24 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.457 -0.497 . . . . 1.0 111.054 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 80.6 mt -63.29 -44.28 95.49 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.325 -0.55 . . . . 1.0 110.732 -179.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 980' ' ' LEU . . . . . 0.417 ' O ' HG23 ' A' ' 984' ' ' VAL . 83.8 mt -63.51 -39.47 94.52 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.08 0.467 . . . . 1.0 110.115 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 981' ' ' THR . . . . . 0.508 HG22 ' CD1' ' A' ' 985' ' ' LEU . 7.3 m -64.59 -46.2 83.7 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.474 -0.785 . . . . 1.0 110.225 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 3.2 mm -64.09 -43.62 97.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.296 -0.411 . . . . 1.0 111.854 -178.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 98.2 mt -66.71 -40.72 88.55 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.093 -0.503 . . . . 1.0 111.377 -179.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 984' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 980' ' ' LEU . 65.8 t -68.61 -46.65 79.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.438 0.637 . . . . 1.0 109.492 179.465 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 985' ' ' LEU . . . . . 0.508 ' CD1' HG22 ' A' ' 981' ' ' THR . 80.9 mt -63.08 -43.44 98.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.261 -0.881 . . . . 1.0 109.039 178.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 986' ' ' ALA . . . . . 0.872 ' O ' HG13 ' A' ' 990' ' ' VAL . . . -62.01 -43.84 97.98 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.141 -0.688 . . . . 1.0 109.141 179.636 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 987' ' ' MET . . . . . 0.431 ' HA ' HG22 ' A' ' 990' ' ' VAL . 29.5 mtp -64.07 -32.58 74.19 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 114.955 -1.021 . . . . 1.0 110.367 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 988' ' ' TRP . . . . . 0.477 ' O ' ' CD1' ' A' ' 988' ' ' TRP . 12.7 t90 -73.48 -34.08 65.16 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.171 -1.377 . . . . 1.0 107.75 178.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.37 -39.37 71.27 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 114.866 -1.061 . . . . 1.0 110.478 -179.558 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 990' ' ' VAL . . . . . 0.872 HG13 ' O ' ' A' ' 986' ' ' ALA . 1.4 m -85.26 -7.6 10.96 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 CA-C-N 115.128 -0.942 . . . . 1.0 110.339 -178.478 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 991' ' ' GLY . . . . . 0.504 ' C ' ' H ' ' A' ' 993' ' ' PHE . . . 81.54 5.09 90.19 Favored Glycine 0 C--N 1.331 0.304 0 CA-C-O 118.813 -0.993 . . . . 1.0 112.76 179.35 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -52.79 -1.87 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 120.07 1.935 . . . . 1.0 112.729 -178.036 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 993' ' ' PHE . . . . . 0.504 ' H ' ' C ' ' A' ' 991' ' ' GLY . 17.5 m-85 . . . . . 0 C--O 1.236 0.383 0 CA-C-O 121.03 0.443 . . . . 1.0 110.37 179.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 967' ' ' TRP . . . . . 0.784 ' O ' HG23 ' A' ' 971' ' ' VAL . 89.7 m95 . . . . . 0 C--O 1.226 -0.172 0 N-CA-C 113.293 0.849 . . . . 1.0 113.293 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 39.3 m95 -71.57 -39.61 70.49 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 112.957 0.725 . . . . 1.0 112.957 -178.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 969' ' ' VAL . . . . . 0.445 ' O ' HG23 ' A' ' 973' ' ' VAL . 17.3 m -66.86 -41.3 87.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 119.536 -0.866 . . . . 1.0 109.23 179.355 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 61.9 tp -64.35 -42.78 96.04 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.246 -0.888 . . . . 1.0 109.973 179.052 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 971' ' ' VAL . . . . . 0.784 HG23 ' O ' ' A' ' 967' ' ' TRP . 70.2 t -62.79 -44.83 99.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 120.523 -0.471 . . . . 1.0 110.668 -179.1 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -59.34 -41.65 97.02 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.555 -0.618 . . . . 1.0 111.555 -179.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 973' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 969' ' ' VAL . 77.0 t -64.63 -46.9 91.05 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.593 0 CA-C-O 121.038 0.447 . . . . 1.0 110.623 -179.303 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 98.7 mt -61.99 -40.67 96.44 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 108.595 -0.891 . . . . 1.0 108.595 179.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -67.13 -48.21 60.65 Favored Glycine 0 C--N 1.334 0.419 0 CA-C-N 115.1 -0.955 . . . . 1.0 110.943 -179.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -60.12 -36.41 90.47 Favored Glycine 0 N--CA 1.449 -0.446 0 N-CA-C 108.915 -1.674 . . . . 1.0 108.915 179.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 977' ' ' LEU . . . . . 0.455 ' O ' ' OG1' ' A' ' 981' ' ' THR . 54.1 tp -66.97 -43.22 83.63 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.179 -0.608 . . . . 1.0 109.993 179.138 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 4.3 tt -61.64 -45.24 94.88 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.348 -0.541 . . . . 1.0 110.33 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 96.1 mt -62.17 -45.16 94.65 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.487 -0.485 . . . . 1.0 111.315 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 980' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -64.13 -39.97 95.16 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.083 0.468 . . . . 1.0 111.163 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 981' ' ' THR . . . . . 0.455 ' OG1' ' O ' ' A' ' 977' ' ' LEU . 6.9 m -64.11 -46.71 83.01 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.487 -0.778 . . . . 1.0 110.121 -179.647 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 4.0 mm -63.68 -43.82 98.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.499 -0.319 . . . . 1.0 111.477 -179.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 83.7 mt -63.67 -41.58 98.17 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.381 -0.372 . . . . 1.0 110.366 179.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 984' ' ' VAL . . . . . . . . . . . . . 40.0 t -66.7 -47.1 84.11 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.332 0 CA-C-O 121.345 0.593 . . . . 1.0 110.356 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 82.2 mt -64.43 -43.04 95.6 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.292 -0.867 . . . . 1.0 109.919 179.134 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 986' ' ' ALA . . . . . 0.939 ' O ' HG13 ' A' ' 990' ' ' VAL . . . -63.85 -46.05 86.76 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 121.371 0.605 . . . . 1.0 109.726 -179.344 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 30.2 mtp -61.8 -33.75 74.68 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.817 -1.083 . . . . 1.0 109.286 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 988' ' ' TRP . . . . . 0.505 ' O ' ' CD1' ' A' ' 988' ' ' TRP . 12.8 t90 -72.1 -37.27 69.57 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.338 -1.301 . . . . 1.0 108.57 178.186 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.91 -40.3 79.19 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 121.717 0.77 . . . . 1.0 110.204 -179.501 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 990' ' ' VAL . . . . . 0.939 HG13 ' O ' ' A' ' 986' ' ' ALA . 1.2 m -82.63 -6.63 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 CA-C-N 114.707 -1.133 . . . . 1.0 109.989 -178.617 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 991' ' ' GLY . . . . . 0.543 ' C ' ' H ' ' A' ' 993' ' ' PHE . . . 83.58 2.6 89.99 Favored Glycine 0 C--N 1.337 0.586 0 CA-C-O 119.296 -0.724 . . . . 1.0 112.317 178.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -52.16 -2.5 0.02 OUTLIER 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 119.418 1.609 . . . . 1.0 112.145 -177.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 993' ' ' PHE . . . . . 0.543 ' H ' ' C ' ' A' ' 991' ' ' GLY . 11.6 m-85 . . . . . 0 C--N 1.332 -0.191 0 CA-C-O 121.077 0.465 . . . . 1.0 110.101 179.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 967' ' ' TRP . . . . . 0.635 ' O ' HG23 ' A' ' 971' ' ' VAL . 96.9 m95 . . . . . 0 N--CA 1.456 -0.147 0 CA-C-O 120.573 0.225 . . . . 1.0 111.578 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 24.7 m95 -70.33 -34.66 72.95 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.577 -0.283 . . . . 1.0 110.479 179.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 74.1 t -67.38 -43.93 87.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 108.99 -0.744 . . . . 1.0 108.99 178.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 51.6 tp -63.91 -41.33 97.71 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.232 -0.894 . . . . 1.0 109.104 179.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 971' ' ' VAL . . . . . 0.635 HG23 ' O ' ' A' ' 967' ' ' TRP . 53.2 t -62.29 -45.33 99.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 C-N-CA 120.895 -0.322 . . . . 1.0 111.372 -179.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.63 -41.31 98.83 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 112.161 -0.376 . . . . 1.0 112.161 -178.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 72.8 t -67.22 -47.23 82.15 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.517 0 CA-C-O 120.94 0.4 . . . . 1.0 110.668 -178.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 6.9 mp -63.44 -41.04 98.66 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.974 -0.557 . . . . 1.0 109.522 179.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -66.08 -44.95 90.29 Favored Glycine 0 C--N 1.334 0.433 0 N-CA-C 110.348 -1.101 . . . . 1.0 110.348 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -61.32 -36.11 91.98 Favored Glycine 0 N--CA 1.448 -0.527 0 N-CA-C 109.061 -1.615 . . . . 1.0 109.061 179.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 54.2 tp -67.37 -43.72 80.74 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.443 -0.503 . . . . 1.0 110.075 178.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 50.9 tp -62.43 -44.82 95.51 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.289 -0.564 . . . . 1.0 109.998 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 87.5 mt -61.94 -42.93 99.67 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 119.783 -0.767 . . . . 1.0 110.118 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 980' ' ' LEU . . . . . 0.428 ' O ' HG23 ' A' ' 984' ' ' VAL . 33.2 mt -63.42 -40.41 97.1 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.058 0.456 . . . . 1.0 110.334 -179.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 6.9 m -64.16 -46.27 84.79 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.409 -0.814 . . . . 1.0 110.17 -179.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 90.8 mt -64.29 -44.27 97.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.332 -0.394 . . . . 1.0 111.236 -179.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 983' ' ' LEU . . . . . 0.57 HD11 ' SD ' ' A' ' 987' ' ' MET . 39.1 tp -65.67 -42.74 90.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.544 -0.298 . . . . 1.0 111.454 -179.773 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 984' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 980' ' ' LEU . 53.1 t -66.81 -47.64 82.19 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.402 0 CA-C-O 121.411 0.624 . . . . 1.0 110.341 -179.404 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 84.0 mt -63.58 -41.59 98.36 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.134 -0.939 . . . . 1.0 109.132 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 986' ' ' ALA . . . . . 0.836 ' O ' HG13 ' A' ' 990' ' ' VAL . . . -62.65 -47.77 82.23 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.275 0.559 . . . . 1.0 110.38 -179.491 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 987' ' ' MET . . . . . 0.57 ' SD ' HD11 ' A' ' 983' ' ' LEU . 16.2 mtp -62.81 -30.26 71.35 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 122.632 1.206 . . . . 1.0 110.313 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 988' ' ' TRP . . . . . 0.467 ' O ' ' CD1' ' A' ' 988' ' ' TRP . 12.1 t90 -75.64 -35.34 60.48 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 113.976 -1.465 . . . . 1.0 107.926 178.523 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.25 -39.57 74.94 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-O 121.516 0.674 . . . . 1.0 109.902 -179.447 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 990' ' ' VAL . . . . . 0.836 HG13 ' O ' ' A' ' 986' ' ' ALA . 1.4 m -78.28 -3.45 5.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 114.946 -1.025 . . . . 1.0 109.221 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 991' ' ' GLY . . . . . . . . . . . . . . . 82.83 1.44 90.59 Favored Glycine 0 C--N 1.333 0.414 0 CA-C-O 119.404 -0.664 . . . . 1.0 112.397 177.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -47.22 -41.92 19.26 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-N 119.046 1.423 . . . . 1.0 110.926 -176.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 993' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 . . . . . 0 N--CA 1.466 0.344 0 CA-C-O 121.861 0.838 . . . . 1.0 111.1 179.479 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 967' ' ' TRP . . . . . 0.638 ' O ' HG23 ' A' ' 971' ' ' VAL . 98.8 m95 . . . . . 0 N--CA 1.455 -0.195 0 CA-C-O 120.688 0.28 . . . . 1.0 110.313 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 87.4 m95 -68.58 -36.6 78.94 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.462 -0.335 . . . . 1.0 111.4 179.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 72.6 t -66.3 -44.56 91.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.307 0.575 . . . . 1.0 109.551 178.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 90.4 mt -62.82 -42.19 99.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.04 -0.982 . . . . 1.0 109.597 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 971' ' ' VAL . . . . . 0.638 HG23 ' O ' ' A' ' 967' ' ' TRP . 54.1 t -61.6 -45.33 98.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.51 -0.314 . . . . 1.0 111.14 -179.402 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.78 -41.67 99.19 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 121.377 -0.44 . . . . 1.0 112.331 -178.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 57.2 t -65.82 -47.45 85.63 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.534 0 CA-C-O 121.145 0.497 . . . . 1.0 110.605 -178.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 86.9 mt -62.59 -41.58 99.04 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.556 -0.747 . . . . 1.0 109.365 179.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -66.02 -46.25 82.28 Favored Glycine 0 N--CA 1.452 -0.243 0 N-CA-C 110.421 -1.072 . . . . 1.0 110.421 -179.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -61.0 -37.33 93.69 Favored Glycine 0 N--CA 1.451 -0.339 0 N-CA-C 109.244 -1.542 . . . . 1.0 109.244 179.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 977' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' A' ' 977' ' ' LEU . 30.1 mt -64.34 -42.4 96.29 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.437 -0.505 . . . . 1.0 109.753 178.677 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -62.98 -43.78 97.86 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 119.628 -0.829 . . . . 1.0 110.144 179.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 98.4 mt -61.72 -43.66 98.43 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.17 -0.612 . . . . 1.0 109.906 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 980' ' ' LEU . . . . . 0.408 ' HA ' HD23 ' A' ' 980' ' ' LEU . 31.1 mt -62.82 -41.93 99.51 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.56 -0.456 . . . . 1.0 109.891 179.628 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 981' ' ' THR . . . . . 0.496 HG22 HD12 ' A' ' 985' ' ' LEU . 7.3 m -62.69 -47.32 84.13 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.646 -0.707 . . . . 1.0 111.183 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 92.7 mt -64.26 -43.94 97.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 C-N-CA 120.775 -0.37 . . . . 1.0 111.152 -179.389 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 983' ' ' LEU . . . . . 0.403 ' O ' ' SD ' ' A' ' 987' ' ' MET . 83.0 mt -65.04 -41.76 94.92 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.329 -0.396 . . . . 1.0 111.307 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 984' ' ' VAL . . . . . . . . . . . . . 42.2 t -69.15 -49.86 58.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.208 0.528 . . . . 1.0 110.793 -179.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 985' ' ' LEU . . . . . 0.496 HD12 HG22 ' A' ' 981' ' ' THR . 90.7 mt -63.37 -42.53 98.87 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.47 -0.786 . . . . 1.0 109.44 179.32 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 986' ' ' ALA . . . . . 0.874 ' O ' HG13 ' A' ' 990' ' ' VAL . . . -61.87 -43.97 97.77 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 109.18 -0.674 . . . . 1.0 109.18 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 987' ' ' MET . . . . . 0.403 ' SD ' ' O ' ' A' ' 983' ' ' LEU . 21.9 mtp -62.14 -30.29 70.94 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 114.653 -1.158 . . . . 1.0 109.387 179.028 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 988' ' ' TRP . . . . . . . . . . . . . 1.8 t90 -74.87 -36.12 62.31 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 113.797 -1.547 . . . . 1.0 108.28 178.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.44 -38.92 71.29 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.599 0.714 . . . . 1.0 110.0 -179.374 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 990' ' ' VAL . . . . . 0.874 HG13 ' O ' ' A' ' 986' ' ' ALA . 1.3 m -80.41 -5.33 8.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 114.957 -1.02 . . . . 1.0 109.873 -179.333 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 991' ' ' GLY . . . . . 0.547 ' C ' ' H ' ' A' ' 993' ' ' PHE . . . 85.05 0.38 88.93 Favored Glycine 0 C--N 1.338 0.686 0 CA-C-O 119.466 -0.63 . . . . 1.0 112.546 177.576 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -51.92 -2.98 0.02 OUTLIER 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 118.901 1.35 . . . . 1.0 112.386 -177.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 993' ' ' PHE . . . . . 0.547 ' H ' ' C ' ' A' ' 991' ' ' GLY . 32.8 m-85 . . . . . 0 N--CA 1.463 0.202 0 CA-C-O 122.511 1.148 . . . . 1.0 110.543 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 967' ' ' TRP . . . . . 0.519 ' O ' HG23 ' A' ' 971' ' ' VAL . 99.4 m95 . . . . . 0 N--CA 1.46 0.056 0 CA-C-O 120.556 0.217 . . . . 1.0 110.569 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 90.9 m95 -70.01 -34.3 73.12 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.614 -0.434 . . . . 1.0 110.426 179.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 969' ' ' VAL . . . . . 0.439 ' O ' HG22 ' A' ' 973' ' ' VAL . 53.9 t -66.94 -45.59 86.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.694 -0.484 . . . . 1.0 109.694 178.31 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 80.7 mt -63.72 -40.83 97.73 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.285 -0.871 . . . . 1.0 109.908 179.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 971' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 967' ' ' TRP . 45.2 t -64.77 -45.18 95.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 C-N-CA 120.694 -0.403 . . . . 1.0 111.309 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -63.05 -43.76 98.32 Favored Glycine 0 CA--C 1.529 0.932 0 CA-C-N 116.365 -0.38 . . . . 1.0 113.49 -177.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 973' ' ' VAL . . . . . 0.439 HG22 ' O ' ' A' ' 969' ' ' VAL . 31.6 m -67.48 -43.12 87.61 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.403 0 CA-C-O 120.897 0.38 . . . . 1.0 110.352 -178.24 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 974' ' ' LEU . . . . . 0.419 HD23 ' HA ' ' A' ' 974' ' ' LEU . 93.3 mt -63.39 -41.24 98.76 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.962 -0.755 . . . . 1.0 108.962 178.385 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -66.21 -46.16 81.49 Favored Glycine 0 C--N 1.329 0.151 0 N-CA-C 110.338 -1.105 . . . . 1.0 110.338 -179.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -59.2 -38.51 93.29 Favored Glycine 0 N--CA 1.446 -0.64 0 N-CA-C 108.647 -1.781 . . . . 1.0 108.647 178.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 977' ' ' LEU . . . . . 0.424 HD23 ' HA ' ' A' ' 977' ' ' LEU . 38.3 mt -63.87 -42.17 97.58 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.135 -0.626 . . . . 1.0 109.518 178.538 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 55.6 tp -62.44 -46.22 89.53 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.713 -0.395 . . . . 1.0 110.408 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 9.5 mp -62.29 -42.49 99.39 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 119.724 -0.79 . . . . 1.0 110.148 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 980' ' ' LEU . . . . . 0.526 ' O ' HG23 ' A' ' 984' ' ' VAL . 86.7 mt -63.04 -40.25 97.17 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.486 -0.486 . . . . 1.0 110.11 179.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 7.1 m -63.86 -46.72 83.73 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.667 -0.697 . . . . 1.0 110.808 -179.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 97.6 mt -63.56 -44.52 98.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.396 -0.365 . . . . 1.0 110.815 -179.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -65.73 -40.18 91.89 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.168 -0.469 . . . . 1.0 111.309 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 984' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 980' ' ' LEU . 45.6 t -67.24 -48.66 77.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.301 0.572 . . . . 1.0 110.337 -179.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 88.2 mt -63.67 -42.29 98.07 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.224 -0.898 . . . . 1.0 109.407 178.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 986' ' ' ALA . . . . . 0.827 ' O ' HG13 ' A' ' 990' ' ' VAL . . . -63.01 -46.93 85.33 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-O 121.384 0.611 . . . . 1.0 110.487 -179.081 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 19.2 mtp -63.18 -32.23 73.57 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 122.601 1.191 . . . . 1.0 109.607 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 988' ' ' TRP . . . . . . . . . . . . . 14.2 t90 -72.99 -36.96 67.16 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 114.202 -1.363 . . . . 1.0 107.554 178.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 989' ' ' LYS . . . . . 0.537 ' O ' ' NZ ' ' A' ' 989' ' ' LYS . 0.1 OUTLIER -66.7 -41.18 88.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.224 -0.898 . . . . 1.0 109.816 -179.875 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 990' ' ' VAL . . . . . 0.827 HG13 ' O ' ' A' ' 986' ' ' ALA . 1.3 m -79.15 -3.03 5.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.112 -0.949 . . . . 1.0 109.518 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 991' ' ' GLY . . . . . . . . . . . . . . . 82.97 1.21 90.64 Favored Glycine 0 C--N 1.338 0.668 0 CA-C-O 119.28 -0.733 . . . . 1.0 112.565 177.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -45.87 -42.81 12.99 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 118.953 1.377 . . . . 1.0 111.332 -177.157 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 993' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 . . . . . 0 N--CA 1.468 0.467 0 CA-C-O 121.684 0.754 . . . . 1.0 111.454 179.836 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 967' ' ' TRP . . . . . 0.669 ' O ' HG23 ' A' ' 971' ' ' VAL . 98.4 m95 . . . . . 0 N--CA 1.46 0.075 0 CA-C-O 120.608 0.242 . . . . 1.0 110.677 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 24.6 m95 -70.16 -35.25 73.88 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.636 -0.256 . . . . 1.0 110.422 179.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 91.2 t -67.03 -45.93 85.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.682 0.753 . . . . 1.0 109.201 178.015 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 57.1 tp -63.0 -42.74 99.93 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.75 -1.114 . . . . 1.0 109.207 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 971' ' ' VAL . . . . . 0.669 HG23 ' O ' ' A' ' 967' ' ' TRP . 55.6 t -62.4 -45.4 98.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.952 0.406 . . . . 1.0 110.756 -179.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.35 -42.06 98.7 Favored Glycine 0 CA--C 1.524 0.603 0 CA-C-N 115.928 -0.578 . . . . 1.0 111.891 -179.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 63.6 t -66.1 -44.78 91.71 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.458 0 CA-C-O 120.909 0.385 . . . . 1.0 110.662 -178.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 80.9 mt -61.94 -40.49 95.71 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.402 -0.962 . . . . 1.0 108.402 178.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -66.63 -43.82 91.17 Favored Glycine 0 N--CA 1.46 0.261 0 N-CA-C 110.22 -1.152 . . . . 1.0 110.22 -179.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -61.29 -37.09 93.45 Favored Glycine 0 N--CA 1.447 -0.624 0 N-CA-C 109.297 -1.521 . . . . 1.0 109.297 179.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 977' ' ' LEU . . . . . 0.444 ' O ' ' OG1' ' A' ' 981' ' ' THR . 76.2 mt -67.38 -42.53 83.21 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 119.815 -0.754 . . . . 1.0 110.207 178.68 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 70.8 mt -62.04 -44.75 96.03 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.26 -0.576 . . . . 1.0 110.507 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 90.3 mt -63.5 -44.59 93.89 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 119.815 -0.754 . . . . 1.0 110.855 -179.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 980' ' ' LEU . . . . . 0.486 ' O ' HG23 ' A' ' 984' ' ' VAL . 6.2 mp -64.1 -40.76 96.9 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.232 -0.587 . . . . 1.0 110.606 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 981' ' ' THR . . . . . 0.444 ' OG1' ' O ' ' A' ' 977' ' ' LEU . 7.4 m -62.35 -47.8 82.6 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.883 -0.599 . . . . 1.0 110.352 -179.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 96.6 mt -64.56 -44.85 96.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 C-N-CA 120.403 -0.519 . . . . 1.0 111.563 -178.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 7.1 mp -64.74 -41.93 95.57 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 111.801 0.297 . . . . 1.0 111.801 -179.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 984' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 980' ' ' LEU . 51.1 t -65.64 -48.68 81.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-O 121.313 0.578 . . . . 1.0 110.383 -179.136 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 82.5 mt -62.28 -41.9 98.88 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.967 -1.015 . . . . 1.0 109.478 178.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 986' ' ' ALA . . . . . 0.892 ' O ' HG13 ' A' ' 990' ' ' VAL . . . -61.58 -46.34 90.28 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.314 0.578 . . . . 1.0 110.106 -179.447 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 22.7 mtp -63.33 -29.77 71.02 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 122.679 1.228 . . . . 1.0 110.043 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 988' ' ' TRP . . . . . . . . . . . . . 1.6 t90 -76.31 -34.87 59.05 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 113.57 -1.65 . . . . 1.0 107.549 179.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.22 -38.67 68.92 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.113 -0.949 . . . . 1.0 110.14 -179.43 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 990' ' ' VAL . . . . . 0.892 HG13 ' O ' ' A' ' 986' ' ' ALA . 1.5 m -79.37 -0.69 3.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.118 -0.946 . . . . 1.0 109.129 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 991' ' ' GLY . . . . . . . . . . . . . . . 80.8 1.0 89.18 Favored Glycine 0 C--N 1.337 0.585 0 CA-C-O 119.137 -0.813 . . . . 1.0 112.783 177.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -47.04 -40.88 15.71 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 119.263 1.531 . . . . 1.0 111.53 -177.075 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 993' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 . . . . . 0 N--CA 1.465 0.296 0 CA-C-O 121.981 0.896 . . . . 1.0 111.673 -179.308 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 967' ' ' TRP . . . . . 0.619 ' O ' HG13 ' A' ' 971' ' ' VAL . 98.0 m95 . . . . . 0 N--CA 1.455 -0.193 0 N-CA-C 112.407 0.521 . . . . 1.0 112.407 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 38.9 m95 -69.67 -33.89 73.2 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.903 -0.406 . . . . 1.0 109.903 179.501 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 969' ' ' VAL . . . . . 0.631 ' O ' HG23 ' A' ' 973' ' ' VAL . 90.7 t -68.34 -46.04 81.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 C-N-CA 119.925 -0.71 . . . . 1.0 110.032 178.092 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 61.5 tp -66.15 -46.35 77.77 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 115.372 -0.831 . . . . 1.0 112.389 -179.165 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 971' ' ' VAL . . . . . 0.619 HG13 ' O ' ' A' ' 967' ' ' TRP . 26.9 m -63.69 -41.56 93.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 119.732 -0.787 . . . . 1.0 110.614 -177.974 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 972' ' ' GLY . . . . . 0.496 ' N ' HG23 ' A' ' 971' ' ' VAL . . . -60.51 -40.45 97.77 Favored Glycine 0 CA--C 1.525 0.657 0 CA-C-N 115.569 -0.741 . . . . 1.0 111.541 -179.459 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 973' ' ' VAL . . . . . 0.631 HG23 ' O ' ' A' ' 969' ' ' VAL . 92.2 t -66.09 -47.08 86.11 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.34 0 CA-C-O 121.007 0.432 . . . . 1.0 110.364 -179.048 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 92.9 mt -62.27 -40.38 96.03 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 108.655 -0.869 . . . . 1.0 108.655 179.312 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -65.36 -45.19 91.66 Favored Glycine 0 CA--C 1.516 0.146 0 N-CA-C 109.866 -1.294 . . . . 1.0 109.866 -179.84 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -61.03 -38.05 94.89 Favored Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 109.417 -1.473 . . . . 1.0 109.417 178.864 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 977' ' ' LEU . . . . . 0.58 HD13 ' O ' ' A' ' 977' ' ' LEU . 0.2 OUTLIER -66.24 -43.97 85.04 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 120.24 -0.584 . . . . 1.0 109.556 179.51 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 39.1 mt -61.56 -44.77 96.42 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.352 -0.539 . . . . 1.0 110.208 -179.724 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 97.1 mt -62.63 -43.47 98.73 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.419 -0.512 . . . . 1.0 110.368 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 980' ' ' LEU . . . . . 0.467 ' O ' HG23 ' A' ' 984' ' ' VAL . 56.0 mt -63.48 -39.88 95.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.111 0.482 . . . . 1.0 109.847 -179.86 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 5.6 m -64.26 -47.1 80.89 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.592 -0.731 . . . . 1.0 110.248 -179.633 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 97.4 mt -64.23 -45.25 96.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.473 -0.331 . . . . 1.0 111.66 -178.608 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -64.89 -40.75 95.6 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.869 -0.332 . . . . 1.0 110.775 179.575 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 984' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 980' ' ' LEU . 55.5 t -67.2 -48.08 79.57 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.402 0 CA-C-O 121.441 0.638 . . . . 1.0 110.024 179.904 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 985' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 985' ' ' LEU . 84.4 mt -63.55 -42.29 98.38 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.172 -0.922 . . . . 1.0 109.584 179.175 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 986' ' ' ALA . . . . . 0.886 ' O ' HG13 ' A' ' 990' ' ' VAL . . . -62.99 -42.49 99.86 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-O 121.66 0.743 . . . . 1.0 109.34 -179.716 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 28.9 mtp -63.87 -30.06 71.19 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 114.643 -1.162 . . . . 1.0 109.426 179.677 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 988' ' ' TRP . . . . . . . . . . . . . 1.7 t90 -76.11 -35.86 59.13 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.073 -1.421 . . . . 1.0 108.042 178.734 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.02 -38.98 76.05 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.494 0.664 . . . . 1.0 109.885 -179.693 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 990' ' ' VAL . . . . . 0.886 HG13 ' O ' ' A' ' 986' ' ' ALA . 1.4 m -81.95 -7.38 10.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.194 -0.912 . . . . 1.0 110.145 -179.175 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 991' ' ' GLY . . . . . 0.541 ' C ' ' H ' ' A' ' 993' ' ' PHE . . . 84.17 2.49 89.3 Favored Glycine 0 C--N 1.337 0.592 0 CA-C-O 119.074 -0.848 . . . . 1.0 112.672 178.613 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -53.52 -2.67 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 119.68 1.74 . . . . 1.0 112.159 -177.741 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 993' ' ' PHE . . . . . 0.541 ' H ' ' C ' ' A' ' 991' ' ' GLY . 28.3 m-85 . . . . . 0 N--CA 1.464 0.227 0 CA-C-O 123.194 1.473 . . . . 1.0 110.632 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 957' ' ' GLY . . . . . 0.534 ' O ' ' NH2' ' A' ' 962' ' ' ARG . . . . . . . . 0 N--CA 1.493 2.434 0 N-CA-C 108.93 -1.668 . . . . 10.49 108.93 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -162.88 -50.35 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.456 -0.942 . . . . 9.99 108.456 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 959' ' ' LEU . . . . . 0.801 HD12 ' H ' ' A' ' 959' ' ' LEU . 0.0 OUTLIER -62.64 -39.71 94.71 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 106.754 -1.573 . . . . 9.25 106.754 178.031 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 960' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -43.73 146.03 0.6 Allowed 'General case' 0 CA--C 1.511 -0.548 0 CA-C-N 114.776 -1.102 . . . . 10.19 108.726 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 961' ' ' GLU . . . . . 0.489 ' C ' ' N ' ' A' ' 963' ' ' ALA . 0.0 OUTLIER -94.3 70.71 3.78 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.993 -0.549 . . . . 9.03 110.753 -179.383 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 962' ' ' ARG . . . . . 0.543 ' C ' ' H ' ' A' ' 964' ' ' ILE . 1.0 OUTLIER -56.09 -28.52 58.03 Favored 'General case' 0 CA--C 1.503 -0.864 0 N-CA-C 102.284 -3.228 . . . . 9.38 102.284 174.042 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 963' ' ' ALA . . . . . 0.671 ' O ' ' C ' ' A' ' 964' ' ' ILE . . . 72.16 -14.85 0.51 Allowed 'General case' 0 N--CA 1.412 -2.332 0 CA-C-N 109.944 -3.298 . . . . 4.33 107.977 -178.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 964' ' ' ILE . . . . . 0.671 ' C ' ' O ' ' A' ' 963' ' ' ALA . 0.3 OUTLIER 17.29 61.12 0.19 Allowed Pre-proline 0 C--N 1.386 2.167 0 N-CA-C 104.008 -2.59 . . . . 6.17 104.008 -177.736 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 965' ' ' PRO . . . . . 0.603 ' HB2' ' HB2' ' A' ' 968' ' ' TRP . 14.1 Cg_endo -63.57 68.34 0.18 Allowed 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 121.006 1.137 . . . . 2.13 111.173 -169.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 966' ' ' ILE . . . . . 0.607 ' N ' ' O ' ' A' ' 964' ' ' ILE . 0.2 OUTLIER -46.21 -34.67 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.211 0 CA-C-N 112.768 -2.014 . . . . 1.54 108.003 178.301 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 967' ' ' TRP . . . . . 0.895 ' O ' HG23 ' A' ' 971' ' ' VAL . 98.4 m95 -65.45 -46.4 79.99 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.238 -0.892 . . . . 0.64 110.658 178.023 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 968' ' ' TRP . . . . . 0.603 ' HB2' ' HB2' ' A' ' 965' ' ' PRO . 64.4 m95 -65.33 -32.73 74.53 Favored 'General case' 0 CA--C 1.518 -0.272 0 C-N-CA 120.277 -0.569 . . . . 0.94 110.144 178.268 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 969' ' ' VAL . . . . . 0.726 ' O ' HG23 ' A' ' 973' ' ' VAL . 95.5 t -67.79 -47.24 80.39 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.391 0 N-CA-C 108.248 -1.019 . . . . 0.59 108.248 178.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 2.0 tp -61.84 -42.35 98.93 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 114.088 -1.415 . . . . 1.76 107.414 178.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 971' ' ' VAL . . . . . 0.895 HG23 ' O ' ' A' ' 967' ' ' TRP . 99.4 t -62.03 -46.06 97.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.872 0.368 . . . . 0.65 110.299 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -59.15 -42.32 97.07 Favored Glycine 0 C--N 1.338 0.644 0 N-CA-C 111.736 -0.546 . . . . 0.13 111.736 -179.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 973' ' ' VAL . . . . . 0.726 HG23 ' O ' ' A' ' 969' ' ' VAL . 63.6 t -67.31 -48.48 77.84 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.512 0 CA-C-N 114.94 -0.63 . . . . 0.86 109.48 -178.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 89.5 mt -61.99 -42.0 98.66 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 115.37 -0.832 . . . . 1.18 109.15 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -67.88 -47.5 60.19 Favored Glycine 0 C--N 1.335 0.478 0 N-CA-C 110.342 -1.103 . . . . 0.13 110.342 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -60.59 -37.98 94.26 Favored Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 108.805 -1.718 . . . . 0.14 108.805 178.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 977' ' ' LEU . . . . . 0.466 ' O ' ' OG1' ' A' ' 981' ' ' THR . 46.0 tp -66.11 -44.4 84.39 Favored 'General case' 0 C--O 1.225 -0.197 0 N-CA-C 109.364 -0.606 . . . . 1.56 109.364 178.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 1.1 mt -61.52 -46.27 90.66 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.689 -0.486 . . . . 1.73 109.689 178.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 57.2 mt -61.67 -43.62 98.51 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.186 -0.606 . . . . 0.89 109.884 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 980' ' ' LEU . . . . . 0.682 ' O ' HG23 ' A' ' 984' ' ' VAL . 22.7 mt -63.69 -41.45 98.13 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 119.981 -0.688 . . . . 1.23 109.971 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 981' ' ' THR . . . . . 0.466 ' OG1' ' O ' ' A' ' 977' ' ' LEU . 7.2 m -63.15 -47.4 82.85 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.254 -0.885 . . . . 0.19 110.928 -179.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 93.6 mt -64.38 -44.54 97.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.655 0.264 . . . . 0.71 110.598 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 13.1 mt -63.31 -36.81 84.91 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.978 -0.749 . . . . 1.66 108.978 179.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 984' ' ' VAL . . . . . 0.682 HG23 ' O ' ' A' ' 980' ' ' LEU . 23.0 t -69.14 -50.37 53.61 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 CA-C-N 115.321 -0.854 . . . . 0.28 110.92 -178.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 94.9 mt -65.45 -40.22 92.98 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.39 -0.823 . . . . 0.33 109.329 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 986' ' ' ALA . . . . . 0.678 ' O ' HG13 ' A' ' 990' ' ' VAL . . . -64.54 -45.4 87.31 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 121.509 0.671 . . . . 0.11 110.273 -179.002 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 987' ' ' MET . . . . . 0.45 ' O ' ' N ' ' A' ' 992' ' ' PHE . 25.6 mtp -63.25 -28.63 70.16 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 122.174 0.988 . . . . 0.53 109.582 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 988' ' ' TRP . . . . . . . . . . . . . 7.8 t90 -77.64 -35.41 52.57 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.016 -1.447 . . . . 2.42 108.014 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.5 -41.08 76.55 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.514 0.673 . . . . 0.74 109.874 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 990' ' ' VAL . . . . . 0.678 HG13 ' O ' ' A' ' 986' ' ' ALA . 2.4 m -79.42 -8.91 11.91 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 CA-C-N 115.124 -0.944 . . . . 0.15 109.72 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 991' ' ' GLY . . . . . . . . . . . . . . . 85.87 3.66 85.47 Favored Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 114.772 -1.104 . . . . 0.16 112.19 179.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 992' ' ' PHE . . . . . 0.45 ' N ' ' O ' ' A' ' 987' ' ' MET . 0.3 OUTLIER -55.07 -37.92 67.38 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 120.133 1.966 . . . . 0.51 113.762 -176.232 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 993' ' ' PHE . . . . . 0.407 ' CE2' ' HE2' ' A' ' 987' ' ' MET . 4.0 m-85 -73.22 -13.92 61.24 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-O 124.684 2.183 . . . . 1.53 109.293 178.177 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 994' ' ' LYS . . . . . . . . . . . . . 3.7 tttt -86.0 154.87 21.13 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 108.401 -4.0 . . . . 5.87 110.843 178.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 995' ' ' ARG . . . . . 0.497 ' O ' ' N ' ' A' ' 997' ' ' ARG . 15.1 mtm105 -115.63 -78.67 0.58 Allowed 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 118.491 0.587 . . . . 7.38 110.856 -177.268 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 996' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 45.56 17.66 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.128 -0.629 . . . . 6.94 110.297 179.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 997' ' ' ARG . . . . . 0.497 ' N ' ' O ' ' A' ' 995' ' ' ARG . 0.2 OUTLIER -56.26 158.56 7.36 Favored Pre-proline 0 CA--C 1.531 0.248 0 N-CA-C 108.774 -0.825 . . . . 9.24 108.774 179.872 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 998' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo . . . . . 0 C--N 1.308 -1.591 0 C-N-CA 122.289 1.992 . . . . 10.05 111.712 -179.229 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 957' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.542 0 N-CA-C 109.29 -1.524 . . . . 1.0 109.29 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -62.5 -41.43 98.82 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.971 -0.292 . . . . 1.0 110.62 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 94.1 mt -115.19 125.42 53.37 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.597 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 960' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -80.78 140.83 35.27 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.991 -0.549 . . . . 1.0 111.227 -179.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 961' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -67.12 137.54 56.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.831 -0.622 . . . . 1.0 110.365 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 962' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -125.89 149.02 49.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.941 -0.572 . . . . 1.0 110.872 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 963' ' ' ALA . . . . . . . . . . . . . . . -154.82 0.78 0.18 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.752 -0.658 . . . . 1.0 110.084 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 964' ' ' ILE . . . . . . . . . . . . . 5.1 pt -141.95 76.3 19.84 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.028 -0.533 . . . . 1.0 110.895 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -61.79 147.86 94.35 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.811 2.341 . . . . 1.0 111.734 179.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 83.2 mt -63.44 -44.36 98.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.007 -0.542 . . . . 1.0 111.675 -179.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 967' ' ' TRP . . . . . 0.759 ' O ' HG23 ' A' ' 971' ' ' VAL . 98.7 m95 -58.03 -38.33 76.02 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 112.03 0.381 . . . . 1.0 112.03 -178.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 31.3 m95 -69.3 -35.54 76.09 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 110.279 -0.267 . . . . 1.0 110.279 179.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 969' ' ' VAL . . . . . 0.451 ' O ' HG23 ' A' ' 973' ' ' VAL . 67.5 t -66.31 -45.01 90.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 109.097 -0.705 . . . . 1.0 109.097 178.127 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 92.4 mt -63.79 -41.81 97.85 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.997 -1.002 . . . . 1.0 109.961 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 971' ' ' VAL . . . . . 0.759 HG23 ' O ' ' A' ' 967' ' ' TRP . 76.0 t -62.71 -45.27 99.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.965 0.412 . . . . 1.0 110.855 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.14 -41.78 98.27 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.665 -0.574 . . . . 1.0 111.665 -179.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 973' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 969' ' ' VAL . 72.2 t -65.57 -46.78 88.63 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.541 0 CA-C-O 120.998 0.428 . . . . 1.0 110.574 -179.045 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 88.9 mt -62.24 -41.18 98.2 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.921 -0.77 . . . . 1.0 108.921 179.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -65.92 -46.18 83.41 Favored Glycine 0 C--N 1.329 0.163 0 N-CA-C 110.284 -1.126 . . . . 1.0 110.284 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -61.25 -37.93 94.82 Favored Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 109.141 -1.584 . . . . 1.0 109.141 179.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 55.4 tp -65.49 -42.53 92.07 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.196 -0.668 . . . . 1.0 109.196 178.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 42.9 tp -63.66 -45.47 90.0 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.304 -0.558 . . . . 1.0 110.694 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 90.9 mt -61.89 -42.8 99.5 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.017 -0.673 . . . . 1.0 109.908 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 980' ' ' LEU . . . . . 0.649 ' O ' HG23 ' A' ' 984' ' ' VAL . 84.6 mt -63.99 -41.41 97.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.988 0.423 . . . . 1.0 110.437 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 7.7 m -62.65 -46.41 88.34 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.738 -0.664 . . . . 1.0 110.29 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 94.5 mt -63.65 -43.75 98.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 C-N-CA 120.781 -0.368 . . . . 1.0 110.838 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 33.0 mt -64.72 -41.04 96.26 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.867 -0.333 . . . . 1.0 111.236 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 984' ' ' VAL . . . . . 0.649 HG23 ' O ' ' A' ' 980' ' ' LEU . 88.3 t -67.83 -49.07 72.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.25 0.548 . . . . 1.0 110.033 -179.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 81.6 mt -63.22 -43.32 98.45 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.433 -0.803 . . . . 1.0 109.698 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 986' ' ' ALA . . . . . 0.927 ' O ' HG13 ' A' ' 990' ' ' VAL . . . -61.72 -43.48 98.78 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 108.918 -0.771 . . . . 1.0 108.918 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 27.3 mtp -62.29 -30.79 71.38 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 114.804 -1.089 . . . . 1.0 109.648 179.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 988' ' ' TRP . . . . . . . . . . . . . 1.8 t90 -75.3 -37.79 60.65 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.035 -1.438 . . . . 1.0 108.271 179.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.22 -39.11 78.76 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.766 0.793 . . . . 1.0 110.048 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 990' ' ' VAL . . . . . 0.927 HG13 ' O ' ' A' ' 986' ' ' ALA . 1.4 m -83.39 -8.78 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-N 115.052 -0.976 . . . . 1.0 110.756 -178.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 991' ' ' GLY . . . . . 0.537 ' C ' ' H ' ' A' ' 993' ' ' PHE . . . 83.53 2.55 90.05 Favored Glycine 0 C--N 1.337 0.591 0 CA-C-O 119.222 -0.766 . . . . 1.0 112.594 178.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -52.64 -1.64 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 119.644 1.722 . . . . 1.0 112.386 -177.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 993' ' ' PHE . . . . . 0.537 ' H ' ' C ' ' A' ' 991' ' ' GLY . 12.2 m-85 -87.0 4.08 43.31 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.426 -0.51 . . . . 1.0 110.975 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 994' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -59.06 -43.74 91.76 Favored 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 108.238 -1.023 . . . . 1.0 108.238 177.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -91.82 140.22 29.9 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.099 -0.5 . . . . 1.0 110.61 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 996' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -100.5 7.54 44.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.141 -0.482 . . . . 1.0 111.708 -179.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 997' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -110.9 160.44 28.82 Favored Pre-proline 0 N--CA 1.464 0.228 0 CA-C-N 116.605 -0.27 . . . . 1.0 110.454 179.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 998' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo . . . . . 0 N--CA 1.493 1.449 0 C-N-CA 122.307 2.005 . . . . 1.0 111.824 179.816 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 957' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.356 0 N-CA-C 109.377 -1.489 . . . . 1.0 109.377 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -63.76 -37.23 86.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.0 0.429 . . . . 1.0 109.858 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 62.4 mt -103.41 132.45 49.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.824 -0.625 . . . . 1.0 110.231 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 960' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -65.71 -34.32 77.93 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.064 -0.517 . . . . 1.0 110.182 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 961' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -64.56 -35.95 82.63 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.726 -0.67 . . . . 1.0 111.112 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 962' ' ' ARG . . . . . . . . . . . . . 59.3 ttt85 -62.29 137.32 58.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.938 0.399 . . . . 1.0 110.236 -179.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 963' ' ' ALA . . . . . . . . . . . . . . . -66.41 145.78 55.3 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.993 -0.549 . . . . 1.0 111.124 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 964' ' ' ILE . . . . . . . . . . . . . 1.3 pt -132.52 66.08 76.06 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.76 -0.655 . . . . 1.0 110.11 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 965' ' ' PRO . . . . . 0.639 ' O ' HG23 ' A' ' 969' ' ' VAL . 30.2 Cg_endo -68.4 -12.26 34.38 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.325 2.016 . . . . 1.0 112.748 -179.197 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 97.5 mt -63.65 -44.77 98.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.526 -0.306 . . . . 1.0 111.336 -179.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 967' ' ' TRP . . . . . 0.676 ' O ' HG23 ' A' ' 971' ' ' VAL . 91.5 m95 -67.25 -35.87 80.43 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.31 -0.556 . . . . 1.0 110.704 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 87.0 m95 -68.37 -37.03 80.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.74 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 969' ' ' VAL . . . . . 0.639 HG23 ' O ' ' A' ' 965' ' ' PRO . 96.2 t -66.78 -42.78 89.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 109.046 -0.724 . . . . 1.0 109.046 178.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 87.4 mt -62.9 -41.77 99.56 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.209 -0.905 . . . . 1.0 109.796 178.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 971' ' ' VAL . . . . . 0.676 HG23 ' O ' ' A' ' 967' ' ' TRP . 76.2 t -62.5 -45.57 98.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.819 0.342 . . . . 1.0 110.829 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -61.24 -40.96 99.31 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 111.837 -0.505 . . . . 1.0 111.837 -179.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 973' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 969' ' ' VAL . 62.6 t -65.87 -46.22 89.18 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.376 0 CA-C-N 115.092 -0.554 . . . . 1.0 110.037 -179.194 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 86.7 mt -63.26 -41.4 99.03 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 121.327 0.584 . . . . 1.0 109.432 178.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -66.44 -46.8 74.79 Favored Glycine 0 C--N 1.332 0.341 0 N-CA-C 110.489 -1.044 . . . . 1.0 110.489 -179.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -60.18 -36.74 91.5 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 108.886 -1.686 . . . . 1.0 108.886 178.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 977' ' ' LEU . . . . . 0.433 ' O ' ' OG1' ' A' ' 981' ' ' THR . 50.5 tp -66.41 -43.4 85.84 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.263 -0.575 . . . . 1.0 109.912 178.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 978' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' A' ' 978' ' ' LEU . 53.0 mt -61.94 -44.13 97.41 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 119.739 -0.784 . . . . 1.0 109.726 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 84.5 mt -62.5 -43.41 98.89 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 119.744 -0.782 . . . . 1.0 110.297 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 980' ' ' LEU . . . . . 0.527 ' O ' HG23 ' A' ' 984' ' ' VAL . 66.6 mt -64.56 -42.19 95.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.075 0.464 . . . . 1.0 110.606 -179.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 981' ' ' THR . . . . . 0.433 ' OG1' ' O ' ' A' ' 977' ' ' LEU . 5.9 m -64.18 -47.1 81.12 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.558 -0.747 . . . . 1.0 110.109 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 94.3 mt -64.07 -44.49 97.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 120.74 -0.384 . . . . 1.0 111.433 -179.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 6.4 mp -64.55 -40.27 95.27 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.638 -0.425 . . . . 1.0 111.087 179.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 984' ' ' VAL . . . . . 0.527 HG23 ' O ' ' A' ' 980' ' ' LEU . 54.1 t -68.5 -48.98 69.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.21 0.529 . . . . 1.0 109.843 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 85.3 mt -63.33 -43.27 98.24 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.574 -0.739 . . . . 1.0 109.451 178.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 986' ' ' ALA . . . . . 0.906 ' O ' HG13 ' A' ' 990' ' ' VAL . . . -62.08 -42.7 99.48 Favored 'General case' 0 CA--C 1.511 -0.544 0 N-CA-C 108.997 -0.742 . . . . 1.0 108.997 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 987' ' ' MET . . . . . 0.414 ' HA ' HG22 ' A' ' 990' ' ' VAL . 30.9 mtp -62.1 -31.69 72.17 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 114.729 -1.123 . . . . 1.0 109.238 178.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 988' ' ' TRP . . . . . . . . . . . . . 1.8 t90 -73.23 -38.57 66.0 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 113.884 -1.507 . . . . 1.0 108.166 179.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.26 -39.6 78.34 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.434 -0.803 . . . . 1.0 110.39 -179.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 990' ' ' VAL . . . . . 0.906 HG13 ' O ' ' A' ' 986' ' ' ALA . 1.4 m -83.58 -8.66 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 CA-C-N 115.003 -0.998 . . . . 1.0 110.204 -178.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 991' ' ' GLY . . . . . 0.51 ' C ' ' H ' ' A' ' 993' ' ' PHE . . . 81.43 5.07 90.25 Favored Glycine 0 C--N 1.339 0.713 0 CA-C-O 119.199 -0.779 . . . . 1.0 112.508 179.148 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -52.5 -1.24 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 119.74 1.77 . . . . 1.0 112.932 -177.031 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 993' ' ' PHE . . . . . 0.51 ' H ' ' C ' ' A' ' 991' ' ' GLY . 16.1 m-85 -88.42 3.63 49.29 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 120.646 -0.422 . . . . 1.0 111.18 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 994' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -50.35 145.31 6.41 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.938 -0.764 . . . . 1.0 108.938 178.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 89.6 mtm180 -63.43 -42.52 98.7 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.137 -0.483 . . . . 1.0 111.297 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 996' ' ' ASN . . . . . . . . . . . . . 57.0 t-20 -91.62 104.94 17.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.908 0.385 . . . . 1.0 111.006 -179.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 997' ' ' ARG . . . . . . . . . . . . . 23.8 mtt85 -63.72 153.17 84.56 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.116 -0.493 . . . . 1.0 109.994 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 998' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo . . . . . 0 C--N 1.313 -1.305 0 C-N-CA 122.441 2.094 . . . . 1.0 112.051 179.523 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 957' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.41 0 N-CA-C 109.356 -1.498 . . . . 1.0 109.356 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 958' ' ' ALA . . . . . 0.413 ' O ' ' N ' ' A' ' 962' ' ' ARG . . . -69.92 141.69 53.06 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.542 -0.463 . . . . 1.0 110.297 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 57.9 tp -62.04 -40.71 96.67 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.175 -0.466 . . . . 1.0 109.885 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 960' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -65.45 -36.4 83.79 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.892 -0.595 . . . . 1.0 110.814 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 961' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -117.32 39.45 3.28 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-O 121.142 0.496 . . . . 1.0 110.195 178.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 962' ' ' ARG . . . . . 0.413 ' N ' ' O ' ' A' ' 958' ' ' ALA . 77.6 ttt-85 -59.46 -43.41 93.22 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.594 -0.73 . . . . 1.0 109.139 179.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 963' ' ' ALA . . . . . . . . . . . . . . . -72.76 -13.83 61.41 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.361 -0.836 . . . . 1.0 110.071 179.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 964' ' ' ILE . . . . . . . . . . . . . 57.2 mt 49.01 77.35 0.47 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.923 -0.58 . . . . 1.0 110.791 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -59.36 145.52 97.65 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 C-N-CA 122.672 2.248 . . . . 1.0 111.822 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 36.8 pt -69.46 -25.4 28.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.729 -0.669 . . . . 1.0 111.152 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 967' ' ' TRP . . . . . 0.825 ' O ' HG23 ' A' ' 971' ' ' VAL . 98.9 m95 -54.38 -38.66 66.4 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 116.147 -0.478 . . . . 1.0 111.447 -178.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 90.9 m95 -70.53 -36.42 73.71 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.474 -0.33 . . . . 1.0 110.367 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 95.2 t -66.81 -45.12 88.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 N-CA-C 108.389 -0.967 . . . . 1.0 108.389 178.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 58.9 tp -63.2 -42.51 99.32 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 114.564 -1.198 . . . . 1.0 109.199 178.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 971' ' ' VAL . . . . . 0.825 HG23 ' O ' ' A' ' 967' ' ' TRP . 79.3 t -62.29 -45.08 99.6 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.087 0 N-CA-C 109.727 -0.472 . . . . 1.0 109.727 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.23 -43.25 98.66 Favored Glycine 0 CA--C 1.526 0.736 0 CA-C-N 116.151 -0.477 . . . . 1.0 112.127 -179.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 58.2 t -65.24 -46.72 89.9 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.416 0 CA-C-N 115.169 -0.515 . . . . 1.0 110.066 -179.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 974' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 974' ' ' LEU . 88.8 mt -62.11 -41.98 98.76 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 109.038 -0.727 . . . . 1.0 109.038 178.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -65.98 -47.4 74.45 Favored Glycine 0 C--O 1.225 -0.418 0 N-CA-C 110.248 -1.141 . . . . 1.0 110.248 -179.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -59.13 -37.46 91.73 Favored Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 109.144 -1.582 . . . . 1.0 109.144 178.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 977' ' ' LEU . . . . . 0.431 HD23 ' HA ' ' A' ' 977' ' ' LEU . 35.7 mt -65.49 -42.97 91.56 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 119.982 -0.687 . . . . 1.0 110.257 178.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 35.7 mt -61.98 -44.05 97.55 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.021 -0.671 . . . . 1.0 110.304 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 10.7 mp -63.82 -43.57 95.82 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 119.555 -0.858 . . . . 1.0 111.501 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 980' ' ' LEU . . . . . 0.433 ' O ' HG23 ' A' ' 984' ' ' VAL . 2.6 mm? -63.66 -39.58 94.68 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.731 -0.388 . . . . 1.0 110.966 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 6.7 m -64.64 -47.74 77.38 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.137 -0.483 . . . . 1.0 110.853 -179.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 92.9 mt -63.27 -44.48 99.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.385 -0.371 . . . . 1.0 111.265 -178.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -64.83 -40.83 95.82 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.333 -0.394 . . . . 1.0 111.564 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 984' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 980' ' ' LEU . 41.2 t -67.48 -48.48 77.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.425 0.631 . . . . 1.0 110.277 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 85.9 mt -64.45 -42.78 95.78 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.136 -0.938 . . . . 1.0 109.894 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 986' ' ' ALA . . . . . 0.941 ' O ' HG13 ' A' ' 990' ' ' VAL . . . -62.92 -45.74 91.06 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.351 0.596 . . . . 1.0 109.825 -179.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 26.8 mtp -62.0 -32.56 73.05 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.966 -1.016 . . . . 1.0 109.522 179.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 988' ' ' TRP . . . . . 0.471 ' O ' ' CD1' ' A' ' 988' ' ' TRP . 11.4 t90 -74.47 -37.52 63.19 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.315 -1.311 . . . . 1.0 108.838 178.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.98 -40.58 78.72 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.797 0.808 . . . . 1.0 110.071 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 990' ' ' VAL . . . . . 0.941 HG13 ' O ' ' A' ' 986' ' ' ALA . 1.4 m -81.43 -8.08 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-N 114.639 -1.164 . . . . 1.0 110.1 -179.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 991' ' ' GLY . . . . . 0.551 ' C ' ' H ' ' A' ' 993' ' ' PHE . . . 83.28 2.83 90.33 Favored Glycine 0 C--N 1.338 0.654 0 CA-C-O 119.116 -0.825 . . . . 1.0 112.479 178.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -52.98 -1.95 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 119.722 1.761 . . . . 1.0 112.132 -177.306 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 993' ' ' PHE . . . . . 0.551 ' H ' ' C ' ' A' ' 991' ' ' GLY . 11.0 m-85 -86.43 2.48 47.54 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.398 -0.364 . . . . 1.0 110.961 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 994' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -54.65 132.78 46.17 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.052 -1.092 . . . . 1.0 108.052 177.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -63.75 -38.92 92.9 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.158 -0.473 . . . . 1.0 110.594 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 996' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -93.44 110.82 22.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.095 -0.502 . . . . 1.0 111.201 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 997' ' ' ARG . . . . . . . . . . . . . 19.7 mtt85 -52.85 152.78 6.64 Favored Pre-proline 0 CA--C 1.534 0.356 0 C-N-CA 120.765 -0.374 . . . . 1.0 110.047 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 998' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo . . . . . 0 N--CA 1.499 1.845 0 C-N-CA 122.661 2.24 . . . . 1.0 112.254 179.999 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 957' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.231 0 N-CA-C 109.317 -1.513 . . . . 1.0 109.317 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -64.75 -39.26 93.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.885 0.374 . . . . 1.0 110.504 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 87.1 mt -107.88 132.0 53.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.908 -0.587 . . . . 1.0 110.481 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 960' ' ' GLU . . . . . 0.446 ' HG2' ' H ' ' A' ' 962' ' ' ARG . 81.5 tt0 -56.27 -76.33 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.145 -0.48 . . . . 1.0 110.793 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 961' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 55.32 38.07 29.82 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.06 -0.518 . . . . 1.0 111.047 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 962' ' ' ARG . . . . . 0.446 ' H ' ' HG2' ' A' ' 960' ' ' GLU . 85.4 mtp180 -103.51 133.97 47.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.438 -0.346 . . . . 1.0 110.264 179.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 963' ' ' ALA . . . . . . . . . . . . . . . -66.78 141.81 57.58 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.325 -0.398 . . . . 1.0 110.742 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 964' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -86.6 156.03 56.25 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 1.0 109.905 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -77.47 44.13 1.46 Allowed 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.106 1.87 . . . . 1.0 111.819 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 966' ' ' ILE . . . . . 0.492 HG23 ' N ' ' A' ' 967' ' ' TRP . 19.7 tt -66.1 -40.87 88.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.996 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 967' ' ' TRP . . . . . 0.568 ' O ' HG23 ' A' ' 971' ' ' VAL . 97.6 m95 -53.94 -37.96 64.41 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.716 -179.229 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -69.05 -35.49 76.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.166 -0.47 . . . . 1.0 109.98 178.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 969' ' ' VAL . . . . . 0.566 ' O ' HG23 ' A' ' 973' ' ' VAL . 77.6 t -67.33 -44.6 87.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.539 0.685 . . . . 1.0 109.284 178.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 57.3 tp -63.61 -43.16 97.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.702 -1.135 . . . . 1.0 109.468 179.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 971' ' ' VAL . . . . . 0.568 HG23 ' O ' ' A' ' 967' ' ' TRP . 46.7 t -62.08 -45.01 99.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.998 0.428 . . . . 1.0 110.469 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.08 -39.42 95.74 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 111.348 -0.701 . . . . 1.0 111.348 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 973' ' ' VAL . . . . . 0.566 HG23 ' O ' ' A' ' 969' ' ' VAL . 74.5 t -66.61 -47.51 83.14 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.29 0 CA-C-N 114.999 -0.6 . . . . 1.0 110.585 -179.243 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 92.9 mt -62.91 -41.69 99.54 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.191 -0.67 . . . . 1.0 109.191 179.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -66.28 -46.71 76.88 Favored Glycine 0 C--N 1.329 0.175 0 N-CA-C 110.74 -0.944 . . . . 1.0 110.74 -179.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -60.29 -37.03 92.41 Favored Glycine 0 N--CA 1.448 -0.505 0 N-CA-C 109.181 -1.568 . . . . 1.0 109.181 179.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 38.2 mt -65.97 -42.54 89.74 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.119 -0.632 . . . . 1.0 110.158 179.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 76.7 mt -62.38 -44.46 96.41 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.149 -0.62 . . . . 1.0 110.496 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 96.7 mt -63.1 -43.61 98.0 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.248 -0.581 . . . . 1.0 110.676 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 980' ' ' LEU . . . . . . . . . . . . . 81.3 mt -64.35 -40.38 95.75 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.079 0.466 . . . . 1.0 110.417 -179.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 981' ' ' THR . . . . . 0.43 HG22 ' CD1' ' A' ' 985' ' ' LEU . 7.1 m -63.54 -45.79 88.94 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.525 -0.761 . . . . 1.0 109.748 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 89.7 mt -63.57 -44.18 98.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.318 -0.401 . . . . 1.0 111.366 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 85.1 mt -64.48 -42.63 95.77 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 121.125 -0.23 . . . . 1.0 111.347 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 984' ' ' VAL . . . . . . . . . . . . . 47.3 t -67.9 -47.96 77.12 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.374 0 CA-C-O 121.223 0.535 . . . . 1.0 109.968 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 985' ' ' LEU . . . . . 0.43 ' CD1' HG22 ' A' ' 981' ' ' THR . 89.3 mt -63.49 -42.75 98.53 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.458 -0.792 . . . . 1.0 109.348 179.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 986' ' ' ALA . . . . . 0.881 ' O ' HG13 ' A' ' 990' ' ' VAL . . . -63.18 -45.64 90.84 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 121.513 0.673 . . . . 1.0 109.621 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 32.6 mtp -62.34 -33.44 74.71 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.614 -1.175 . . . . 1.0 109.188 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 988' ' ' TRP . . . . . 0.489 ' O ' ' CD1' ' A' ' 988' ' ' TRP . 12.9 t90 -73.2 -35.2 66.32 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.473 -1.239 . . . . 1.0 108.379 178.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.04 -40.14 75.32 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.589 -0.732 . . . . 1.0 109.795 -179.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 990' ' ' VAL . . . . . 0.881 HG13 ' O ' ' A' ' 986' ' ' ALA . 1.2 m -81.91 -7.12 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 CA-C-N 114.989 -1.005 . . . . 1.0 110.063 -179.237 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 991' ' ' GLY . . . . . 0.517 ' C ' ' H ' ' A' ' 993' ' ' PHE . . . 82.15 3.77 90.45 Favored Glycine 0 C--N 1.34 0.784 0 CA-C-O 119.011 -0.883 . . . . 1.0 112.666 178.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -54.13 -0.93 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 119.607 1.704 . . . . 1.0 112.839 -177.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 993' ' ' PHE . . . . . 0.517 ' H ' ' C ' ' A' ' 991' ' ' GLY . 13.1 m-85 -88.5 1.78 54.17 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.051 0.453 . . . . 1.0 110.135 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 994' ' ' LYS . . . . . 0.402 ' O ' ' O ' ' A' ' 993' ' ' PHE . 15.5 mttt 60.28 129.52 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.68 -0.691 . . . . 1.0 110.975 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 88.5 mtm-85 -92.23 146.8 23.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.063 -0.517 . . . . 1.0 110.74 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 996' ' ' ASN . . . . . . . . . . . . . 60.3 t-20 53.99 41.66 31.95 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.002 0.43 . . . . 1.0 110.345 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 997' ' ' ARG . . . . . 0.418 ' HG2' ' H ' ' A' ' 997' ' ' ARG . 0.0 OUTLIER -41.39 163.4 0.11 Allowed Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 115.974 -0.557 . . . . 1.0 110.764 -179.666 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 998' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo . . . . . 0 C--N 1.31 -1.479 0 C-N-CA 122.708 2.272 . . . . 1.0 112.094 179.89 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 957' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.351 0 N-CA-C 109.507 -1.437 . . . . 1.0 109.507 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -142.38 147.1 35.68 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.906 0.384 . . . . 1.0 111.085 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 959' ' ' LEU . . . . . 0.529 HD12 ' N ' ' A' ' 959' ' ' LEU . 10.3 mp -62.99 -42.55 99.88 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.138 179.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 960' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -121.84 121.74 37.88 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.116 -0.493 . . . . 1.0 109.789 179.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 961' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -118.02 125.85 51.15 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 121.032 0.444 . . . . 1.0 110.97 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 962' ' ' ARG . . . . . . . . . . . . . 90.7 mtt180 -64.62 -40.42 95.47 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.817 -0.629 . . . . 1.0 111.226 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 963' ' ' ALA . . . . . . . . . . . . . . . -152.3 154.85 36.53 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.768 0.318 . . . . 1.0 111.115 -179.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 964' ' ' ILE . . . . . . . . . . . . . 2.8 pt -130.0 75.12 79.89 Favored Pre-proline 0 N--CA 1.463 0.203 0 CA-C-N 116.104 -0.498 . . . . 1.0 110.656 179.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 965' ' ' PRO . . . . . 0.605 ' O ' HG23 ' A' ' 969' ' ' VAL . 58.0 Cg_endo -80.03 -3.0 12.47 Favored 'Trans proline' 0 C--N 1.303 -1.839 0 C-N-CA 122.789 2.326 . . . . 1.0 112.572 -179.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 966' ' ' ILE . . . . . 0.499 HG23 ' N ' ' A' ' 967' ' ' TRP . 20.1 tt -64.19 -41.62 92.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 C-N-CA 120.787 -0.365 . . . . 1.0 110.725 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 967' ' ' TRP . . . . . 0.499 ' N ' HG23 ' A' ' 966' ' ' ILE . 99.5 m95 -70.8 -35.58 72.59 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.578 -0.449 . . . . 1.0 110.98 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 94.0 m95 -69.56 -34.47 74.23 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.361 -0.382 . . . . 1.0 110.247 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 969' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 965' ' ' PRO . 73.9 t -65.83 -43.22 93.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 C-N-CA 119.889 -0.724 . . . . 1.0 109.175 177.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 93.2 mt -62.74 -42.35 99.63 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.145 -0.934 . . . . 1.0 109.923 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 971' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 967' ' ' TRP . 47.5 t -61.87 -46.23 96.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.864 0.364 . . . . 1.0 110.175 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -59.79 -43.55 97.81 Favored Glycine 0 CA--C 1.521 0.418 0 CA-C-N 116.095 -0.502 . . . . 1.0 112.016 -179.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 973' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 969' ' ' VAL . 71.6 t -65.17 -46.45 90.94 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.555 0 CA-C-O 120.996 0.426 . . . . 1.0 110.703 -178.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 91.5 mt -63.12 -40.38 97.43 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 109.17 -0.678 . . . . 1.0 109.17 179.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -67.76 -45.35 76.01 Favored Glycine 0 CA--C 1.518 0.236 0 N-CA-C 110.415 -1.074 . . . . 1.0 110.415 -179.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -61.24 -37.54 94.17 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 109.622 -1.391 . . . . 1.0 109.622 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 57.9 tp -67.52 -41.68 84.01 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 119.698 -0.801 . . . . 1.0 109.874 179.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 65.9 mt -62.04 -43.77 98.13 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 119.86 -0.736 . . . . 1.0 110.298 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 82.3 mt -62.59 -44.03 97.32 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.323 -0.551 . . . . 1.0 110.825 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 980' ' ' LEU . . . . . 0.724 ' O ' HG23 ' A' ' 984' ' ' VAL . 88.6 mt -63.96 -40.26 96.0 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.067 0.461 . . . . 1.0 110.168 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 6.8 m -64.09 -46.65 83.31 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.612 -0.722 . . . . 1.0 110.293 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 93.9 mt -64.07 -44.57 97.73 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 C-N-CA 120.827 -0.349 . . . . 1.0 111.118 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 59.7 tp -63.96 -40.88 97.43 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.624 -0.43 . . . . 1.0 110.21 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 984' ' ' VAL . . . . . 0.724 HG23 ' O ' ' A' ' 980' ' ' LEU . 77.8 t -65.7 -47.69 85.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.311 0.577 . . . . 1.0 110.252 -179.312 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 64.7 mt -63.71 -41.38 98.11 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.37 -0.832 . . . . 1.0 109.533 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 986' ' ' ALA . . . . . 0.87 ' O ' HG13 ' A' ' 990' ' ' VAL . . . -62.96 -47.13 84.5 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.107 0.48 . . . . 1.0 110.511 -179.136 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 13.3 mtm -64.09 -32.35 73.87 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 122.112 0.958 . . . . 1.0 109.622 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 988' ' ' TRP . . . . . 0.483 ' O ' ' CD1' ' A' ' 988' ' ' TRP . 9.4 t90 -69.27 -36.46 77.11 Favored 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 107.499 -1.297 . . . . 1.0 107.499 178.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.81 -39.56 76.47 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.117 -0.947 . . . . 1.0 110.321 -179.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 990' ' ' VAL . . . . . 0.87 HG13 ' O ' ' A' ' 986' ' ' ALA . 1.0 OUTLIER -84.88 -9.89 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 CA-C-N 115.198 -0.91 . . . . 1.0 110.651 -178.892 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 991' ' ' GLY . . . . . 0.484 ' C ' ' H ' ' A' ' 993' ' ' PHE . . . 82.47 6.53 88.55 Favored Glycine 0 C--N 1.336 0.56 0 CA-C-O 118.744 -1.031 . . . . 1.0 112.876 179.171 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -57.45 0.26 0.05 Allowed 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 120.056 1.928 . . . . 1.0 112.997 -177.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 993' ' ' PHE . . . . . 0.484 ' H ' ' C ' ' A' ' 991' ' ' GLY . 10.3 m-85 -92.12 7.74 41.09 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.379 0.609 . . . . 1.0 109.688 179.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 994' ' ' LYS . . . . . . . . . . . . . 6.6 tttp 62.71 105.22 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.182 -0.917 . . . . 1.0 110.866 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 92.4 mtm-85 -64.98 -40.57 95.16 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.898 -0.592 . . . . 1.0 110.903 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 996' ' ' ASN . . . . . . . . . . . . . 43.5 p-10 -157.05 171.93 19.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.114 -0.494 . . . . 1.0 110.549 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 997' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.73 160.17 26.98 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 115.88 -0.6 . . . . 1.0 110.205 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 998' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo . . . . . 0 C--N 1.308 -1.581 0 C-N-CA 122.415 2.076 . . . . 1.0 112.033 179.529 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 957' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.216 0 N-CA-C 109.402 -1.479 . . . . 1.0 109.402 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -70.15 140.05 52.54 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.757 -0.377 . . . . 1.0 110.318 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 78.7 mt -61.72 -41.62 97.87 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.29 -0.414 . . . . 1.0 110.696 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 960' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -64.81 -41.57 95.68 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.992 -0.549 . . . . 1.0 111.074 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 961' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -127.94 111.68 13.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.31 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 962' ' ' ARG . . . . . . . . . . . . . 77.4 ttt180 -76.49 142.04 41.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.321 -0.4 . . . . 1.0 110.374 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 963' ' ' ALA . . . . . . . . . . . . . . . -68.03 138.97 56.26 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.397 -0.365 . . . . 1.0 110.147 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 964' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -135.95 155.29 77.87 Favored Pre-proline 0 CA--C 1.534 0.36 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.449 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 965' ' ' PRO . . . . . 0.478 ' O ' HG23 ' A' ' 969' ' ' VAL . 57.6 Cg_endo -71.42 -10.55 27.16 Favored 'Trans proline' 0 N--CA 1.498 1.755 0 C-N-CA 122.87 2.38 . . . . 1.0 113.205 -179.248 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 42.3 mm -60.46 -48.94 86.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.666 -0.243 . . . . 1.0 111.058 -179.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 967' ' ' TRP . . . . . 0.515 ' O ' HG23 ' A' ' 971' ' ' VAL . 81.7 m95 -63.1 -36.37 83.37 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.636 -0.425 . . . . 1.0 110.621 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 95.3 m95 -68.73 -36.72 78.77 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.3 178.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 969' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 965' ' ' PRO . 56.1 t -66.02 -43.88 92.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.149 -0.685 . . . . 1.0 109.149 178.327 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 62.9 tp -62.72 -41.94 99.41 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.179 -0.919 . . . . 1.0 109.484 179.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 971' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 967' ' ' TRP . 41.6 t -63.47 -45.79 96.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.165 -0.47 . . . . 1.0 111.321 -179.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -62.51 -44.17 97.96 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-N 116.253 -0.43 . . . . 1.0 113.532 -178.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 35.0 m -68.29 -42.96 84.8 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 CA-C-O 120.787 0.327 . . . . 1.0 110.861 -178.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 97.9 mt -63.09 -40.17 96.86 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.444 -0.947 . . . . 1.0 108.444 178.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -66.13 -46.75 78.05 Favored Glycine 0 C--N 1.33 0.222 0 N-CA-C 110.447 -1.061 . . . . 1.0 110.447 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -59.33 -36.16 87.83 Favored Glycine 0 N--CA 1.448 -0.514 0 N-CA-C 108.804 -1.718 . . . . 1.0 108.804 178.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 977' ' ' LEU . . . . . 0.427 ' O ' ' OG1' ' A' ' 981' ' ' THR . 58.9 tp -65.54 -43.64 89.32 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.17 -0.612 . . . . 1.0 109.719 178.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 45.7 tp -61.84 -45.45 93.77 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.653 -0.419 . . . . 1.0 110.436 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 10.8 mp -63.18 -43.16 99.0 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 119.935 -0.706 . . . . 1.0 110.719 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 980' ' ' LEU . . . . . 0.53 ' O ' HG23 ' A' ' 984' ' ' VAL . 80.7 mt -63.94 -40.85 97.4 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 121.186 0.517 . . . . 1.0 110.149 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 981' ' ' THR . . . . . 0.444 HG22 HD12 ' A' ' 985' ' ' LEU . 8.2 m -62.75 -46.79 86.42 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.37 -0.832 . . . . 1.0 110.015 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 88.9 mt -63.84 -43.83 97.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 C-N-CA 120.633 -0.427 . . . . 1.0 111.203 -179.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 91.1 mt -65.2 -41.07 94.88 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.519 -0.309 . . . . 1.0 111.03 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 984' ' ' VAL . . . . . 0.53 HG23 ' O ' ' A' ' 980' ' ' LEU . 72.0 t -70.02 -50.16 50.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.064 0.459 . . . . 1.0 110.449 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 985' ' ' LEU . . . . . 0.444 HD12 HG22 ' A' ' 981' ' ' THR . 89.8 mt -63.79 -42.92 97.63 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.783 -0.644 . . . . 1.0 109.622 179.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 986' ' ' ALA . . . . . 0.863 ' O ' HG13 ' A' ' 990' ' ' VAL . . . -62.53 -43.28 99.2 Favored 'General case' 0 CA--C 1.511 -0.531 0 N-CA-C 108.926 -0.768 . . . . 1.0 108.926 -179.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 31.5 mtp -61.95 -30.53 70.97 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 122.512 1.148 . . . . 1.0 109.073 178.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 988' ' ' TRP . . . . . . . . . . . . . 1.6 t90 -74.02 -36.98 64.48 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 113.64 -1.618 . . . . 1.0 107.874 179.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.71 -39.05 73.64 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.595 0.712 . . . . 1.0 110.248 -179.359 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 990' ' ' VAL . . . . . 0.863 HG13 ' O ' ' A' ' 986' ' ' ALA . 1.1 m -81.76 -7.28 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-N 114.967 -1.015 . . . . 1.0 110.09 -179.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 991' ' ' GLY . . . . . 0.51 ' C ' ' H ' ' A' ' 993' ' ' PHE . . . 81.85 3.73 90.51 Favored Glycine 0 C--N 1.34 0.79 0 CA-C-O 119.136 -0.813 . . . . 1.0 112.414 178.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -52.63 -1.56 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 119.45 1.625 . . . . 1.0 112.932 -177.016 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 993' ' ' PHE . . . . . 0.51 ' H ' ' C ' ' A' ' 991' ' ' GLY . 15.4 m-85 -90.45 -1.88 57.92 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.287 0.565 . . . . 1.0 110.433 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 994' ' ' LYS . . . . . 0.406 ' CG ' ' O ' ' A' ' 993' ' ' PHE . 96.9 mttt -161.58 -39.64 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 114.948 -1.024 . . . . 1.0 112.253 -179.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 71.4 ttt180 -72.82 134.68 44.99 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.125 -0.488 . . . . 1.0 109.877 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 996' ' ' ASN . . . . . . . . . . . . . 60.0 t30 58.66 41.32 22.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.348 -0.387 . . . . 1.0 111.056 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 997' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -50.13 157.66 1.1 Allowed Pre-proline 0 C--N 1.329 -0.284 0 N-CA-C 109.942 -0.392 . . . . 1.0 109.942 179.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 998' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo . . . . . 0 C--N 1.308 -1.556 0 C-N-CA 122.507 2.138 . . . . 1.0 111.898 179.84 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 957' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.321 0 N-CA-C 109.94 -1.264 . . . . 1.0 109.94 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -62.49 -34.85 77.68 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.679 0.276 . . . . 1.0 110.726 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 52.8 tp -64.09 -39.84 94.93 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.956 0.408 . . . . 1.0 110.45 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 960' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -66.37 -37.52 85.47 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.964 -0.562 . . . . 1.0 110.047 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 961' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -66.04 137.86 57.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.949 -0.569 . . . . 1.0 110.757 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 962' ' ' ARG . . . . . . . . . . . . . 74.7 ttt180 -60.1 -43.81 95.3 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.661 -0.7 . . . . 1.0 110.338 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 963' ' ' ALA . . . . . . . . . . . . . . . -107.37 132.59 52.98 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.991 -0.55 . . . . 1.0 109.78 179.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 964' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -87.63 156.06 53.33 Favored Pre-proline 0 C--N 1.324 -0.505 0 N-CA-C 109.375 -0.602 . . . . 1.0 109.375 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -76.83 48.33 2.43 Favored 'Trans proline' 0 N--CA 1.496 1.637 0 C-N-CA 122.407 2.071 . . . . 1.0 112.21 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 966' ' ' ILE . . . . . 0.506 HG23 ' N ' ' A' ' 967' ' ' TRP . 20.5 tt -66.16 -43.29 92.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.736 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 967' ' ' TRP . . . . . 0.684 ' O ' HG23 ' A' ' 971' ' ' VAL . 98.7 m95 -54.83 -37.24 65.92 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.516 -0.311 . . . . 1.0 110.877 -179.411 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -69.25 -34.88 75.47 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 110.029 -0.36 . . . . 1.0 110.029 179.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 969' ' ' VAL . . . . . 0.458 ' O ' HG23 ' A' ' 973' ' ' VAL . 75.3 t -68.52 -47.02 79.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.203 0.525 . . . . 1.0 110.489 178.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 8.8 mp -64.01 -41.68 97.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.509 -0.768 . . . . 1.0 110.18 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 971' ' ' VAL . . . . . 0.684 HG23 ' O ' ' A' ' 967' ' ' TRP . 59.1 t -62.3 -44.53 99.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.879 0.371 . . . . 1.0 110.541 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -61.43 -40.49 98.74 Favored Glycine 0 CA--C 1.529 0.915 0 CA-C-N 116.064 -0.516 . . . . 1.0 112.006 -179.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 973' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 969' ' ' VAL . 75.9 t -67.0 -45.26 87.46 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.519 0 CA-C-N 115.445 -0.378 . . . . 1.0 110.735 -178.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 9.2 mp -62.5 -40.23 96.06 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.597 -0.89 . . . . 1.0 108.597 178.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -65.07 -45.8 90.78 Favored Glycine 0 N--CA 1.46 0.247 0 N-CA-C 110.29 -1.124 . . . . 1.0 110.29 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -59.69 -36.73 90.74 Favored Glycine 0 N--CA 1.444 -0.767 0 N-CA-C 108.771 -1.731 . . . . 1.0 108.771 178.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 55.7 tp -66.86 -44.11 81.83 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.187 -0.605 . . . . 1.0 110.514 179.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 83.2 mt -62.54 -44.94 95.09 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.091 -0.643 . . . . 1.0 110.757 -179.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 10.2 mp -63.51 -44.11 95.22 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 119.675 -0.81 . . . . 1.0 111.924 -179.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 980' ' ' LEU . . . . . . . . . . . . . 7.1 mp -63.83 -37.65 88.15 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.156 -0.618 . . . . 1.0 110.79 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 5.4 m -65.5 -46.61 79.04 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.521 -179.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 80.1 mt -63.11 -43.41 98.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 120.495 -0.482 . . . . 1.0 110.732 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 57.1 mt -63.66 -41.78 98.17 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 121.153 -0.219 . . . . 1.0 110.722 179.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 984' ' ' VAL . . . . . . . . . . . . . 56.6 t -68.38 -47.99 75.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 120.928 0.394 . . . . 1.0 110.052 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 84.3 mt -62.63 -42.41 99.58 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.937 -0.574 . . . . 1.0 109.524 179.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 986' ' ' ALA . . . . . 0.869 ' O ' HG13 ' A' ' 990' ' ' VAL . . . -63.26 -44.32 95.48 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 121.696 0.76 . . . . 1.0 108.981 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 30.7 mtp -62.11 -32.44 73.01 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 114.566 -1.197 . . . . 1.0 109.159 178.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 988' ' ' TRP . . . . . . . . . . . . . 2.0 t90 -72.32 -38.25 68.73 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.292 -1.322 . . . . 1.0 108.104 178.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.58 -39.62 84.85 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.335 -0.848 . . . . 1.0 110.306 -179.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 990' ' ' VAL . . . . . 0.869 HG13 ' O ' ' A' ' 986' ' ' ALA . 1.2 m -83.88 -8.94 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-N 115.286 -0.87 . . . . 1.0 110.956 -178.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 991' ' ' GLY . . . . . 0.556 ' C ' ' H ' ' A' ' 993' ' ' PHE . . . 82.58 4.24 90.19 Favored Glycine 0 C--N 1.338 0.671 0 CA-C-O 119.245 -0.753 . . . . 1.0 112.703 178.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -53.02 -2.91 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 119.259 1.529 . . . . 1.0 111.867 -177.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 993' ' ' PHE . . . . . 0.556 ' H ' ' C ' ' A' ' 991' ' ' GLY . 11.7 m-85 -84.88 -1.57 56.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.037 0.446 . . . . 1.0 109.916 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 994' ' ' LYS . . . . . . . . . . . . . 14.2 mttt 54.8 -178.93 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.671 -0.695 . . . . 1.0 111.656 179.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 97.1 mtt-85 -81.94 147.01 29.47 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.36 -0.837 . . . . 1.0 110.355 -179.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 996' ' ' ASN . . . . . . . . . . . . . 63.3 t-20 -95.85 106.05 18.14 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.135 0.493 . . . . 1.0 111.511 -179.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 997' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.4 159.57 65.75 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 115.791 -0.64 . . . . 1.0 110.211 179.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 998' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo . . . . . 0 N--CA 1.498 1.79 0 C-N-CA 122.947 2.431 . . . . 1.0 112.689 -179.79 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 957' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.351 0 N-CA-C 109.941 -1.263 . . . . 1.0 109.941 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -71.9 148.45 46.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.001 0.429 . . . . 1.0 111.385 -179.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 84.7 mt -110.23 140.33 44.48 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.755 -0.657 . . . . 1.0 109.832 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 960' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -63.22 -35.2 79.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.532 -0.304 . . . . 1.0 110.923 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 961' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -63.63 -39.33 94.08 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 120.776 -0.37 . . . . 1.0 110.677 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 962' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -62.86 -40.83 98.67 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.886 0.374 . . . . 1.0 110.261 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 963' ' ' ALA . . . . . . . . . . . . . . . 44.19 -158.85 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.468 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 964' ' ' ILE . . . . . 0.697 HG23 ' O ' ' A' ' 964' ' ' ILE . 3.7 tt -172.37 74.63 0.45 Allowed Pre-proline 0 C--N 1.328 -0.33 0 C-N-CA 120.875 -0.33 . . . . 1.0 110.889 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -80.19 47.54 2.57 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.893 2.395 . . . . 1.0 112.19 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 966' ' ' ILE . . . . . 0.509 HG23 ' N ' ' A' ' 967' ' ' TRP . 19.9 tt -66.13 -41.43 89.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.627 -0.715 . . . . 1.0 111.236 -179.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 967' ' ' TRP . . . . . 0.786 ' O ' HG23 ' A' ' 971' ' ' VAL . 98.3 m95 -55.82 -36.5 67.54 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 120.895 -0.322 . . . . 1.0 111.498 -178.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -70.24 -36.84 74.78 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.605 -0.27 . . . . 1.0 110.475 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 969' ' ' VAL . . . . . 0.445 ' O ' HG23 ' A' ' 973' ' ' VAL . 73.8 t -66.66 -44.35 89.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 108.937 -0.764 . . . . 1.0 108.937 178.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 60.9 tp -62.96 -43.2 99.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.817 -1.083 . . . . 1.0 109.499 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 971' ' ' VAL . . . . . 0.786 HG23 ' O ' ' A' ' 967' ' ' TRP . 56.2 t -61.93 -46.19 97.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.391 -0.368 . . . . 1.0 111.102 -179.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.15 -40.6 97.43 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 111.612 -0.595 . . . . 1.0 111.612 -179.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 973' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 969' ' ' VAL . 64.8 t -66.8 -48.37 80.05 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.483 0 CA-C-O 121.028 0.442 . . . . 1.0 111.068 -178.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 974' ' ' LEU . . . . . 0.406 HD13 ' HA ' ' A' ' 974' ' ' LEU . 3.9 mm? -62.74 -41.2 99.08 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 109.297 -0.631 . . . . 1.0 109.297 179.224 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -65.16 -43.52 95.37 Favored Glycine 0 C--O 1.229 -0.172 0 N-CA-C 109.456 -1.457 . . . . 1.0 109.456 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -62.01 -37.24 94.09 Favored Glycine 0 CA--C 1.521 0.462 0 N-CA-C 109.759 -1.336 . . . . 1.0 109.759 179.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 977' ' ' LEU . . . . . 0.41 ' O ' ' OG1' ' A' ' 981' ' ' THR . 60.7 tp -67.81 -44.53 77.06 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 109.856 -0.424 . . . . 1.0 109.856 179.18 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -62.16 -43.81 98.0 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.329 -0.548 . . . . 1.0 110.28 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 86.3 mt -62.88 -43.67 98.18 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.07 -0.652 . . . . 1.0 110.62 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 980' ' ' LEU . . . . . . . . . . . . . 64.4 mt -63.99 -40.62 96.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.123 0.487 . . . . 1.0 110.269 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 981' ' ' THR . . . . . 0.439 HG22 ' CD1' ' A' ' 985' ' ' LEU . 7.5 m -63.4 -45.78 89.46 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.439 -0.801 . . . . 1.0 109.725 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 85.6 mt -63.97 -44.71 97.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.266 -0.425 . . . . 1.0 111.118 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 56.9 tp -64.89 -43.55 92.54 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.171 -0.468 . . . . 1.0 111.397 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 984' ' ' VAL . . . . . . . . . . . . . 51.9 t -66.71 -47.97 81.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.438 0.637 . . . . 1.0 110.134 -179.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 985' ' ' LEU . . . . . 0.439 ' CD1' HG22 ' A' ' 981' ' ' THR . 81.6 mt -63.22 -42.9 99.32 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.07 -0.968 . . . . 1.0 109.605 178.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 986' ' ' ALA . . . . . 0.879 ' O ' HG13 ' A' ' 990' ' ' VAL . . . -61.98 -44.92 95.74 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-O 121.348 0.594 . . . . 1.0 109.487 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 987' ' ' MET . . . . . 0.431 ' HA ' HG22 ' A' ' 990' ' ' VAL . 19.6 mtp -62.17 -30.29 70.96 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 122.349 1.071 . . . . 1.0 109.563 179.199 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 988' ' ' TRP . . . . . . . . . . . . . 1.7 t90 -74.75 -38.09 62.33 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.018 -1.446 . . . . 1.0 108.396 178.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.88 -39.94 79.53 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.467 -0.788 . . . . 1.0 109.741 -179.068 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 990' ' ' VAL . . . . . 0.879 HG13 ' O ' ' A' ' 986' ' ' ALA . 1.4 m -82.14 -7.9 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 CA-C-N 114.829 -1.078 . . . . 1.0 110.408 -179.11 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 991' ' ' GLY . . . . . 0.549 ' C ' ' H ' ' A' ' 993' ' ' PHE . . . 82.4 3.41 90.55 Favored Glycine 0 C--N 1.336 0.567 0 CA-C-O 119.366 -0.685 . . . . 1.0 112.385 178.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -52.67 -1.37 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 119.624 1.712 . . . . 1.0 112.418 -177.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 993' ' ' PHE . . . . . 0.549 ' H ' ' C ' ' A' ' 991' ' ' GLY . 14.0 m-85 -89.3 4.91 47.27 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 120.713 -0.395 . . . . 1.0 111.497 -179.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 994' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -51.75 134.88 30.22 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 108.764 -0.828 . . . . 1.0 108.764 178.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -101.04 0.09 37.38 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.366 -0.379 . . . . 1.0 111.363 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 996' ' ' ASN . . . . . . . . . . . . . 63.2 t-20 -65.36 -40.0 93.04 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.815 0.34 . . . . 1.0 110.875 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 997' ' ' ARG . . . . . . . . . . . . . 10.0 mpt_? -44.5 154.9 0.39 Allowed Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.184 -0.462 . . . . 1.0 111.198 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 998' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo . . . . . 0 N--CA 1.494 1.51 0 C-N-CA 122.626 2.217 . . . . 1.0 112.056 179.061 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 957' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.258 0 N-CA-C 109.498 -1.441 . . . . 1.0 109.498 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -65.74 151.26 47.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.752 0.31 . . . . 1.0 110.606 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 72.9 mt -101.64 126.17 48.43 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.136 0.494 . . . . 1.0 111.1 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 960' ' ' GLU . . . . . . . . . . . . . 51.0 tp10 -71.23 -37.98 72.01 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.436 -0.802 . . . . 1.0 109.724 178.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 961' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -71.15 139.53 50.26 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.994 -0.548 . . . . 1.0 110.502 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 962' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -72.18 149.73 44.39 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.052 0.453 . . . . 1.0 110.571 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 963' ' ' ALA . . . . . . . . . . . . . . . -64.62 -40.35 95.32 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.796 -0.638 . . . . 1.0 110.837 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 964' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -114.49 169.58 6.45 Favored Pre-proline 0 CA--C 1.535 0.373 0 CA-C-N 116.154 -0.476 . . . . 1.0 109.899 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -59.42 145.44 97.93 Favored 'Trans proline' 0 N--CA 1.496 1.651 0 C-N-CA 121.558 1.505 . . . . 1.0 112.275 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 966' ' ' ILE . . . . . 0.446 HG23 ' N ' ' A' ' 967' ' ' TRP . 18.7 tt -66.63 -39.82 84.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.888 -0.597 . . . . 1.0 110.598 -179.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 967' ' ' TRP . . . . . 0.733 ' O ' HG23 ' A' ' 971' ' ' VAL . 97.7 m95 -53.84 -38.85 65.06 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.016 -0.538 . . . . 1.0 111.101 -179.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 23.9 m95 -69.3 -34.66 75.03 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.569 -0.287 . . . . 1.0 110.557 178.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 93.8 t -66.97 -44.61 88.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 108.715 -0.846 . . . . 1.0 108.715 178.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 80.1 mt -63.16 -41.43 99.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.728 -1.124 . . . . 1.0 109.39 178.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 971' ' ' VAL . . . . . 0.733 HG23 ' O ' ' A' ' 967' ' ' TRP . 66.8 t -61.88 -45.0 99.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 CA-C-O 120.989 0.423 . . . . 1.0 109.978 179.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -59.83 -41.05 97.49 Favored Glycine 0 CA--C 1.523 0.594 0 N-CA-C 111.301 -0.72 . . . . 1.0 111.301 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 54.1 t -65.63 -45.16 93.0 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.374 0 CA-C-N 115.333 -0.434 . . . . 1.0 109.882 -179.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 974' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 974' ' ' LEU . 86.9 mt -62.25 -42.18 99.1 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.197 -0.668 . . . . 1.0 109.197 178.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -65.96 -45.74 85.95 Favored Glycine 0 N--CA 1.459 0.175 0 N-CA-C 110.26 -1.136 . . . . 1.0 110.26 -179.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -60.92 -37.98 94.66 Favored Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 109.142 -1.583 . . . . 1.0 109.142 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 977' ' ' LEU . . . . . 0.473 ' O ' ' OG1' ' A' ' 981' ' ' THR . 56.2 tp -65.82 -44.46 85.55 Favored 'General case' 0 C--O 1.226 -0.172 0 N-CA-C 109.736 -0.468 . . . . 1.0 109.736 178.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 50.6 tp -62.42 -46.04 90.38 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.375 -0.53 . . . . 1.0 110.642 -179.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 87.8 mt -62.58 -44.5 96.15 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.281 -0.567 . . . . 1.0 110.952 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 980' ' ' LEU . . . . . . . . . . . . . 80.7 mt -63.58 -40.92 98.19 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.852 -0.425 . . . . 1.0 109.852 -179.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 981' ' ' THR . . . . . 0.473 ' OG1' ' O ' ' A' ' 977' ' ' LEU . 6.8 m -63.96 -46.84 82.9 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.718 -0.674 . . . . 1.0 110.64 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 93.4 mt -63.59 -44.41 98.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 120.807 -0.357 . . . . 1.0 111.562 -178.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 983' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 983' ' ' LEU . 93.9 mt -64.76 -40.18 94.86 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.727 -0.389 . . . . 1.0 110.976 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 984' ' ' VAL . . . . . . . . . . . . . 38.9 t -69.02 -48.05 72.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.257 0.551 . . . . 1.0 111.014 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 86.5 mt -62.96 -42.63 99.88 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.037 -0.727 . . . . 1.0 109.037 178.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 986' ' ' ALA . . . . . 0.871 ' O ' HG13 ' A' ' 990' ' ' VAL . . . -63.52 -44.6 93.78 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.265 0.555 . . . . 1.0 110.11 -179.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 21.5 mtp -63.52 -31.12 72.19 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 122.527 1.156 . . . . 1.0 110.153 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 988' ' ' TRP . . . . . 0.439 ' O ' ' CD1' ' A' ' 988' ' ' TRP . 14.0 t90 -75.89 -35.03 59.98 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.163 -1.38 . . . . 1.0 108.313 179.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.5 -38.36 74.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.468 0.651 . . . . 1.0 109.807 -179.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 990' ' ' VAL . . . . . 0.871 HG13 ' O ' ' A' ' 986' ' ' ALA . 1.6 m -78.96 0.2 3.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.19 -0.913 . . . . 1.0 109.394 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 991' ' ' GLY . . . . . 0.446 ' O ' ' N ' ' A' ' 994' ' ' LYS . . . 79.69 1.13 86.44 Favored Glycine 0 CA--C 1.506 -0.502 0 CA-C-O 119.478 -0.623 . . . . 1.0 112.252 177.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -48.38 -41.45 28.89 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-N 118.88 1.34 . . . . 1.0 111.256 -176.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 993' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -81.85 -6.21 58.89 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.819 0.819 . . . . 1.0 111.009 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 994' ' ' LYS . . . . . 0.446 ' N ' ' O ' ' A' ' 991' ' ' GLY . 98.2 mttt -95.74 145.8 25.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.161 -1.381 . . . . 1.0 108.222 176.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -66.58 -39.39 88.44 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.949 -0.568 . . . . 1.0 110.448 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 996' ' ' ASN . . . . . . . . . . . . . 29.7 t-20 -95.45 107.45 19.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.984 -0.553 . . . . 1.0 111.014 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 997' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.72 160.37 82.09 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.07 -0.513 . . . . 1.0 109.937 179.247 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 998' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo . . . . . 0 C--N 1.309 -1.536 0 C-N-CA 122.347 2.032 . . . . 1.0 111.875 179.922 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 957' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.202 0 N-CA-C 109.22 -1.552 . . . . 1.0 109.22 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -64.41 -37.81 88.83 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.044 0.45 . . . . 1.0 109.869 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 41.7 tp -114.47 124.86 52.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.482 -0.781 . . . . 1.0 109.797 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 960' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -72.03 141.79 49.3 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.594 -0.443 . . . . 1.0 110.565 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 961' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -68.75 -28.23 66.62 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.786 -0.643 . . . . 1.0 111.029 -179.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 962' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -91.37 16.55 9.92 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.531 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 963' ' ' ALA . . . . . . . . . . . . . . . -58.92 -42.55 89.94 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.093 -0.503 . . . . 1.0 110.98 -179.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 964' ' ' ILE . . . . . . . . . . . . . 42.0 mt 46.89 84.52 0.19 Allowed Pre-proline 0 C--N 1.327 -0.388 0 C-N-CA 120.825 -0.35 . . . . 1.0 111.106 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -58.25 147.21 85.53 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.197 1.931 . . . . 1.0 111.846 179.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 45.2 pt -67.7 -24.45 30.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 116.318 -0.401 . . . . 1.0 111.312 -179.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 967' ' ' TRP . . . . . 0.755 ' O ' HG23 ' A' ' 971' ' ' VAL . 98.2 m95 -52.03 -37.68 54.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.254 -0.43 . . . . 1.0 111.181 -179.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 99.7 m95 -70.29 -35.58 73.81 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.571 -0.286 . . . . 1.0 110.334 179.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 969' ' ' VAL . . . . . 0.545 ' O ' HG23 ' A' ' 973' ' ' VAL . 86.2 t -67.31 -45.63 85.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 N-CA-C 109.107 -0.701 . . . . 1.0 109.107 178.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 10.0 mp -63.29 -43.01 99.1 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.656 -0.702 . . . . 1.0 109.866 178.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 971' ' ' VAL . . . . . 0.755 HG23 ' O ' ' A' ' 967' ' ' TRP . 77.8 t -62.37 -45.06 99.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.378 -0.374 . . . . 1.0 110.922 -179.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.45 -41.48 98.62 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 112.074 -0.41 . . . . 1.0 112.074 -179.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 973' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 969' ' ' VAL . 84.5 t -66.61 -45.97 87.22 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.306 0 CA-C-N 115.195 -0.503 . . . . 1.0 110.392 -178.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 90.7 mt -62.41 -41.38 98.63 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 109.042 -0.725 . . . . 1.0 109.042 178.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -65.77 -46.0 85.54 Favored Glycine 0 C--N 1.331 0.299 0 N-CA-C 110.26 -1.136 . . . . 1.0 110.26 -179.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -60.77 -37.48 93.68 Favored Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 109.195 -1.562 . . . . 1.0 109.195 179.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 56.0 tp -66.97 -43.28 83.44 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.49 -0.484 . . . . 1.0 109.936 178.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 978' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 978' ' ' LEU . 39.9 mt -61.94 -44.94 95.73 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.359 -0.382 . . . . 1.0 110.223 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 94.8 mt -62.86 -42.96 99.95 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 119.669 -0.812 . . . . 1.0 110.315 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 980' ' ' LEU . . . . . . . . . . . . . 81.1 mt -64.17 -41.57 97.08 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.964 0.411 . . . . 1.0 111.093 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 7.5 m -62.81 -47.63 82.61 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.693 -0.685 . . . . 1.0 110.188 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 84.7 mt -63.61 -44.28 98.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 116.111 -0.495 . . . . 1.0 111.117 -179.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 15.1 tp -64.19 -43.14 95.99 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.498 -0.319 . . . . 1.0 110.955 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 984' ' ' VAL . . . . . . . . . . . . . 54.1 t -68.57 -48.7 70.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.171 0.51 . . . . 1.0 110.974 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 83.5 mt -62.15 -42.61 99.43 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.805 -0.813 . . . . 1.0 108.805 179.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 986' ' ' ALA . . . . . 0.831 ' O ' HG13 ' A' ' 990' ' ' VAL . . . -61.69 -44.01 97.76 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 109.062 -0.718 . . . . 1.0 109.062 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 27.4 mtp -61.59 -30.87 70.95 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.761 -1.108 . . . . 1.0 108.964 178.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 988' ' ' TRP . . . . . . . . . . . . . 1.7 t90 -73.46 -38.64 65.4 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 113.928 -1.487 . . . . 1.0 108.455 179.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.2 -37.79 78.29 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.594 -0.73 . . . . 1.0 110.378 -179.204 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 990' ' ' VAL . . . . . 0.831 HG13 ' O ' ' A' ' 986' ' ' ALA . 1.3 m -85.16 -7.56 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 CA-C-N 115.116 -0.947 . . . . 1.0 110.668 -178.528 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 991' ' ' GLY . . . . . 0.499 ' C ' ' H ' ' A' ' 993' ' ' PHE . . . 80.02 6.51 89.11 Favored Glycine 0 C--N 1.339 0.719 0 CA-C-O 119.264 -0.742 . . . . 1.0 112.192 179.307 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -53.0 -1.58 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 119.32 1.56 . . . . 1.0 112.736 -176.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 993' ' ' PHE . . . . . 0.499 ' H ' ' C ' ' A' ' 991' ' ' GLY . 17.1 m-85 -93.15 0.7 57.26 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.401 0.62 . . . . 1.0 110.704 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 994' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -158.22 140.52 14.27 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 114.823 -1.08 . . . . 1.0 113.01 -179.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 92.0 mtm-85 -80.17 148.58 30.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 1.0 111.022 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 996' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -101.07 141.55 33.8 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.958 -0.565 . . . . 1.0 109.819 179.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 997' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.02 159.0 44.65 Favored Pre-proline 0 N--CA 1.463 0.222 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.587 -179.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 998' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_exo . . . . . 0 C--N 1.313 -1.322 0 C-N-CA 122.549 2.166 . . . . 1.0 112.339 179.817 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 957' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.283 0 N-CA-C 109.557 -1.417 . . . . 1.0 109.557 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -68.46 132.43 46.98 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.976 0.417 . . . . 1.0 110.707 -179.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 93.4 mt -61.4 -41.97 97.99 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.824 -0.626 . . . . 1.0 110.532 -179.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 960' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -56.84 140.5 47.88 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.081 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 961' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -72.26 140.75 48.79 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.343 -0.39 . . . . 1.0 110.473 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 962' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -69.05 -39.82 78.94 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.492 -0.322 . . . . 1.0 111.039 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 963' ' ' ALA . . . . . . . . . . . . . . . 43.01 -165.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 1.0 111.11 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 964' ' ' ILE . . . . . . . . . . . . . 2.1 pt -130.11 59.35 44.64 Favored Pre-proline 0 N--CA 1.464 0.248 0 CA-C-N 116.2 -0.454 . . . . 1.0 111.191 -179.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 965' ' ' PRO . . . . . 0.531 ' O ' HG23 ' A' ' 969' ' ' VAL . 37.5 Cg_endo -67.66 -20.02 47.17 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 122.504 2.136 . . . . 1.0 112.487 179.487 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 45.7 mm -64.01 -48.05 87.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.638 -0.256 . . . . 1.0 111.461 -179.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 967' ' ' TRP . . . . . 0.567 ' O ' HG23 ' A' ' 971' ' ' VAL . 89.7 m95 -61.08 -36.59 80.05 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.589 0.233 . . . . 1.0 111.559 -179.185 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 88.8 m95 -71.04 -35.18 71.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.724 -0.216 . . . . 1.0 110.837 179.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 969' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 965' ' ' PRO . 76.0 t -67.14 -44.88 87.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 108.808 -0.812 . . . . 1.0 108.808 178.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 59.4 tp -64.07 -43.02 96.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.039 -0.982 . . . . 1.0 110.199 179.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 971' ' ' VAL . . . . . 0.567 HG23 ' O ' ' A' ' 967' ' ' TRP . 51.0 t -62.99 -45.14 99.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.959 0.409 . . . . 1.0 111.294 -179.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.29 -41.03 98.2 Favored Glycine 0 CA--C 1.528 0.882 0 CA-C-N 116.025 -0.534 . . . . 1.0 111.853 -179.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 973' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 969' ' ' VAL . 74.8 t -66.95 -47.5 82.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.115 0.483 . . . . 1.0 111.092 -178.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -62.87 -40.88 98.85 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.88 -0.6 . . . . 1.0 109.499 178.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -65.97 -45.27 88.86 Favored Glycine 0 CA--C 1.513 -0.051 0 N-CA-C 109.869 -1.292 . . . . 1.0 109.869 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 976' ' ' GLY . . . . . 0.468 ' O ' HD13 ' A' ' 980' ' ' LEU . . . -61.26 -37.39 93.94 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 109.233 -1.547 . . . . 1.0 109.233 178.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 53.5 tp -64.87 -42.48 94.8 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 109.433 -0.581 . . . . 1.0 109.433 178.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 60.3 tp -62.28 -44.82 95.64 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.894 -0.409 . . . . 1.0 109.894 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 92.3 mt -62.59 -45.09 94.51 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.462 -0.495 . . . . 1.0 111.355 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 980' ' ' LEU . . . . . 0.468 HD13 ' O ' ' A' ' 976' ' ' GLY . 9.2 mp -63.05 -39.28 94.28 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.322 -0.551 . . . . 1.0 110.217 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 7.8 m -62.5 -47.3 84.58 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.839 -0.619 . . . . 1.0 110.846 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 96.4 mt -64.21 -44.6 97.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.39 -0.368 . . . . 1.0 111.863 -178.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 7.5 mp -65.08 -40.09 94.13 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 120.663 -0.415 . . . . 1.0 110.943 179.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 984' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 980' ' ' LEU . 55.7 t -68.47 -48.85 70.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.288 -0.414 . . . . 1.0 110.367 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 86.3 mt -64.4 -41.77 96.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.959 -0.564 . . . . 1.0 109.53 178.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 986' ' ' ALA . . . . . 0.89 ' O ' HG13 ' A' ' 990' ' ' VAL . . . -62.96 -43.87 97.6 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-O 121.689 0.757 . . . . 1.0 109.032 -179.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 32.7 mtp -62.57 -31.13 71.89 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 114.415 -1.266 . . . . 1.0 109.174 178.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 988' ' ' TRP . . . . . . . . . . . . . 1.6 t90 -74.22 -37.82 63.73 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 113.957 -1.474 . . . . 1.0 108.037 179.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.24 -39.43 78.49 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.944 0.878 . . . . 1.0 110.303 -179.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 990' ' ' VAL . . . . . 0.89 HG13 ' O ' ' A' ' 986' ' ' ALA . 1.4 m -82.57 -7.94 11.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 114.92 -1.036 . . . . 1.0 110.57 -178.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 991' ' ' GLY . . . . . 0.574 ' C ' ' H ' ' A' ' 993' ' ' PHE . . . 82.68 2.94 90.69 Favored Glycine 0 C--N 1.339 0.698 0 CA-C-O 119.145 -0.808 . . . . 1.0 112.439 178.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -52.63 -1.37 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 119.723 1.762 . . . . 1.0 112.112 -177.505 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 993' ' ' PHE . . . . . 0.574 ' H ' ' C ' ' A' ' 991' ' ' GLY . 10.4 m-85 -87.33 2.53 50.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.567 -0.288 . . . . 1.0 111.44 -179.053 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 994' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -55.11 135.51 49.12 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.419 -0.956 . . . . 1.0 108.419 177.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 93.1 mtt180 -103.41 135.91 44.14 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.897 -0.321 . . . . 1.0 110.66 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 996' ' ' ASN . . . . . . . . . . . . . 66.1 t30 56.98 47.48 17.54 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 116.022 -0.535 . . . . 1.0 111.191 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 997' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -49.57 153.48 1.95 Allowed Pre-proline 0 N--CA 1.466 0.34 0 CA-C-N 116.423 -0.353 . . . . 1.0 110.52 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 998' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo . . . . . 0 N--CA 1.495 1.572 0 C-N-CA 122.338 2.026 . . . . 1.0 112.43 -179.96 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 957' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.327 0 N-CA-C 109.968 -1.253 . . . . 1.0 109.968 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -62.87 -38.21 89.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.998 0.427 . . . . 1.0 110.711 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 96.9 mt -61.64 -43.25 99.21 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.852 -0.613 . . . . 1.0 110.628 -179.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 960' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -70.13 133.34 47.03 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.836 0.351 . . . . 1.0 110.148 179.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 961' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -68.97 -40.49 78.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.038 -0.528 . . . . 1.0 111.092 -179.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 962' ' ' ARG . . . . . . . . . . . . . 94.5 mtt-85 -74.71 143.66 44.07 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.377 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 963' ' ' ALA . . . . . . . . . . . . . . . -148.32 13.2 0.96 Allowed 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.855 -0.338 . . . . 1.0 111.291 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 964' ' ' ILE . . . . . 0.475 HG22 HG22 ' A' ' 966' ' ' ILE . 1.0 OUTLIER -134.53 82.87 44.44 Favored Pre-proline 0 CA--C 1.536 0.423 0 CA-C-O 120.917 0.389 . . . . 1.0 110.351 -179.69 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -85.57 11.51 3.33 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.891 2.394 . . . . 1.0 112.588 -179.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 966' ' ' ILE . . . . . 0.51 HG23 ' N ' ' A' ' 967' ' ' TRP . 20.7 tt -65.52 -39.68 85.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.243 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 967' ' ' TRP . . . . . 0.659 ' O ' HG23 ' A' ' 971' ' ' VAL . 88.5 m95 -56.22 -39.68 72.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.178 -0.464 . . . . 1.0 111.358 -179.239 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 96.1 m95 -68.43 -34.91 76.83 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 110.117 -0.327 . . . . 1.0 110.117 179.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 969' ' ' VAL . . . . . 0.638 ' O ' HG23 ' A' ' 973' ' ' VAL . 57.1 t -67.14 -43.96 88.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 CA-C-O 121.649 0.737 . . . . 1.0 109.06 178.26 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 98.2 mt -63.34 -42.55 98.94 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 114.749 -1.114 . . . . 1.0 109.675 179.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 971' ' ' VAL . . . . . 0.659 HG23 ' O ' ' A' ' 967' ' ' TRP . 71.0 t -62.27 -45.31 99.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.064 0.459 . . . . 1.0 110.507 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.49 -41.34 98.63 Favored Glycine 0 C--N 1.332 0.306 0 N-CA-C 111.271 -0.732 . . . . 1.0 111.271 -179.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 973' ' ' VAL . . . . . 0.638 HG23 ' O ' ' A' ' 969' ' ' VAL . 84.4 t -65.57 -47.56 85.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 114.971 -0.615 . . . . 1.0 110.678 -179.151 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 78.3 mt -61.36 -40.43 94.27 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.697 -0.853 . . . . 1.0 108.697 178.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -64.54 -46.04 91.35 Favored Glycine 0 N--CA 1.461 0.305 0 N-CA-C 110.843 -0.903 . . . . 1.0 110.843 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -60.86 -36.93 92.86 Favored Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 109.474 -1.45 . . . . 1.0 109.474 179.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 82.2 mt -67.3 -43.21 82.29 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 120.4 -0.52 . . . . 1.0 110.619 179.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 55.7 tp -61.94 -44.89 95.82 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.673 -0.411 . . . . 1.0 110.178 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 97.2 mt -63.77 -42.92 97.7 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 120.187 -0.605 . . . . 1.0 110.91 -179.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 980' ' ' LEU . . . . . . . . . . . . . 76.2 mt -64.03 -39.52 94.27 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.918 0.39 . . . . 1.0 110.362 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 7.1 m -64.12 -46.67 83.16 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.877 -0.601 . . . . 1.0 109.764 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 90.9 mt -62.65 -44.46 99.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.052 -0.522 . . . . 1.0 111.145 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 97.6 mt -64.72 -40.69 95.77 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.728 -0.389 . . . . 1.0 111.143 179.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 984' ' ' VAL . . . . . . . . . . . . . 46.7 t -67.99 -48.09 76.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.04 0.448 . . . . 1.0 110.323 179.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 85.2 mt -64.17 -43.83 93.91 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.733 -0.667 . . . . 1.0 109.564 179.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 986' ' ' ALA . . . . . 0.936 ' O ' HG13 ' A' ' 990' ' ' VAL . . . -62.09 -44.94 95.57 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-O 121.361 0.601 . . . . 1.0 109.397 -179.375 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 30.9 mtp -61.99 -34.19 75.72 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 114.885 -1.052 . . . . 1.0 109.537 179.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 988' ' ' TRP . . . . . 0.463 ' O ' ' CD1' ' A' ' 988' ' ' TRP . 13.0 t90 -73.25 -36.02 66.32 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 114.137 -1.392 . . . . 1.0 108.527 179.33 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.22 -41.38 77.13 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 115.402 -0.817 . . . . 1.0 109.912 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 990' ' ' VAL . . . . . 0.936 HG13 ' O ' ' A' ' 986' ' ' ALA . 1.2 m -82.42 -8.7 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 CA-C-N 114.811 -1.086 . . . . 1.0 110.062 -179.122 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 991' ' ' GLY . . . . . 0.529 ' C ' ' H ' ' A' ' 993' ' ' PHE . . . 82.2 5.14 89.9 Favored Glycine 0 C--N 1.342 0.91 0 CA-C-O 119.15 -0.805 . . . . 1.0 112.692 179.022 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -51.93 -2.17 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 119.543 1.672 . . . . 1.0 112.851 -177.384 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 993' ' ' PHE . . . . . 0.529 ' H ' ' C ' ' A' ' 991' ' ' GLY . 13.6 m-85 -85.4 -0.12 53.88 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.992 -0.283 . . . . 1.0 110.399 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 994' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -59.18 -44.03 92.19 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 108.687 -0.857 . . . . 1.0 108.687 178.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 995' ' ' ARG . . . . . 0.613 ' NH1' ' NH2' ' A' ' 997' ' ' ARG . 78.9 mtp85 -88.62 -126.47 0.06 Allowed 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 110.021 -0.363 . . . . 1.0 110.021 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 996' ' ' ASN . . . . . . . . . . . . . 59.9 t30 52.74 39.07 27.96 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.552 -0.459 . . . . 1.0 110.444 179.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 997' ' ' ARG . . . . . 0.613 ' NH2' ' NH1' ' A' ' 995' ' ' ARG . 0.0 OUTLIER -66.97 161.39 62.98 Favored Pre-proline 0 C--N 1.328 -0.368 0 N-CA-C 109.473 -0.566 . . . . 1.0 109.473 -179.999 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 998' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo . . . . . 0 C--N 1.304 -1.801 0 C-N-CA 121.885 1.723 . . . . 1.0 111.609 -179.648 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 957' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.278 0 N-CA-C 109.681 -1.367 . . . . 1.0 109.681 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . 46.15 94.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.921 -0.311 . . . . 1.0 110.671 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 959' ' ' LEU . . . . . 0.481 HD12 ' N ' ' A' ' 959' ' ' LEU . 11.0 mp -98.78 126.41 44.41 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.118 0.485 . . . . 1.0 110.411 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 960' ' ' GLU . . . . . 0.496 ' OE1' ' N ' ' A' ' 960' ' ' GLU . 55.9 mp0 -66.09 -33.59 76.14 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.552 -0.749 . . . . 1.0 110.339 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 961' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -63.0 -35.26 79.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.866 -0.606 . . . . 1.0 110.621 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 962' ' ' ARG . . . . . . . . . . . . . 96.0 mtt-85 53.96 56.57 6.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.487 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 963' ' ' ALA . . . . . . . . . . . . . . . -126.05 156.36 40.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.776 -179.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 964' ' ' ILE . . . . . . . . . . . . . 16.2 mm 60.35 79.16 0.3 Allowed Pre-proline 0 CA--C 1.534 0.334 0 CA-C-N 115.89 -0.596 . . . . 1.0 110.9 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -59.05 147.47 90.12 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 122.458 2.105 . . . . 1.0 112.268 179.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 21.1 tt -65.97 -26.58 38.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.69 -0.686 . . . . 1.0 110.824 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 967' ' ' TRP . . . . . 0.537 ' O ' HG23 ' A' ' 971' ' ' VAL . 97.1 m95 -54.16 -38.07 65.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.251 -0.431 . . . . 1.0 111.304 -179.255 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 93.1 m95 -69.1 -35.69 76.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.462 . . . . 1.0 110.38 179.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 969' ' ' VAL . . . . . 0.476 ' O ' HG23 ' A' ' 973' ' ' VAL . 71.4 t -65.3 -43.87 94.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 108.396 -0.964 . . . . 1.0 108.396 177.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 970' ' ' LEU . . . . . 0.444 ' O ' HD13 ' A' ' 974' ' ' LEU . 89.9 mt -62.33 -42.86 99.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 114.513 -1.221 . . . . 1.0 109.688 179.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 971' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 967' ' ' TRP . 49.9 t -60.99 -44.87 99.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.865 0.364 . . . . 1.0 110.128 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.88 -39.01 96.3 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 111.538 -0.625 . . . . 1.0 111.538 -179.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 973' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 969' ' ' VAL . 56.8 t -66.67 -47.47 83.09 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.382 0 CA-C-N 114.92 -0.64 . . . . 1.0 110.439 -179.398 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 974' ' ' LEU . . . . . 0.444 HD13 ' O ' ' A' ' 970' ' ' LEU . 7.9 mp -62.95 -41.1 99.4 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.663 -0.866 . . . . 1.0 108.663 179.087 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -66.08 -45.58 86.27 Favored Glycine 0 CA--C 1.518 0.258 0 N-CA-C 110.308 -1.117 . . . . 1.0 110.308 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 976' ' ' GLY . . . . . 0.558 ' O ' HD13 ' A' ' 980' ' ' LEU . . . -60.19 -38.72 94.91 Favored Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 108.903 -1.679 . . . . 1.0 108.903 178.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 52.7 tp -66.66 -44.32 82.16 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.313 -0.555 . . . . 1.0 110.26 179.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 59.1 tp -62.29 -45.86 91.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.619 -0.264 . . . . 1.0 110.364 -179.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 93.5 mt -63.26 -43.53 97.73 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 119.976 -0.69 . . . . 1.0 110.765 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 980' ' ' LEU . . . . . 0.558 HD13 ' O ' ' A' ' 976' ' ' GLY . 8.5 mp -63.99 -39.06 93.26 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.74 -0.384 . . . . 1.0 110.708 -179.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 6.9 m -64.35 -45.98 85.45 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.963 -0.562 . . . . 1.0 110.188 -179.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 97.5 mt -63.45 -44.01 98.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 C-N-CA 120.938 -0.305 . . . . 1.0 111.539 -179.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 91.0 mt -65.07 -41.08 95.42 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 120.954 -0.298 . . . . 1.0 110.788 179.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 984' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 980' ' ' LEU . 54.4 t -66.39 -47.78 82.94 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.426 0 CA-C-O 121.472 0.653 . . . . 1.0 109.538 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 87.1 mt -63.4 -43.71 96.77 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.058 -0.974 . . . . 1.0 109.739 178.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 986' ' ' ALA . . . . . 0.824 ' O ' HG13 ' A' ' 990' ' ' VAL . . . -61.49 -45.12 95.57 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-O 121.595 0.712 . . . . 1.0 109.406 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 29.5 mtp -61.62 -30.19 70.53 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.651 -1.158 . . . . 1.0 108.778 179.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 988' ' ' TRP . . . . . . . . . . . . . 1.7 t90 -74.29 -38.85 63.26 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 113.912 -1.495 . . . . 1.0 108.424 179.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.22 -38.55 82.02 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.357 -0.838 . . . . 1.0 110.223 -179.05 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 990' ' ' VAL . . . . . 0.824 HG13 ' O ' ' A' ' 986' ' ' ALA . 1.4 m -84.55 -7.96 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 115.075 -0.966 . . . . 1.0 110.747 -178.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 991' ' ' GLY . . . . . 0.524 ' C ' ' H ' ' A' ' 993' ' ' PHE . . . 81.27 5.33 90.12 Favored Glycine 0 C--N 1.338 0.655 0 CA-C-O 119.17 -0.794 . . . . 1.0 112.453 179.056 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -53.4 -1.81 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 119.34 1.57 . . . . 1.0 112.532 -177.323 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 993' ' ' PHE . . . . . 0.524 ' H ' ' C ' ' A' ' 991' ' ' GLY . 10.2 m-85 -92.54 0.11 57.39 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.584 0.707 . . . . 1.0 110.501 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 994' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -156.08 145.1 20.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.663 -1.153 . . . . 1.0 113.566 -178.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -78.46 144.76 35.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.892 -0.595 . . . . 1.0 110.953 -179.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 996' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -62.61 -41.8 99.2 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 109.821 -0.437 . . . . 1.0 109.821 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 997' ' ' ARG . . . . . 0.429 ' HG3' ' H ' ' A' ' 997' ' ' ARG . 0.0 OUTLIER -80.7 158.22 71.11 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.025 -0.534 . . . . 1.0 109.72 179.474 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 998' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo . . . . . 0 C--N 1.309 -1.527 0 C-N-CA 122.277 1.985 . . . . 1.0 112.19 -179.315 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 957' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.479 0 N-CA-C 109.5 -1.44 . . . . 1.0 109.5 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -132.12 150.56 52.13 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.019 0.438 . . . . 1.0 110.72 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 959' ' ' LEU . . . . . 0.407 ' O ' ' C ' ' A' ' 960' ' ' GLU . 85.4 mt -116.92 132.61 56.66 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.829 -0.623 . . . . 1.0 110.588 -179.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 960' ' ' GLU . . . . . 0.407 ' C ' ' O ' ' A' ' 959' ' ' LEU . 94.4 mt-10 37.78 82.83 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.901 -0.59 . . . . 1.0 110.676 179.294 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 961' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -64.07 139.37 58.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.977 -0.556 . . . . 1.0 110.975 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 962' ' ' ARG . . . . . . . . . . . . . 94.9 mtt-85 -63.11 -38.69 92.19 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.308 -0.627 . . . . 1.0 109.308 179.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 963' ' ' ALA . . . . . . . . . . . . . . . -65.81 144.16 57.03 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.052 -0.976 . . . . 1.0 111.76 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 964' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -74.78 167.42 36.65 Favored Pre-proline 0 CA--C 1.536 0.408 0 CA-C-N 116.043 -0.526 . . . . 1.0 110.578 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -60.61 147.61 94.08 Favored 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 121.609 1.54 . . . . 1.0 111.367 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 71.9 mt -66.67 -25.88 35.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.013 -0.539 . . . . 1.0 110.927 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 967' ' ' TRP . . . . . 0.722 ' O ' HG23 ' A' ' 971' ' ' VAL . 94.2 m95 -53.1 -37.41 61.69 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.821 -179.717 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 83.9 m95 -72.06 -36.27 69.54 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.695 -0.229 . . . . 1.0 111.113 179.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 969' ' ' VAL . . . . . 0.408 ' O ' HG23 ' A' ' 973' ' ' VAL . 62.1 t -67.03 -44.82 88.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 108.691 -0.855 . . . . 1.0 108.691 178.497 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 56.4 tp -63.3 -44.22 95.64 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.738 -1.119 . . . . 1.0 110.204 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 971' ' ' VAL . . . . . 0.722 HG23 ' O ' ' A' ' 967' ' ' TRP . 54.4 t -61.85 -45.44 98.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 120.625 -0.43 . . . . 1.0 111.367 -178.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.23 -36.93 92.1 Favored Glycine 0 CA--C 1.529 0.959 0 CA-C-O 121.659 0.588 . . . . 1.0 111.679 -179.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 973' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 969' ' ' VAL . 53.5 t -68.28 -49.08 70.05 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.492 0 CA-C-N 114.87 -0.665 . . . . 1.0 109.948 -179.093 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 69.4 mt -62.21 -42.23 99.1 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 115.493 -0.776 . . . . 1.0 109.008 179.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -65.96 -45.55 87.08 Favored Glycine 0 N--CA 1.46 0.259 0 N-CA-C 110.061 -1.216 . . . . 1.0 110.061 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -59.62 -38.7 94.11 Favored Glycine 0 C--O 1.226 -0.366 0 N-CA-C 108.642 -1.783 . . . . 1.0 108.642 178.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 977' ' ' LEU . . . . . 0.42 ' O ' ' OG1' ' A' ' 981' ' ' THR . 49.1 tp -65.55 -42.93 91.33 Favored 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 120.717 -0.393 . . . . 1.0 110.188 179.313 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 76.3 mt -64.52 -44.32 91.24 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.457 -0.497 . . . . 1.0 111.054 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 80.6 mt -63.29 -44.28 95.49 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.325 -0.55 . . . . 1.0 110.732 -179.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 980' ' ' LEU . . . . . 0.417 ' O ' HG23 ' A' ' 984' ' ' VAL . 83.8 mt -63.51 -39.47 94.52 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.08 0.467 . . . . 1.0 110.115 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 981' ' ' THR . . . . . 0.508 HG22 ' CD1' ' A' ' 985' ' ' LEU . 7.3 m -64.59 -46.2 83.7 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.474 -0.785 . . . . 1.0 110.225 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 3.2 mm -64.09 -43.62 97.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.296 -0.411 . . . . 1.0 111.854 -178.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 98.2 mt -66.71 -40.72 88.55 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.093 -0.503 . . . . 1.0 111.377 -179.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 984' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 980' ' ' LEU . 65.8 t -68.61 -46.65 79.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.438 0.637 . . . . 1.0 109.492 179.465 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 985' ' ' LEU . . . . . 0.508 ' CD1' HG22 ' A' ' 981' ' ' THR . 80.9 mt -63.08 -43.44 98.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.261 -0.881 . . . . 1.0 109.039 178.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 986' ' ' ALA . . . . . 0.872 ' O ' HG13 ' A' ' 990' ' ' VAL . . . -62.01 -43.84 97.98 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.141 -0.688 . . . . 1.0 109.141 179.636 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 987' ' ' MET . . . . . 0.431 ' HA ' HG22 ' A' ' 990' ' ' VAL . 29.5 mtp -64.07 -32.58 74.19 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 114.955 -1.021 . . . . 1.0 110.367 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 988' ' ' TRP . . . . . 0.477 ' O ' ' CD1' ' A' ' 988' ' ' TRP . 12.7 t90 -73.48 -34.08 65.16 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.171 -1.377 . . . . 1.0 107.75 178.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.37 -39.37 71.27 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 114.866 -1.061 . . . . 1.0 110.478 -179.558 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 990' ' ' VAL . . . . . 0.872 HG13 ' O ' ' A' ' 986' ' ' ALA . 1.4 m -85.26 -7.6 10.96 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 CA-C-N 115.128 -0.942 . . . . 1.0 110.339 -178.478 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 991' ' ' GLY . . . . . 0.504 ' C ' ' H ' ' A' ' 993' ' ' PHE . . . 81.54 5.09 90.19 Favored Glycine 0 C--N 1.331 0.304 0 CA-C-O 118.813 -0.993 . . . . 1.0 112.76 179.35 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -52.79 -1.87 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 120.07 1.935 . . . . 1.0 112.729 -178.036 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 993' ' ' PHE . . . . . 0.504 ' H ' ' C ' ' A' ' 991' ' ' GLY . 17.5 m-85 -90.67 -1.48 57.87 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 121.03 0.443 . . . . 1.0 110.37 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 994' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -157.5 152.72 26.0 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 113.671 0.989 . . . . 1.0 113.671 -178.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 86.6 mtm-85 -88.83 36.03 0.8 Allowed 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.937 -0.574 . . . . 1.0 110.637 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 996' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -63.56 -42.85 98.33 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.208 -0.451 . . . . 1.0 109.791 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 997' ' ' ARG . . . . . . . . . . . . . 3.5 mtt180 -117.28 152.54 49.29 Favored Pre-proline 0 CA--C 1.535 0.398 0 CA-C-N 116.255 -0.43 . . . . 1.0 110.346 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 998' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo . . . . . 0 N--CA 1.491 1.368 0 C-N-CA 122.58 2.186 . . . . 1.0 112.841 -179.342 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 957' ' ' GLY . . . . . 0.448 ' N ' ' OE2' ' A' ' 960' ' ' GLU . . . . . . . . 0 N--CA 1.491 2.349 0 N-CA-C 109.498 -1.441 . . . . 1.0 109.498 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -62.93 -36.72 84.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.564 0.221 . . . . 1.0 110.659 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 73.3 mt -113.08 140.25 48.02 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.671 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 960' ' ' GLU . . . . . 0.448 ' OE2' ' N ' ' A' ' 957' ' ' GLY . 73.7 mm-40 -128.72 143.15 50.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.969 -0.559 . . . . 1.0 109.902 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 961' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -66.91 -39.93 87.53 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.912 0.386 . . . . 1.0 110.308 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 962' ' ' ARG . . . . . . . . . . . . . 83.6 mtp180 -99.72 140.27 34.16 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.987 -0.551 . . . . 1.0 111.369 -179.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 963' ' ' ALA . . . . . 0.448 ' O ' ' C ' ' A' ' 964' ' ' ILE . . . -150.21 150.13 31.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.775 -0.648 . . . . 1.0 110.482 179.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 964' ' ' ILE . . . . . 0.448 ' C ' ' O ' ' A' ' 963' ' ' ALA . 1.2 tt 29.94 72.28 0.5 Allowed Pre-proline 0 N--CA 1.462 0.174 0 O-C-N 123.896 0.747 . . . . 1.0 111.131 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -63.23 145.27 93.15 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 122.383 2.055 . . . . 1.0 111.756 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 87.4 mt -64.39 -43.97 97.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.018 -0.537 . . . . 1.0 110.697 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 967' ' ' TRP . . . . . 0.784 ' O ' HG23 ' A' ' 971' ' ' VAL . 89.7 m95 -58.37 -40.47 82.34 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 113.293 0.849 . . . . 1.0 113.293 -178.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 39.3 m95 -71.57 -39.61 70.49 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 112.957 0.725 . . . . 1.0 112.957 -178.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 969' ' ' VAL . . . . . 0.445 ' O ' HG23 ' A' ' 973' ' ' VAL . 17.3 m -66.86 -41.3 87.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 119.536 -0.866 . . . . 1.0 109.23 179.355 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 61.9 tp -64.35 -42.78 96.04 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.246 -0.888 . . . . 1.0 109.973 179.052 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 971' ' ' VAL . . . . . 0.784 HG23 ' O ' ' A' ' 967' ' ' TRP . 70.2 t -62.79 -44.83 99.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 120.523 -0.471 . . . . 1.0 110.668 -179.1 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -59.34 -41.65 97.02 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.555 -0.618 . . . . 1.0 111.555 -179.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 973' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 969' ' ' VAL . 77.0 t -64.63 -46.9 91.05 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.593 0 CA-C-O 121.038 0.447 . . . . 1.0 110.623 -179.303 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 98.7 mt -61.99 -40.67 96.44 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 108.595 -0.891 . . . . 1.0 108.595 179.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -67.13 -48.21 60.65 Favored Glycine 0 C--N 1.334 0.419 0 CA-C-N 115.1 -0.955 . . . . 1.0 110.943 -179.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -60.12 -36.41 90.47 Favored Glycine 0 N--CA 1.449 -0.446 0 N-CA-C 108.915 -1.674 . . . . 1.0 108.915 179.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 977' ' ' LEU . . . . . 0.455 ' O ' ' OG1' ' A' ' 981' ' ' THR . 54.1 tp -66.97 -43.22 83.63 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.179 -0.608 . . . . 1.0 109.993 179.138 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 4.3 tt -61.64 -45.24 94.88 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.348 -0.541 . . . . 1.0 110.33 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 96.1 mt -62.17 -45.16 94.65 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.487 -0.485 . . . . 1.0 111.315 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 980' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -64.13 -39.97 95.16 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.083 0.468 . . . . 1.0 111.163 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 981' ' ' THR . . . . . 0.455 ' OG1' ' O ' ' A' ' 977' ' ' LEU . 6.9 m -64.11 -46.71 83.01 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.487 -0.778 . . . . 1.0 110.121 -179.647 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 4.0 mm -63.68 -43.82 98.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.499 -0.319 . . . . 1.0 111.477 -179.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 83.7 mt -63.67 -41.58 98.17 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.381 -0.372 . . . . 1.0 110.366 179.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 984' ' ' VAL . . . . . . . . . . . . . 40.0 t -66.7 -47.1 84.11 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.332 0 CA-C-O 121.345 0.593 . . . . 1.0 110.356 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 82.2 mt -64.43 -43.04 95.6 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.292 -0.867 . . . . 1.0 109.919 179.134 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 986' ' ' ALA . . . . . 0.939 ' O ' HG13 ' A' ' 990' ' ' VAL . . . -63.85 -46.05 86.76 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 121.371 0.605 . . . . 1.0 109.726 -179.344 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 30.2 mtp -61.8 -33.75 74.68 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.817 -1.083 . . . . 1.0 109.286 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 988' ' ' TRP . . . . . 0.505 ' O ' ' CD1' ' A' ' 988' ' ' TRP . 12.8 t90 -72.1 -37.27 69.57 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.338 -1.301 . . . . 1.0 108.57 178.186 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.91 -40.3 79.19 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 121.717 0.77 . . . . 1.0 110.204 -179.501 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 990' ' ' VAL . . . . . 0.939 HG13 ' O ' ' A' ' 986' ' ' ALA . 1.2 m -82.63 -6.63 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 CA-C-N 114.707 -1.133 . . . . 1.0 109.989 -178.617 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 991' ' ' GLY . . . . . 0.543 ' C ' ' H ' ' A' ' 993' ' ' PHE . . . 83.58 2.6 89.99 Favored Glycine 0 C--N 1.337 0.586 0 CA-C-O 119.296 -0.724 . . . . 1.0 112.317 178.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -52.16 -2.5 0.02 OUTLIER 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 119.418 1.609 . . . . 1.0 112.145 -177.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 993' ' ' PHE . . . . . 0.543 ' H ' ' C ' ' A' ' 991' ' ' GLY . 11.6 m-85 -88.29 -5.29 58.43 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.077 0.465 . . . . 1.0 110.101 179.509 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 994' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -158.9 154.68 26.38 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.247 -0.888 . . . . 1.0 113.302 -179.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 89.0 mtm180 -64.57 -39.94 94.65 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.302 -0.408 . . . . 1.0 110.765 179.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 996' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -75.33 148.0 39.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.149 0.499 . . . . 1.0 110.712 -179.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 997' ' ' ARG . . . . . . . . . . . . . 46.4 mtp85 -68.19 155.11 92.94 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.625 -0.716 . . . . 1.0 110.96 -179.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 998' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo . . . . . 0 C--N 1.31 -1.45 0 C-N-CA 122.306 2.004 . . . . 1.0 112.334 -179.961 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 957' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.274 0 N-CA-C 109.795 -1.322 . . . . 1.0 109.795 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -153.2 159.49 42.66 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.988 0.423 . . . . 1.0 110.794 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 959' ' ' LEU . . . . . 0.457 HD22 ' N ' ' A' ' 959' ' ' LEU . 4.3 mm? -95.02 131.19 41.25 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.088 -0.505 . . . . 1.0 110.246 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 960' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -65.67 142.79 57.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.943 -0.571 . . . . 1.0 110.281 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 961' ' ' GLU . . . . . . . . . . . . . 89.0 mt-10 -65.77 -41.84 91.56 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.5 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 962' ' ' ARG . . . . . . . . . . . . . 28.1 mmt180 -107.33 132.35 53.23 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 120.889 0.376 . . . . 1.0 110.719 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 963' ' ' ALA . . . . . . . . . . . . . . . -75.38 142.62 43.08 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.046 -0.525 . . . . 1.0 110.038 179.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 964' ' ' ILE . . . . . 0.636 HG23 ' O ' ' A' ' 964' ' ' ILE . 1.3 tt -173.15 72.45 0.39 Allowed Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.144 -179.38 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -65.8 147.93 85.95 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.685 2.257 . . . . 1.0 111.753 -179.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 96.0 mt -64.86 -43.19 96.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.955 -0.566 . . . . 1.0 111.334 -179.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 967' ' ' TRP . . . . . 0.635 ' O ' HG23 ' A' ' 971' ' ' VAL . 96.9 m95 -55.7 -38.64 69.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 1.0 111.578 -178.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 24.7 m95 -70.33 -34.66 72.95 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.577 -0.283 . . . . 1.0 110.479 179.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 74.1 t -67.38 -43.93 87.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 108.99 -0.744 . . . . 1.0 108.99 178.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 51.6 tp -63.91 -41.33 97.71 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.232 -0.894 . . . . 1.0 109.104 179.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 971' ' ' VAL . . . . . 0.635 HG23 ' O ' ' A' ' 967' ' ' TRP . 53.2 t -62.29 -45.33 99.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 C-N-CA 120.895 -0.322 . . . . 1.0 111.372 -179.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.63 -41.31 98.83 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 112.161 -0.376 . . . . 1.0 112.161 -178.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 72.8 t -67.22 -47.23 82.15 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.517 0 CA-C-O 120.94 0.4 . . . . 1.0 110.668 -178.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 6.9 mp -63.44 -41.04 98.66 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.974 -0.557 . . . . 1.0 109.522 179.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -66.08 -44.95 90.29 Favored Glycine 0 C--N 1.334 0.433 0 N-CA-C 110.348 -1.101 . . . . 1.0 110.348 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -61.32 -36.11 91.98 Favored Glycine 0 N--CA 1.448 -0.527 0 N-CA-C 109.061 -1.615 . . . . 1.0 109.061 179.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 977' ' ' LEU . . . . . . . . . . . . . 54.2 tp -67.37 -43.72 80.74 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.443 -0.503 . . . . 1.0 110.075 178.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 50.9 tp -62.43 -44.82 95.51 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.289 -0.564 . . . . 1.0 109.998 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 87.5 mt -61.94 -42.93 99.67 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 119.783 -0.767 . . . . 1.0 110.118 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 980' ' ' LEU . . . . . 0.428 ' O ' HG23 ' A' ' 984' ' ' VAL . 33.2 mt -63.42 -40.41 97.1 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.058 0.456 . . . . 1.0 110.334 -179.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 6.9 m -64.16 -46.27 84.79 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.409 -0.814 . . . . 1.0 110.17 -179.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 90.8 mt -64.29 -44.27 97.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.332 -0.394 . . . . 1.0 111.236 -179.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 983' ' ' LEU . . . . . 0.57 HD11 ' SD ' ' A' ' 987' ' ' MET . 39.1 tp -65.67 -42.74 90.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.544 -0.298 . . . . 1.0 111.454 -179.773 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 984' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 980' ' ' LEU . 53.1 t -66.81 -47.64 82.19 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.402 0 CA-C-O 121.411 0.624 . . . . 1.0 110.341 -179.404 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 84.0 mt -63.58 -41.59 98.36 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.134 -0.939 . . . . 1.0 109.132 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 986' ' ' ALA . . . . . 0.836 ' O ' HG13 ' A' ' 990' ' ' VAL . . . -62.65 -47.77 82.23 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.275 0.559 . . . . 1.0 110.38 -179.491 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 987' ' ' MET . . . . . 0.57 ' SD ' HD11 ' A' ' 983' ' ' LEU . 16.2 mtp -62.81 -30.26 71.35 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 122.632 1.206 . . . . 1.0 110.313 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 988' ' ' TRP . . . . . 0.467 ' O ' ' CD1' ' A' ' 988' ' ' TRP . 12.1 t90 -75.64 -35.34 60.48 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 113.976 -1.465 . . . . 1.0 107.926 178.523 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.25 -39.57 74.94 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-O 121.516 0.674 . . . . 1.0 109.902 -179.447 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 990' ' ' VAL . . . . . 0.836 HG13 ' O ' ' A' ' 986' ' ' ALA . 1.4 m -78.28 -3.45 5.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 114.946 -1.025 . . . . 1.0 109.221 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 991' ' ' GLY . . . . . 0.439 ' O ' ' N ' ' A' ' 994' ' ' LYS . . . 82.83 1.44 90.59 Favored Glycine 0 C--N 1.333 0.414 0 CA-C-O 119.404 -0.664 . . . . 1.0 112.397 177.643 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -47.22 -41.92 19.26 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-N 119.046 1.423 . . . . 1.0 110.926 -176.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 993' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -82.19 0.16 42.31 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.861 0.838 . . . . 1.0 111.1 179.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 994' ' ' LYS . . . . . 0.439 ' N ' ' O ' ' A' ' 991' ' ' GLY . 75.5 mmtt -111.68 151.09 29.28 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 113.992 -1.458 . . . . 1.0 108.394 177.485 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 59.6 ttp180 -131.97 127.12 35.63 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.435 -0.58 . . . . 1.0 109.435 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 996' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -94.89 144.35 25.73 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.893 -0.323 . . . . 1.0 110.249 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 997' ' ' ARG . . . . . . . . . . . . . 29.8 mtt180 -91.41 156.93 43.03 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.239 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 998' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo . . . . . 0 C--N 1.309 -1.515 0 C-N-CA 122.733 2.289 . . . . 1.0 112.35 179.944 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 957' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.271 0 N-CA-C 109.235 -1.546 . . . . 1.0 109.235 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -64.83 -37.09 86.47 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.868 -0.333 . . . . 1.0 110.2 179.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 10.5 mp -96.66 129.64 44.02 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.231 0.538 . . . . 1.0 110.256 179.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 960' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -61.75 -35.0 76.84 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.379 -0.828 . . . . 1.0 110.383 -179.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 961' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -98.54 137.41 37.24 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.814 0.34 . . . . 1.0 110.41 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 962' ' ' ARG . . . . . 0.648 ' O ' ' HB2' ' A' ' 963' ' ' ALA . 94.9 mtt-85 -61.44 -41.75 97.68 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.76 -179.42 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 963' ' ' ALA . . . . . 0.648 ' HB2' ' O ' ' A' ' 962' ' ' ARG . . . 165.88 80.16 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.03 0.443 . . . . 1.0 111.541 179.248 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 964' ' ' ILE . . . . . . . . . . . . . 6.4 mt 41.1 70.41 1.61 Allowed Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.98 -0.554 . . . . 1.0 111.177 178.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -81.2 1.68 9.12 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 123.156 2.57 . . . . 1.0 112.628 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 94.5 mt -62.67 -44.61 99.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.266 -0.424 . . . . 1.0 110.927 -179.261 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 967' ' ' TRP . . . . . 0.638 ' O ' HG23 ' A' ' 971' ' ' VAL . 98.8 m95 -56.69 -38.49 72.33 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.948 -0.301 . . . . 1.0 110.313 -179.763 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 87.4 m95 -68.58 -36.6 78.94 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.462 -0.335 . . . . 1.0 111.4 179.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 969' ' ' VAL . . . . . . . . . . . . . 72.6 t -66.3 -44.56 91.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.307 0.575 . . . . 1.0 109.551 178.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 90.4 mt -62.82 -42.19 99.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.04 -0.982 . . . . 1.0 109.597 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 971' ' ' VAL . . . . . 0.638 HG23 ' O ' ' A' ' 967' ' ' TRP . 54.1 t -61.6 -45.33 98.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.51 -0.314 . . . . 1.0 111.14 -179.402 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.78 -41.67 99.19 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 121.377 -0.44 . . . . 1.0 112.331 -178.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 57.2 t -65.82 -47.45 85.63 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.534 0 CA-C-O 121.145 0.497 . . . . 1.0 110.605 -178.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 86.9 mt -62.59 -41.58 99.04 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.556 -0.747 . . . . 1.0 109.365 179.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -66.02 -46.25 82.28 Favored Glycine 0 N--CA 1.452 -0.243 0 N-CA-C 110.421 -1.072 . . . . 1.0 110.421 -179.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -61.0 -37.33 93.69 Favored Glycine 0 N--CA 1.451 -0.339 0 N-CA-C 109.244 -1.542 . . . . 1.0 109.244 179.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 977' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' A' ' 977' ' ' LEU . 30.1 mt -64.34 -42.4 96.29 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.437 -0.505 . . . . 1.0 109.753 178.677 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -62.98 -43.78 97.86 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 119.628 -0.829 . . . . 1.0 110.144 179.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 98.4 mt -61.72 -43.66 98.43 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.17 -0.612 . . . . 1.0 109.906 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 980' ' ' LEU . . . . . 0.408 ' HA ' HD23 ' A' ' 980' ' ' LEU . 31.1 mt -62.82 -41.93 99.51 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.56 -0.456 . . . . 1.0 109.891 179.628 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 981' ' ' THR . . . . . 0.496 HG22 HD12 ' A' ' 985' ' ' LEU . 7.3 m -62.69 -47.32 84.13 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.646 -0.707 . . . . 1.0 111.183 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 92.7 mt -64.26 -43.94 97.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 C-N-CA 120.775 -0.37 . . . . 1.0 111.152 -179.389 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 983' ' ' LEU . . . . . 0.403 ' O ' ' SD ' ' A' ' 987' ' ' MET . 83.0 mt -65.04 -41.76 94.92 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.329 -0.396 . . . . 1.0 111.307 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 984' ' ' VAL . . . . . . . . . . . . . 42.2 t -69.15 -49.86 58.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.208 0.528 . . . . 1.0 110.793 -179.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 985' ' ' LEU . . . . . 0.496 HD12 HG22 ' A' ' 981' ' ' THR . 90.7 mt -63.37 -42.53 98.87 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.47 -0.786 . . . . 1.0 109.44 179.32 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 986' ' ' ALA . . . . . 0.874 ' O ' HG13 ' A' ' 990' ' ' VAL . . . -61.87 -43.97 97.77 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 109.18 -0.674 . . . . 1.0 109.18 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 987' ' ' MET . . . . . 0.403 ' SD ' ' O ' ' A' ' 983' ' ' LEU . 21.9 mtp -62.14 -30.29 70.94 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 114.653 -1.158 . . . . 1.0 109.387 179.028 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 988' ' ' TRP . . . . . . . . . . . . . 1.8 t90 -74.87 -36.12 62.31 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 113.797 -1.547 . . . . 1.0 108.28 178.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.44 -38.92 71.29 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.599 0.714 . . . . 1.0 110.0 -179.374 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 990' ' ' VAL . . . . . 0.874 HG13 ' O ' ' A' ' 986' ' ' ALA . 1.3 m -80.41 -5.33 8.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 114.957 -1.02 . . . . 1.0 109.873 -179.333 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 991' ' ' GLY . . . . . 0.547 ' C ' ' H ' ' A' ' 993' ' ' PHE . . . 85.05 0.38 88.93 Favored Glycine 0 C--N 1.338 0.686 0 CA-C-O 119.466 -0.63 . . . . 1.0 112.546 177.576 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -51.92 -2.98 0.02 OUTLIER 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 118.901 1.35 . . . . 1.0 112.386 -177.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 993' ' ' PHE . . . . . 0.547 ' H ' ' C ' ' A' ' 991' ' ' GLY . 32.8 m-85 -118.75 -6.3 10.61 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 122.511 1.148 . . . . 1.0 110.543 179.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 994' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -93.8 -7.27 43.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 112.693 -2.049 . . . . 1.0 108.514 177.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -68.3 143.29 55.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.643 -0.708 . . . . 1.0 109.512 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 996' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -77.53 148.51 35.23 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.782 -0.367 . . . . 1.0 110.666 -179.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 997' ' ' ARG . . . . . . . . . . . . . 45.3 mtt85 -141.37 153.09 65.59 Favored Pre-proline 0 CA--C 1.534 0.33 0 CA-C-N 116.418 -0.355 . . . . 1.0 110.648 -179.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 998' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo . . . . . 0 N--CA 1.495 1.582 0 C-N-CA 122.211 1.941 . . . . 1.0 112.01 179.854 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 957' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.275 0 N-CA-C 109.792 -1.323 . . . . 1.0 109.792 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -155.65 152.79 29.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.841 0.353 . . . . 1.0 110.51 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 91.5 mt -79.58 141.44 36.58 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.353 -0.385 . . . . 1.0 110.445 179.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 960' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 49.46 -167.95 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.437 -0.347 . . . . 1.0 111.294 179.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 961' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -118.06 140.66 49.44 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.112 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 962' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 -112.36 150.9 30.41 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.217 0.532 . . . . 1.0 111.407 -179.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 963' ' ' ALA . . . . . 0.45 ' HB1' ' HD3' ' A' ' 965' ' ' PRO . . . -141.87 154.27 45.02 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.393 -0.821 . . . . 1.0 110.484 -179.538 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 964' ' ' ILE . . . . . 0.45 ' N ' ' CD ' ' A' ' 965' ' ' PRO . 4.4 pt -142.8 52.75 2.39 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.083 -0.508 . . . . 1.0 110.452 179.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 965' ' ' PRO . . . . . 0.649 ' O ' HG23 ' A' ' 969' ' ' VAL . 47.6 Cg_endo -68.91 -15.7 40.49 Favored 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 122.902 2.401 . . . . 1.0 112.863 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 87.2 mt -63.56 -44.03 98.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 111.953 0.353 . . . . 1.0 111.953 -178.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 967' ' ' TRP . . . . . 0.519 ' O ' HG23 ' A' ' 971' ' ' VAL . 99.4 m95 -69.43 -36.62 76.83 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.643 -0.423 . . . . 1.0 110.569 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 90.9 m95 -70.01 -34.3 73.12 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.614 -0.434 . . . . 1.0 110.426 179.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 969' ' ' VAL . . . . . 0.649 HG23 ' O ' ' A' ' 965' ' ' PRO . 53.9 t -66.94 -45.59 86.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.694 -0.484 . . . . 1.0 109.694 178.31 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 80.7 mt -63.72 -40.83 97.73 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.285 -0.871 . . . . 1.0 109.908 179.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 971' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 967' ' ' TRP . 45.2 t -64.77 -45.18 95.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 C-N-CA 120.694 -0.403 . . . . 1.0 111.309 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -63.05 -43.76 98.32 Favored Glycine 0 CA--C 1.529 0.932 0 CA-C-N 116.365 -0.38 . . . . 1.0 113.49 -177.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 973' ' ' VAL . . . . . 0.439 HG22 ' O ' ' A' ' 969' ' ' VAL . 31.6 m -67.48 -43.12 87.61 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.403 0 CA-C-O 120.897 0.38 . . . . 1.0 110.352 -178.24 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 974' ' ' LEU . . . . . 0.419 HD23 ' HA ' ' A' ' 974' ' ' LEU . 93.3 mt -63.39 -41.24 98.76 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.962 -0.755 . . . . 1.0 108.962 178.385 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -66.21 -46.16 81.49 Favored Glycine 0 C--N 1.329 0.151 0 N-CA-C 110.338 -1.105 . . . . 1.0 110.338 -179.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -59.2 -38.51 93.29 Favored Glycine 0 N--CA 1.446 -0.64 0 N-CA-C 108.647 -1.781 . . . . 1.0 108.647 178.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 977' ' ' LEU . . . . . 0.424 HD23 ' HA ' ' A' ' 977' ' ' LEU . 38.3 mt -63.87 -42.17 97.58 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.135 -0.626 . . . . 1.0 109.518 178.538 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 55.6 tp -62.44 -46.22 89.53 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.713 -0.395 . . . . 1.0 110.408 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 9.5 mp -62.29 -42.49 99.39 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 119.724 -0.79 . . . . 1.0 110.148 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 980' ' ' LEU . . . . . 0.526 ' O ' HG23 ' A' ' 984' ' ' VAL . 86.7 mt -63.04 -40.25 97.17 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.486 -0.486 . . . . 1.0 110.11 179.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 7.1 m -63.86 -46.72 83.73 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.667 -0.697 . . . . 1.0 110.808 -179.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 97.6 mt -63.56 -44.52 98.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.396 -0.365 . . . . 1.0 110.815 -179.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -65.73 -40.18 91.89 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.168 -0.469 . . . . 1.0 111.309 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 984' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 980' ' ' LEU . 45.6 t -67.24 -48.66 77.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.301 0.572 . . . . 1.0 110.337 -179.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 88.2 mt -63.67 -42.29 98.07 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.224 -0.898 . . . . 1.0 109.407 178.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 986' ' ' ALA . . . . . 0.827 ' O ' HG13 ' A' ' 990' ' ' VAL . . . -63.01 -46.93 85.33 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-O 121.384 0.611 . . . . 1.0 110.487 -179.081 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 19.2 mtp -63.18 -32.23 73.57 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 122.601 1.191 . . . . 1.0 109.607 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 988' ' ' TRP . . . . . 0.711 ' HE1' ' NZ ' ' A' ' 994' ' ' LYS . 14.2 t90 -72.99 -36.96 67.16 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 114.202 -1.363 . . . . 1.0 107.554 178.408 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 989' ' ' LYS . . . . . 0.537 ' O ' ' NZ ' ' A' ' 989' ' ' LYS . 0.1 OUTLIER -66.7 -41.18 88.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.224 -0.898 . . . . 1.0 109.816 -179.875 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 990' ' ' VAL . . . . . 0.827 HG13 ' O ' ' A' ' 986' ' ' ALA . 1.3 m -79.15 -3.03 5.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.112 -0.949 . . . . 1.0 109.518 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 991' ' ' GLY . . . . . . . . . . . . . . . 82.97 1.21 90.64 Favored Glycine 0 C--N 1.338 0.668 0 CA-C-O 119.28 -0.733 . . . . 1.0 112.565 177.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -45.87 -42.81 12.99 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 118.953 1.377 . . . . 1.0 111.332 -177.157 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 993' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -83.25 -3.44 57.42 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.684 0.754 . . . . 1.0 111.454 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 994' ' ' LYS . . . . . 0.711 ' NZ ' ' HE1' ' A' ' 988' ' ' TRP . 98.9 mttt -131.12 98.58 4.61 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.453 -1.249 . . . . 1.0 108.723 177.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 83.5 mtp180 -65.28 -40.96 94.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.454 . . . . 1.0 110.642 179.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 996' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -85.49 115.52 23.26 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.129 -0.487 . . . . 1.0 111.482 -179.405 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 997' ' ' ARG . . . . . . . . . . . . . 3.9 ttt180 -74.17 129.97 83.47 Favored Pre-proline 0 CA--C 1.536 0.418 0 CA-C-N 115.871 -0.604 . . . . 1.0 109.406 179.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 998' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_exo . . . . . 0 N--CA 1.49 1.278 0 C-N-CA 121.86 1.707 . . . . 1.0 112.416 -179.898 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 957' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.422 0 N-CA-C 109.742 -1.343 . . . . 1.0 109.742 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -73.45 140.98 46.86 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 110.171 -0.307 . . . . 1.0 110.171 179.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 97.3 mt 56.11 -169.04 0.09 Allowed 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 120.899 -0.32 . . . . 1.0 110.433 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 960' ' ' GLU . . . . . 0.414 ' O ' ' C ' ' A' ' 961' ' ' GLU . 99.9 mt-10 -125.08 137.54 54.2 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.589 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 961' ' ' GLU . . . . . 0.414 ' C ' ' O ' ' A' ' 960' ' ' GLU . 95.7 mt-10 36.45 68.14 0.27 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.998 -0.546 . . . . 1.0 111.293 178.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 962' ' ' ARG . . . . . . . . . . . . . 91.0 mtm180 -63.52 -42.29 98.47 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.995 -0.548 . . . . 1.0 110.02 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 963' ' ' ALA . . . . . . . . . . . . . . . -65.24 140.94 58.78 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.134 -0.485 . . . . 1.0 110.372 179.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 964' ' ' ILE . . . . . . . . . . . . . 1.7 pt -135.76 75.15 56.71 Favored Pre-proline 0 N--CA 1.469 0.484 0 CA-C-O 120.902 0.382 . . . . 1.0 111.268 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 965' ' ' PRO . . . . . 0.501 ' O ' HG23 ' A' ' 969' ' ' VAL . 24.2 Cg_exo -59.92 145.38 98.44 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 123.07 2.513 . . . . 1.0 112.437 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 93.2 mt -64.28 -43.85 97.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.551 -0.749 . . . . 1.0 111.335 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 967' ' ' TRP . . . . . 0.669 ' O ' HG23 ' A' ' 971' ' ' VAL . 98.4 m95 -57.14 -36.59 70.9 Favored 'General case' 0 N--CA 1.46 0.075 0 C-N-CA 120.625 -0.43 . . . . 1.0 110.677 -179.159 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 24.6 m95 -70.16 -35.25 73.88 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.636 -0.256 . . . . 1.0 110.422 179.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 969' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 965' ' ' PRO . 91.2 t -67.03 -45.93 85.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.682 0.753 . . . . 1.0 109.201 178.015 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 57.1 tp -63.0 -42.74 99.93 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.75 -1.114 . . . . 1.0 109.207 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 971' ' ' VAL . . . . . 0.669 HG23 ' O ' ' A' ' 967' ' ' TRP . 55.6 t -62.4 -45.4 98.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.952 0.406 . . . . 1.0 110.756 -179.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -60.35 -42.06 98.7 Favored Glycine 0 CA--C 1.524 0.603 0 CA-C-N 115.928 -0.578 . . . . 1.0 111.891 -179.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 973' ' ' VAL . . . . . . . . . . . . . 63.6 t -66.1 -44.78 91.71 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.458 0 CA-C-O 120.909 0.385 . . . . 1.0 110.662 -178.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 80.9 mt -61.94 -40.49 95.71 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.402 -0.962 . . . . 1.0 108.402 178.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -66.63 -43.82 91.17 Favored Glycine 0 N--CA 1.46 0.261 0 N-CA-C 110.22 -1.152 . . . . 1.0 110.22 -179.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -61.29 -37.09 93.45 Favored Glycine 0 N--CA 1.447 -0.624 0 N-CA-C 109.297 -1.521 . . . . 1.0 109.297 179.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 977' ' ' LEU . . . . . 0.444 ' O ' ' OG1' ' A' ' 981' ' ' THR . 76.2 mt -67.38 -42.53 83.21 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 119.815 -0.754 . . . . 1.0 110.207 178.68 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 70.8 mt -62.04 -44.75 96.03 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.26 -0.576 . . . . 1.0 110.507 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 90.3 mt -63.5 -44.59 93.89 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 119.815 -0.754 . . . . 1.0 110.855 -179.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 980' ' ' LEU . . . . . 0.486 ' O ' HG23 ' A' ' 984' ' ' VAL . 6.2 mp -64.1 -40.76 96.9 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.232 -0.587 . . . . 1.0 110.606 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 981' ' ' THR . . . . . 0.444 ' OG1' ' O ' ' A' ' 977' ' ' LEU . 7.4 m -62.35 -47.8 82.6 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.883 -0.599 . . . . 1.0 110.352 -179.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 96.6 mt -64.56 -44.85 96.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 C-N-CA 120.403 -0.519 . . . . 1.0 111.563 -178.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 7.1 mp -64.74 -41.93 95.57 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 111.801 0.297 . . . . 1.0 111.801 -179.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 984' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 980' ' ' LEU . 51.1 t -65.64 -48.68 81.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-O 121.313 0.578 . . . . 1.0 110.383 -179.136 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 82.5 mt -62.28 -41.9 98.88 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.967 -1.015 . . . . 1.0 109.478 178.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 986' ' ' ALA . . . . . 0.892 ' O ' HG13 ' A' ' 990' ' ' VAL . . . -61.58 -46.34 90.28 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.314 0.578 . . . . 1.0 110.106 -179.447 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 22.7 mtp -63.33 -29.77 71.02 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 122.679 1.228 . . . . 1.0 110.043 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 988' ' ' TRP . . . . . . . . . . . . . 1.6 t90 -76.31 -34.87 59.05 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 113.57 -1.65 . . . . 1.0 107.549 179.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.22 -38.67 68.92 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.113 -0.949 . . . . 1.0 110.14 -179.43 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 990' ' ' VAL . . . . . 0.892 HG13 ' O ' ' A' ' 986' ' ' ALA . 1.5 m -79.37 -0.69 3.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.118 -0.946 . . . . 1.0 109.129 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 991' ' ' GLY . . . . . 0.466 ' O ' ' O ' ' A' ' 994' ' ' LYS . . . 80.8 1.0 89.18 Favored Glycine 0 C--N 1.337 0.585 0 CA-C-O 119.137 -0.813 . . . . 1.0 112.783 177.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -47.04 -40.88 15.71 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 119.263 1.531 . . . . 1.0 111.53 -177.075 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 993' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -81.48 -3.93 54.45 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.981 0.896 . . . . 1.0 111.673 -179.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 994' ' ' LYS . . . . . 0.466 ' O ' ' O ' ' A' ' 991' ' ' GLY . 68.7 mttm -113.1 140.1 48.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 113.53 -1.668 . . . . 1.0 109.153 177.069 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 34.2 ttm180 43.15 51.59 5.58 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.933 0.397 . . . . 1.0 110.597 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 996' ' ' ASN . . . . . 0.404 ' OD1' ' O ' ' A' ' 996' ' ' ASN . 47.2 t-20 -63.3 -40.77 98.28 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.629 -0.428 . . . . 1.0 110.663 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 997' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.18 159.86 32.23 Favored Pre-proline 0 C--N 1.332 -0.171 0 CA-C-N 116.187 -0.46 . . . . 1.0 110.707 -179.404 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 998' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo . . . . . 0 C--N 1.311 -1.415 0 C-N-CA 122.244 1.962 . . . . 1.0 111.562 179.419 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 957' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.203 0 N-CA-C 109.526 -1.43 . . . . 1.0 109.526 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -64.74 -36.55 84.67 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 121.197 -0.201 . . . . 1.0 110.816 -179.917 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 959' ' ' LEU . . . . . 0.404 ' HA ' HD12 ' A' ' 959' ' ' LEU . 34.1 tp -113.55 123.51 50.16 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 110.051 -0.351 . . . . 1.0 110.051 179.572 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 960' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -94.79 124.41 38.81 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.966 0.413 . . . . 1.0 110.411 -179.925 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 961' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -90.58 131.22 36.43 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.144 -0.48 . . . . 1.0 111.56 -178.781 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 962' ' ' ARG . . . . . . . . . . . . . 81.6 mtm-85 -65.02 -40.87 95.5 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.835 -0.62 . . . . 1.0 110.458 179.421 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 963' ' ' ALA . . . . . . . . . . . . . . . -72.94 153.51 40.94 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.873 -0.603 . . . . 1.0 110.854 -179.735 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 964' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -97.71 169.35 8.66 Favored Pre-proline 0 CA--C 1.533 0.29 0 CA-C-N 116.007 -0.542 . . . . 1.0 109.6 179.666 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 965' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -59.26 143.28 99.8 Favored 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 121.763 1.642 . . . . 1.0 112.738 -179.934 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 966' ' ' ILE . . . . . . . . . . . . . 93.9 mt -64.35 -43.91 97.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.456 -0.793 . . . . 1.0 111.425 -179.737 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 967' ' ' TRP . . . . . 0.619 ' O ' HG13 ' A' ' 971' ' ' VAL . 98.0 m95 -56.73 -40.0 74.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.639 -0.71 . . . . 1.0 112.407 -178.317 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 968' ' ' TRP . . . . . . . . . . . . . 38.9 m95 -69.67 -33.89 73.2 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.903 -0.406 . . . . 1.0 109.903 179.501 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 969' ' ' VAL . . . . . 0.631 ' O ' HG23 ' A' ' 973' ' ' VAL . 90.7 t -68.34 -46.04 81.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 C-N-CA 119.925 -0.71 . . . . 1.0 110.032 178.092 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 970' ' ' LEU . . . . . . . . . . . . . 61.5 tp -66.15 -46.35 77.77 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 115.372 -0.831 . . . . 1.0 112.389 -179.165 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 971' ' ' VAL . . . . . 0.619 HG13 ' O ' ' A' ' 967' ' ' TRP . 26.9 m -63.69 -41.56 93.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 119.732 -0.787 . . . . 1.0 110.614 -177.974 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 972' ' ' GLY . . . . . 0.496 ' N ' HG23 ' A' ' 971' ' ' VAL . . . -60.51 -40.45 97.77 Favored Glycine 0 CA--C 1.525 0.657 0 CA-C-N 115.569 -0.741 . . . . 1.0 111.541 -179.459 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 973' ' ' VAL . . . . . 0.631 HG23 ' O ' ' A' ' 969' ' ' VAL . 92.2 t -66.09 -47.08 86.11 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.34 0 CA-C-O 121.007 0.432 . . . . 1.0 110.364 -179.048 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 974' ' ' LEU . . . . . . . . . . . . . 92.9 mt -62.27 -40.38 96.03 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 108.655 -0.869 . . . . 1.0 108.655 179.312 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 975' ' ' GLY . . . . . . . . . . . . . . . -65.36 -45.19 91.66 Favored Glycine 0 CA--C 1.516 0.146 0 N-CA-C 109.866 -1.294 . . . . 1.0 109.866 -179.84 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . -61.03 -38.05 94.89 Favored Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 109.417 -1.473 . . . . 1.0 109.417 178.864 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 977' ' ' LEU . . . . . 0.58 HD13 ' O ' ' A' ' 977' ' ' LEU . 0.2 OUTLIER -66.24 -43.97 85.04 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 120.24 -0.584 . . . . 1.0 109.556 179.51 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 39.1 mt -61.56 -44.77 96.42 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.352 -0.539 . . . . 1.0 110.208 -179.724 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 979' ' ' LEU . . . . . . . . . . . . . 97.1 mt -62.63 -43.47 98.73 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.419 -0.512 . . . . 1.0 110.368 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 980' ' ' LEU . . . . . 0.467 ' O ' HG23 ' A' ' 984' ' ' VAL . 56.0 mt -63.48 -39.88 95.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.111 0.482 . . . . 1.0 109.847 -179.86 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 981' ' ' THR . . . . . . . . . . . . . 5.6 m -64.26 -47.1 80.89 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.592 -0.731 . . . . 1.0 110.248 -179.633 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 982' ' ' ILE . . . . . . . . . . . . . 97.4 mt -64.23 -45.25 96.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.473 -0.331 . . . . 1.0 111.66 -178.608 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 983' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -64.89 -40.75 95.6 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.869 -0.332 . . . . 1.0 110.775 179.575 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 984' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 980' ' ' LEU . 55.5 t -67.2 -48.08 79.57 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.402 0 CA-C-O 121.441 0.638 . . . . 1.0 110.024 179.904 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 985' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 985' ' ' LEU . 84.4 mt -63.55 -42.29 98.38 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.172 -0.922 . . . . 1.0 109.584 179.175 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 986' ' ' ALA . . . . . 0.886 ' O ' HG13 ' A' ' 990' ' ' VAL . . . -62.99 -42.49 99.86 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-O 121.66 0.743 . . . . 1.0 109.34 -179.716 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 987' ' ' MET . . . . . . . . . . . . . 28.9 mtp -63.87 -30.06 71.19 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 114.643 -1.162 . . . . 1.0 109.426 179.677 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 988' ' ' TRP . . . . . . . . . . . . . 1.7 t90 -76.11 -35.86 59.13 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.073 -1.421 . . . . 1.0 108.042 178.734 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 989' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.02 -38.98 76.05 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.494 0.664 . . . . 1.0 109.885 -179.693 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 990' ' ' VAL . . . . . 0.886 HG13 ' O ' ' A' ' 986' ' ' ALA . 1.4 m -81.95 -7.38 10.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.194 -0.912 . . . . 1.0 110.145 -179.175 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 991' ' ' GLY . . . . . 0.541 ' C ' ' H ' ' A' ' 993' ' ' PHE . . . 84.17 2.49 89.3 Favored Glycine 0 C--N 1.337 0.592 0 CA-C-O 119.074 -0.848 . . . . 1.0 112.672 178.613 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 992' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -53.52 -2.67 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 119.68 1.74 . . . . 1.0 112.159 -177.741 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 993' ' ' PHE . . . . . 0.541 ' H ' ' C ' ' A' ' 991' ' ' GLY . 28.3 m-85 -112.25 6.23 18.81 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 123.194 1.473 . . . . 1.0 110.632 179.781 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 994' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -127.11 133.31 50.42 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 111.703 -2.499 . . . . 1.0 112.74 -178.893 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 995' ' ' ARG . . . . . . . . . . . . . 94.2 mtt-85 -67.19 -37.04 83.01 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.866 -1.061 . . . . 1.0 110.359 178.65 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 996' ' ' ASN . . . . . . . . . . . . . 31.2 m120 55.97 34.87 24.49 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.98 -0.555 . . . . 1.0 110.509 -179.464 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 997' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.62 160.05 0.41 Allowed Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.287 -179.895 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 998' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo . . . . . 0 C--N 1.31 -1.493 0 C-N-CA 122.461 2.107 . . . . 1.0 112.052 -179.656 . . . . . . . . 0 0 . 1 stop_ save_